0001727644-20-000084.txt : 20201228 0001727644-20-000084.hdr.sgml : 20201228 20201228153638 ACCESSION NUMBER: 0001727644-20-000084 CONFORMED SUBMISSION TYPE: N-CSRS PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20201031 FILED AS OF DATE: 20201228 DATE AS OF CHANGE: 20201228 EFFECTIVENESS DATE: 20201228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FRANKLIN STRATEGIC SERIES CENTRAL INDEX KEY: 0000872625 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: N-CSRS SEC ACT: 1940 Act SEC FILE NUMBER: 811-06243 FILM NUMBER: 201418288 BUSINESS ADDRESS: STREET 1: ONE FRANKLIN PARKWAY CITY: SAN MATEO STATE: CA ZIP: 94403-1906 BUSINESS PHONE: 650-570-3000 MAIL ADDRESS: STREET 1: ONE FRANKLIN PARKWAY CITY: SAN MATEO STATE: CA ZIP: 94403-1906 FORMER COMPANY: FORMER CONFORMED NAME: FRANKLIN CALIFORNIA 250 GROWTH FUND DATE OF NAME CHANGE: 19911216 FORMER COMPANY: FORMER CONFORMED NAME: FRANKLIN CALIFORNIA 250 GROWTH INDEX FUND DATE OF NAME CHANGE: 19910917 0000872625 S000006878 FRANKLIN GROWTH OPPORTUNITIES FUND C000018615 CLASS A FGRAX C000018617 CLASS C FKACX C000018618 ADVISOR CLASS FRAAX C000018619 CLASS R FKARX C000128860 Class R6 FOPPX 0000872625 S000006879 FRANKLIN STRATEGIC INCOME FUND C000018620 CLASS A FRSTX C000018622 CLASS C FSGCX C000018623 ADVISOR CLASS FKSAX C000018624 CLASS R FKSRX C000128861 Class R6 FGKNX 0000872625 S000006882 FRANKLIN BIOTECHNOLOGY DISCOVERY FUND C000018631 CLASS A FBDIX C000081539 ADVISOR CLASS FTDZX C000128862 Class R6 FRBRX C000141458 Class C FBTDX 0000872625 S000006887 FRANKLIN NATURAL RESOURCES FUND C000018647 CLASS C FNCRX C000018648 CLASS A FRNRX C000018649 ADVISOR CLASS FNRAX C000132949 Class R6 FNCSX 0000872625 S000006888 FRANKLIN SMALL-MID CAP GROWTH FUND C000018650 CLASS A FRSGX C000018652 CLASS C FRSIX C000018653 ADVISOR CLASS FSGAX C000018654 CLASS R FSMRX C000128864 Class R6 FMGGX 0000872625 S000006889 FRANKLIN SMALL CAP GROWTH FUND C000018655 CLASS A FSGRX C000018657 CLASS C FCSGX C000018658 ADVISOR CLASS FSSAX C000018659 CLASS R FSSRX C000128865 Class R6 FSMLX N-CSRS 1 primary-document.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM N-CSRS
 
CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES
 
             Investment Company Act file number 811-06243
 
Franklin Strategic Series

(Exact name of registrant as specified in charter)
 
_One Franklin Parkway, San Mateo, CA 94403-1906
(Address of principal executive offices)    (Zip code)
 
_Craig S. Tyle, One Franklin Parkway, San Mateo, CA 94403-1906
(Name and address of agent for service)
 
Registrant's telephone number, including area code: 650 312-2000
 
Date of fiscal year end: 4/30
 
Date of reporting period: 10/31/20
 
Item 1. Reports to Stockholders.
 
 
 
SEMIANNUAL
REPORT
AND
SHAREHOLDER
LETTER
Franklin
Strategic
Series
October
31,
2020
Sign
up
for
electronic
delivery
at
franklintempleton.com/edelivery
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-Mid
Cap
Growth
Fund
Internet
Delivery
of
Fund
Reports
Unless
You
Request
Paper
Copies
:
Effective
January
1,
2021,
as
permitted
by
the
SEC,
paper
copies
of
the
Fund’s
shareholder
reports
will
no
longer
be
sent
by
mail,
unless
you
specifically
request
them
from
the
Fund
or
your
financial
intermediary.
Instead,
the
reports
will
be
made
available
on
a
website,
and
you
will
be
notified
by
mail
each
time
a
report
is
posted
and
provided
with
a
website
link
to
access
the
report.
If
you
already
elected
to
receive
shareholder
reports
electronically,
you
will
not
be
affected
by
this
change
and
you
need
not
take
any
action.
If
you
have
not
signed
up
for
electronic
delivery,
we
would
encourage
you
to
join
fellow
shareholders
who
have.
You
may
elect
to
receive
shareholder
reports
and
other
communications
electronically
from
the
Fund
by
calling
(800)
632-2301
or
by
contacting
your
financial
intermediary.
You
may
elect
to
continue
to
receive
paper
copies
of
all
your
future
shareholder
reports
free
of
charge
by
contacting
your
financial
intermediary
or,
if
you
invest
directly
with
a
Fund,
calling
(800)
632-2301
to
let
the
Fund
know
of
your
request.
Your
election
to
receive
reports
in
paper
will
apply
to
all
funds
held
in
your
account.
Not
FDIC
Insured
May
Lose
Value
No
Bank
Guarantee
franklintempleton.com
Not
part
of
the
semiannual
report
1
Shareholder
Letter
Dear
Shareholder:
During
the
six
months
ended
October
31,
2020,
first-
and
second-quarter
2020
data
reported
during
the
period
indicated
that
the
U.S.
economy
contracted
in
response
to
the
novel
coronavirus
(COVID-19)
pandemic.
In
the
third
quarter,
the
economy
recovered
substantially
based
on
increased
business
and
residential
investment
and
consumer
spending.
Before
the
reporting
period,
the
U.S.
Federal
Reserve
(Fed),
in
its
efforts
to
support
U.S.
economic
activity,
lowered
the
federal
funds
rate
twice
in
March
2020
and
implemented
broad
quantitative
easing
measures
to
support
credit
markets.
During
the
reporting
period,
the
Fed
held
its
key
rate
unchanged
at
0.25%,
but
continued
quantitative
easing
and
adjusted
its
policy
in
August
2020
to
allow
more
flexibility
to
keep
interest
rates
low,
while
maintaining
a
2%
average
inflation
target.
U.S.
equity
prices
rose
considerably
during
the
period,
helped
by
monetary
and
fiscal
actions
and
optimism
about
the
economy,
which
propelled
valuations
to
all-time
highs
in
September
before
stocks
trended
lower
amid
renewed
investor
concerns.
In
this
environment,
U.S.
stocks,
as
measured
by
the
Standard
&
Poor’s
®
500
Index,
posted
a
strong
positive
total
return
for
the
six-month
period.
We
are
committed
to
our
long-term
perspective
and
disciplined
investment
approach
as
we
conduct
a
rigorous,
fundamental
analysis
of
securities
with
a
regular
emphasis
on
investment
risk
management.
We
believe
active,
professional
investment
management
serves
investors
well.
We
also
recognize
the
important
role
of
financial
advisors
in
today’s
markets
and
encourage
investors
to
continue
to
seek
their
advice.
Amid
changing
markets
and
economic
conditions,
we
are
confident
investors
with
a
well-diversified
portfolio
and
a
patient,
long-term
outlook
should
be
well-positioned
for
the
years
ahead.
In
addition,
Franklin
Strategic
Series’
semiannual
report
includes
more
detail
about
prevailing
conditions
and
a
discussion
about
investment
decisions
during
the
period.
All
securities
markets
fluctuate,
as
do
mutual
fund
share
prices.
We
thank
you
for
investing
with
Franklin
Templeton,
welcome
your
questions
and
comments,
and
look
forward
to
serving
your
future
investment
needs.
Sincerely,
Edward
Perks,
CFA
President
and
Chief
Executive
Officer
Investment
Management
Franklin
Strategic
Series
This
letter
reflects
our
analysis
and
opinions
as
of
October
31,
2020
,
unless
otherwise
indicated.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
fund.
Statements
of
fact
are
from
sources
considered
reliable.
CFA
®
is
a
trademark
owned
by
CFA
Institute.
franklintempleton.com
Semiannual
Report
2
Contents
Semiannual
Report
Economic
and
Market
Overview
3
Franklin
Growth
Opportunities
Fund
4
Franklin
Small
Cap
Growth
Fund
9
Franklin
Small-Mid
Cap
Growth
Fund
14
Financial
Highlights
and
Statements
of
Investments
20
Financial
Statements
50
Notes
to
Financial
Statements
55
Shareholder
Information
79
Visit
franklintempleton.com
for
fund
updates,
to
access
your
account,
or
to
find
helpful
financial
planning
tools.
3
franklintempleton.com
Semiannual
Report
SEMIANNUAL
REPORT
Economic
and
Market
Overview
U.S.
equities,
as
measured
by
the
Standard
&
Poor’s
500
Index
(S&P
500
®
),
advanced
significantly
during
the
six
months
ended
October
31,
2020,
as
markets
continued
to
recover
from
the
disruption
caused
by
the
novel
coronavirus
(COVID-19)
pandemic.
The
nascent
equity
market
recovery
that
began
in
late
March
gained
momentum
during
the
period,
supported
by
monetary
and
fiscal
measures,
which
drove
stocks,
as
measured
by
the
S&P
500,
to
all-time
price
highs
in
early
September,
before
retreating
in
the
period’s
final
months.
The
U.S.
Federal
Reserve
(Fed)
continued
its
efforts
to
support
the
U.S.
economy
by
maintaining
the
federal
funds
target
rate
at
a
range
of
0.00%–0.25%,
expanding
quantitative
easing
measures
aimed
at
ensuring
credit
flows
to
borrowers
and
supporting
credit
markets
with
unlimited
amounts
of
bond
purchasing.
Furthermore,
the
Fed
signaled
that
interest
rates
would
potentially
remain
low,
even
if
inflation
persistently
exceeded
the
Fed’s
2%
target.
Pandemic-related
restrictions
implemented
prior
to
the
period
caused
stiff
economic
headwinds.
The
longest
U.S.
economic
expansion
in
history
ended
in
February
2020,
according
to
the
National
Bureau
of
Economic
Research,
and
the
country
slipped
into
a
deep
recession
with
second-
quarter
2020
gross
domestic
product
(GDP)
posting
a
record
annualized
decline.
Optimism
about
an
economic
rebound
amid
the
government’s
fiscal
and
monetary
stimulus,
along
with
rising
retail
sales
and
resilient
consumer
spending,
drove
a
sharp
equity
rally
throughout
much
of
the
summer.
Improving
economic
activity
led
third-quarter
GDP
to
expand
at
a
record
annualized
pace,
while
declining
jobless
claims
drove
the
unemployment
rate
from
a
pandemic
high
of
14.7%
in
April
to
6.9%
in
October.
1
Optimism
about
treatments
and
potential
vaccines
for
COVID-19
also
supported
stock
prices.
However,
stocks
declined
in
the
period’s
last
two
months
amid
investor
concerns
that
the
economic
recovery
was
stalling,
as
new
job
growth
slowed
and
unemployment
claims
remained
high.
Concerns
that
possible
new
restrictions
due
to
rising
COVID-19
cases
could
disrupt
the
economic
recovery,
the
government’s
lack
of
consensus
about
additional
stimulus
and
uncertainties
surrounding
the
upcoming
presidential
election
also
tempered
investor
enthusiasm.
The
foregoing
information
reflects
our
analysis
and
opinions
as
of
October
31,
2020.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
fund.
Statements
of
fact
are
from
sources
considered
reliable.
1.
Source:
Bureau
of
Labor
Statistics.
4
franklintempleton.com
Semiannual
Report
Franklin
Growth
Opportunities
Fund
This
semiannual
report
for
Franklin
Growth
Opportunities
Fund
covers
the
period
ended
October
31,
2020
.
Your
Fund’s
Goal
and
Main
Investments
The
Fund
seeks
capital
appreciation.
Under
normal
conditions,
the
Fund
invests
predominantly
in
equity
securities
of
companies
demonstrating
accelerating
growth,
increasing
profitability,
or
above-average
growth
or
growth
potential
as
compared
with
the
overall
economy.
Performance
Overview
The
Fund’s
Class
A
shares
posted
a
+24.75%
cumulative
total
return
for
the
six
months
under
review.
In
comparison,
the
Fund’s
narrow
benchmark,
the
Russell
3000
®
Growth
Index,
which
measures
performance
of
those
Russell
3000
®
Index
companies
with
relatively
higher
price-to-book
ratios
and
higher
forecasted
growth
rates,
posted
a
+21.85%
total
return.
1
The
Fund’s
broad
benchmark,
the
Standard
&
Poor’s
500
Index
(S&P
500),
which
tracks
the
broad
U.S.
stock
market,
posted
a
+13.29%
total
return.
1
You
can
find
the
Fund’s
long-term
performance
data
in
the
Performance
Summary
beginning
on
page
6
.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Investment
Strategy
We
use
fundamental,
bottom-up
research
to
seek
companies
meeting
our
criteria
of
growth
potential,
quality
and
valuation.
In
seeking
sustainable
growth
characteristics,
we
look
for
companies
we
believe
can
produce
sustainable
earnings
and
cash
flow
growth,
evaluating
the
long-term
market
opportunity
and
competitive
structure
of
an
industry
to
target
leaders
and
emerging
leaders.
We
define
quality
companies
as
those
with
strong
and
improving
competitive
positions
in
attractive
markets.
We
also
believe
important
attributes
of
quality
are
experienced
and
talented
management
teams
as
well
as
financial
strength
reflected
in
the
capital
structure,
gross
and
operating
margins,
free
cash
flow
generation
and
returns
on
capital
employed.
Our
valuation
analysis
includes
a
range
of
potential
outcomes
based
on
an
assessment
of
multiple
scenarios.
In
assessing
value,
we
consider
whether
security
prices
fully
reflect
the
balance
of
the
sustainable
growth
opportunities
relative
to
business
and
financial
risks.
Manager’s
Discussion
During
the
six
months
under
review,
all
sectors
represented
in
the
Fund’s
portfolio
posted
positive
returns
and
contributed
to
absolute
performance.
Relative
to
the
Russell
3000
®
Growth
Index,
key
contributors
to
the
Fund’s
performance
included
stock
selection
in
the
health
care,
information
technology
(IT)
and
consumer
discretionary
sectors.
Portfolio
Composition
10/31/20
%
of
Total
Net
Assets
Software
20.2%
IT
Services
13.3%
Internet
&
Direct
Marketing
Retail
10.0%
Health
Care
Equipment
&
Supplies
7.0%
Professional
Services
5.1%
Capital
Markets
5.1%
Technology
Hardware,
Storage
&
Peripherals
3.7%
Semiconductors
&
Semiconductor
Equipment
3.6%
Interactive
Media
&
Services
3.4%
Equity
Real
Estate
Investment
Trusts
(REITs)
2.9%
Health
Care
Providers
&
Services
2.6%
Biotechnology
2.2%
Health
Care
Technology
2.1%
Automobiles
1.9%
Pharmaceuticals
1.7%
Industrial
Conglomerates
1.6%
Wireless
Telecommunication
Services
1.3%
Food
Products
1.3%
Chemicals
1.2%
Beverages
1.1%
Commercial
Services
&
Supplies
1.1%
Other
7.4%
Short-Term
Investments
&
Other
Net
Assets
0.2%
1.
Source:
Morningstar.
Frank
Russell
Company
is
the
source
and
owner
of
the
trademarks,
service
marks
and
copyrights
related
to
the
Russell
Indexes.
Russell
®
is
a
trademark
of
Frank
Russell
Company.
The
indexes
are
unmanaged
and
include
reinvestment
of
any
income
or
distributions.
They
do
not
reflect
any
fees,
expenses
or
sales
charges.
One
cannot
invest
directly
in
an
index,
and
an
index
is
not
representative
of
the
Fund’s
portfolio.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
The
dollar
value,
number
of
shares
or
principal
amount,
and
names
of
all
portfolio
holdings
are
listed
in
the
Fund’s
Statement
of
Investments
(SOI).
The
SOI
begins
on
page
25
.
Franklin
Growth
Opportunities
Fund
5
franklintempleton.com
Semiannual
Report
Within
health
care,
the
development
of
a
novel
coronavirus
(COVID-19)
vaccine
candidate
bolstered
the
shares
of
vaccine
developer
Novavax.
In
the
IT
sector,
communications
software
and
cloud-based
platform
company
Twilio,
cloud-based
software
solutions
firm
Bill.com
Holdings
and
cloud
computing
solutions
provider
ServiceNow
were
leading
contributors
to
relative
returns.
The
pandemic
has
increased
demand
for
Twilio’s
digital
communication
services
from
telehealth,
online
education,
remote
customer
care
and
food
delivery
companies,
among
others.
Bill.com
Holdings
generated
solid
subscription
and
transaction
growth,
and
its
subscription
base
continued
to
improve
as
the
pandemic
accelerated
adoption
of
its
platform.
Other
notable
relative
contributors
included
positions
in
at-
home
fitness
platform
Peloton
Interactive,
which
saw
a
surge
in
demand
for
its
at-home,
connected
fitness
products.
In
contrast,
key
detractors
from
the
Fund’s
relative
performance
included
overweightings
in
the
real
estate
and
financials
sectors.
Within
real
estate,
SBA
Communications,
a
real
estate
investment
trust
that
provides
wireless
communication
towers,
underperformed
the
index,
and
an
overweighting
hurt
relative
results.
We
believe
the
company
is
an
attractive
long-term
investment
opportunity
given
the
tower
industry’s
strong
barriers
to
entry
and
increasing
mobile
carrier
spending
on
5G
network
upgrades.
In
the
financials
sector,
our
position
in
investment
decision
support
tools
provider
MSCI
hindered
relative
results.
Other
key
relative
detractors
included
our
positions
in
electronic
products
company
Apple,
electronic
vehicle
manufacturer
Tesla
and
payment
solutions
company
Mastercard.
An
underweighting
in
the
strong-performing
shares
of
Apple
detracted
from
relative
performance.
Apple
has
seen
strong
demand
for
its
products
as
consumers
required
more
devices
at
home
to
support
streaming
needs
for
work,
school
and
entertainment
during
the
pandemic.
An
underweighting
in
Tesla
hurt
relative
results,
as
the
company
generated
strong
vehicle
sales.
Mastercard
experienced
weakness
in
cross-border
transactions.
We
believe
the
positive
trend
in
digital
payments
will
continue
and
likely
be
strengthened
by
the
pandemic.
Thank
you
for
your
continued
participation
in
Franklin
Growth
Opportunities
Fund.
We
look
forward
to
serving
your
future
investment
needs.
Grant
Bowers
Sara
Araghi,
CFA
Portfolio
Management
Team
The
foregoing
information
reflects
our
analysis,
opinions
and
portfolio
holdings
as
of
October
31,
2020
,
the
end
of
the
reporting
period.
The
way
we
implement
our
main
investment
strategies
and
the
resulting
portfolio
holdings
may
change
depending
on
factors
such
as
market
and
economic
conditions.
These
opinions
may
not
be
relied
upon
as
investment
advice
or
an
offer
for
a
particular
security.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
the
Fund.
Statements
of
fact
are
from
sources
considered
reliable,
but
the
investment
manager
makes
no
representation
or
warranty
as
to
their
completeness
or
accuracy.
Although
historical
performance
is
no
guarantee
of
future
results,
these
insights
may
help
you
understand
our
investment
management
philosophy.
Top
10
Holdings
10/31/20
Company
Industry
,
Country
%
of
Total
Net
Assets
a
a
Amazon.com,
Inc.
9.1%
Internet
&
Direct
Marketing
Retail,
United
States
Microsoft
Corp.
5.5%
Software,
United
States
Apple,
Inc.
3.7%
Technology
Hardware,
Storage
&
Peripherals,
United
States
Mastercard
,
Inc.
3.7%
IT
Services,
United
States
ServiceNow
,
Inc.
3.2%
Software,
United
States
Visa,
Inc.
3.0%
IT
Services,
United
States
SBA
Communications
Corp.
2.5%
Equity
Real
Estate
Investment
Trusts
(REITs),
United
States
CoStar
Group,
Inc.
2.4%
Professional
Services,
United
States
Alphabet,
Inc.
2.3%
Interactive
Media
&
Services,
United
States
Veeva
Systems,
Inc.
2.1%
Health
Care
Technology,
United
States
Performance
Summary
as
of
October
31,
2020
Franklin
Growth
Opportunities
Fund
6
franklintempleton.com
Semiannual
Report
The
performance
table
does
not
reflect
any
taxes
that
a
shareholder
would
pay
on
Fund
dividends,
capital
gain
distributions,
if
any,
or
any
realized
gains
on
the
sale
of
Fund
shares.
Total
return
reflects
reinvestment
of
the
Fund’s
dividends
and
capital
gain
distributions,
if
any,
and
any
unrealized
gains
or
losses.
Your
dividend
income
will
vary
depending
on
dividends
or
interest
paid
by
securities
in
the
Fund’s
portfolio,
adjusted
for
operating
expenses
of
each
class.
Capital
gain
distributions
are
net
profits
realized
from
the
sale
of
portfolio
securities.
Performance
as
of
10/31/20
Cumulative
total
return
excludes
sales
charges.
Average
annual
total
return
includes
maximum
sales
charges.
Sales
charges
will
vary
depending
on
the
size
of
the
investment
and
the
class
of
share
purchased.
The
maximum
is
5.50%
and
the
minimum
is
0%.
Class
A
:
5.50%
maximum
initial
sales
charge;
Advisor
Class:
no
sales
charges.
For
other
share
classes,
visit
franklintempleton.com.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Share
Class
Cumulative
Total
Return
1
Average
Annual
Total
Return
2
A
3
6-Month
+24.75%
+17.93%
1-Year
+34.89%
+27.47%
5-Year
+106.65%
+14.32%
10-Year
+289.94%
+13.93%
Advisor
6-Month
+24.91%
+24.91%
1-Year
+35.24%
+35.24%
5-Year
+109.21%
+15.91%
10-Year
+300.49%
+14.88%
See
page
7
for
Performance
Summary
footnotes.
Franklin
Growth
Opportunities
Fund
Performance
Summary
7
franklintempleton.com
Semiannual
Report
Each
class
of
shares
is
available
to
certain
eligible
investors
and
has
different
annual
fees
and
expenses,
as
described
in
the
prospectus.
All
investments
involve
risks,
including
possible
loss
of
principal.
Growth
stock
prices
reflect
projections
of
future
earnings
or
revenues,
and
can,
therefore,
fall
dramatically
if
the
company
fails
to
meet
those
projections.
To
the
extent
the
Fund
focuses
on
particular
countries,
regions,
industries,
sectors
or
types
of
invest-
ment
from
time
to
time,
it
may
be
subject
to
greater
risks
of
adverse
developments
in
such
areas
of
focus
than
a
fund
that
invests
in
a
wider
variety
of
countries,
regions,
industries,
sectors
or
investments.
Smaller,
midsized
and
relatively
new
or
unseasoned
companies
can
be
particularly
sensitive
to
changing
economic
conditions,
and
their
prospects
for
growth
are
less
certain
than
those
of
larger,
more
established
companies.
Historically,
these
securities
have
experienced
more
price
volatility
than
larger-company
stocks,
especially
over
the
short
term.
Unexpected
events
and
their
aftermaths,
such
as
the
spread
of
deadly
diseases;
natural,
environmental
or
man-made
disasters;
financial,
political
or
social
disruptions;
terrorism
and
war;
and
other
tragedies
or
catastrophes,
can
cause
investor
fear
and
panic,
which
can
adversely
affect
the
economies
of
many
companies,
sectors,
nations,
regions
and
the
market
in
general,
in
ways
that
cannot
necessarily
be
foreseen.
The
Fund’s
prospectus
also
includes
a
description
of
the
main
investment
risks.
1.
Cumulative
total
return
represents
the
change
in
value
of
an
investment
over
the
periods
indicated.
2.
Average
annual
total
return
represents
the
average
annual
change
in
value
of
an
investment
over
the
periods
indicated.
Return
for
less
than
one
year,
if
any,
has
not
been
annualized.
3.
Prior
to
9/10/18,
these
shares
were
offered
at
a
higher
initial
sales
charge
of
5.75%,
thus
actual
returns
(with
sales
charges)
would
have
differed.
Average
annual
total
returns
(with
sales
charges)
have
been
restated
to
reflect
the
current
maximum
initial
sales
charge
of
5.50%.
4.
Figures
are
as
stated
in
the
Fund’s
current
prospectus
and
may
differ
from
the
expense
ratios
disclosed
in
the
Your
Fund’s
Expenses
and
Financial
Highlights
sections
in
this
report.
In
periods
of
market
volatility,
assets
may
decline
significantly,
causing
total
annual
Fund
operating
expenses
to
become
higher
than
the
figures
shown.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
Total
Annual
Operating
Expenses
4
Share
Class
A
0.95%
Advisor
0.70%
Your
Fund’s
Expenses
Franklin
Growth
Opportunities
Fund
8
franklintempleton.com
Semiannual
Report
As
a
Fund
shareholder,
you
can
incur
two
types
of
costs:
(1)
transaction
costs,
including
sales
charges
(loads)
on
Fund
purchases
and
redemptions;
and
(2)
ongoing
Fund
costs,
including
management
fees,
distribution
and
service
(12b-1)
fees,
and
other
Fund
expenses.
All
mutual
funds
have
ongoing
costs,
sometimes
referred
to
as
operating
expenses.
The
table
below
shows
ongoing
costs
of
investing
in
the
Fund
and
can
help
you
understand
these
costs
and
compare
them
with
those
of
other
mutual
funds.
The
table
assumes
a
$1,000
investment
held
for
the
six
months
indicated.
Actual
Fund
Expenses
The
table
below
provides
information
about
actual
account
values
and
actual
expenses
in
the
columns
under
the
heading
“Actual.”
In
these
columns
the
Fund’s
actual
return,
which
includes
the
effect
of
Fund
expenses,
is
used
to
calculate
the
“Ending
Account
Value”
for
each
class
of
shares.
You
can
estimate
the
expenses
you
paid
during
the
period
by
following
these
steps
(
of
course,
your
account
value
and
expenses
will
differ
from
those
in
this
illustration
):
Divide
your
account
value
by
$1,000
(
if
your
account
had
an
$8,600
value,
then
$8,600
÷
$1,000
=
8.6).
Then
multiply
the
result
by
the
number
in
the
row
for
your
class
of
shares
under
the
headings
“Actual”
and
“Expenses
Paid
During
Period”
(
if
Actual
Expenses
Paid
During
Period
were
$7.50,
then
8.6
x
$7.50
=
$64.
50
).
In
this
illustration,
the
actual
expenses
paid
this
period
are
$64.50.
Hypothetical
Example
for
Comparison
with
Other
Funds
Under
the
heading
“Hypothetical”
in
the
table,
information
is
provided
about
hypothetical
account
values
and
hypothetical
expenses
based
on
the
Fund’s
actual
expense
ratio
and
an
assumed
rate
of
return
of
5%
per
year
before
expenses,
which
is
not
the
Fund’s
actual
return.
This
information
may
not
be
used
to
estimate
the
actual
ending
account
balance
or
expenses
you
paid
for
the
period,
but
it
can
help
you
compare
ongoing
costs
of
investing
in
the
Fund
with
those
of
other
funds.
To
do
so,
compare
this
5%
hypothetical
example
for
the
class
of
shares
you
hold
with
the
5%
hypothetical
examples
that
appear
in
the
shareholder
reports
of
other
funds.
Please
note
that
expenses
shown
in
the
table
are
meant
to
highlight
ongoing
costs
and
do
not
reflect
any
transactional
costs.
Therefore,
information
under
the
heading
“Hypothetical”
is
useful
in
comparing
ongoing
costs
only,
and
will
not
help
you
compare
total
costs
of
owning
different
funds.
In
addition,
if
transactional
costs
were
included,
your
total
costs
would
have
been
higher.
1.
Expenses
are
equal
to
the
annualized
expense
ratio
for
the
six-month
period
as
indicated
above—in
the
far
right
column—multiplied
by
the
simple
average
account
value
over
the
period
indicated,
and
then
multiplied
by
184/365
to
reflect
the
one-half
year
period.
2.
Reflects
expenses
after
fee
waivers
and
expense
reimbursements.
Does
not
include
acquired
fund
fees
and
expenses.
Actual
(actual
return
after
expenses)
Hypothetical
(5%
annual
return
before
expenses)
Share
Class
Beginning
Account
Value
5/1/20
Ending
Account
Value
10/31/20
Expenses
Paid
During
Period
5/1/20–10/31/20
1,2
Ending
Account
Value
10/31/20
Expenses
Paid
During
Period
5/1/20–10/31/20
1,2
a
Net
Annualized
Expense
Ratio
2
A
$1,000
$1,247.48
$5.18
$1,020.60
$4.66
0.92%
C
$1,000
$1,242.65
$9.41
$1,016.82
$8.46
1.67%
R
$1,000
$1,245.98
$6.55
$1,019.37
$5.89
1.16%
R6
$1,000
$1,249.72
$3.26
$1,022.31
$2.93
0.58%
Advisor
$1,000
$1,249.14
$3.77
$1,021.85
$3.39
0.67%
9
franklintempleton.com
Semiannual
Report
Franklin
Small
Cap
Growth
Fund
This
annual
report
for
Franklin
Small
Cap
Growth
Fund
covers
the
period
ended
October
31,
2020
.
Your
Fund’s
Goal
and
Main
Investments
The
Fund
seeks
long-term
capital
growth.
Under
normal
market
conditions,
the
Fund
invests
at
least
80%
of
its
net
assets
in
the
equity
securities
of
small-cap
companies.
For
this
Fund,
small-cap
companies
are
those
with
market
capitalizations
not
exceeding
$1.5
billion
or
the
highest
market
capitalization
in
the
Russell
2000
®
Index,
whichever
is
greater,
at
the
time
of
purchase.
1
Performance
Overview
The
Fund’s
Class
A
shares
posted
a
+32.63%
cumulative
total
return
for
the
six
months
under
review.
In
comparison,
the
Russell
2000
®
Growth
Index,
which
measures
performance
of
small-cap
companies
with
relatively
higher
price-to-book
ratios
and
higher
forecasted
growth
rates,
posted
a
+22.72%
total
return.
2
The
Standard
&
Poor’s
500
Index
(S&P
500),
which
tracks
the
broad
U.S.
stock
market,
posted
a
+13.29%
total
return.
2
You
can
find
the
Fund’s
long-term
performance
data
in
the
Performance
Summary
beginning
on
page
11
.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Investment
Strategy
We
use
fundamental,
bottom-up
research
to
seek
companies
meeting
our
criteria
of
growth
potential,
quality
and
valuation.
In
seeking
sustainable
growth
characteristics,
we
look
for
companies
we
believe
can
produce
sustainable
earnings
and
cash
flow
growth,
evaluating
the
long-term
market
opportunity
and
competitive
structure
of
an
industry.
We
define
quality
companies
as
those
with
strong
and
improving
competitive
positions
in
attractive
markets.
We
also
believe
important
attributes
of
quality
are
experienced
and
talented
management
teams
as
well
as
financial
strength
reflected
in
the
capital
structure,
gross
and
operating
margins,
free
cash
flow
generation
and
returns
on
capital
employed.
Our
valuation
analysis
includes
a
range
of
potential
outcomes
based
on
an
assessment
of
multiple
scenarios.
In
assessing
value,
we
consider
whether
security
prices
fully
reflect
the
balance
of
the
sustainable
growth
opportunities
relative
to
business
and
financial
risks.
Portfolio
Composition
10/31/20
%
of
Total
Net
Assets
Biotechnology
11.1%
Software
9.5%
Specialty
Retail
6.8%
Health
Care
Equipment
&
Supplies
6.4%
IT
Services
5.8%
Aerospace
&
Defense
5.4%
Semiconductors
&
Semiconductor
Equipment
5.4%
Hotels,
Restaurants
&
Leisure
5.1%
Health
Care
Technology
3.1%
Pharmaceuticals
3.0%
Capital
Markets
3.0%
Banks
2.4%
Commercial
Services
&
Supplies
2.3%
Airlines
2.3%
Household
Durables
2.2%
Food
Products
2.1%
Trading
Companies
&
Distributors
2.1%
Construction
&
Engineering
2.0%
Communications
Equipment
1.9%
Automobiles
1.7%
Health
Care
Providers
&
Services
1.7%
Food
&
Staples
Retailing
1.5%
Equity
Real
Estate
Investment
Trusts
(REITs)
1.3%
Textiles,
Apparel
&
Luxury
Goods
1.3%
Life
Sciences
Tools
&
Services
1.3%
Machinery
1.2%
Chemicals
1.2%
Insurance
1.2%
Other
3.4%
Short-Term
Investments
&
Other
Net
Assets
2.3%
1.
The
Russell
2000
Index
is
market
capitalization
weighted
and
measures
performance
of
the
2,000
smallest
companies
in
the
Russell
3000
Index,
which
represent
a
small
amount
of
the
total
market
capitalization
of
the
Russell
3000
Index.
2.
Source:
Morningstar.
The
indexes
are
unmanaged
and
include
reinvestment
of
any
income
or
distributions.
They
do
not
reflect
any
fees,
expenses
or
sales
charges.
One
cannot
invest
directly
in
an
index,
and
an
index
is
not
representative
of
the
Fund’s
portfolio.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
The
dollar
value,
number
of
shares
or
principal
amount,
and
names
of
all
portfolio
holdings
are
listed
in
the
Fund’s
Statement
of
Investments
(SOI).
The
SOI
begins
on
page
35
.
Franklin
Small
Cap
Growth
Fund
10
franklintempleton.com
Semiannual
Report
Manager’s
Discussion
During
the
six
months
under
review,
all
sectors
represented
in
the
Fund’s
portfolio
posted
positive
returns
and
contributed
to
absolute
performance.
Relative
to
the
Russell
2000
®
Growth
Index,
key
contributors
to
the
Fund’s
performance
included
stock
selection
in
the
information
technology
(IT)
sector,
stock
selection
and
an
overweighting
in
the
consumer
discretionary
sector,
and
stock
selection
and
an
underweighting
in
the
health
care
sector.
In
the
IT
sector,
our
off-benchmark
investment
in
web-
building
platform
Wix.com
(not
held
at
period-end)
bolstered
relative
results.
The
company’s
web
services
have
become
increasingly
important
as
more
people
access
the
cloud
to
work
remotely
during
the
novel
coronavirus
(COVID-19)
pandemic.
Our
off-benchmark
positions
in
cloud-based
internet
security
platform
Zscaler
(not
held
at
period-end)
and
web
performance
and
security
company
Cloudflare
also
aided
relative
results.
Within
consumer
discretionary,
our
off-benchmark
positions
in
online
sports-betting
company
DraftKings
and
at-home
fitness
platform
Peloton
Interactive
(not
held
at
period-end)
helped
relative
results.
DraftKings’
share
price
reached
record
highs
amid
positive
news
flow
that
included
the
announcement
of
an
exclusive
agreement
with
a
major
sports
media
company
to
provide
fantasy
sports
information.
Peloton
Interactive
benefited
from
a
surge
in
demand
for
its
at-home,
connected
fitness
products.
In
the
health
care
sector,
our
positions
in
digital
health
care
provider
Livongo
Health
(not
held
at
period-end)
and
vaccine
developer
Novavax
supported
relative
performance.
Livongo
Health’s
share
price
surged
as
COVID-19
social
distancing
measures
drove
up
demand
for
the
company’s
remote
monitoring
services.
The
share
price
of
Novavax
rose
as
the
company
developed
a
COVID-19
vaccine
candidate.
In
contrast,
key
detractors
from
the
Fund’s
relative
performance
included
stock
selection
in
the
industrials
sector.
Within
the
sector,
our
position
in
Mercury
Systems,
a
technology
company
that
serves
the
aerospace
and
defense
industry,
hurt
relative
results.
Other
key
relative
detractors
included
satellite
communications
company
ViaSat
(not
part
of
the
index),
biopharmaceutical
firms
Reata
Pharmaceuticals
and
Global
Blood
Therapeutics,
medical
device
manufacturer
Integer
Holdings,
and
education
services
provider
Grand
Canyon
Education
(not
part
of
the
index).
ViaSat
was
negatively
affected
by
emerging
competition
and
the
economic
impact
associated
with
the
pandemic.
Reata
Pharmaceuticals
was
advised
by
the
U.S.
Food
and
Drug
Administration
to
conduct
a
second
trial
of
its
treatment
for
a
rare
neurological
disorder,
causing
a
delay
in
the
launch
of
the
therapy,
which
hurt
its
stock.
Shares
of
Global
Blood
Therapeutics
were
pressured
by
investor
concerns
about
the
sales
growth
trajectory
of
its
sickle
cell
disease
treatment.
Thank
you
for
your
continued
participation
in
Franklin
Small
Cap
Growth
Fund.
We
look
forward
to
serving
your
future
investment
needs.
Michael
P.
McCarthy,
CFA
Bradley
T.
Carris,
CFA
Portfolio
Management
Team
The
foregoing
information
reflects
our
analysis,
opinions
and
portfolio
holdings
as
of
October
31,
2020
,
the
end
of
the
reporting
period.
The
way
we
implement
our
main
investment
strategies
and
the
resulting
portfolio
holdings
may
change
depending
on
factors
such
as
market
and
economic
conditions.
These
opinions
may
not
be
relied
upon
as
investment
advice
or
an
offer
for
a
particular
security.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
the
Fund.
Statements
of
fact
are
from
sources
considered
reliable,
but
the
investment
manager
makes
no
representation
or
warranty
as
to
their
completeness
or
accuracy.
Although
historical
performance
is
no
guarantee
of
future
results,
these
insights
may
help
you
understand
our
investment
management
philosophy.
Top
10
Holdings
10/31/20
Company
Industry
,
Country
%
of
Total
Net
Assets
a
a
Lattice
Semiconductor
Corp.
1.9%
Semiconductors
&
Semiconductor
Equipment,
United
States
Proterra,
Inc.
1.7%
Automobiles,
United
States
Cubic
Corp.
1.7%
Aerospace
&
Defense,
United
States
Allegiant
Travel
Co.
1.7%
Airlines,
United
States
DraftKings,
Inc.
1.6%
Hotels,
Restaurants
&
Leisure,
United
States
Iovance
Biotherapeutics,
Inc.
1.5%
Biotechnology,
United
States
Arcosa,
Inc.
1.3%
Construction
&
Engineering,
United
States
Penumbra,
Inc.
1.3%
Health
Care
Equipment
&
Supplies,
United
States
Rexford
Industrial
Realty,
Inc.
1.3%
Equity
Real
Estate
Investment
Trusts
(REITs),
United
States
LiveRamp
Holdings,
Inc.
1.3%
IT
Services,
United
States
Performance
Summary
as
of
October
31,
2020
Franklin
Small
Cap
Growth
Fund
11
franklintempleton.com
Semiannual
Report
The
performance
table
does
not
reflect
any
taxes
that
a
shareholder
would
pay
on
Fund
dividends,
capital
gain
distributions,
if
any,
or
any
realized
gains
on
the
sale
of
Fund
shares.
Total
return
reflects
reinvestment
of
the
Fund’s
dividends
and
capital
gain
distributions,
if
any,
and
any
unrealized
gains
or
losses.
Your
dividend
income
will
vary
depending
on
dividends
or
interest
paid
by
securities
in
the
Fund’s
portfolio,
adjusted
for
operating
expenses
of
each
class.
Capital
gain
distributions
are
net
profits
realized
from
the
sale
of
portfolio
securities.
Performance
as
of
10/31/20
1
Cumulative
total
return
excludes
sales
charges.
Average
annual
total
return
includes
maximum
sales
charges.
Sales
charges
will
vary
depending
on
the
size
of
the
investment
and
the
class
of
share
purchased.
The
maximum
is
5.50%
and
the
minimum
is
0%.
Class
A
:
5.50%
maximum
initial
sales
charge;
Advisor
Class:
no
sales
charges.
For
other
share
classes,
visit
franklintempleton.com.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Share
Class
Cumulative
Total
Return
2
Average
Annual
Total
Return
3
A
4
6-Month
+32.63%
+25.31%
1-Year
+24.27%
+17.44%
5-Year
+100.89%
+13.68%
10-Year
+267.85%
+13.27%
Advisor
6-Month
+32.75%
+32.75%
1-Year
+24.58%
+24.58%
5-Year
+103.29%
+15.25%
10-Year
+277.83%
+14.22%
See
page
12
for
Performance
Summary
footnotes.
Franklin
Small
Cap
Growth
Fund
Performance
Summary
12
franklintempleton.com
Semiannual
Report
Each
class
of
shares
is
available
to
certain
eligible
investors
and
has
different
annual
fees
and
expenses,
as
described
in
the
prospectus.
All
investments
involve
risks,
including
possible
loss
of
principal.
Smaller,
midsized
and
relatively
new
or
unseasoned
companies
can
be
particularly
sensitive
to
changing
economic
conditions,
and
their
prospects
for
growth
are
less
certain
than
those
of
larger,
more
established
companies.
Historically,
these
securities
have
experienced
more
price
volatility
than
larger-company
stocks,
especially
over
the
short
term.
Growth
stock
prices
reflect
projections
of
future
earnings
or
revenues,
and
can,
therefore,
fall
dramatically
if
the
company
fails
to
meet
those
projections.
To
the
extent
the
Fund
focuses
on
particular
countries,
regions,
industries,
sectors
or
types
of
investment
from
time
to
time,
it
may
be
subject
to
greater
risks
of
adverse
developments
in
such
areas
of
focus
than
a
fund
that
invests
in
a
wider
variety
of
countries,
regions,
industries,
sectors
or
investments.
From
time
to
time,
the
trading
market
for
a
particular
security
or
type
of
secu-
rity
in
which
the
Fund
invests
may
become
less
liquid
or
even
illiquid.
Unexpected
events
and
their
aftermaths,
such
as
the
spread
of
deadly
diseases;
natural,
environmental
or
man-made
disasters;
financial,
political
or
social
disruptions;
terrorism
and
war;
and
other
tragedies
or
catastrophes,
can
cause
investor
fear
and
panic,
which
can
adversely
affect
the
economies
of
many
companies,
sectors,
nations,
regions
and
the
market
in
general,
in
ways
that
cannot
necessarily
be
foreseen.
The
Fund’s
prospectus
also
includes
a
description
of
the
main
investment
risks.
1.
The
Fund
has
a
fee
waiver
associated
with
any
investment
it
makes
in
a
Franklin
Templeton
money
fund
and/or
other
Franklin
Templeton
fund,
contractually
guaranteed
through
8/31/21.
Fund
investment
results
reflect
the
fee
waiver;
without
this
waiver,
the
results
would
have
been
lower.
2.
Cumulative
total
return
represents
the
change
in
value
of
an
investment
over
the
periods
indicated.
3.
Average
annual
total
return
represents
the
average
annual
change
in
value
of
an
investment
over
the
periods
indicated.
Return
for
less
than
one
year,
if
any,
has
not
been
annualized.
4.
Prior
to
9/10/18,
these
shares
were
offered
at
a
higher
initial
sales
charge
of
5.75%,
thus
actual
returns
(with
sales
charges)
would
have
differed.
Average
annual
total
returns
(with
sales
charges)
have
been
restated
to
reflect
the
current
maximum
initial
sales
charge
of
5.50%.
5.
Figures
are
as
stated
in
the
Fund’s
current
prospectus
and
may
differ
from
the
expense
ratios
disclosed
in
the
Your
Fund’s
Expenses
and
Financial
Highlights
sections
in
this
report.
In
periods
of
market
volatility,
assets
may
decline
significantly,
causing
total
annual
Fund
operating
expenses
to
become
higher
than
the
figures
shown.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
Total
Annual
Operating
Expenses
5
Share
Class
With
Fee
Waiver
Without
Fee
Waiver
A
1.07%
1.08%
Advisor
0.82%
0.83%
Your
Fund’s
Expenses
Franklin
Small
Cap
Growth
Fund
13
franklintempleton.com
Semiannual
Report
As
a
Fund
shareholder,
you
can
incur
two
types
of
costs:
(1)
transaction
costs,
including
sales
charges
(loads)
on
Fund
purchases
and
redemptions;
and
(2)
ongoing
Fund
costs,
including
management
fees,
distribution
and
service
(12b-1)
fees,
and
other
Fund
expenses.
All
mutual
funds
have
ongoing
costs,
sometimes
referred
to
as
operating
expenses.
The
table
below
shows
ongoing
costs
of
investing
in
the
Fund
and
can
help
you
understand
these
costs
and
compare
them
with
those
of
other
mutual
funds.
The
table
assumes
a
$1,000
investment
held
for
the
six
months
indicated.
Actual
Fund
Expenses
The
table
below
provides
information
about
actual
account
values
and
actual
expenses
in
the
columns
under
the
heading
“Actual.”
In
these
columns
the
Fund’s
actual
return,
which
includes
the
effect
of
Fund
expenses,
is
used
to
calculate
the
“Ending
Account
Value”
for
each
class
of
shares.
You
can
estimate
the
expenses
you
paid
during
the
period
by
following
these
steps
(
of
course,
your
account
value
and
expenses
will
differ
from
those
in
this
illustration
):
Divide
your
account
value
by
$1,000
(
if
your
account
had
an
$8,600
value,
then
$8,600
÷
$1,000
=
8.6).
Then
multiply
the
result
by
the
number
in
the
row
for
your
class
of
shares
under
the
headings
“Actual”
and
“Expenses
Paid
During
Period”
(
if
Actual
Expenses
Paid
During
Period
were
$7.50,
then
8.6
x
$7.50
=
$64.
50
).
In
this
illustration,
the
actual
expenses
paid
this
period
are
$64.50.
Hypothetical
Example
for
Comparison
with
Other
Funds
Under
the
heading
“Hypothetical”
in
the
table,
information
is
provided
about
hypothetical
account
values
and
hypothetical
expenses
based
on
the
Fund’s
actual
expense
ratio
and
an
assumed
rate
of
return
of
5%
per
year
before
expenses,
which
is
not
the
Fund’s
actual
return.
This
information
may
not
be
used
to
estimate
the
actual
ending
account
balance
or
expenses
you
paid
for
the
period,
but
it
can
help
you
compare
ongoing
costs
of
investing
in
the
Fund
with
those
of
other
funds.
To
do
so,
compare
this
5%
hypothetical
example
for
the
class
of
shares
you
hold
with
the
5%
hypothetical
examples
that
appear
in
the
shareholder
reports
of
other
funds.
Please
note
that
expenses
shown
in
the
table
are
meant
to
highlight
ongoing
costs
and
do
not
reflect
any
transactional
costs.
Therefore,
information
under
the
heading
“Hypothetical”
is
useful
in
comparing
ongoing
costs
only,
and
will
not
help
you
compare
total
costs
of
owning
different
funds.
In
addition,
if
transactional
costs
were
included,
your
total
costs
would
have
been
higher.
1.
Expenses
are
equal
to
the
annualized
expense
ratio
for
the
six-month
period
as
indicated
above—in
the
far
right
column—multiplied
by
the
simple
average
account
value
over
the
period
indicated,
and
then
multiplied
by
184/365
to
reflect
the
one-half
year
period.
2.
Reflects
expenses
after
fee
waivers
and
expense
reimbursements.
Does
not
include
acquired
fund
fees
and
expenses.
Actual
(actual
return
after
expenses)
Hypothetical
(5%
annual
return
before
expenses)
Share
Class
Beginning
Account
Value
5/1/20
Ending
Account
Value
10/31/20
Expenses
Paid
During
Period
5/1/20–10/31/20
1,2
Ending
Account
Value
10/31/20
Expenses
Paid
During
Period
5/1/20–10/31/20
1,2
a
Net
Annualized
Expense
Ratio
2
A
$1,000
$1,326.26
$6.19
$1,019.89
$5.37
1.06%
C
$1,000
$1,321.31
$10.56
$1,016.11
$9.17
1.81%
R
$1,000
$1,324.23
$7.65
$1,018.63
$6.64
1.31%
R6
$1,000
$1,328.90
$3.76
$1,021.98
$3.26
0.64%
Advisor
$1,000
$1,327.54
$4.73
$1,021.14
$4.11
0.81%
14
franklintempleton.com
Semiannual
Report
Franklin
Small-Mid
Cap
Growth
Fund
This
semiannual
report
for
Franklin
Small-Mid
Cap
Growth
Fund
covers
the
period
ended
October
31,
2020
.
Your
Fund’s
Goal
and
Main
Investments
The
Fund
seeks
long-term
capital
growth.
Under
normal
market
conditions,
the
Fund
invests
at
least
80%
of
its
net
assets
in
the
equity
securities
of
small-cap
and
mid-
cap
companies.
For
this
Fund,
small-cap
companies
are
companies
within
the
market
capitalization
range
of
companies
in
the
Russell
2500
Index
at
the
time
of
purchase,
and
mid-cap
companies
are
companies
within
the
market
capitalization
range
of
companies
in
the
Russell
Midcap
®
Index
at
the
time
of
purchase.
1
Performance
Overview
The
Fund’s
Class
A
shares
posted
a
+35.37%
cumulative
total
return
for
the
six
months
under
review.
In
comparison,
the
Russell
Midcap
®
Growth
Index,
which
measures
performance
of
those
Russell
Midcap
®
Index
companies
with
relatively
higher
price-to-book
ratios
and
higher
forecasted
growth
rates,
posted
a
+23.33%
total
return.
2
Also
in
comparison,
the
Standard
&
Poor’s
500
Index
(S&P
500),
which
tracks
the
broad
U.S.
stock
market,
posted
a
+13.29%
total
return.
2
You
can
find
the
Fund’s
long-term
performance
data
in
the
Performance
Summary
beginning
on
page
17
.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Investment
Strategy
We
use
fundamental,
bottom-up
research
to
seek
companies
meeting
our
criteria
of
growth
potential,
quality
and
valuation.
In
seeking
sustainable
growth
characteristics,
we
look
for
companies
we
believe
can
produce
sustainable
earnings
and
cash
flow
growth,
evaluating
the
long-term
market
opportunity
and
competitive
structure
of
an
industry
to
target
leaders
and
emerging
leaders.
We
define
quality
companies
as
those
with
strong
and
improving
competitive
positions
in
attractive
markets.
We
also
believe
important
attributes
of
quality
are
experienced
and
talented
management
teams
as
well
as
financial
strength
reflected
in
the
capital
structure,
gross
and
operating
margins,
free
cash
flow
generation
and
returns
on
capital
employed.
Our
valuation
analysis
includes
a
range
of
potential
outcomes
based
on
an
assessment
of
multiple
scenarios.
In
assessing
value,
we
consider
whether
security
prices
fully
reflect
the
balance
of
the
sustainable
growth
opportunities
relative
to
business
and
financial
risks.
Portfolio
Composition
10/31/20
%
of
Total
Net
Assets
Software
15.9%
IT
Services
11.4%
Semiconductors
&
Semiconductor
Equipment
6.6%
Health
Care
Equipment
&
Supplies
6.3%
Hotels,
Restaurants
&
Leisure
5.1%
Professional
Services
4.9%
Capital
Markets
4.4%
Biotechnology
3.8%
Life
Sciences
Tools
&
Services
3.6%
Entertainment
2.8%
Specialty
Retail
2.7%
Health
Care
Technology
2.6%
Electronic
Equipment,
Instruments
&
Components
2.4%
Interactive
Media
&
Services
2.4%
Machinery
2.2%
Health
Care
Providers
&
Services
2.1%
Pharmaceuticals
2.0%
Equity
Real
Estate
Investment
Trusts
(REITs)
1.9%
Internet
&
Direct
Marketing
Retail
1.4%
Road
&
Rail
1.3%
Containers
&
Packaging
1.2%
Textiles,
Apparel
&
Luxury
Goods
1.1%
Aerospace
&
Defense
1.1%
Commercial
Services
&
Supplies
1.1%
Other
6.7%
Short-Term
Investments
&
Other
Net
Assets
3.0%
1.
The
Russell
2500
Index
is
market
capitalization
weighted
and
measures
performance
of
the
2,500
smallest
companies
in
the
Russell
3000
Index,
which
represent
a
modest
amount
of
the
Russell
3000
Index’s
total
market
capitalization.
The
Russell
Midcap
Index
is
market
capitalization
weighted
and
measures
performance
of
the
smallest
companies
in
the
Russell
1000
Index,
which
represent
a
modest
amount
of
the
Russell
1000
Index’s
total
market
capitalization.
2.
Source:
Morningstar.
The
indexes
are
unmanaged
and
include
reinvestment
of
any
income
or
distributions.
They
do
not
reflect
any
fees,
expenses
or
sales
charges.
One
cannot
invest
directly
in
an
index,
and
an
index
is
not
representative
of
the
Fund’s
portfolio.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
The
dollar
value,
number
of
shares
or
principal
amount,
and
names
of
all
portfolio
holdings
are
listed
in
the
Fund’s
Statement
of
Investments
(SOI).
The
SOI
begins
on
page
45
.
Franklin
Small-Mid
Cap
Growth
Fund
15
franklintempleton.com
Semiannual
Report
Manager’s
Discussion
During
the
six
months
under
review,
all
sectors
represented
in
the
Fund’s
portfolio
posted
positive
returns
and
contributed
to
absolute
performance.
Relative
to
the
Russell
Midcap
®
Growth
Index,
key
contributors
included
stock
selection
and
a
slight
underweighting
in
the
information
technology
(IT)
sector,
stock
selection
and
an
overweighting
in
the
consumer
discretionary
sector,
and
stock
selection
in
the
communication
services
sector.
Within
IT,
our
investments
in
communications
software
and
cloud-based
platform
company
Twilio
and
cloud-
based
electronic
signature
solutions
provider
DocuSign
were
leading
contributors
to
relative
returns.
The
novel
coronavirus
(COVID-19)
pandemic
has
increased
demand
for
Twilio’s
digital
communication
services
from
telehealth,
online
education,
remote
customer
care
and
food
delivery
companies,
among
others.
DocuSign’s
stock
benefited
from
subscription
revenue
and
billings
growth.
While
the
company
is
benefiting
from
work-from-home
trends
in
the
near
term,
we
believe
that
in
the
long
term
the
company
can
potentially
benefit
from
the
large
market
for
the
digital
transformation
of
documents
that
require
e-signatures.
In
the
consumer
discretionary
sector,
our
positions
in
online
sports-betting
company
DraftKings
(not
part
of
the
index)
and
at-home
fitness
platform
Peloton
Interactive
aided
relative
results.
DraftKings’
share
price
reached
record
highs
amid
positive
news
flow
that
included
the
announcement
of
an
exclusive
agreement
with
a
major
sports
media
company
to
provide
fantasy
sports
information.
Peloton
Interactive
benefited
from
a
surge
in
demand
for
the
company’s
at-
home,
connected
fitness
products.
In
the
communication
services
sector,
photo-sharing
website
Pinterest
supported
relative
results.
In
contrast,
key
detractors
from
the
Fund’s
relative
performance
included
stock
selection
in
the
industrials
and
real
estate
sectors.
In
the
industrials
sector,
Mercury
Systems,
a
technology
company
that
serves
the
aerospace
and
defense
industry,
faced
pandemic-related
supply-side
challenges
and
concerns
about
the
federal
government’s
defense
budget.
However,
we
believe
the
company
is
well-positioned
as
a
leading
independent
and
trusted
supplier
of
microelectronics
to
the
aerospace
and
defense
industry.
In
the
real
estate
sector,
SBA
Communications,
a
real
estate
investment
trust
that
provides
wireless
communication
towers,
underperformed
the
index,
and
an
overweighting
hurt
relative
results.
We
believe
the
company
is
an
attractive
long-term
investment
opportunity
given
the
tower
industry’s
strong
barriers
to
entry
and
increasing
mobile
carrier
spending
on
5G
network
upgrades.
Other
key
relative
detractors
included
our
positions
in
biopharmaceutical
firm
Reata
Pharmaceuticals
and
technology
solutions
and
payment
processing
services
company
Jack
Henry
&
Associates.
Reata
Pharmaceuticals
was
advised
by
the
U.S.
Food
and
Drug
Administration
to
conduct
a
second
trial
of
its
treatment
for
a
rare
neurological
disorder,
causing
a
delay
in
the
launch
of
the
therapy,
which
hurt
its
stock.
Thank
you
for
your
continued
participation
in
Franklin
Small-
Mid
Cap
Growth
Fund.
We
look
forward
to
serving
your
future
investment
needs.
John
P.
Scandalios
Michael
P.
McCarthy,
CFA
Portfolio
Management
Team
The
foregoing
information
reflects
our
analysis,
opinions
and
portfolio
holdings
as
of
October
31,
2020
,
the
end
of
the
reporting
period.
The
way
we
implement
our
main
investment
strategies
and
the
resulting
portfolio
holdings
may
change
depending
on
factors
such
as
market
and
economic
conditions.
These
opinions
may
not
be
relied
upon
as
investment
advice
or
an
offer
for
a
particular
security.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
the
Fund.
Statements
of
Top
10
Holdings
10/31/20
Company
Industry
,
Country
%
of
Total
Net
Assets
a
a
Twilio
,
Inc.
2.8%
IT
Services,
United
States
Synopsys,
Inc.
2.3%
Software,
United
States
DocuSign,
Inc.
2.2%
Software,
United
States
CoStar
Group,
Inc.
2.2%
Professional
Services,
United
States
IDEXX
Laboratories,
Inc.
2.0%
Health
Care
Equipment
&
Supplies,
United
States
Mettler
-Toledo
International,
Inc.
1.8%
Life
Sciences
Tools
&
Services,
United
States
Verisk
Analytics,
Inc.
1.8%
Professional
Services,
United
States
DraftKings
,
Inc.
1.7%
Hotels,
Restaurants
&
Leisure,
United
States
Black
Knight,
Inc.
1.7%
IT
Services,
United
States
Veeva
Systems,
Inc.
1.7%
Health
Care
Technology,
United
States
Franklin
Small-Mid
Cap
Growth
Fund
16
franklintempleton.com
Semiannual
Report
fact
are
from
sources
considered
reliable,
but
the
investment
manager
makes
no
representation
or
warranty
as
to
their
completeness
or
accuracy.
Although
historical
performance
is
no
guarantee
of
future
results,
these
insights
may
help
you
understand
our
investment
management
philosophy.
Performance
Summary
as
of
October
31,
2020
Franklin
Small-Mid
Cap
Growth
Fund
17
franklintempleton.com
Semiannual
Report
The
performance
table
does
not
reflect
any
taxes
that
a
shareholder
would
pay
on
Fund
dividends,
capital
gain
distributions,
if
any,
or
any
realized
gains
on
the
sale
of
Fund
shares.
Total
return
reflects
reinvestment
of
the
Fund’s
dividends
and
capital
gain
distributions,
if
any,
and
any
unrealized
gains
or
losses.
Your
dividend
income
will
vary
depending
on
dividends
or
interest
paid
by
securities
in
the
Fund’s
portfolio,
adjusted
for
operating
expenses
of
each
class.
Capital
gain
distributions
are
net
profits
realized
from
the
sale
of
portfolio
securities.
Performance
as
of
10/31/20
1
Cumulative
total
return
excludes
sales
charges.
Average
annual
total
return
includes
maximum
sales
charges.
Sales
charges
will
vary
depending
on
the
size
of
the
investment
and
the
class
of
share
purchased.
The
maximum
is
5.50%
and
the
minimum
is
0%.
Class
A
:
5.50%
maximum
initial
sales
charge;
Advisor
Class:
no
sales
charges.
For
other
share
classes,
visit
franklintempleton.com.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Share
Class
Cumulative
Total
Return
2
Average
Annual
Total
Return
3
A
4
6-Month
+35.37%
+27.92%
1-Year
+41.47%
+33.70%
5-Year
+106.42%
+14.30%
10-Year
+263.25%
+13.13%
Advisor
6-Month
+35.51%
+35.51%
1-Year
+41.89%
+41.89%
5-Year
+109.01%
+15.89%
10-Year
+272.40%
+14.05%
See
page
18
for
Performance
Summary
footnotes.
Franklin
Small-Mid
Cap
Growth
Fund
Performance
Summary
18
franklintempleton.com
Semiannual
Report
Each
class
of
shares
is
available
to
certain
eligible
investors
and
has
different
annual
fees
and
expenses,
as
described
in
the
prospectus.
All
investments
involve
risks,
including
possible
loss
of
principal.
Growth
stock
prices
reflect
projections
of
future
earnings
or
revenues,
and
can,
therefore,
fall
dramatically
if
the
company
fails
to
meet
those
projections.
Smaller,
midsized
and
relatively
new
or
unseasoned
companies
can
be
particularly
sensitive
to
changing
economic
conditions,
and
their
prospects
for
growth
are
less
certain
than
those
of
larger,
more
established
companies.
Historically,
these
securities
have
experienced
more
price
volatility
than
larger-company
stocks,
especially
over
the
short
term.
To
the
extent
the
Fund
focuses
on
particular
countries,
regions,
industries,
sectors
or
types
of
investment
from
time
to
time,
it
may
be
subject
to
greater
risks
of
adverse
developments
in
such
areas
of
focus
than
a
fund
that
invests
in
a
wider
variety
of
countries,
regions,
industries,
sectors
or
investments.
From
time
to
time,
the
trading
market
for
a
particular
security
or
type
of
security
in
which
the
Fund
invests
may
become
less
liquid
or
even
illiquid.
Unexpected
events
and
their
aftermaths,
such
as
the
spread
of
deadly
diseases;
natural,
environmental
or
man-made
disasters;
financial,
political
or
social
disruptions;
terrorism
and
war;
and
other
tragedies
or
catastrophes,
can
cause
investor
fear
and
panic,
which
can
adversely
affect
the
economies
of
many
companies,
sectors,
nations,
regions
and
the
market
in
general,
in
ways
that
cannot
necessarily
be
foreseen.
The
Fund’s
prospectus
also
includes
a
description
of
the
main
investment
risks.
1.
The
Fund
has
a
fee
waiver
associated
with
any
investment
it
makes
in
a
Franklin
Templeton
money
fund
and/or
other
Franklin
Templeton
fund,
contractually
guaranteed
through
8/31/21.
Fund
investment
results
reflect
the
fee
waiver;
without
this
waiver,
the
results
would
have
been
lower.
2.
Cumulative
total
return
represents
the
change
in
value
of
an
investment
over
the
periods
indicated.
3.
Average
annual
total
return
represents
the
average
annual
change
in
value
of
an
investment
over
the
periods
indicated.
Return
for
less
than
one
year,
if
any,
has
not
been
annualized.
4.
Prior
to
9/10/18,
these
shares
were
offered
at
a
higher
initial
sales
charge
of
5.75%,
thus
actual
returns
(with
sales
charges)
would
have
differed.
Average
annual
total
returns
(with
sales
charges)
have
been
restated
to
reflect
the
current
maximum
initial
sales
charge
of
5.50%.
5.
Figures
are
as
stated
in
the
Fund’s
current
prospectus
and
may
differ
from
the
expense
ratios
disclosed
in
the
Your
Fund’s
Expenses
and
Financial
Highlights
sections
in
this
report.
In
periods
of
market
volatility,
assets
may
decline
significantly,
causing
total
annual
Fund
operating
expenses
to
become
higher
than
the
figures
shown.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
Total
Annual
Operating
Expenses
5
Share
Class
With
Fee
Waiver
Without
Fee
Waiver
A
0.88%
0.89%
Advisor
0.63%
0.64%
Your
Fund’s
Expenses
Franklin
Small-Mid
Cap
Growth
Fund
19
franklintempleton.com
Semiannual
Report
As
a
Fund
shareholder,
you
can
incur
two
types
of
costs:
(1)
transaction
costs,
including
sales
charges
(loads)
on
Fund
purchases
and
redemptions;
and
(2)
ongoing
Fund
costs,
including
management
fees,
distribution
and
service
(12b-1)
fees,
and
other
Fund
expenses.
All
mutual
funds
have
ongoing
costs,
sometimes
referred
to
as
operating
expenses.
The
table
below
shows
ongoing
costs
of
investing
in
the
Fund
and
can
help
you
understand
these
costs
and
compare
them
with
those
of
other
mutual
funds.
The
table
assumes
a
$1,000
investment
held
for
the
six
months
indicated.
Actual
Fund
Expenses
The
table
below
provides
information
about
actual
account
values
and
actual
expenses
in
the
columns
under
the
heading
“Actual.”
In
these
columns
the
Fund’s
actual
return,
which
includes
the
effect
of
Fund
expenses,
is
used
to
calculate
the
“Ending
Account
Value”
for
each
class
of
shares.
You
can
estimate
the
expenses
you
paid
during
the
period
by
following
these
steps
(
of
course,
your
account
value
and
expenses
will
differ
from
those
in
this
illustration
):
Divide
your
account
value
by
$1,000
(
if
your
account
had
an
$8,600
value,
then
$8,600
÷
$1,000
=
8.6).
Then
multiply
the
result
by
the
number
in
the
row
for
your
class
of
shares
under
the
headings
“Actual”
and
“Expenses
Paid
During
Period”
(
if
Actual
Expenses
Paid
During
Period
were
$7.50,
then
8.6
x
$7.50
=
$64.
50
).
In
this
illustration,
the
actual
expenses
paid
this
period
are
$64.50.
Hypothetical
Example
for
Comparison
with
Other
Funds
Under
the
heading
“Hypothetical”
in
the
table,
information
is
provided
about
hypothetical
account
values
and
hypothetical
expenses
based
on
the
Fund’s
actual
expense
ratio
and
an
assumed
rate
of
return
of
5%
per
year
before
expenses,
which
is
not
the
Fund’s
actual
return.
This
information
may
not
be
used
to
estimate
the
actual
ending
account
balance
or
expenses
you
paid
for
the
period,
but
it
can
help
you
compare
ongoing
costs
of
investing
in
the
Fund
with
those
of
other
funds.
To
do
so,
compare
this
5%
hypothetical
example
for
the
class
of
shares
you
hold
with
the
5%
hypothetical
examples
that
appear
in
the
shareholder
reports
of
other
funds.
Please
note
that
expenses
shown
in
the
table
are
meant
to
highlight
ongoing
costs
and
do
not
reflect
any
transactional
costs.
Therefore,
information
under
the
heading
“Hypothetical”
is
useful
in
comparing
ongoing
costs
only,
and
will
not
help
you
compare
total
costs
of
owning
different
funds.
In
addition,
if
transactional
costs
were
included,
your
total
costs
would
have
been
higher.
1.
Expenses
are
equal
to
the
annualized
expense
ratio
for
the
six-month
period
as
indicated
above—in
the
far
right
column—multiplied
by
the
simple
average
account
value
over
the
period
indicated,
and
then
multiplied
by
184/365
to
reflect
the
one-half
year
period.
2.
Reflects
expenses
after
fee
waivers
and
expense
reimbursements.
Does
not
include
acquired
fund
fees
and
expenses.
Actual
(actual
return
after
expenses)
Hypothetical
(5%
annual
return
before
expenses)
Share
Class
Beginning
Account
Value
5/1/20
Ending
Account
Value
10/31/20
Expenses
Paid
During
Period
5/1/20–10/31/20
1,2
Ending
Account
Value
10/31/20
Expenses
Paid
During
Period
5/1/20–10/31/20
1,2
a
Net
Annualized
Expense
Ratio
2
A
$1,000
$1,353.66
$5.10
$1,020.87
$4.38
0.86%
C
$1,000
$1,348.79
$9.52
$1,017.10
$8.18
1.61%
R
$1,000
$1,352.20
$6.51
$1,019.67
$5.59
1.10%
R6
$1,000
$1,355.87
$2.91
$1,022.74
$2.49
0.49%
Advisor
$1,000
$1,355.10
$3.62
$1,022.13
$3.11
0.61%
Franklin
Strategic
Series
Financial
Highlights
Franklin
Growth
Opportunities
Fund
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
20
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
A
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$39.60
$39.57
$38.58
$34.81
$30.40
$33.13
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..............
(0.12)
(0.14)
(0.13)
(0.10)
(0.09)
(0.19)
Net
realized
and
unrealized
gains
(losses)
9.92
3.59
5.29
7.03
5.14
(1.88)
Total
from
investment
operations
........
9.80
3.45
5.16
6.93
5.05
(2.07)
Less
distributions
from:
Net
realized
gains
.................
(3.42)
(4.17)
(3.16)
(0.64)
(0.66)
Net
asset
value,
end
of
period
..........
$49.40
$39.60
$39.57
$38.58
$34.81
$30.40
Total
return
c
.......................
24.75%
8.90%
15.91%
20.43%
16.88%
(6.36)%
Ratios
to
average
net
assets
d
Expenses
before
waiver
and
payments
by
affiliates
..........................
0.92%
0.95%
0.94%
1.02%
1.05%
1.11%
Expenses
net
of
waiver
and
payments
by
affiliates
..........................
0.92%
e,f
0.95%
e,f
0.94%
e,f
0.99%
e
0.97%
e
1.10%
Net
investment
(loss)
................
(0.51)%
(0.35)%
(0.32)%
(0.27)%
(0.30)%
(0.58)%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$3,538,712
$2,883,392
$2,819,007
$2,428,175
$2,272,831
$548,871
Portfolio
turnover
rate
................
10.54%
19.47%
24.21%
22.68%
47.75%
25.56%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable,
and
is
not
annualized
for
periods
less
than
one
year.
d
Ratios
are
annualized
for
periods
less
than
one
year.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Growth
Opportunities
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
21
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
C
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$31.61
$32.47
$32.67
$30.12
$26.59
$29.27
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..............
(0.24)
(0.35)
(0.35)
(0.33)
(0.29)
(0.37)
Net
realized
and
unrealized
gains
(losses)
7.91
2.91
4.32
6.04
4.46
(1.65)
Total
from
investment
operations
........
7.67
2.56
3.97
5.71
4.17
(2.02)
Less
distributions
from:
Net
realized
gains
.................
(3.42)
(4.17)
(3.16)
(0.64)
(0.66)
Net
asset
value,
end
of
period
..........
$39.28
$31.61
$32.47
$32.67
$30.12
$26.59
Total
return
c
.......................
24.26%
8.10%
15.10%
19.53%
15.98%
(7.03)%
Ratios
to
average
net
assets
d
Expenses
before
waiver
and
payments
by
affiliates
..........................
1.67%
1.70%
1.69%
1.77%
1.80%
1.85%
Expenses
net
of
waiver
and
payments
by
affiliates
..........................
1.67%
e,f
1.70%
e,f
1.69%
e,f
1.74%
e
1.72%
e
1.84%
Net
investment
(loss)
................
(1.25)%
(1.10)%
(1.07)%
(1.02)%
(1.05)%
(1.32)%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$247,145
$216,757
$244,574
$400,295
$390,123
$137,882
Portfolio
turnover
rate
................
10.54%
19.47%
24.21%
22.68%
47.75%
25.56%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable,
and
is
not
annualized
for
periods
less
than
one
year.
d
Ratios
are
annualized
for
periods
less
than
one
year.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Growth
Opportunities
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
22
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
R
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
..
$37.32
$37.57
$36.93
$33.52
$29.37
$32.10
Income
from
investment
operations
a
:
Net
investment
(loss)
b
...........
(0.17)
(0.22)
(0.21)
(0.18)
(0.17)
(0.26)
Net
realized
and
unrealized
gains
(losses)
....................
9.35
3.39
5.02
6.75
4.96
(1.81)
Total
from
investment
operations
.....
9.18
3.17
4.81
6.57
4.79
(2.07)
Less
distributions
from:
Net
realized
gains
..............
(3.42)
(4.17)
(3.16)
(0.64)
(0.66)
Net
asset
value,
end
of
period
.......
$46.50
$37.32
$37.57
$36.93
$33.52
$29.37
Total
return
c
....................
24.60%
8.64%
15.66%
20.14%
16.62%
(6.60)%
Ratios
to
average
net
assets
d
Expenses
before
waiver
and
payments
by
affiliates
...................
1.16%
1.20%
1.19%
1.27%
1.30%
1.35%
Expenses
net
of
waiver
and
payments
by
affiliates
...................
1.16%
e,f
1.20%
e,f
1.19%
e,f
1.24%
e
1.22%
e
1.34%
Net
investment
(loss)
.............
(0.75)%
(0.60)%
(0.57)%
(0.52)%
(0.55)%
(0.82)%
Supplemental
data
Net
assets,
end
of
period
(000’s)
.....
$36,270
$31,060
$37,105
$36,582
$50,429
$39,786
Portfolio
turnover
rate
.............
10.54%
19.47%
24.21%
22.68%
47.75%
25.56%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
is
not
annualized
for
periods
less
than
one
year.
d
Ratios
are
annualized
for
periods
less
than
one
year.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Growth
Opportunities
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
23
In
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
R6
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$43.97
$43.42
$41.78
$37.30
$32.39
$35.09
Income
from
investment
operations
a
:
Net
investment
income
(loss)
b
........
(0.04)
0.01
0.01
0.07
0.05
(0.05)
Net
realized
and
unrealized
gains
(losses)
11.02
3.96
5.80
7.57
5.50
(1.99)
Total
from
investment
operations
........
10.98
3.97
5.81
7.64
5.55
(2.04)
Less
distributions
from:
Net
realized
gains
.................
(3.42)
(4.17)
(3.16)
(0.64)
(0.66)
Net
asset
value,
end
of
period
..........
$54.95
$43.97
$43.42
$41.78
$37.30
$32.39
Total
return
c
.......................
24.97%
9.34%
16.26%
20.98%
17.42%
(5.94)%
Ratios
to
average
net
assets
d
Expenses
before
waiver
and
payments
by
affiliates
..........................
0.58%
0.59%
0.59%
0.58%
0.59%
0.67%
Expenses
net
of
waiver
and
payments
by
affiliates
..........................
0.58%
e,f
0.59%
e,f
0.58%
e
0.55%
e
0.51%
e
0.66%
Net
investment
income
(loss)
..........
(0.17)%
0.01%
0.04%
0.17%
0.16%
(0.14)%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$464,198
$383,208
$418,174
$369,688
$291,825
$235,620
Portfolio
turnover
rate
................
10.54%
19.47%
24.21%
22.68%
47.75%
25.56%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
is
not
annualized
for
periods
less
than
one
year.
d
Ratios
are
annualized
for
periods
less
than
one
year.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Growth
Opportunities
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
24
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Advisor
Class
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$43.31
$42.87
$41.34
$37.02
$32.20
$34.96
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..............
(0.07)
(0.04)
(0.03)
(0.01)
(0.02)
(0.11)
Net
realized
and
unrealized
gains
(losses)
10.86
3.90
5.73
7.49
5.48
(1.99)
Total
from
investment
operations
........
10.79
3.86
5.70
7.48
5.46
(2.10)
Less
distributions
from:
Net
realized
gains
.................
(3.42)
(4.17)
(3.16)
(0.64)
(0.66)
Net
asset
value,
end
of
period
..........
$54.10
$43.31
$42.87
$41.34
$37.02
$32.20
Total
return
c
.......................
24.91%
9.20%
16.16%
20.71%
17.21%
(6.11)%
Ratios
to
average
net
assets
d
Expenses
before
waiver
and
payments
by
affiliates
..........................
0.67%
0.70%
0.69%
0.77%
0.80%
0.85%
Expenses
net
of
waiver
and
payments
by
affiliates
..........................
0.67%
e,f
0.70%
e,f
0.69%
e,f
0.74%
e
0.72%
e
0.84%
Net
investment
(loss)
................
(0.25)%
(0.10)%
(0.07)%
(0.02)%
(0.05)%
(0.32)%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$536,204
$467,727
$506,964
$583,509
$537,193
$256,377
Portfolio
turnover
rate
................
10.54%
19.47%
24.21%
22.68%
47.75%
25.56%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
is
not
annualized
for
periods
less
than
one
year.
d
Ratios
are
annualized
for
periods
less
than
one
year.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Statement
of
Investments
(unaudited),
October
31,
2020
Franklin
Growth
Opportunities
Fund
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
25
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
95.2%
Auto
Components
0.4%
Aptiv
plc
............................................
United
States
193,320
$
18,653,447
Automobiles
0.7%
a
Tesla,
Inc.
...........................................
United
States
82,105
31,860,024
a
Beverages
1.1%
Constellation
Brands,
Inc.,
A
.............................
United
States
161,588
26,699,185
a
Monster
Beverage
Corp.
................................
United
States
338,906
25,950,033
52,649,218
Biotechnology
2.2%
a
Deciphera
Pharmaceuticals,
Inc.
..........................
United
States
172,150
9,996,751
a
Heron
Therapeutics,
Inc.
................................
United
States
2,189,291
35,707,336
a
Novavax
,
Inc.
........................................
United
States
414,775
33,476,490
a
PTC
Therapeutics,
Inc.
.................................
United
States
477,403
24,915,663
104,096,240
Capital
Markets
5.1%
a
Dragoneer
Growth
Opportunities
Corp.
.....................
United
States
1,112,700
13,018,590
Intercontinental
Exchange,
Inc.
...........................
United
States
502,148
47,402,771
MarketAxess
Holdings,
Inc.
..............................
United
States
87,543
47,172,546
MSCI,
Inc.
...........................................
United
States
213,698
74,760,108
S&P
Global,
Inc.
......................................
United
States
200,171
64,601,187
246,955,202
Chemicals
1.2%
Ecolab,
Inc.
..........................................
United
States
126,472
23,218,995
Linde
plc
............................................
United
Kingdom
160,557
35,377,129
58,596,124
Commercial
Services
&
Supplies
0.8%
a,b,c
Legalzoom.com,
Inc.
...................................
United
States
1,673,284
22,391,396
Republic
Services,
Inc.
.................................
United
States
158,671
13,990,022
36,381,418
Entertainment
0.5%
Walt
Disney
Co.
(The)
..................................
United
States
195,942
23,757,968
Equity
Real
Estate
Investment
Trusts
(REITs)
2.9%
American
Tower
Corp.
..................................
United
States
92,470
21,235,735
SBA
Communications
Corp.
.............................
United
States
415,242
120,573,820
141,809,555
Food
Products
1.3%
a
Freshpet
,
Inc.
........................................
United
States
212,775
24,362,737
Lamb
Weston
Holdings,
Inc.
.............................
United
States
258,057
16,373,717
a
Nomad
Foods
Ltd.
....................................
United
Kingdom
874,298
21,201,727
61,938,181
Health
Care
Equipment
&
Supplies
7.0%
Danaher
Corp.
.......................................
United
States
282,961
64,950,868
a
Edwards
Lifesciences
Corp.
.............................
United
States
599,068
42,947,185
a
IDEXX
Laboratories,
Inc.
................................
United
States
100,841
42,839,274
a
Intuitive
Surgical,
Inc.
..................................
United
States
54,140
36,115,711
a
Nevro
Corp.
.........................................
United
States
345,493
51,551,010
West
Pharmaceutical
Services,
Inc.
........................
United
States
363,072
98,780,999
337,185,047
Health
Care
Providers
&
Services
2.1%
a
Guardant
Health,
Inc.
..................................
United
States
170,094
18,142,226
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Growth
Opportunities
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
26
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Health
Care
Providers
&
Services
(continued)
UnitedHealth
Group,
Inc.
................................
United
States
280,118
$
85,475,207
103,617,433
Health
Care
Technology
2.1%
a
Veeva
Systems,
Inc.,
A
.................................
United
States
375,387
101,373,259
a
Hotels,
Restaurants
&
Leisure
1.0%
a
Chipotle
Mexican
Grill,
Inc.
..............................
United
States
39,938
47,984,708
a
Industrial
Conglomerates
1.6%
Honeywell
International,
Inc.
.............................
United
States
200,615
33,091,444
Roper
Technologies,
Inc.
................................
United
States
123,763
45,958,153
79,049,597
Insurance
0.1%
a
Root,
Inc.,
A
.........................................
United
States
108,300
2,595,951
a
Interactive
Media
&
Services
3.4%
a
Alphabet,
Inc.,
C
......................................
United
States
69,737
113,044,374
a
Facebook,
Inc.,
A
.....................................
United
States
146,069
38,432,215
a,d
ZoomInfo
Technologies,
Inc.,
A
...........................
United
States
302,278
11,483,541
162,960,130
Internet
&
Direct
Marketing
Retail
9.6%
a
Amazon.com,
Inc.
.....................................
United
States
144,019
437,263,287
a
Booking
Holdings,
Inc.
.................................
United
States
7,746
12,567,885
b,c
Marqeta
,
Inc.
.........................................
United
States
1,196,245
10,919,384
460,750,556
IT
Services
13.0%
a
Black
Knight,
Inc.
.....................................
United
States
368,592
32,417,666
Mastercard
,
Inc.,
A
....................................
United
States
619,925
178,935,152
a
Okta
,
Inc.
...........................................
United
States
96,161
20,177,463
a
PayPal
Holdings,
Inc.
..................................
United
States
475,661
88,534,782
a
Shopify,
Inc.,
A
.......................................
Canada
43,685
40,427,410
a
Snowflake,
Inc.,
A
.....................................
United
States
135,760
33,942,715
a
Twilio
,
Inc.,
A
.........................................
United
States
309,357
86,301,322
Visa,
Inc.,
A
..........................................
United
States
802,292
145,784,479
626,520,989
Leisure
Products
0.6%
a
Peloton
Interactive,
Inc.,
A
...............................
United
States
255,728
28,183,783
a
Life
Sciences
Tools
&
Services
1.0%
a
Illumina,
Inc.
.........................................
United
States
69,033
20,205,959
a,e
Wuxi
Biologics
Cayman,
Inc.,
144A,
Reg
S
..................
China
931,394
27,001,112
47,207,071
Media
0.9%
a
Liberty
Broadband
Corp.,
C
..............................
United
States
319,240
45,239,500
a
Pharmaceuticals
1.7%
AstraZeneca
plc,
ADR
..................................
United
Kingdom
663,092
33,260,695
a
Catalent
,
Inc.
........................................
United
States
202,153
17,742,969
a,d
GW
Pharmaceuticals
plc,
ADR
...........................
United
Kingdom
49,491
4,454,685
a
Reata
Pharmaceuticals,
Inc.,
A
...........................
United
States
114,500
13,363,295
Royalty
Pharma
plc,
A
..................................
United
States
325,046
11,929,188
80,750,832
Professional
Services
5.1%
a
CoStar
Group,
Inc.
....................................
United
States
142,484
117,351,247
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Growth
Opportunities
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
27
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Professional
Services
(continued)
a
Dun
&
Bradstreet
Holdings,
Inc.
...........................
United
States
225,091
$
5,816,351
IHS
Markit
Ltd.
.......................................
United
States
364,969
29,515,043
TransUnion
..........................................
United
States
230,933
18,396,123
Verisk
Analytics,
Inc.
...................................
United
States
428,140
76,196,076
247,274,840
Road
&
Rail
0.9%
Union
Pacific
Corp.
....................................
United
States
253,106
44,847,852
Semiconductors
&
Semiconductor
Equipment
3.6%
Analog
Devices,
Inc.
...................................
United
States
256,344
30,384,454
Monolithic
Power
Systems,
Inc.
...........................
United
States
194,459
62,149,097
NVIDIA
Corp.
........................................
United
States
161,594
81,016,768
173,550,319
Software
19.1%
a
Adobe,
Inc.
..........................................
United
States
226,042
101,063,378
a
Atlassian
Corp.
plc,
A
..................................
United
States
80,156
15,359,493
a
Autodesk,
Inc.
........................................
United
States
71,892
16,933,442
a
Avalara,
Inc.
.........................................
United
States
38,000
5,663,900
a,b,c,f
Avidxchange
,
Inc.
.....................................
United
States
255,039
12,499,971
a
Bill.com
Holdings,
Inc.
..................................
United
States
675,454
67,545,400
a
DocuSign,
Inc.
.......................................
United
States
156,746
31,701,878
a,d
Duck
Creek
Technologies,
Inc.
...........................
United
States
19,500
845,715
Intuit,
Inc.
...........................................
United
States
68,134
21,440,407
Microsoft
Corp.
.......................................
United
States
1,304,965
264,216,263
a
Paycom
Software,
Inc.
.................................
United
States
34,754
12,653,584
a
PTC,
Inc.
...........................................
United
States
284,951
23,901,690
a
salesforce.com,
Inc.
...................................
United
States
236,006
54,817,114
a
ServiceNow
,
Inc.
......................................
United
States
311,127
154,807,461
a
Synopsys,
Inc.
.......................................
United
States
175,774
37,591,028
a
Tyler
Technologies,
Inc.
.................................
United
States
73,116
28,104,328
a
Workday,
Inc.,
A
......................................
United
States
129,999
27,315,390
a
Zendesk
,
Inc.
........................................
United
States
185,645
20,595,456
a
Zoom
Video
Communications,
Inc.,
A
......................
United
States
52,971
24,414,864
921,470,762
Specialty
Retail
0.2%
a
Burlington
Stores,
Inc.
..................................
United
States
51,461
9,961,820
a
Technology
Hardware,
Storage
&
Peripherals
3.7%
Apple,
Inc.
..........................................
United
States
1,657,148
180,397,131
Textiles,
Apparel
&
Luxury
Goods
1.0%
b,c
Figs,
Inc.
............................................
United
States
230,802
17,756,521
NIKE,
Inc.,
B
.........................................
United
States
264,968
31,817,358
49,573,879
Wireless
Telecommunication
Services
1.3%
a
T-Mobile
US,
Inc.
.....................................
United
States
574,057
62,899,425
a
Total
Common
Stocks
(Cost
$1,749,041,159)
....................................
4,590,092,261
Preferred
Stocks
4.6%
Airlines
0.4%
a,b,c
Wheels
Up
Partners
LLC,
D
.............................
United
States
5,028,735
20,826,898
a
Automobiles
1.2%
a,b,c,e
Proterra
,
Inc.,
144A,
5
..................................
United
States
2,362,202
35,150,615
a,b,c,e
Proterra
,
Inc.,
144A,
6
..................................
United
States
596,775
8,880,277
a,b,c
Proterra
,
Inc.,
7
.......................................
United
States
780,667
11,616,672
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Growth
Opportunities
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
28
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Preferred
Stocks
(continued)
Automobiles
(continued)
a,b,c
Proterra
,
Inc.,
8
.......................................
United
States
289,016
$
4,300,686
59,948,250
Commercial
Services
&
Supplies
0.3%
a,b,c
Optoro
,
Inc.,
E
.......................................
United
States
509,182
13,113,596
a
Food
&
Staples
Retailing
0.4%
a,b,c
Sweetgreen
,
Inc.,
H
...................................
United
States
928,488
14,767,846
a,b,c
Sweetgreen
,
Inc.,
I
....................................
United
States
100,835
1,781,490
16,549,336
Health
Care
Providers
&
Services
0.5%
a,b,c
Tempus
Labs,
Inc.,
F
...................................
United
States
504,854
17,772,425
a,b,c
Tempus
Labs,
Inc.,
G
..................................
United
States
126,131
5,090,745
22,863,170
Internet
&
Direct
Marketing
Retail
0.4%
a,b,c
Fanatics,
Inc.,
E
......................................
United
States
920,577
15,767,643
a,b,c
Marqeta
,
Inc.,
A
.......................................
United
States
181,494
2,087,181
a,b,c
Marqeta
,
Inc.,
B
......................................
United
States
19,136
229,632
18,084,456
IT
Services
0.3%
a,b,c
HashiCorp
,
Inc.,
E
.....................................
United
States
207,551
14,792,293
a
Software
1.1%
a,b,c
ClearMotion
,
Inc.,
C
...................................
United
States
2,610,594
6,809,870
a,b,c
ClearMotion
,
Inc.,
D
...................................
United
States
3,698,772
10,567,181
a,b,c
Confluent,
Inc.,
E
.....................................
United
States
642,459
9,616,776
a,b,c
Gitlab
,
Inc.,
E
........................................
United
States
201,294
8,051,760
a,b,c,f
Talkdesk
,
Inc.,
C
......................................
United
States
1,753,060
11,517,955
a,b,c
Tanium,
Inc.,
G
.......................................
United
States
805,800
8,336,143
54,899,685
Total
Preferred
Stocks
(Cost
$155,692,404)
.....................................
221,077,684
Total
Long
Term
Investments
(Cost
$1,904,733,563)
.............................
4,811,169,945
a
Short
Term
Investments
0.4%
a
a
Country
Shares
a
Value
a
Money
Market
Funds
0.2%
g,h
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
........
United
States
12,036,647
12,036,647
Total
Money
Market
Funds
(Cost
$12,036,647)
..................................
12,036,647
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Growth
Opportunities
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
29
s
Short
Term
Investments
(continued)
a
a
Country
Shares
a
Value
a
a
a
a
a
a
i
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
0.2%
Money
Market
Funds
0.2%
g,h
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
........
United
States
7,852,835
$
7,852,835
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$7,852,835)
............................................................
7,852,835
Total
Short
Term
Investments
(Cost
$19,889,482
)
................................
19,889,482
a
Total
Investments
(Cost
$1,924,623,045)
100.2%
................................
$4,831,059,427
Other
Assets,
less
Liabilities
(0.2)
%
...........................................
(8,531,155)
Net
Assets
100.0%
...........................................................
$4,822,528,272
See
Abbreviations
on
page
78
.
a
Non
-income
producing.
b
Fair
valued
using
significant
unobservable
inputs.
See
Note
11
regarding
fair
value
measurements.
c
See
Note
8
regarding
restricted
securities.
d
A
portion
or
all
of
the
security
is
on
loan
at
October
31,
2020.
See
Note
1
(
c
)
e
Security
was
purchased
pursuant
to
Rule
144A
or
Regulation
S
under
the
Securities
Act
of
1933.
144A
securities
may
be
sold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers
or
in
a
public
offering
registered
under
the
Securities
Act
of
1933.
Regulation
S
securities
cannot
be
sold
in
the
United
States
without
either
an
effective
registration
statement
filed
pursuant
to
the
Securities
Act
of
1933,
or
pursuant
to
an
exemption
from
registration.
At
October
31,
2020,
the
aggregate
value
of
these
securities
was
$71,032,004,
representing
1.5%
of
net
assets.
f
See
Note
9
regarding
holdings
of
5%
voting
securities.
g
See
Note
3
(
f
)
regarding
investments
in
affiliated
management
investment
companies.
h
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
i
See
Note
1
(
c
)
regarding
securities
on
loan.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small
Cap
Growth
Fund
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
30
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
A
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$18.85
$21.46
$23.01
$19.60
$16.37
$18.83
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..............
(0.08)
(0.11)
(0.15)
(0.13)
(0.11)
(0.08)
Net
realized
and
unrealized
gains
(losses)
6.23
(1.07)
2.86
3.96
3.34
(2.03)
Total
from
investment
operations
........
6.15
(1.18)
2.71
3.83
3.23
(2.11)
Less
distributions
from:
Net
realized
gains
.................
(1.43)
(4.26)
(0.42)
(0.35)
Net
asset
value,
end
of
period
..........
$25.00
$18.85
$21.46
$23.01
$19.60
$16.37
Total
return
c
.......................
32.63%
(6.25)%
16.06%
19.71%
19.73%
(11.28)%
Ratios
to
average
net
assets
d
Expenses
before
waiver
and
payments
by
affiliates
..........................
1.06%
1.07%
1.07%
1.11%
1.10%
1.13%
Expenses
net
of
waiver
and
payments
by
affiliates
..........................
1.06%
e,f
1.06%
e
1.06%
e
1.10%
e
1.08%
e
1.11%
e
Net
investment
(loss)
................
(0.71)%
(0.51)%
(0.68)%
(0.61)%
(0.61)%
(0.44)%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$917,328
$686,791
$713,442
$665,251
$719,752
$792,072
Portfolio
turnover
rate
................
25.32%
35.29%
42.10%
29.82%
29.93%
43.99%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable,
and
is
not
annualized
for
periods
less
than
one
year.
d
Ratios
are
annualized
for
periods
less
than
one
year.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small
Cap
Growth
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
31
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
C
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$14.69
$17.15
$19.41
$16.71
$14.07
$16.36
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..............
(0.13)
(0.21)
(0.28)
(0.25)
(0.21)
(0.18)
Net
realized
and
unrealized
gains
(losses)
4.85
(0.82)
2.28
3.37
2.85
(1.76)
Total
from
investment
operations
........
4.72
(1.03)
2.00
3.12
2.64
(1.94)
Less
distributions
from:
Net
realized
gains
.................
(1.43)
(4.26)
(0.42)
(0.35)
Net
asset
value,
end
of
period
..........
$19.41
$14.69
$17.15
$19.41
$16.71
$14.07
Total
return
c
.......................
32.13%
(6.97)%
15.31%
18.79%
18.76%
(11.95)%
Ratios
to
average
net
assets
d
Expenses
before
waiver
and
payments
by
affiliates
..........................
1.81%
1.82%
1.82%
1.86%
1.85%
1.88%
Expenses
net
of
waiver
and
payments
by
affiliates
..........................
1.81%
e,f
1.81%
e
1.81%
e
1.85%
e
1.83%
e
1.86%
e
Net
investment
(loss)
................
(1.46)%
(1.26)%
(1.43)%
(1.36)%
(1.36)%
(1.19)%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$74,106
$66,269
$90,513
$132,116
$142,539
$157,175
Portfolio
turnover
rate
................
25.32%
35.29%
42.10%
29.82%
29.93%
43.99%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable,
and
is
not
annualized
for
periods
less
than
one
year.
d
Ratios
are
annualized
for
periods
less
than
one
year.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small
Cap
Growth
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
32
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
R
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$17.58
$20.15
$21.93
$18.74
$15.70
$18.11
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..............
(0.11)
(0.15)
(0.20)
(0.17)
(0.15)
(0.12)
Net
realized
and
unrealized
gains
(losses)
5.81
(0.99)
2.68
3.78
3.19
(1.94)
Total
from
investment
operations
........
5.70
(1.14)
2.48
3.61
3.04
(2.06)
Less
distributions
from:
Net
realized
gains
.................
(1.43)
(4.26)
(0.42)
(0.35)
Net
asset
value,
end
of
period
..........
$23.28
$17.58
$20.15
$21.93
$18.74
$15.70
Total
return
c
.......................
32.42%
(6.47)%
15.78%
19.37%
19.36%
(11.46)%
Ratios
to
average
net
assets
d
Expenses
before
waiver
and
payments
by
affiliates
..........................
1.31%
1.32%
1.32%
1.36%
1.35%
1.38%
Expenses
net
of
waiver
and
payments
by
affiliates
..........................
1.31%
e,f
1.31%
e
1.31%
e
1.35%
e
1.33%
e
1.36%
e
Net
investment
(loss)
................
(0.96)%
(0.76)%
(0.93)%
(0.86)%
(0.86)%
(0.69)%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$66,585
$54,369
$74,634
$71,398
$79,995
$79,929
Portfolio
turnover
rate
................
25.32%
35.29%
42.10%
29.82%
29.93%
43.99%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
is
not
annualized
for
periods
less
than
one
year.
d
Ratios
are
annualized
for
periods
less
than
one
year.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small
Cap
Growth
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
33
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
R6
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$21.07
$23.73
$24.88
$21.06
$17.52
$20.02
Income
from
investment
operations
a
:
Net
investment
income
(loss)
b
........
(0.04)
(0.02)
(0.07)
(0.03)
(0.03)
0.01
Net
realized
and
unrealized
gains
(losses)
6.97
(1.21)
3.18
4.27
3.57
(2.16)
Total
from
investment
operations
........
6.93
(1.23)
3.11
4.24
3.54
(2.15)
Less
distributions
from:
Net
realized
gains
.................
(1.43)
(4.26)
(0.42)
(0.35)
Net
asset
value,
end
of
period
..........
$28.00
$21.07
$23.73
$24.88
$21.06
$17.52
Total
return
c
.......................
32.89%
(5.86)%
16.50%
20.23%
20.21%
(10.81)%
Ratios
to
average
net
assets
d
Expenses
before
waiver
and
payments
by
affiliates
..........................
0.66%
0.67%
0.67%
0.65%
0.63%
0.63%
Expenses
net
of
waiver
and
payments
by
affiliates
..........................
0.64%
e
0.64%
e
0.64%
e
0.63%
e
0.61%
e
0.61%
e
Net
investment
(loss)
................
(0.30)%
(0.09)%
(0.26)%
(0.14)%
(0.14)%
(0.06)%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$1,498,046
$1,136,759
$1,084,442
$935,509
$858,972
$846,724
Portfolio
turnover
rate
................
25.32%
35.29%
42.10%
29.82%
29.93%
43.99%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
is
not
annualized
for
periods
less
than
one
year.
d
Ratios
are
annualized
for
periods
less
than
one
year.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small
Cap
Growth
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
34
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Advisor
Class
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$20.70
$23.37
$24.61
$20.88
$17.41
$19.94
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..............
(0.06)
(0.06)
(0.10)
(0.08)
(0.07)
(0.04)
Net
realized
and
unrealized
gains
(losses)
6.84
(1.18)
3.12
4.23
3.54
(2.14)
Total
from
investment
operations
........
6.78
(1.24)
3.02
4.15
3.47
(2.18)
Less
distributions
from:
Net
realized
gains
.................
(1.43)
(4.26)
(0.42)
(0.35)
Net
asset
value,
end
of
period
..........
$27.48
$20.70
$23.37
$24.61
$20.88
$17.41
Total
return
c
.......................
32.75%
(5.99)%
16.30%
19.97%
19.93%
(11.06)%
Ratios
to
average
net
assets
d
Expenses
before
waiver
and
payments
by
affiliates
..........................
0.81%
0.82%
0.82%
0.86%
0.85%
0.88%
Expenses
net
of
waiver
and
payments
by
affiliates
..........................
0.81%
e,f
0.81%
e
0.81%
e
0.85%
e
0.83%
e
0.86%
e
Net
investment
(loss)
................
(0.46)%
(0.26)%
(0.43)%
(0.36)%
(0.36)%
(0.19)%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$560,193
$428,155
$725,622
$713,135
$805,661
$850,975
Portfolio
turnover
rate
................
25.32%
35.29%
42.10%
29.82%
29.93%
43.99%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
is
not
annualized
for
periods
less
than
one
year.
d
Ratios
are
annualized
for
periods
less
than
one
year.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Statement
of
Investments
(unaudited),
October
31,
2020
Franklin
Small
Cap
Growth
Fund
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
35
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
92.6%
Aerospace
&
Defense
5.4%
a
Axon
Enterprise,
Inc.
...................................
United
States
243,100
$
24,042,590
BWX
Technologies,
Inc.
................................
United
States
572,600
31,498,726
Cubic
Corp.
.........................................
United
States
914,300
54,044,273
a
Kratos
Defense
&
Security
Solutions,
Inc.
...................
United
States
1,708,764
32,278,552
a
Mercury
Systems,
Inc.
..................................
United
States
401,116
27,628,870
169,493,011
Airlines
1.7%
Allegiant
Travel
Co.
....................................
United
States
393,248
52,994,100
Banks
2.4%
a
Metropolitan
Bank
Holding
Corp.
..........................
United
States
283,954
8,504,421
Pinnacle
Financial
Partners,
Inc.
..........................
United
States
563,004
25,779,953
TCF
Financial
Corp.
...................................
United
States
580,723
15,801,473
Western
Alliance
Bancorp
...............................
United
States
569,500
23,463,400
73,549,247
Biotechnology
11.1%
a
Alector
,
Inc.
..........................................
United
States
796,500
7,495,065
a
Argenx
SE,
ADR
......................................
Netherlands
75,300
18,684,189
a
Ascendis
Pharma
A/S,
ADR
.............................
Denmark
178,900
29,223,315
a
Blueprint
Medicines
Corp.
...............................
United
States
203,800
20,844,664
a
Deciphera
Pharmaceuticals,
Inc.
..........................
United
States
507,400
29,464,718
a
Dyne
Therapeutics,
Inc.
................................
United
States
217,900
4,506,172
a
Emergent
BioSolutions
,
Inc.
.............................
United
States
359,000
32,299,230
a
Global
Blood
Therapeutics,
Inc.
...........................
United
States
488,700
25,842,456
a
Heron
Therapeutics,
Inc.
................................
United
States
1,775,508
28,958,535
a
Insmed
,
Inc.
.........................................
United
States
673,400
22,181,796
a
Iovance
Biotherapeutics
,
Inc.
.............................
United
States
1,340,500
47,829,040
a
Legend
Biotech
Corp.,
ADR
.............................
United
States
227,800
5,893,186
a
Novavax
,
Inc.
........................................
United
States
105,400
8,506,834
a
PTC
Therapeutics,
Inc.
.................................
United
States
753,100
39,304,289
a,b
Sutro
Biopharma,
Inc.
..................................
United
States
355,536
4,572,193
a,b
Taysha
Gene
Therapies,
Inc.
.............................
United
States
372,000
7,737,600
a
Trillium
Therapeutics,
Inc.
...............................
Canada
530,400
6,603,480
a
Twist
Bioscience
Corp.
.................................
United
States
94,562
7,247,232
347,193,994
Capital
Markets
3.0%
Ares
Management
Corp.
................................
United
States
415,800
17,588,340
Artisan
Partners
Asset
Management,
Inc.,
A
.................
United
States
132,572
5,310,835
Evercore
,
Inc.,
A
......................................
United
States
301,000
23,941,540
Houlihan
Lokey
,
Inc.
...................................
United
States
606,300
38,015,010
a
StepStone
Group,
Inc.,
A
................................
United
States
284,720
7,320,151
92,175,876
Chemicals
1.2%
a
Ingevity
Corp.
........................................
United
States
684,686
37,575,568
a
Commercial
Services
&
Supplies
1.9%
Healthcare
Services
Group,
Inc.
..........................
United
States
822,800
18,825,664
a,c,d
Legalzoom.com,
Inc.
...................................
United
States
1,431,280
19,152,970
US
Ecology,
Inc.
......................................
United
States
648,376
19,788,435
57,767,069
Communications
Equipment
1.9%
a
ViaSat
,
Inc.
..........................................
United
States
940,283
31,875,594
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Small
Cap
Growth
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
36
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Communications
Equipment
(continued)
a
Viavi
Solutions,
Inc.
....................................
United
States
2,253,900
$
27,835,665
59,711,259
Construction
&
Engineering
2.0%
Arcosa
,
Inc.
.........................................
United
States
903,800
41,728,446
Granite
Construction,
Inc.
...............................
United
States
1,049,543
20,266,675
61,995,121
Consumer
Finance
0.8%
a
PRA
Group,
Inc.
......................................
United
States
775,900
26,481,467
a
Diversified
Consumer
Services
1.0%
a
Grand
Canyon
Education,
Inc.
............................
United
States
392,300
30,744,551
a
Electronic
Equipment,
Instruments
&
Components
0.4%
a
Vontier
Corp.
.........................................
United
States
393,500
11,309,190
a
Equity
Real
Estate
Investment
Trusts
(REITs)
1.3%
Rexford
Industrial
Realty,
Inc.
............................
United
States
897,100
41,679,266
Food
&
Staples
Retailing
1.3%
a
Grocery
Outlet
Holding
Corp.
............................
United
States
899,500
39,595,990
a
Food
Products
2.1%
a
Hostess
Brands,
Inc.
...................................
United
States
1,147,600
14,505,664
a
Nomad
Foods
Ltd.
....................................
United
Kingdom
1,088,500
26,396,125
a
Simply
Good
Foods
Co.
(The)
............................
United
States
1,385,500
26,047,400
66,949,189
Health
Care
Equipment
&
Supplies
6.4%
a
CryoPort
,
Inc.
........................................
United
States
217,800
8,742,492
a
Haemonetics
Corp.
....................................
United
States
201,900
20,410,071
a
Inari
Medical,
Inc.
.....................................
United
States
115,900
7,672,580
a
Integer
Holdings
Corp.
.................................
United
States
521,400
30,475,830
a
iRhythm
Technologies,
Inc.
..............................
United
States
193,597
40,936,085
a
Neogen
Corp.
........................................
United
States
165,466
11,539,599
a
Nevro
Corp.
.........................................
United
States
204,300
30,483,603
a
Outset
Medical,
Inc.
...................................
United
States
18,100
841,107
a
Penumbra,
Inc.
.......................................
United
States
159,700
41,686,491
a
Pulmonx
Corp.
.......................................
United
States
185,400
7,797,924
200,585,782
Health
Care
Providers
&
Services
1.7%
a
1Life
Healthcare,
Inc.
..................................
United
States
675,200
19,047,392
a
HealthEquity
,
Inc.
.....................................
United
States
473,016
24,355,594
a,b
Oak
Street
Health,
Inc.
.................................
United
States
206,500
9,827,335
53,230,321
Health
Care
Technology
3.1%
a,b
Accolade,
Inc.
........................................
United
States
300,835
10,535,242
a
Inspire
Medical
Systems,
Inc.
............................
United
States
300,444
35,882,027
a
Phreesia
,
Inc.
........................................
United
States
984,982
36,414,784
a,b
Tabula
Rasa
HealthCare,
Inc.
............................
United
States
378,800
13,083,752
95,915,805
Hotels,
Restaurants
&
Leisure
5.1%
a,b
DraftKings
,
Inc.,
A
.....................................
United
States
1,366,400
48,370,560
Extended
Stay
America,
Inc.
.............................
United
States
2,116,100
24,017,735
Red
Rock
Resorts,
Inc.,
A
...............................
United
States
856,600
16,378,192
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Small
Cap
Growth
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
37
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Hotels,
Restaurants
&
Leisure
(continued)
Texas
Roadhouse,
Inc.
.................................
United
States
428,100
$
29,979,843
Wingstop
,
Inc.
........................................
United
States
332,729
38,706,365
157,452,695
Household
Durables
2.2%
a
M/I
Homes,
Inc.
.......................................
United
States
976,546
39,960,262
a
TRI
Pointe
Group,
Inc.
.................................
United
States
1,670,300
27,443,029
67,403,291
Insurance
1.2%
James
River
Group
Holdings
Ltd.
.........................
United
States
380,500
17,780,765
a,b
Selectquote
,
Inc.
......................................
United
States
1,062,500
18,296,250
36,077,015
Internet
&
Direct
Marketing
Retail
0.3%
c,d
Marqeta
,
Inc.
.........................................
United
States
1,199,415
10,948,320
IT
Services
5.8%
a
LiveRamp
Holdings,
Inc.
................................
United
States
628,100
41,511,129
ManTech
International
Corp.,
A
...........................
United
States
334,500
21,702,360
c,d,e
Paya
Holdings,
Inc.
....................................
United
States
2,000,000
21,940,000
a
Repay
Holdings
Corp.
..................................
United
States
1,331,900
30,007,707
Science
Applications
International
Corp.
....................
United
States
445,500
34,022,835
a
Shift4
Payments,
Inc.,
A
................................
United
States
379,100
19,299,981
a
USA
Technologies,
Inc.
.................................
United
States
1,344,300
11,171,133
179,655,145
Life
Sciences
Tools
&
Services
1.3%
a
NeoGenomics
,
Inc.
....................................
United
States
1,017,300
39,908,679
a
Machinery
1.2%
Kennametal,
Inc.
......................................
United
States
1,256,200
38,942,200
Personal
Products
0.7%
a
BellRing
Brands,
Inc.,
A
.................................
United
States
1,261,200
23,067,348
a
Pharmaceuticals
3.0%
a
Collegium
Pharmaceutical,
Inc.
...........................
United
States
758,300
13,520,489
a
GW
Pharmaceuticals
plc,
ADR
...........................
United
Kingdom
322,500
29,028,225
a
Reata
Pharmaceuticals,
Inc.,
A
...........................
United
States
202,174
23,595,728
a
Revance
Therapeutics,
Inc.
..............................
United
States
1,095,257
28,345,251
94,489,693
Semiconductors
&
Semiconductor
Equipment
5.4%
a
Allegro
MicroSystems
,
Inc.
..............................
United
States
502,600
9,197,580
a
Lattice
Semiconductor
Corp.
.............................
United
States
1,706,900
59,570,810
a
Onto
Innovation,
Inc.
...................................
United
States
857,309
27,493,900
a
Semtech
Corp.
.......................................
United
States
717,500
39,383,575
a
Silicon
Laboratories,
Inc.
................................
United
States
311,100
31,875,306
167,521,171
Software
8.5%
a
Alteryx,
Inc.,
A
........................................
United
States
177,400
22,237,090
a
Avalara,
Inc.
.........................................
United
States
230,846
34,407,596
a
Bill.com
Holdings,
Inc.
..................................
United
States
135,708
13,570,800
a
Cloudflare
,
Inc.,
A
.....................................
United
States
279,400
14,520,418
a
Datto
Holding
Corp.
...................................
United
States
240,000
6,840,000
a
Duck
Creek
Technologies,
Inc.
...........................
United
States
277,269
12,025,157
a
Envestnet
,
Inc.
.......................................
United
States
388,122
29,784,482
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Small
Cap
Growth
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
38
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Software
(continued)
a
HubSpot
,
Inc.
........................................
United
States
117,629
$
34,120,644
a
Paylocity
Holding
Corp.
.................................
United
States
204,532
37,944,777
a
Pluralsight
,
Inc.,
A
.....................................
United
States
189,900
2,981,430
a
Q2
Holdings,
Inc.
.....................................
United
States
335,500
30,611,020
a
Zendesk
,
Inc.
........................................
United
States
222,864
24,724,532
263,767,946
Specialty
Retail
6.3%
American
Eagle
Outfitters,
Inc.
...........................
United
States
2,609,800
35,780,358
a
Boot
Barn
Holdings,
Inc.
................................
United
States
1,119,460
35,845,109
a
Five
Below,
Inc.
.......................................
United
States
277,200
36,961,848
Lithia
Motors,
Inc.,
A
...................................
United
States
153,426
35,222,007
a
RH
................................................
United
States
55,500
18,605,265
a
Sportsman's
Warehouse
Holdings,
Inc.
.....................
United
States
1,184,700
15,424,794
a
Urban
Outfitters,
Inc.
...................................
United
States
797,800
17,822,852
195,662,233
Textiles,
Apparel
&
Luxury
Goods
0.8%
Steven
Madden
Ltd.
...................................
United
States
1,082,650
25,994,427
Trading
Companies
&
Distributors
2.1%
a
Beacon
Roofing
Supply,
Inc.
.............................
United
States
1,043,200
32,026,240
a
Univar
Solutions,
Inc.
..................................
United
States
2,024,132
33,580,350
65,606,590
Total
Common
Stocks
(Cost
$2,013,998,516)
....................................
2,885,443,559
Preferred
Stocks
5.1%
Airlines
0.6%
a,c,d
Wheels
Up
Partners
LLC,
D
.............................
United
States
4,310,344
17,851,626
a
Auto
Components
0.2%
a,c,d
Tula
eTechnology
,
Inc.
..................................
United
States
361,111
a,c,d
Tula
eTechnology
,
Inc.,
E
...............................
United
States
3,611,111
6,919,423
6,919,423
Automobiles
1.7%
a,c,d,f
Proterra
,
Inc.,
144A,
5
..................................
United
States
1,787,047
26,592,053
a,c,d,f
Proterra
,
Inc.,
144A,
6
..................................
United
States
1,310,834
19,505,792
a,c,d
Proterra
,
Inc.,
7
.......................................
United
States
536,367
7,981,379
54,079,224
Commercial
Services
&
Supplies
0.4%
a,c,d
Optoro
,
Inc.,
E
.......................................
United
States
508,130
13,086,502
a
Food
&
Staples
Retailing
0.2%
a,c,d
Sweetgreen
,
Inc.,
H
...................................
United
States
383,435
6,098,635
a,c,d
Sweetgreen
,
Inc.,
I
....................................
United
States
41,641
735,687
6,834,322
Software
1.0%
a,c,d
Alkami
Technology,
Inc.,
F
...............................
United
States
343,750
5,500,000
a,c,d
ClearMotion
,
Inc.,
D
...................................
United
States
3,698,772
10,567,181
a,c,d,f
Smule
,
Inc.,
144A,
G
...................................
United
States
1,542,673
10,412,764
a,c,d,f
Smule
,
Inc.,
144A,
H
...................................
United
States
352,675
2,809,136
29,289,081
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Small
Cap
Growth
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
39
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Preferred
Stocks
(continued)
Specialty
Retail
0.5%
a,c,d,f
Rent
the
Runway,
Inc.,
144A,
F
...........................
United
States
596,471
$
12,797,090
a,c,d
Rent
the
Runway,
Inc.,
G
................................
United
States
203,515
3,606,110
16,403,200
Textiles,
Apparel
&
Luxury
Goods
0.5%
a,c,d
Allbirds
,
Inc.,
E
.......................................
United
States
1,297,305
14,999,998
a
Total
Preferred
Stocks
(Cost
$117,907,767)
.....................................
159,463,376
Total
Long
Term
Investments
(Cost
$2,131,906,283)
.............................
3,044,906,935
a
Short
Term
Investments
4.3%
a
a
Country
Shares
a
Value
a
Money
Market
Funds
2.9%
g,h
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
........
United
States
89,112,859
89,112,859
Total
Money
Market
Funds
(Cost
$89,112,859)
..................................
89,112,859
a
a
a
a
a
i
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
1.4%
Money
Market
Funds
1.4%
g,h
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
........
United
States
44,598,925
44,598,925
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$44,598,925)
...........................................................
44,598,925
Total
Short
Term
Investments
(Cost
$133,711,784
)
...............................
133,711,784
a
Total
Investments
(Cost
$
2,265,618,067)
102.0%
................................
$3,178,618,719
Other
Assets,
less
Liabilities
(2
.0
)
%
...........................................
(62,360,583)
Net
Assets
100.0%
...........................................................
$3,116,258,136
See
Abbreviations
on
page
78
.
a
Non-income
producing.
b
A
portion
or
all
of
the
security
is
on
loan
at
October
31,
2020.
See
Note
1(c)
c
Fair
valued
using
significant
unobservable
inputs.
See
Note
11
regarding
fair
value
measurements.
d
See
Note
8
regarding
restricted
securities.
e
See
Note
9
regarding
holdings
of
5%
voting
securities.
f
Security
was
purchased
pursuant
to
Rule
144A
or
Regulation
S
under
the
Securities
Act
of
1933.
144A
securities
may
be
sold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers
or
in
a
public
offering
registered
under
the
Securities
Act
of
1933.
Regulation
S
securities
cannot
be
sold
in
the
United
States
without
either
an
effective
registration
statement
filed
pursuant
to
the
Securities
Act
of
1933,
or
pursuant
to
an
exemption
from
registration.
At
October
31,
2020,
the
aggregate
value
of
these
securities
was
$72,116,835,
representing
2.3%
of
net
assets.
g
See
Note
3(f)
regarding
investments
in
affiliated
management
investment
companies.
h
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
i
See
Note
1(c)
regarding
securities
on
loan.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small-Mid
Cap
Growth
Fund
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
40
0
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
A
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$32.15
$37.17
$36.07
$34.35
$31.84
$38.38
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..............
(0.10)
(0.07)
(0.09)
(0.15)
(0.11)
(0.03)
c
Net
realized
and
unrealized
gains
(losses)
11.47
1.24
5.33
4.97
4.73
(3.37)
Total
from
investment
operations
........
11.37
1.17
5.24
4.82
4.62
(3.40)
Less
distributions
from:
Net
realized
gains
.................
(6.19)
(4.14)
(3.10)
(2.11)
(3.14)
Net
asset
value,
end
of
period
..........
$43.52
$32.15
$37.17
$36.07
$34.35
$31.84
Total
return
d
.......................
35.37%
2.97%
17.43%
14.28%
15.01%
(9.02)%
Ratios
to
average
net
assets
e
Expenses
before
waiver
and
payments
by
affiliates
..........................
0.86%
0.88%
0.88%
1.02%
0.95%
0.96%
Expenses
net
of
waiver
and
payments
by
affiliates
..........................
0.86%
f,g
0.87%
f
0.87%
f
1.00%
f
0.94%
f
0.95%
f
Net
investment
(loss)
................
(0.51)%
(0.21)%
(0.25)%
(0.41)%
(0.34)%
(0.08)%
c
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$3,377,036
$2,515,801
$2,684,131
$2,262,471
$2,303,113
$2,231,822
Portfolio
turnover
rate
................
28.27%
52.98%
54.28%
38.35%
35.46%
38.72%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Net
investment
income
per
share
includes
approximately
$0.11
per
share
related
to
income
received
in
the
form
of
special
dividends
in
connection
with
certain
Fund
hold-
ings.
Excluding
this
amount,
the
ratio
of
net
investment
income
to
average
net
assets
would
have
been
(0.38)%.
d
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable,
and
is
not
annualized
for
periods
less
than
one
year.
e
Ratios
are
annualized
for
periods
less
than
one
year.
f
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
g
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
41
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
C
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$19.41
$24.98
$25.84
$25.59
$24.40
$30.43
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..............
(0.15)
(0.22)
(0.26)
(0.31)
(0.27)
(0.23)
c
Net
realized
and
unrealized
gains
(losses)
6.92
0.84
3.54
3.66
3.57
(2.66)
Total
from
investment
operations
........
6.77
0.62
3.28
3.35
3.30
(2.89)
Less
distributions
from:
Net
realized
gains
.................
(6.19)
(4.14)
(3.10)
(2.11)
(3.14)
Net
asset
value,
end
of
period
..........
$26.18
$19.41
$24.98
$25.84
$25.59
$24.40
Total
return
d
.......................
34.88%
2.14%
16.68%
13.39%
14.15%
(9.72)%
Ratios
to
average
net
assets
e
Expenses
before
waiver
and
payments
by
affiliates
..........................
1.61%
1.63%
1.63%
1.77%
1.70%
1.71%
Expenses
net
of
waiver
and
payments
by
affiliates
..........................
1.61%
f,g
1.62%
f
1.62%
f
1.75%
f
1.69%
f
1.70%
f
Net
investment
(loss)
................
(1.26)%
(0.96)%
(1.00)%
(1.16)%
(1.09)%
(0.83)%
c
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$170,066
$138,940
$173,334
$334,769
$371,262
$377,024
Portfolio
turnover
rate
................
28.27%
52.98%
54.28%
38.35%
35.46%
38.72%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Net
investment
income
per
share
includes
approximately
$0.11
per
share
related
to
income
received
in
the
form
of
special
dividends
in
connection
with
certain
Fund
hold-
ings.
Excluding
this
amount,
the
ratio
of
net
investment
income
to
average
net
assets
would
have
been
(1.13)%.
d
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable,
and
is
not
annualized
for
periods
less
than
one
year.
e
Ratios
are
annualized
for
periods
less
than
one
year.
f
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
g
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
42
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
R
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$28.45
$33.66
$33.15
$31.87
$29.75
$36.18
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..............
(0.13)
(0.14)
(0.16)
(0.22)
(0.18)
(0.11)
c
Net
realized
and
unrealized
gains
(losses)
10.15
1.12
4.81
4.60
4.41
(3.18)
Total
from
investment
operations
........
10.02
0.98
4.65
4.38
4.23
(3.29)
Less
distributions
from:
Net
realized
gains
.................
(6.19)
(4.14)
(3.10)
(2.11)
(3.14)
Net
asset
value,
end
of
period
..........
$38.47
$28.45
$33.66
$33.15
$31.87
$29.75
Total
return
d
.......................
35.22%
2.69%
17.17%
14.00%
14.70%
(9.24)%
Ratios
to
average
net
assets
e
Expenses
before
waiver
and
payments
by
affiliates
..........................
1.10%
1.12%
1.12%
1.26%
1.19%
1.21%
Expenses
net
of
waiver
and
payments
by
affiliates
..........................
1.10%
f,g
1.11%
f
1.11%
f
1.24%
f
1.18%
f
1.20%
f
Net
investment
(loss)
................
(0.75
)%
(0.45)%
(0.49)%
(0.65)%
(0.58)%
(0.33)%
c
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$50,717
$40,997
$50,721
$70,692
$81,864
$86,989
Portfolio
turnover
rate
................
28.27%
52.98%
54.28%
38.35%
35.46%
38.72%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Net
investment
income
per
share
includes
approximately
$0.11
per
share
related
to
income
received
in
the
form
of
special
dividends
in
connection
with
certain
Fund
hold-
ings.
Excluding
this
amount,
the
ratio
of
net
investment
income
to
average
net
assets
would
have
been
(0.63)%.
d
Total
return
is
not
annualized
for
periods
less
than
one
year.
e
Ratios
are
annualized
for
periods
less
than
one
year.
f
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
g
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
43
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
R6
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$37.12
$41.83
$39.91
$37.51
$34.43
$41.04
Income
from
investment
operations
a
:
Net
investment
income
(loss)
b
........
(0.03)
0.07
0.05
0.05
0.05
0.15
c
Net
realized
and
unrealized
gains
(losses)
13.24
1.41
6.01
5.45
5.14
(3.62)
Total
from
investment
operations
........
13.21
1.48
6.06
5.50
5.19
(3.47)
Less
distributions
from:
Net
realized
gains
.................
(6.19)
(4.14)
(3.10)
(2.11)
(3.14)
Net
asset
value,
end
of
period
..........
$50.33
$37.12
$41.83
$39.91
$37.51
$34.43
Total
return
d
.......................
35.59%
3.40%
17.82%
14.90%
15.51%
(8.54)%
Ratios
to
average
net
assets
e
Expenses
before
waiver
and
payments
by
affiliates
..........................
0.52%
0.52%
0.52%
0.50%
0.48%
0.48%
Expenses
net
of
waiver
and
payments
by
affiliates
..........................
0.49%
f
0.48%
f
0.49%
f
0.47%
f
0.47%
f
0.47%
f
Net
investment
income
(loss)
..........
(0.14)%
0.18%
0.13%
0.12%
0.13%
0.40%
c
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$365,950
$224,341
$259,053
$275,835
$222,577
$242,237
Portfolio
turnover
rate
................
28.27%
52.98%
54.28%
38.35%
35.46%
38.72%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Net
investment
income
per
share
includes
approximately
$0.11
per
share
related
to
income
received
in
the
form
of
special
dividends
in
connection
with
certain
Fund
hold-
ings.
Excluding
this
amount,
the
ratio
of
net
investment
income
to
average
net
assets
would
have
been
0.10%.
d
Total
return
is
not
annualized
for
periods
less
than
one
year.
e
Ratios
are
annualized
for
periods
less
than
one
year.
f
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
44
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Advisor
Class
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$36.30
$41.09
$39.33
$37.11
$34.15
$40.83
Income
from
investment
operations
a
:
Net
investment
income
(loss)
b
........
(0.06)
0.02
0.01
(0.06)
(0.03)
0.06
c
Net
realized
and
unrealized
gains
(losses)
12.95
1.38
5.89
5.38
5.10
(3.60)
Total
from
investment
operations
........
12.89
1.40
5.90
5.32
5.07
(3.54)
Less
distributions
from:
Net
realized
gains
.................
(6.19)
(4.14)
(3.10)
(2.11)
(3.14)
Net
asset
value,
end
of
period
..........
$49.19
$36.30
$41.09
$39.33
$37.11
$34.15
Total
return
d
.......................
35.51%
3.26%
17.67%
14.57%
15.28%
(8.79)%
Ratios
to
average
net
assets
e
Expenses
before
waiver
and
payments
by
affiliates
..........................
0.61%
0.63%
0.63%
0.77%
0.70%
0.71%
Expenses
net
of
waiver
and
payments
by
affiliates
..........................
0.61%
f,g
0.62%
f
0.62%
f
0.75%
f
0.69%
f
0.70%
f
Net
investment
income
(loss)
..........
(0.26)%
0.04%
—%
(0.16)%
(0.09)%
0.17%
c
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$440,443
$302,329
$355,141
$520,842
$584,840
$551,176
Portfolio
turnover
rate
................
28.27%
52.98%
54.28%
38.35%
35.46%
38.72%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Net
investment
income
per
share
includes
approximately
$0.11
per
share
related
to
income
received
in
the
form
of
special
dividends
in
connection
with
certain
Fund
hold-
ings.
Excluding
this
amount,
the
ratio
of
net
investment
income
to
average
net
assets
would
have
been
(0.13)%.
d
Total
return
is
not
annualized
for
periods
less
than
one
year.
e
Ratios
are
annualized
for
periods
less
than
one
year.
f
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
g
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Statement
of
Investments
(unaudited),
October
31,
2020
Franklin
Small-Mid
Cap
Growth
Fund
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
45
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
95.7%
Aerospace
&
Defense
1.1%
a
Axon
Enterprise,
Inc.
...................................
United
States
87,500
$
8,653,750
a
Kratos
Defense
&
Security
Solutions,
Inc.
...................
United
States
561,600
10,608,624
a
Mercury
Systems,
Inc.
..................................
United
States
433,000
29,825,040
49,087,414
Airlines
0.4%
Southwest
Airlines
Co.
.................................
United
States
470,000
18,579,100
Banks
0.4%
TCF
Financial
Corp.
...................................
United
States
651,300
17,721,873
Biotechnology
3.8%
a
Deciphera
Pharmaceuticals,
Inc.
..........................
United
States
369,500
21,456,865
a
Global
Blood
Therapeutics,
Inc.
...........................
United
States
477,000
25,223,760
a
Heron
Therapeutics,
Inc.
................................
United
States
1,274,000
20,778,940
a
Iovance
Biotherapeutics
,
Inc.
.............................
United
States
1,096,000
39,105,280
a
Novavax
,
Inc.
........................................
United
States
88,200
7,118,622
a
PTC
Therapeutics,
Inc.
.................................
United
States
433,000
22,598,270
a
Seagen
,
Inc.
.........................................
United
States
184,000
30,691,200
166,972,937
Capital
Markets
4.4%
Ares
Management
Corp.
................................
United
States
829,000
35,066,700
MarketAxess
Holdings,
Inc.
..............................
United
States
112,900
60,836,165
MSCI,
Inc.
...........................................
United
States
159,000
55,624,560
Tradeweb
Markets,
Inc.,
A
...............................
United
States
748,600
40,783,728
192,311,153
Chemicals
0.4%
a
Ingevity
Corp.
........................................
United
States
354,780
19,470,326
a
Commercial
Services
&
Supplies
1.1%
Republic
Services,
Inc.
.................................
United
States
529,000
46,641,930
Communications
Equipment
0.2%
a
ViaSat
,
Inc.
..........................................
United
States
274,050
9,290,295
a
Construction
Materials
0.9%
Martin
Marietta
Materials,
Inc.
............................
United
States
144,000
38,354,400
Containers
&
Packaging
1.2%
Ball
Corp.
...........................................
United
States
595,000
52,955,000
Electronic
Equipment,
Instruments
&
Components
2.4%
Amphenol
Corp.,
A
....................................
United
States
451,000
50,890,840
a
Keysight
Technologies,
Inc.
..............................
United
States
516,500
54,165,355
105,056,195
Entertainment
2.8%
a
Roku,
Inc.
...........................................
United
States
260,278
52,680,267
a
Spotify
Technology
SA
..................................
United
States
139,500
33,464,655
a
Zynga,
Inc.,
A
........................................
United
States
4,040,000
36,319,600
122,464,522
Equity
Real
Estate
Investment
Trusts
(REITs)
1.9%
SBA
Communications
Corp.
.............................
United
States
241,500
70,124,355
Terreno
Realty
Corp.
...................................
United
States
238,500
13,422,780
83,547,135
Food
&
Staples
Retailing
0.4%
a
Grocery
Outlet
Holding
Corp.
............................
United
States
425,000
18,708,500
a
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
46
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Health
Care
Equipment
&
Supplies
6.3%
a
DexCom
,
Inc.
........................................
United
States
86,314
$
27,584,228
a
IDEXX
Laboratories,
Inc.
................................
United
States
210,500
89,424,610
a
Inari
Medical,
Inc.
.....................................
United
States
138,000
9,135,600
a
Insulet
Corp.
.........................................
United
States
78,200
17,379,950
a
iRhythm
Technologies,
Inc.
..............................
United
States
130,050
27,499,073
a
Penumbra,
Inc.
.......................................
United
States
237,247
61,928,584
Teleflex,
Inc.
.........................................
United
States
140,000
44,552,200
277,504,245
Health
Care
Providers
&
Services
2.1%
a
Guardant
Health,
Inc.
..................................
United
States
483,500
51,570,110
a
HealthEquity
,
Inc.
.....................................
United
States
483,700
24,905,713
a,b
Oak
Street
Health,
Inc.
.................................
United
States
351,200
16,713,608
93,189,431
Health
Care
Technology
2.6%
a
American
Well
Corp.,
A
.................................
United
States
147,600
3,809,556
a,c
Livongo
Health,
Inc.
...................................
United
States
267,300
34,116,654
a
Teladoc
Health,
Inc.
...................................
United
States
11,840
2,326,086
a
Veeva
Systems,
Inc.,
A
.................................
United
States
274,000
73,993,700
114,245,996
Hotels,
Restaurants
&
Leisure
5.1%
a
Chipotle
Mexican
Grill,
Inc.
..............................
United
States
32,800
39,408,544
Domino's
Pizza,
Inc.
...................................
United
States
85,500
32,346,360
a
DraftKings
,
Inc.,
A
.....................................
United
States
2,173,158
76,929,793
Vail
Resorts,
Inc.
......................................
United
States
199,500
46,291,980
Wingstop
,
Inc.
........................................
United
States
266,500
31,001,945
225,978,622
Household
Durables
1.0%
a
NVR,
Inc.
...........................................
United
States
10,900
43,088,681
a
Household
Products
0.9%
Church
&
Dwight
Co.,
Inc.
...............................
United
States
455,600
40,270,484
Interactive
Media
&
Services
2.4%
a
Match
Group,
Inc.
.....................................
United
States
345,859
40,389,414
a
Pinterest,
Inc.,
A
......................................
United
States
1,088,400
64,161,180
104,550,594
Internet
&
Direct
Marketing
Retail
1.1%
Expedia
Group,
Inc.
...................................
United
States
266,100
25,053,315
c,d
Marqeta
,
Inc.
.........................................
United
States
1,070,236
9,769,168
a
Wayfair,
Inc.,
A
.......................................
United
States
59,200
14,683,376
49,505,859
IT
Services
11.4%
a,b
BigCommerce
Holdings,
Inc.,
1
...........................
United
States
238,100
17,476,540
a
Black
Knight,
Inc.
.....................................
United
States
853,000
75,021,350
Booz
Allen
Hamilton
Holding
Corp.
........................
United
States
413,200
32,436,200
a
EPAM
Systems,
Inc.
...................................
United
States
133,500
41,244,825
a
GoDaddy
,
Inc.,
A
......................................
United
States
565,300
39,989,322
Jack
Henry
&
Associates,
Inc.
............................
United
States
319,500
47,365,875
a,e
Nuvei
Corp.,
144A,
Reg
S
...............................
Canada
117,900
4,381,164
a
Okta
,
Inc.
...........................................
United
States
331,500
69,558,645
a
Shift4
Payments,
Inc.,
A
................................
United
States
368,300
18,750,153
a
Twilio
,
Inc.,
A
.........................................
United
States
434,200
121,128,774
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
47
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
IT
Services
(continued)
a
Wix.com
Ltd.
.........................................
Israel
145,500
$
35,985,060
503,337,908
Leisure
Products
0.5%
a
Peloton
Interactive,
Inc.,
A
...............................
United
States
185,200
20,410,892
a
Life
Sciences
Tools
&
Services
3.6%
a
10X
Genomics,
Inc.,
A
..................................
United
States
260,000
35,594,000
Bio-
Techne
Corp.
.....................................
United
States
170,200
42,960,182
a
Mettler
-Toledo
International,
Inc.
..........................
United
States
80,900
80,730,919
159,285,101
Machinery
2.2%
Fortive
Corp.
.........................................
United
States
574,500
35,389,200
IDEX
Corp.
..........................................
United
States
177,000
30,159,030
Stanley
Black
&
Decker,
Inc.
.............................
United
States
180,500
29,999,100
95,547,330
Personal
Products
0.4%
a
BellRing
Brands,
Inc.,
A
.................................
United
States
1,074,300
19,648,947
a
Pharmaceuticals
2.0%
a,b
GW
Pharmaceuticals
plc,
ADR
...........................
United
Kingdom
224,200
20,180,242
a
Horizon
Therapeutics
plc
................................
United
States
589,000
44,133,770
a
Reata
Pharmaceuticals,
Inc.,
A
...........................
United
States
211,200
24,649,152
88,963,164
Professional
Services
4.9%
a
CoStar
Group,
Inc.
....................................
United
States
116,800
96,197,648
TransUnion
..........................................
United
States
482,000
38,396,120
Verisk
Analytics,
Inc.
...................................
United
States
452,000
80,442,440
215,036,208
Road
&
Rail
1.3%
Kansas
City
Southern
..................................
United
States
163,000
28,710,820
Old
Dominion
Freight
Line,
Inc.
...........................
United
States
150,150
28,584,056
57,294,876
Semiconductors
&
Semiconductor
Equipment
6.4%
a
Allegro
MicroSystems
,
Inc.
..............................
United
States
716,500
13,111,950
Entegris
,
Inc.
.........................................
United
States
194,000
14,505,380
KLA
Corp.
...........................................
United
States
260,500
51,365,390
a
Lattice
Semiconductor
Corp.
.............................
United
States
1,322,214
46,145,269
Microchip
Technology,
Inc.
..............................
United
States
240,000
25,219,200
Monolithic
Power
Systems,
Inc.
...........................
United
States
125,500
40,109,800
NXP
Semiconductors
NV
...............................
Netherlands
182,000
24,591,840
a
Semtech
Corp.
.......................................
United
States
467,963
25,686,489
a
SiTime
Corp.
.........................................
United
States
496,000
41,411,040
282,146,358
Software
15.8%
a
Alteryx,
Inc.,
A
........................................
United
States
321,700
40,325,095
a
ANSYS,
Inc.
.........................................
United
States
219,500
66,809,215
a
Atlassian
Corp.
plc,
A
..................................
United
States
221,000
42,348,020
a
Avalara,
Inc.
.........................................
United
States
272,500
40,616,125
a
Bentley
Systems,
Inc.,
B
................................
United
States
63,500
2,226,310
a
Bill.com
Holdings,
Inc.
..................................
United
States
446,233
44,623,300
a
Cloudflare
,
Inc.,
A
.....................................
United
States
882,400
45,858,328
a
DocuSign,
Inc.
.......................................
United
States
481,700
97,423,825
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
48
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Software
(continued)
a,b
Duck
Creek
Technologies,
Inc.
...........................
United
States
205,800
$
8,925,546
a
HubSpot
,
Inc.
........................................
United
States
45,100
13,082,157
a
Lightspeed
POS,
Inc.
..................................
Canada
714,400
22,882,232
a
Paylocity
Holding
Corp.
.................................
United
States
383,000
71,054,160
a
Q2
Holdings,
Inc.
.....................................
United
States
342,000
31,204,080
a
Synopsys,
Inc.
.......................................
United
States
480,500
102,759,730
a
Zendesk
,
Inc.
........................................
United
States
574,000
63,679,560
693,817,683
Specialty
Retail
2.7%
a
Burlington
Stores,
Inc.
..................................
United
States
254,000
49,169,320
a
Five
Below,
Inc.
.......................................
United
States
278,500
37,135,190
Tractor
Supply
Co.
....................................
United
States
228,000
30,371,880
116,676,390
Textiles,
Apparel
&
Luxury
Goods
0.9%
Levi
Strauss
&
Co.,
A
..................................
United
States
1,460,000
23,038,800
VF
Corp.
............................................
United
States
265,700
17,855,040
40,893,840
Trading
Companies
&
Distributors
0.7%
Fastenal
Co.
.........................................
United
States
744,000
32,163,120
Total
Common
Stocks
(Cost
$2,604,801,812)
....................................
4,214,716,509
Preferred
Stocks
1.3%
Automobiles
0.5%
a,c,d,e
Proterra
,
Inc.,
144A,
5
..................................
United
States
1,416,913
21,084,294
a
Internet
&
Direct
Marketing
Retail
0.3%
a,c,d
Fanatics,
Inc.,
E
......................................
United
States
775,014
13,274,440
a
Semiconductors
&
Semiconductor
Equipment
0.2%
a,c,d
Phononic
Devices,
Inc.,
F
...............................
United
States
2,970,061
5,912,774
a
Software
0.1%
a,c,d
Alkami
Technology,
Inc.,
F
...............................
United
States
405,100
6,481,600
a
Textiles,
Apparel
&
Luxury
Goods
0.2%
a,c,d
Allbirds
,
Inc.,
E
.......................................
United
States
772,477
8,931,711
a
Total
Preferred
Stocks
(Cost
$43,449,215)
......................................
55,684,819
Warrants
Warrants
0.0%
Semiconductors
&
Semiconductor
Equipment
0.0%
a,c,d
Phononic
Devices,
Inc.,
12/01/29
.........................
United
States
511,298
1,127,996
Total
Warrants
(Cost
$47)
.....................................................
1,127,996
Principal
Amount
*
f,g
Senior
Floating
Rate
Interests
0.0%
c,d,h
Phononic
,
Inc.,
Term
Loan,
A,
12%,
PIK,
(1-month
USD
LIBOR;
3-month
USD
LIBOR),
1/17/24
..........................
United
States
523,663
480,267
Franklin
Strategic
Series
Statement
of
Investments
(unaudited)
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
49
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
f,g
Senior
Floating
Rate
Interests
(continued)
Semiconductors
&
Semiconductor
Equipment
(continued)
c,d,h
Phononic
,
Inc.,
Term
Loan
Advance,
B,
12%,
PIK,
(1-month
USD
LIBOR),
7/31/26
.....................................
United
States
107,694
$
97,377
577,644
a
a
a
a
a
a
Total
Senior
Floating
Rate
Interests
(Cost
$619,395)
.............................
577,644
Total
Long
Term
Investments
(Cost
$2,648,870,469)
.............................
4,272,106,968
a
Short
Term
Investments
4.4%
a
a
Country
Shares
a
Value
a
Money
Market
Funds
3.5%
i,j
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
........
United
States
153,680,493
153,680,493
Total
Money
Market
Funds
(Cost
$153,680,493)
.................................
153,680,493
a
a
a
a
a
k
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
0.9%
Money
Market
Funds
0.9%
i,j
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
........
United
States
41,659,325
41,659,325
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$41,659,325)
...........................................................
41,659,325
Total
Short
Term
Investments
(Cost
$195,339,818
)
...............................
195,339,818
a
Total
Investments
(Cost
$2,844,210,287)
101.4%
................................
$4,467,446,786
Other
Assets,
less
Liabilities
(1.4)%
...........................................
(63,234,628)
Net
Assets
100.0%
...........................................................
$4,404,212,158
See
Abbreviations
on
page
78
.
*
The
principal
amount
is
stated
in
U.S.
dollars
unless
otherwise
indicated.
Rounds
to
less
than
0.1%
of
net
assets.
a
Non-income
producing.
b
A
portion
or
all
of
the
security
is
on
loan
at
October
31,
2020.
See
Note
1(c)
c
Fair
valued
using
significant
unobservable
inputs.
See
Note
11
regarding
fair
value
measurements.
d
See
Note
8
regarding
restricted
securities.
e
Security
was
purchased
pursuant
to
Rule
144A
or
Regulation
S
under
the
Securities
Act
of
1933.
144A
securities
may
be
sold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers
or
in
a
public
offering
registered
under
the
Securities
Act
of
1933.
Regulation
S
securities
cannot
be
sold
in
the
United
States
without
either
an
effective
registration
statement
filed
pursuant
to
the
Securities
Act
of
1933,
or
pursuant
to
an
exemption
from
registration.
At
October
31,
2020,
the
aggregate
value
of
these
securities
was
$25,465,458,
representing
0.6%
of
net
assets.
f
See
Note
1(d)
regarding
senior
floating
rate
interests.
g
The
coupon
rate
shown
represents
the
rate
at
period
end.
h
Income
may
be
received
in
additional
securities
and/or
cash.
i
See
Note
3(f)
regarding
investments
in
affiliated
management
investment
companies.
j
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
k
See
Note
1(c)
regarding
securities
on
loan.
Franklin
Strategic
Series
Financial
Statements
Statements
of
Assets
and
Liabilities
October
31,
2020
(unaudited)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
50
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Assets:
Investments
in
securities:
Cost
-
Unaffiliated
issuers
.................................
$1,880,715,637
$2,111,906,283
$2,648,870,469
Cost
-
Non-controlled
affiliates
(Note
3
f
and
9
)
..................
43,907,408
153,711,784
195,339,818
Value
-
Unaffiliated
issuers
(Includes
securities
loaned
$7,580,943,
$41,401,258
and
$39,009,128
respectively)
...................
$4,787,152,019
$3,022,966,935
$4,272,106,968
Value
-
Non-controlled
affiliates
(Note
3
f
and
9
)
.................
43,907,408
155,651,784
195,339,818
Cash
..................................................
44,586
Receivables:
Investment
securities
sold
.................................
3,713,057
7,251,227
3,991,478
Capital
shares
sold
......................................
4,149,691
3,971,491
7,610,467
Dividends
and
interest
...................................
316,552
28,903
450,020
Other
assets
............................................
1,474
963
1,213
Total
assets
........................................
4,839,284,787
3,189,871,303
4,479,499,964
Liabilities:
Payables:
Investment
securities
purchased
............................
20,749,320
21,723,495
Capital
shares
redeemed
.................................
4,654,146
5,564,053
8,053,122
Management
fees
.......................................
2,309,956
1,669,373
1,706,462
Distribution
fees
........................................
1,027,250
294,921
918,615
Transfer
agent
fees
......................................
779,001
655,457
1,027,425
Payable
upon
return
of
securities
loaned
.......................
7,852,835
44,598,950
41,659,325
Accrued
expenses
and
other
liabilities
.........................
133,327
81,093
199,362
Total
liabilities
.......................................
16,756,515
73,613,167
75,287,806
Net
assets,
at
value
...............................
$4,822,528,272
$3,116,258,136
$4,404,212,158
Net
assets
consist
of:
Paid-in
capital
...........................................
$1,630,707,868
$1,842,533,148
$2,347,786,778
Total
distributable
earnings
(losses)
...........................
3,191,820,404
1,273,724,988
2,056,425,380
Net
assets,
at
value
...............................
$4,822,528,272
$3,116,258,136
$4,404,212,158
Franklin
Strategic
Series
Financial
Statements
Statements
of
Assets
and
Liabilities
(continued)
October
31,
2020
(unaudited)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
51
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Class
A:
Net
assets,
at
value
.....................................
$3,538,711,615
$917,327,835
$3,377,035,884
Shares
outstanding
......................................
71,638,419
36,697,927
77,600,378
Net
asset
value
per
share
a
................................
$49.40
$25.00
$43.52
Maximum
offering
price
per
share
(net
asset
value
per
share
÷
94.50
%
)
..............................................
$52.28
$26.46
$46.05
Class
C:
Net
assets,
at
value
.....................................
$247,145,434
$74,105,743
$170,066,466
Shares
outstanding
......................................
6,291,643
3,817,537
6,496,799
Net
asset
value
and
maximum
offering
price
per
share
a
...........
$39.28
$19.41
$26.18
Class
R:
Net
assets,
at
value
.....................................
$36,269,834
$66,585,219
$50,717,390
Shares
outstanding
......................................
780,011
2,860,228
1,318,468
Net
asset
value
and
maximum
offering
price
per
share
...........
$46.50
$23.28
$38.47
Class
R6:
Net
assets,
at
value
.....................................
$464,197,888
$1,498,046,323
$365,949,686
Shares
outstanding
......................................
8,448,007
53,497,701
7,270,601
Net
asset
value
and
maximum
offering
price
per
share
...........
$54.95
$28.00
$50.33
Advisor
Class:
Net
assets,
at
value
.....................................
$536,203,501
$560,193,016
$440,442,732
Shares
outstanding
......................................
9,910,887
20,383,671
8,953,499
Net
asset
value
and
maximum
offering
price
per
share
...........
$54.10
$27.48
$49.19
a
Redemption
price
is
equal
to
net
asset
value
less
contingent
deferred
sales
charges,
if
applicable.
Franklin
Strategic
Series
Financial
Statements
Statements
of
Operations
for
the
six
months
ended
October
31,
2020
(unaudited)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
52
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Investment
income:
Dividends:
(net
of
foreign
taxes
of
$–,
$–
and
$20,475,
respectively)
Unaffiliated
issuers
......................................
$9,579,073
$4,648,975
$6,686,765
Interest:
Unaffiliated
issuers:
Payment-in-kind
.......................................
25,308
Income
from
securities
loaned:
Unaffiliated
entities
(net
of
fees
and
rebates)
...................
90,872
414,169
564,112
Total
investment
income
.................................
9,669,945
5,063,144
7,276,185
Expenses:
Management
fees
(Note
3
a
)
.................................
12,715,620
9,019,590
9,294,214
Distribution
fees:
(Note
3c
)
Class
A
..............................................
4,322,386
1,076,496
3,936,782
Class
C
..............................................
1,256,632
381,360
837,115
Class
R
..............................................
89,995
162,017
122,663
Transfer
agent
fees:
(Note
3e
)
Class
A
..............................................
2,013,801
800,449
2,215,923
Class
C
..............................................
146,539
70,967
117,899
Class
R
..............................................
21,302
60,278
35,263
Class
R6
.............................................
56,961
249,927
68,359
Advisor
Class
..........................................
313,534
501,787
284,217
Custodian
fees
(Note
4
)
....................................
17,934
20,557
15,393
Reports
to
shareholders
....................................
137,997
82,985
164,439
Registration
and
filing
fees
..................................
78,440
61,772
77,953
Professional
fees
.........................................
45,408
51,888
45,510
Trustees'
fees
and
expenses
................................
24,270
16,296
21,482
Other
..................................................
39,826
26,939
37,630
Total
expenses
.......................................
21,280,645
12,583,308
17,274,842
Expense
reductions
(Note
4
)
.............................
(13,747)
(5,845)
(190)
Expenses
waived/paid
by
affiliates
(Note
3
f
and
3
g
)
............
(46,344)
(189,048)
(112,377)
Net
expenses
.......................................
21,220,554
12,388,415
17,162,275
Net
investment
income
(loss)
..........................
(11,550,609)
(7,325,271)
(9,886,090)
Realized
and
unrealized
gains
(losses):
Net
realized
gain
(loss)
from:
Investments:
Unaffiliated
issuers
....................................
272,905,209
399,725,237
396,253,720
Foreign
currency
transactions
..............................
(28,985)
Net
realized
gain
(loss)
................................
272,905,209
399,725,237
396,224,735
Net
change
in
unrealized
appreciation
(depreciation)
on:
Investments:
Unaffiliated
issuers
....................................
717,752,487
382,722,251
755,152,518
Non-controlled
affiliates
(Note
3
f
and
9
)
.....................
1,940,000
Net
change
in
unrealized
appreciation
(depreciation)
..........
717,752,487
384,662,251
755,152,518
Net
realized
and
unrealized
gain
(loss)
..........................
990,657,696
784,387,488
1,151,377,253
Net
increase
(decrease)
in
net
assets
resulting
from
operations
........
$979,107,087
$777,062,217
$1,141,491,163
Franklin
Strategic
Series
Financial
Statements
Statements
of
Changes
in
Net
Assets
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
53
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
Increase
(decrease)
in
net
assets:
Operations:
Net
investment
income
(loss)
.......
$(11,550,609)
$(12,850,118)
$(7,325,271)
$(7,894,136)
Net
realized
gain
(loss)
............
272,905,209
133,545,617
399,725,237
17,675,243
Net
change
in
unrealized
appreciation
(depreciation)
.................
717,752,487
214,046,447
384,662,251
(167,481,598)
Net
increase
(decrease)
in
net
assets
resulting
from
operations
.
979,107,087
334,741,946
777,062,217
(157,700,491)
Distributions
to
shareholders:
Class
A
........................
(237,578,955)
(48,340,636)
Class
C
........................
(22,239,105)
(6,520,298)
Class
R
........................
(2,892,923)
(4,473,797)
Class
R6
.......................
(28,916,895)
(64,617,144)
Advisor
Class
...................
(38,146,343)
(40,149,307)
Total
distributions
to
shareholders
.....
(329,774,221)
(164,101,182)
Capital
share
transactions:
(Note
2
)
Class
A
........................
(57,315,736)
62,785,864
5,873,981
68,255,158
Class
C
........................
(21,957,738)
(22,481,948)
(12,652,828)
(12,115,565)
Class
R
........................
(2,393,908)
(5,745,243)
(5,010,461)
(11,347,524)
Class
R6
.......................
(10,931,645)
(39,007,657)
(11,250,885)
198,501,453
Advisor
Class
...................
(46,122,989)
(44,198,935)
(10,105,648)
(237,802,378)
Total
capital
share
transactions
.......
(138,722,016)
(48,647,919)
(33,145,841)
5,491,144
Net
increase
(decrease)
in
net
assets
.....................
840,385,071
(43,680,194)
743,916,376
(316,310,529)
Net
assets:
Beginning
of
period
................
3,982,143,201
4,025,823,395
2,372,341,760
2,688,652,289
End
of
period
.....................
$4,822,528,272
$3,982,143,201
$3,116,258,136
$2,372,341,760
Franklin
Strategic
Series
Financial
Statements
Statements
of
Changes
in
Net
Assets
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
54
Franklin
Small-Mid
Cap
Growth
Fund
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
Increase
(decrease)
in
net
assets:
Operations:
Net
investment
income
(loss)
............................................
$(9,886,090)
$(6,543,509)
Net
realized
gain
(loss)
.................................................
396,224,735
192,334,944
Net
change
in
unrealized
appreciation
(depreciation)
...........................
755,152,518
(99,401,303)
Net
increase
(decrease)
in
net
assets
resulting
from
operations
................
1,141,491,163
86,390,132
Distributions
to
shareholders:
Class
A
.............................................................
(425,921,425)
Class
C
.............................................................
(36,725,001)
Class
R
.............................................................
(8,320,703)
Class
R6
............................................................
(36,761,924)
Advisor
Class
........................................................
(46,972,961)
Total
distributions
to
shareholders
..........................................
(554,702,014)
Capital
share
transactions:
(Note
2
)
Class
A
.............................................................
(25,831,938)
190,363,531
Class
C
.............................................................
(16,330,110)
(152,558)
Class
R
.............................................................
(4,432,621)
(2,601,164)
Class
R6
............................................................
60,639,288
(3,283,468)
Advisor
Class
........................................................
26,269,237
(15,986,912)
Total
capital
share
transactions
............................................
40,313,856
168,339,429
Net
increase
(decrease)
in
net
assets
...................................
1,181,805,019
(299,972,453)
Net
assets:
Beginning
of
period
.....................................................
3,222,407,139
3,522,379,592
End
of
period
..........................................................
$4,404,212,158
$3,222,407,139
Franklin
Strategic
Series
55
franklintempleton.com
Semiannual
Report
Notes
to
Financial
Statements
(unaudited)
1.
Organization
and
Significant
Accounting
Policies
Franklin
Strategic
Series (Trust)
is
registered
under
the
Investment
Company
Act
of
1940
(1940
Act)
as
an
open-
end
management
investment
company,
consisting
of
ten
separate
funds, three
of
which
are
included
in
this
report
(Funds)
and
applies
the
specialized
accounting
and
reporting
guidance
in
U.S.
Generally
Accepted
Accounting
Principles
(U.S.
GAAP).
The
Funds
offer five classes
of
shares: Class
A,
Class
C,
Class
R,
Class
R6,
and
Advisor
Class. Class
C
shares
automatically
convert
to
Class
A
shares
after
they
have
been
held
for
10
years.
Each
class
of
shares
may
differ
by
its initial
sales
load,
contingent
deferred
sales
charges,
voting
rights
on
matters
affecting
a
single
class,
its
exchange
privilege
and
fees
due
to
differing
arrangements
for
distribution
and
transfer
agent
fees.
The
following
summarizes
the Funds'
significant
accounting
policies. 
a.
Financial
Instrument
Valuation 
The Funds'
investments
in
financial
instruments
are
carried
at
fair
value
daily.
Fair
value
is
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
on
the
measurement
date.
The Funds calculate the
net
asset
value
(NAV)
per
share
each
business
day
as
of
4
p.m.
Eastern
time
or
the
regularly
scheduled
close
of
the
New
York
Stock
Exchange
(NYSE),
whichever
is
earlier.
Under
compliance
policies
and
procedures
approved
by
the
Trust's
Board
of
Trustees
(the
Board),
the
Funds' administrator
has
responsibility
for
oversight
of
valuation,
including
leading
the
cross-functional
Valuation
Committee
(VC).
The
Funds
may
utilize
independent
pricing
services,
quotations
from
securities
and
financial
instrument
dealers,
and
other
market
sources
to
determine
fair
value. 
Equity
securities
listed
on
an
exchange
or
on
the
NASDAQ
National
Market
System
are
valued
at
the
last
quoted
sale
price
or
the
official
closing
price of
the
day,
respectively.
Foreign
equity
securities
are
valued
as
of
the
close
of
trading
on
the
foreign
stock
exchange
on
which
the
security
is
primarily
traded,
or
as
of
4
p.m.
Eastern
time.
The
value
is
then
converted
into
its
U.S.
dollar
equivalent
at
the
foreign
exchange
rate
in
effect
at
4
p.m.
Eastern
time
on
the
day
that
the
value
of
the
security
is
determined.
Over-the-counter
(OTC)
securities
are
valued
within
the
range
of
the
most
recent
quoted
bid
and
ask
prices.
Securities
that
trade
in
multiple
markets
or
on
multiple
exchanges
are
valued
according
to
the
broadest
and
most
representative
market.
Certain
equity
securities
are
valued
based
upon
fundamental
characteristics
or
relationships
to
similar
securities. 
Debt
securities
generally
trade
in
the
OTC
market
rather
than
on
a
securities
exchange.
The
Funds'
pricing
services
use
multiple
valuation
techniques
to
determine
fair
value.
In
instances
where
sufficient
market
activity
exists,
the
pricing
services
may
utilize
a
market-based
approach
through
which
quotes
from
market
makers
are
used
to
determine
fair
value.
In
instances
where
sufficient
market
activity
may
not
exist
or
is
limited,
the
pricing
services
also
utilize
proprietary
valuation
models
which
may
consider
market
characteristics
such
as
benchmark
yield
curves,
credit
spreads,
estimated
default
rates,
anticipated
market
interest
rate
volatility,
coupon
rates,
anticipated
timing
of
principal
repayments,
underlying
collateral,
and
other
unique
security
features
in
order
to
estimate
the
relevant
cash
flows,
which
are
then
discounted
to
calculate
the
fair
value.
Securities
denominated
in
a
foreign
currency
are
converted
into
their
U.S.
dollar
equivalent
at
the
foreign
exchange
rate
in
effect
at
4
p.m.
Eastern
time
on
the
date
that
the
values
of
the
foreign
debt
securities
are
determined.
Investments
in open-end mutual
funds
are
valued
at
the
closing
NAV.
The
Funds
have
procedures
to
determine
the
fair
value
of
financial
instruments
for
which
market
prices
are
not
reliable
or
readily
available.
Under
these
procedures,
the
Funds
primarily
employ
a
market-based
approach
which
may
use
related
or
comparable
assets
or
liabilities,
recent
transactions,
market
multiples,
book
values,
and
other
relevant
information
for
the
investment
to
determine
the
fair
value
of
the
investment.
An
income-based
valuation
approach
may
also
be
used
in
which
the
anticipated
future
cash
flows
of
the
investment
are
discounted
to
calculate
fair
value.
Discounts
may
also
be
applied
due
to
the
nature
or
duration
of
any
restrictions
on
the
disposition
of
the
investments.
Due
to
the
inherent
uncertainty
of
valuations
of
such
investments,
the
fair
values
may
differ
significantly
from
the
values
that
would
have
been
used
had
an
active
market
existed.
Trading
in
securities
on
foreign
securities
stock
exchanges
and
OTC
markets
may
be
completed
before
4
p.m.
Eastern
time.
In
addition,
trading
in
certain
foreign
markets
may
not
take
place
on
every
Funds'
business
day.
Occasionally,
events
occur
between
the
time
at
which
trading
in
a
foreign
security
is
completed
and
4
p.m.
Eastern
time
that
might
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
56
franklintempleton.com
Semiannual
Report
call
into
question
the
reliability
of
the
value
of
a
portfolio
security
held
by
the
Funds.
As
a
result,
differences
may
arise
between
the
value
of
the
Funds'
portfolio
securities
as
determined
at
the
foreign
market
close
and
the
latest
indications
of
value
at
4
p.m.
Eastern
time.
The
VC
monitors
price
movements
for
significant
events
following
the
close
of
trading
in
foreign
stock
markets
through
a
series
of
country
specific
market
proxies
(such
as
baskets
of
American
Depositary
Receipts,
futures
contracts
and
exchange
traded
funds).
These
price
movements
are
measured
against
established
trigger
thresholds
for
each
specific
market
proxy
to
assist
in
determining
if
an
event
has
occurred
that
may
call
into
question
the
reliability
of
the
values
of
the
foreign
securities
held
by
the
Funds.
If
such
an
event
occurs,
the
securities
may
be
valued
using
fair
value
procedures,
which
may
include
the
use
of
independent
pricing
services.
When
the
last
day
of
the
reporting
period
is
a
non-business
day,
certain
foreign
markets
may
be
open
on
those
days
that
the
Funds'
NAV
is
not
calculated,
which
could
result
in
differences
between
the
value
of
the
Funds'
portfolio
securities
on
the
last
business
day
and
the
last
calendar
day
of
the
reporting
period.
Any
security
valuation
changes
due
to
an
open
foreign
market
are
adjusted
and
reflected
by
the
Funds
for
financial
reporting
purposes.
b.
Foreign
Currency
Translation 
Portfolio
securities
and
other
assets
and
liabilities
denominated
in
foreign
currencies
are
translated
into
U.S.
dollars
based
on
the
exchange
rate
of
such
currencies
against
U.S.
dollars
on
the
date
of
valuation.
The
Funds
may
enter
into
foreign
currency
exchange
contracts
to
facilitate
transactions
denominated
in
a
foreign
currency.
Purchases
and
sales
of
securities,
income
and
expense
items
denominated
in
foreign
currencies
are
translated
into
U.S.
dollars
at
the
exchange
rate
in
effect
on
the
transaction
date.
Portfolio
securities
and
assets
and
liabilities
denominated
in
foreign
currencies
contain
risks
that
those
currencies
will
decline
in
value
relative
to
the
U.S.
dollar.
Occasionally,
events
may
impact
the
availability
or
reliability
of
foreign
exchange
rates
used
to
convert
the
U.S.
dollar
equivalent
value.
If
such
an
event
occurs,
the
foreign
exchange
rate
will
be
valued
at
fair
value
using
procedures
established
and
approved
by
the
Board.
The
Funds
do
not
separately
report
the
effect
of
changes
in
foreign
exchange
rates
from
changes
in
market
prices
on
securities
held.
Such
changes
are
included
in
net
realized
and
unrealized
gain
or
loss
from
investments
in
the
Statements
of
Operations.
Realized
foreign
exchange
gains
or
losses
arise
from
sales
of
foreign
currencies,
currency
gains
or
losses
realized
between
the
trade
and
settlement
dates
on
securities
transactions
and
the
difference
between
the
recorded
amounts
of
dividends,
interest,
and
foreign
withholding
taxes
and
the
U.S.
dollar
equivalent
of
the
amounts
actually
received
or
paid.
Net
unrealized
foreign
exchange
gains
and
losses
arise
from
changes
in
foreign
exchange
rates
on
foreign
denominated
assets
and
liabilities
other
than
investments
in
securities
held
at
the
end
of
the
reporting
period.
c.
Securities
Lending
Certain
or
all
Funds
participate
in
an
agency
based
securities
lending
program
to
earn
additional
income.
The
Fund
receives
collateral
in
the
form
of
cash
and/or
U.S.
Government
and
Agency
securities
against
the
loaned
securities
in
an
amount
equal
to
at
least
102%
of
the
fair
value
of
the
loaned
securities.
Collateral
is
maintained
over
the
life
of
the
loan
in
an
amount
not
less
than
100%
of
the
fair
value
of
loaned
securities,
as
determined
at
the
close
of
Fund
business
each
day;
any
additional
collateral
required
due
to
changes
in
security
values
is
delivered
to
the
Fund
on
the
next
business
day.
Any
cash
collateral
received
is
deposited
into
a
joint
cash
account
with
other
funds
and
is
used
to
invest
in
a
money
market
fund
managed
by
Franklin
Advisers,
Inc.,
an
affiliate
of
the
Funds,
and/or
a
joint
repurchase
agreement
in
the
Statements
of
Assets
and
Liabilities.
The
Fund
may
receive
income
from
the
investment
of
cash
collateral,
in
addition
to
lending
fees
and
rebates
paid
by
the
borrower.
Income
from
securities
loaned,
net
of
fees
paid
to
the
securities
lending
agent
and/or
third-
party
vendor,
is
reported
separately
in
the
Statements
of
Operations.
The
Fund
bears
the
market
risk
with
respect
to any
cash collateral
investment,
securities
loaned,
and
the
risk
that
the
agent
may
default
on
its
obligations
to
the
Fund.
If
the
borrower
defaults
on
its
obligation
to
return
the
securities
loaned,
the
Fund
has
the
right
to
repurchase
the
securities
in
the
open
market
using
the
collateral
received.
1.
Organization
and
Significant
Accounting
Policies
(continued)
a.
Financial
Instrument
Valuation 
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
57
franklintempleton.com
Semiannual
Report
d.
Senior
Floating
Rate
Interests
Certain
or
all
Funds
invest
in
senior
secured
corporate
loans
that
pay
interest
at
rates
which
are
periodically
reset
by
reference
to
a
base
lending
rate
plus
a
spread.
These
base
lending
rates
are
generally
the
prime
rate
offered
by
a
designated
U.S.
bank
or
the
London
InterBank
Offered
Rate
(LIBOR).
Senior
secured
corporate
loans
often
require
prepayment
of
principal
from
excess
cash
flows
or
at
the
discretion
of
the
borrower.
As
a
result,
actual
maturity
may
be
substantially
less
than
the
stated
maturity.
Senior
secured
corporate
loans
in
which
the
Funds
invest
are
generally
readily
marketable,
but
may
be
subject
to
certain
restrictions
on
resale.
On
July
27,
2017,
the
United
Kingdom's
Financial
Conduct
Authority
announced
its
intention
to
cease
sustaining
LIBOR
after
2021.
There
remains
uncertainty
regarding
the
future
utilization
of
LIBOR
and
the
nature
of
any
replacement
rate.
As
such,
the
potential
effect
of
a
transition
away
from
LIBOR
on
the
Fund
or
the
Fund's
investments
that
use
or
may
use
a
floating
rate
based
on
LIBOR
cannot
yet
be
determined.
e.
Income
and
Deferred
Taxes
It
is each
Fund's
policy
to
qualify
as
a
regulated
investment
company
under
the
Internal
Revenue
Code. Each
Fund
intends
to
distribute
to
shareholders
substantially
all
of
its
taxable
income
and
net
realized
gains
to
relieve
it
from
federal
income
and
excise
taxes.
As
a
result,
no
provision
for
U.S.
federal
income
taxes
is
required.
The
Funds
may
be
subject
to
foreign
taxation
related
to
income
received,
capital
gains
on
the
sale
of
securities
and
certain
foreign
currency
transactions
in
the
foreign
jurisdictions
in
which
the
Funds
invest.
Foreign
taxes,
if
any,
are
recorded
based
on
the
tax
regulations
and
rates
that
exist
in
the
foreign
markets
in
which
the
Funds
invest.
When
a
capital
gain
tax
is
determined
to
apply,
certain
or
all
Funds
record
an
estimated
deferred
tax
liability
in
an
amount
that
would
be
payable
if
the
securities
were
disposed
of
on
the
valuation
date.
Each
Fund
may
recognize
an
income
tax
liability
related
to
its
uncertain
tax
positions
under
U.S.
GAAP
when
the
uncertain
tax
position
has
a
less
than
50%
probability
that
it
will
be
sustained
upon
examination
by
the
tax
authorities
based
on
its
technical
merits.
As
of
October
31,
2020, each
Fund
has
determined
that
no
tax
liability
is
required
in
its
financial
statements
related
to
uncertain
tax
positions
for
any
open
tax
years
(or
expected
to
be
taken
in
future
tax
years).
Open
tax
years
are
those
that
remain
subject
to
examination
and
are
based
on
the
statute
of
limitations
in
each
jurisdiction
in
which
the
Fund
invests. 
f.
Security
Transactions,
Investment
Income,
Expenses
and
Distributions
Security
transactions
are
accounted
for
on
trade
date.
Realized
gains
and
losses
on
security
transactions
are
determined
on
a
specific
identification
basis.
Interest
income
and
estimated
expenses
are
accrued
daily.
Dividend
income
is
recorded
on
the
ex-dividend
date
except
for
certain
dividends
from
securities
where
the
dividend
rate
is
not
available.
In
such
cases,
the
dividend
is
recorded
as
soon
as
the
information
is
received
by
the
Funds.
Distributions
to shareholders
are
recorded
on
the
ex-dividend
date.
Distributable
earnings
are
determined
according
to
income
tax
regulations
(tax
basis)
and
may
differ
from
earnings
recorded
in
accordance
with
U.S.
GAAP.
These
differences
may
be
permanent
or
temporary.
Permanent
differences
are
reclassified
among
capital
accounts
to
reflect
their
tax
character.
These
reclassifications
have
no
impact
on
net
assets
or
the
results
of
operations.
Temporary
differences
are
not
reclassified,
as
they
may
reverse
in
subsequent
periods.
Common
expenses
incurred
by
the
Trust
are
allocated
among
the
Funds
based
on
the
ratio
of
net
assets
of
each
Fund
to
the
combined
net
assets
of
the
Trust
or
based
on
the
ratio
of
number
of
shareholders
of
each
Fund
to
the
combined
number
of
shareholders
of
the
Trust.
Fund
specific
expenses
are
charged
directly
to
the
Fund
that
incurred
the
expense.
Realized
and
unrealized
gains
and
losses
and
net
investment
income,
excluding
class
specific
expenses,
are
allocated
daily
to
each
class
of
shares
based
upon
the
relative
proportion
of
net
assets
of
each
class.
Differences
in
per
share
distributions
by
class
are
generally
due
to
differences
in
class
specific
expenses.
g.
Accounting
Estimates
The
preparation
of
financial
statements
in
accordance
with
U.S.
GAAP
requires
management
to
make
estimates
and
assumptions
that
affect
the
reported
amounts
of
assets
1.
Organization
and
Significant
Accounting
Policies
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
58
franklintempleton.com
Semiannual
Report
and
liabilities
at
the
date
of
the
financial
statements
and
the
amounts
of
income
and
expenses
during
the
reporting
period.
Actual
results
could
differ
from
those
estimates.
h.
Guarantees
and
Indemnifications
Under
the
Trust's
organizational
documents,
its
officers
and
trustees
are
indemnified
by
the
Trust
against
certain
liabilities
arising
out
of
the
performance
of
their
duties
to
the
Trust.
Additionally,
in
the
normal
course
of
business,
the
Trust,
on
behalf
of
the
Funds,
enters
into
contracts
with
service
providers
that
contain
general
indemnification
clauses.
The
Trust's
maximum
exposure
under
these
arrangements
is
unknown
as
this
would
involve
future
claims
that
may
be
made
against
the
Trust
that
have
not
yet
occurred.
Currently,
the
Trust
expects
the
risk
of
loss
to
be
remote.
2.
Shares
of
Beneficial
Interest
At
October
31,
2020,
there
were
an
unlimited
number
of
shares
authorized
(without
par
value).
Transactions
in
the
Funds'
shares
were
as
follows:
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Shares
Amount
Shares
Amount
Class
A
Class
A
Shares:
Six
Months
ended
October
31,
2020
Shares
sold
a
...................................
4,760,414
$226,500,701
4,345,330
$101,385,199
Shares
redeemed
...............................
(5,943,862)
(283,816,437)
(4,084,220)
(95,511,218)
Net
increase
(decrease)
..........................
(1,183,448)
$(57,315,736)
261,110
$5,873,981
Year
ended
April
30,
2020
Shares
sold
a
...................................
9,010,676
$350,593,688
9,570,599
$191,507,079
Shares
issued
in
reinvestment
of
distributions
..........
5,700,998
220,628,503
2,179,464
46,378,986
Shares
redeemed
...............................
(13,139,219)
(508,436,327)
(8,559,848)
(169,630,907)
Net
increase
(decrease)
..........................
1,572,455
$62,785,864
3,190,215
$68,255,158
Class
C
Class
C
Shares:
Six
Months
ended
October
31,
2020
Shares
sold
...................................
651,003
$24,474,252
179,748
$3,291,440
Shares
redeemed
a
..............................
(1,216,963)
(46,431,990)
(872,530)
(15,944,268)
Net
increase
(decrease)
..........................
(565,960)
$(21,957,738)
(692,782)
$(12,652,828)
Year
ended
April
30,
2020
Shares
sold
...................................
1,293,129
$40,701,483
568,029
$8,922,309
Shares
issued
in
reinvestment
of
distributions
..........
702,780
21,772,176
377,981
6,285,830
Shares
redeemed
a
..............................
(2,670,750)
(84,955,607)
(1,712,157)
(27,323,704)
Net
increase
(decrease)
..........................
(674,841)
$(22,481,948)
(766,147)
$(12,115,565)
Class
R
1.
Organization
and
Significant
Accounting
Policies
(continued)
g.
Accounting
Estimates
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
59
franklintempleton.com
Semiannual
Report
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Shares
Amount
Shares
Amount
Class
R
Shares:
Six
Months
ended
October
31,
2020
Shares
sold
...................................
98,310
$4,384,865
319,511
$6,919,530
Shares
redeemed
...............................
(150,606)
(6,778,773)
(552,595)
(11,929,991)
Net
increase
(decrease)
..........................
(52,296)
$(2,393,908)
(233,084)
$(5,010,461)
Year
ended
April
30,
2020
Shares
sold
...................................
153,696
$5,674,779
629,374
$11,840,906
Shares
issued
in
reinvestment
of
distributions
..........
77,840
2,841,942
224,509
4,458,744
Shares
redeemed
...............................
(386,976)
(14,261,964)
(1,464,103)
(27,647,174)
Net
increase
(decrease)
..........................
(155,440)
$(5,745,243)
(610,220)
$(11,347,524)
Class
R6
Class
R6
Shares:
Six
Months
ended
October
31,
2020
Shares
sold
...................................
819,532
$43,702,564
6,355,370
$166,510,351
Shares
redeemed
...............................
(1,086,960)
(54,634,209)
(6,806,827)
(177,761,236)
Net
increase
(decrease)
..........................
(267,428)
$(10,931,645)
(451,457)
$(11,250,885)
Year
ended
April
30,
2020
Shares
sold
...................................
1,145,175
$48,845,021
19,214,024
$441,200,848
Shares
issued
in
reinvestment
of
distributions
..........
497,757
21,363,741
2,403,945
57,093,695
Shares
redeemed
...............................
(2,557,431)
(109,216,419)
(13,369,234)
(299,793,090)
Net
increase
(decrease)
..........................
(914,499)
$(39,007,657)
8,248,735
$198,501,453
Advisor
Class
Advisor
Class
Shares:
Six
Months
ended
October
31,
2020
Shares
sold
...................................
612,690
$31,825,996
3,897,277
$99,333,329
Shares
redeemed
...............................
(1,500,687)
(77,948,985)
(4,200,120)
(109,438,977)
Net
increase
(decrease)
..........................
(887,997)
$(46,122,989)
(302,843)
$(10,105,648)
Year
ended
April
30,
2020
Shares
sold
...................................
1,896,594
$77,753,071
5,254,643
$114,830,032
Shares
issued
in
reinvestment
of
distributions
..........
881,490
37,286,998
1,514,761
35,354,523
Shares
redeemed
...............................
(3,804,471)
(159,239,004)
(17,129,278)
(387,986,933)
Net
increase
(decrease)
..........................
(1,026,387)
$(44,198,935)
(10,359,874)
$(237,802,378)
2.
Shares
of
Beneficial
Interest
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
60
franklintempleton.com
Semiannual
Report
Franklin
Small-Mid
Cap
Growth
Fund
Shares
Amount
Class
A
Class
A
Shares:
Six
Months
ended
October
31,
2020
Shares
sold
a
...................................
5,664,146
$228,791,175
Shares
redeemed
...............................
(6,310,771)
(254,623,113)
Net
increase
(decrease)
..........................
(646,625)
$(25,831,938)
Year
ended
April
30,
2020
Shares
sold
a
...................................
10,129,339
$347,408,925
Shares
issued
in
reinvestment
of
distributions
..........
12,415,749
403,511,847
Shares
redeemed
...............................
(16,517,051)
(560,557,241)
Net
increase
(decrease)
..........................
6,028,037
$190,363,531
Class
C
Class
C
Shares:
Six
Months
ended
October
31,
2020
Shares
sold
...................................
587,311
$14,189,401
Shares
redeemed
a
..............................
(1,247,469)
(30,519,511)
Net
increase
(decrease)
..........................
(660,158)
$(16,330,110)
Year
ended
April
30,
2020
Shares
sold
...................................
923,627
$20,355,427
Shares
issued
in
reinvestment
of
distributions
..........
1,836,941
36,150,992
Shares
redeemed
a
..............................
(2,541,653)
(56,658,977)
Net
increase
(decrease)
..........................
218,915
$(152,558)
Class
R
Class
R
Shares:
Six
Months
ended
October
31,
2020
Shares
sold
...................................
201,470
$7,360,368
Shares
redeemed
...............................
(323,780)
(11,792,989)
Net
increase
(decrease)
..........................
(122,310)
$(4,432,621)
Year
ended
April
30,
2020
Shares
sold
...................................
266,016
$8,098,504
Shares
issued
in
reinvestment
of
distributions
..........
285,909
8,231,336
Shares
redeemed
...............................
(618,220)
(18,931,004)
Net
increase
(decrease)
..........................
(66,295)
$(2,601,164)
Class
R6
Class
R6
Shares:
Six
Months
ended
October
31,
2020
Shares
sold
...................................
2,205,271
$106,305,783
Shares
redeemed
...............................
(978,786)
(45,666,495)
Net
increase
(decrease)
..........................
1,226,485
$60,639,288
Year
ended
April
30,
2020
Shares
sold
...................................
1,909,281
$74,347,388
Shares
issued
in
reinvestment
of
distributions
..........
888,615
33,287,500
Shares
redeemed
...............................
(2,947,420)
(110,918,356)
Net
increase
(decrease)
..........................
(149,524)
$(3,283,468)
Advisor
Class
2.
Shares
of
Beneficial
Interest
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
61
franklintempleton.com
Semiannual
Report
3.
Transactions
with
Affiliates
Franklin
Resources,
Inc.
is
the
holding
company
for
various
subsidiaries
that
together
are
referred
to
as
Franklin
Templeton.
Certain
officers
and
trustees
of
the
Trust
are
also
officers
and/or
directors
of
the
following
subsidiaries:
a.
Management
Fees
Franklin
Growth
Opportunities
Fund
pays
an
investment
management
fee
to
Advisers
based
on
the
average
daily
net
assets
of
the
Fund
as
follows:
Franklin
Small-Mid
Cap
Growth
Fund
Shares
Amount
Advisor
Class
Shares:
Six
Months
ended
October
31,
2020
Shares
sold
...................................
1,570,581
$70,064,095
Shares
redeemed
...............................
(946,055)
(43,794,858)
Net
increase
(decrease)
..........................
624,526
$26,269,237
Year
ended
April
30,
2020
Shares
sold
...................................
1,829,927
$68,814,106
Shares
issued
in
reinvestment
of
distributions
..........
1,212,081
44,434,905
Shares
redeemed
...............................
(3,356,267)
(129,235,923)
Net
increase
(decrease)
..........................
(314,259)
$(15,986,912)
a
May
include
a
portion
of
Class
C
shares
that
were
automatically
converted
to
Class
A.
Subsidiary
Affiliation
Franklin
Advisers,
Inc.
(Advisers)
Investment
manager
Franklin
Templeton
Services,
LLC
(FT
Services)
Administrative
manager
Franklin
Templeton
Distributors,
Inc.
(Distributors)
Principal
underwriter
Franklin
Templeton
Investor
Services,
LLC
(Investor
Services)
Transfer
agent
Annualized
Fee
Rate
Net
Assets
0.700%
Up
to
and
including
$500
million
0.600%
Over
$500
million,
up
to
and
including
$1
billion
0.550%
Over
$1
billion,
up
to
and
including
$1.5
billion
0.500%
Over
$1.5
billion,
up
to
and
including
$6.5
billion
0.475%
Over
$6.5
billion,
up
to
and
including
$11.5
billion
0.450%
Over
$11.5
billion,
up
to
and
including
$16.5
billion
0.440%
Over
$16.5
billion,
up
to
and
including
$19
billion
0.430%
Over
$19
billion,
up
to
and
including
$21.5
billion
0.420%
In
excess
of
$21.5
billion
2.
Shares
of
Beneficial
Interest
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
62
franklintempleton.com
Semiannual
Report
Franklin
Small
Cap
Growth
Fund
pays
an
investment
management
fee
to
Advisers
based
on
the
average
daily
net
assets
of
the
Fund
as
follows:
Franklin
Small-Mid
Cap
Growth
Fund
pays
an
investment
management
fee
to
Advisers
based
on
the
average
daily
net
assets
of
the
Fund
as
follows:
For
the
period
ended
October
31,
2020,
each
Fund's
annualized
gross
effective
investment
management
fee
rate
based
on
average
daily
net
assets
was
as
follows:
b.
Administrative
Fees
Under
an
agreement
with
Advisers,
FT
Services
provides
administrative
services
to
the
Funds.
The
fee
is
paid
by
Advisers
based
on
each
of
the
Fund’s
average
daily
net
assets,
and
is
not
an
additional
expense
of
the
Funds.
c.
Distribution
Fees
The
Board
has
adopted
distribution
plans
for
each
share
class,
with
the
exception
of
Class
R6
and
Advisor
Class
shares,
pursuant
to
Rule
12b-1
under
the
1940
Act.
Under
the
Funds’
Class
A
reimbursement
distribution
plans,
the
Funds
reimburse
Distributors
for
costs
incurred
in
connection
with
the
servicing,
sale
and
distribution
of each
Fund's
shares
up
to
the
maximum
annual
plan
rate.
Under
the
Class
A
reimbursement
distribution
plans,
costs
exceeding
the
maximum
for
the
current
plan
year
cannot
be
reimbursed
in
subsequent
periods.
In
addition,
under
the
Funds’
Class
C
and
R
compensation
distribution
plans,
Annualized
Fee
Rate
Net
Assets
0.750%
Up
to
and
including
$500
million
0.650%
Over
$500
million,
up
to
and
including
$1
billion
0.600%
Over
$1
billion,
up
to
and
including
$1.5
billion
0.550%
Over
$1.5
billion,
up
to
and
including
$6.5
billion
0.525%
Over
$6.5
billion,
up
to
and
including
$11.5
billion
0.500%
Over
$11.5
billion,
up
to
and
including
$16.5
billion
0.490%
Over
$16.5
billion,
up
to
and
including
$19
billion
0.480%
Over
$19
billion,
up
to
and
including
$21.5
billion
0.470%
In
excess
of
$21.5
billion
Annualized
Fee
Rate
Net
Assets
0.625%
Up
to
and
including
$100
million
0.500%
Over
$100
million,
up
to
and
including
$250
million
0.450%
Over
$250
million,
up
to
and
including
$7.5
billion
0.440%
Over
$7.5
billion,
up
to
and
including
$10
billion
0.430%
Over
$10
billion,
up
to
and
including
$12.5
billion
0.420%
Over
$12.5
billion,
up
to
and
including
$15
billion
0.400%
In
excess
of
$15
billion
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Gross
effective
investment
management
fee
rate
........
0.537%
0.609%
0.455%
3.
Transactions
with
Affiliates
(continued)
a.
Management
Fees
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
63
franklintempleton.com
Semiannual
Report
the
Funds
pay
Distributors
for
costs
incurred
in
connection
with
the
servicing,
sale
and
distribution
of
each
Fund's
shares
up
to
the
maximum
annual
plan
rate
for
each
class.
The
plan
year,
for
purposes
of
monitoring
compliance
with
the
maximum
annual
plan
rates,
is
February
1
through
January
31
for
each
Fund.
The
maximum
annual
plan
rates,
based
on
the
average
daily
net
assets,
for
each
class,
are
as
follows:
For
Franklin
Growth
Opportunities
Fund
and
Franklin
Small
Cap
Growth
Fund,
the
Board
has
set
the
current
rate
at
0.25%
per
year
for
Class
A
shares
until
further
notice
and
approval
by
the
Board.
d.
Sales
Charges/Underwriting
Agreements
Front-end
sales
charges
and
contingent
deferred
sales
charges
(CDSC)
do
not
represent
expenses
of
the
Funds.
These
charges
are
deducted
from
the
proceeds
of
sales
of
fund
shares
prior
to
investment
or
from
redemption
proceeds
prior
to
remittance,
as
applicable.
Distributors
has
advised
the
Funds
of
the
following
commission
transactions
related
to
the
sales
and
redemptions
of
the
Funds'
shares
for
the
period:
e.
Transfer
Agent
Fees
Each
class
of
shares
pays
transfer
agent
fees
to
Investor
Services
for
its
performance
of
shareholder
servicing
obligations.
The
fees
are
based
on
an
annualized
asset
based
fee
of
0.02%
plus
a
transaction
based
fee.
In
addition,
each
class
reimburses
Investor
Services
for
out
of
pocket
expenses
incurred
and,
except
for
Class
R6,
reimburses
shareholder
servicing
fees
paid
to
third
parties.
These
fees
are
allocated
daily
based
upon
their
relative
proportion
of
such
classes'
aggregate
net
assets.
Class
R6
pays
Investor
Services
transfer
agent
fees
specific
to
that
class.
For
the
period
ended
October
31,
2020,
the
Funds
paid
transfer
agent
fees
as
noted
in
the
Statements
of
Operations
of
which
the
following
amounts
were
retained
by
Investor
Services:
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Reimbursement
Plans:
Class
A
...............................
0.35%
0.35%
0.25%
Compensation
Plans:
Class
C
...............................
1.00%
1.00%
1.00%
Class
R
...............................
0.50%
0.50%
0.50%
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Sales
charges
retained
net
of
commissions
paid
to
unaffiliated
brokers/dealers
..................
$224,882
$83,676
$211,686
CDSC
retained
...........................
$12,723
$7,977
$11,272
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Transfer
agent
fees
........................
$1,051,698
$738,735
$929,882
3.
Transactions
with
Affiliates
(continued)
c.
Distribution
Fees
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
64
franklintempleton.com
Semiannual
Report
f.
Investments
in
Affiliated
Management
Investment
Companies
Certain
or
all
Funds
invest
in
one
or
more
affiliated
management
investment
companies
for
purposes
other
than
exercising
a
controlling
influence
over
the
management
or
policies.
Management
fees
paid
by
the
Funds
are
waived
on
assets
invested
in
the
affiliated
management
investment
companies,
as
noted
in
the
Statements
of
Operations,
in
an
amount
not
to
exceed
the
management
and
administrative
fees
paid
directly
or
indirectly
by
each
affiliate.
During
the
period
ended
October
31,
2020,
investments
in
affiliated
management
investment
companies
were
as
follows:
a
Value
at
Beginning
of
Period
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Period
Number
of
Shares
Held
at
End
of
Period
Investment
Income
a
a
a
a
a
a
a
a
a
Franklin
Growth
Opportunities
Fund
Non-Controlled
Affiliates
Dividends
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
.........
$47,687,960
$421,482,200
$(457,133,513)
$—
$—
$12,036,647
12,036,647
$—
Non-Controlled
Affiliates
Income
from
securities
loaned
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
.........
$9,585,975
$329,028,545
$(330,761,685)
$
$
$7,852,835
7,852,835
$—
Total
Affiliated
Securities
....
$57,273,935
$750,510,745
$(787,895,198)
$—
$—
$19,889,482
$—
Franklin
Small
Cap
Growth
Fund
Non-Controlled
Affiliates
Dividends
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
.........
$74,538,382
$395,089,612
$(380,515,135)
$—
$—
$89,112,859
89,112,859
$—
Non-Controlled
Affiliates
Income
from
securities
loaned
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
.........
$34,288,350
$285,073,313
$(274,762,738)
$44,598,925
44,598,925
$—
Total
Affiliated
Securities
....
$108,826,732
$680,162,925
$(655,277,873)
$—
$—
$133,711,784
$—
Franklin
Small-Mid
Cap
Growth
Fund
Non-Controlled
Affiliates
Dividends
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
.........
$52,245,134
$542,685,062
$(441,249,703)
$—
$—
$153,680,493
153,680,493
$—
3.
Transactions
with
Affiliates
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
65
franklintempleton.com
Semiannual
Report
g.
Waiver
and
Expense
Reimbursements
For
Franklin
Growth
Opportunities
Fund,
Franklin
Small
Cap
Growth
Fund
and
Franklin
Small-Mid
Cap
Growth
Fund,
Investor
Services
has
contractually
agreed
in
advance
to
waive
or
limit
its
fees
so
that
the
Class
R6
transfer
agent
fees
do
not
exceed
0.03%
based
on
the
average
net
assets
of
the
class
until
August
31,
2021.
4.
Expense
Offset
Arrangement
The
Funds
have entered
into
an
arrangement
with
their
custodian
whereby
credits
realized
as
a
result
of
uninvested
cash
balances
are
used
to
reduce
a
portion
of
the
Funds'
custodian
expenses. During
the period
ended
October
31,
2020 the
custodian
fees
were
reduced
as
noted
in
the
Statements
of
Operations.
5.
Income
Taxes
For
tax
purposes,
the
Funds
may
elect
to
defer
any
portion
of
a
post-October
capital
loss
or
late-year
ordinary
loss
to
the
first
day
of
the
following
fiscal
year.
At
April
30,
2020,
the
deferred
losses
were
as
follows:
At
October
31,
2020,
the
cost
of
investments
and
net
unrealized
appreciation
(depreciation)
for
income
tax
purposes
were
as
follows:
a
Value
at
Beginning
of
Period
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Period
Number
of
Shares
Held
at
End
of
Period
Investment
Income
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
Non-Controlled
Affiliates
Income
from
securities
loaned
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
.........
$14,660,525
$162,807,673
$(135,808,873)
$
$
$41,659,325
41,659,325
$—
Total
Affiliated
Securities
....
$66,905,659
$705,492,735
$(577,058,576)
$—
$—
$195,339,818
$—
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
1
1
1
1
Post-October
capital
losses
................
$
$
16,223,354
$
46,315,087
Late-year
ordinary
losses
..................
5,136,150
3,339,517
2,637,568
3.
Transactions
with
Affiliates
(continued)
f.
Investments
in
Affiliated
Management
Investment
Companies
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
66
franklintempleton.com
Semiannual
Report
Differences
between
income
and/or
capital
gains
as
determined
on
a
book
basis
and
a
tax
basis
are
primarily
due
to
differing
treatment
of
wash
sales.
6.
Investment
Transactions
Purchases
and
sales
of
investments
(excluding
short
term
securities)
for
the
period
ended
October
31,
2020,
were
as
follows:
7. Novel
Coronavirus
Pandemic 
The
global
outbreak
of
the
novel
coronavirus
disease,
known
as
COVID-19, has
caused
adverse
effects
on
many
companies,
sectors,
nations,
regions
and
the
markets
in
general, and
may
continue for
an unpredictable duration.
The
effects
of
this
pandemic
may
materially
impact
the
value
and
performance
of
the
Funds, their ability
to
buy
and
sell
fund
investments
at
appropriate
valuations
and their ability
to
achieve their investment
objectives.
8.
Restricted
Securities
Certain
or
all
Funds
invest
in
securities
that
are
restricted
under
the
Securities
Act
of
1933
(1933
Act).
Restricted
securities
are
often
purchased
in
private
placement
transactions,
and
cannot
be
sold
without
prior
registration
unless
the
sale
is
pursuant
to
an
exemption
under
the
1933
Act.
Disposal
of
these
securities
may
require
greater
effort
and
expense,
and
prompt
sale
at
an
acceptable
price
may
be
difficult.
The
Funds
may
have
registration
rights
for
restricted
securities.
The
issuer
generally
incurs
all
registration
costs.
At
October
31,
2020,
investments
in
restricted
securities,
excluding
securities
exempt
from
registration
under
the
1933
Act,
were
as
follows:
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
a
a
a
a
Cost
of
investments
.......................
$1,924,623,045
$2,264,512,642
$2,844,210,287
Unrealized
appreciation
.....................
$2,916,405,332
$1,042,077,851
$1,689,060,491
Unrealized
depreciation
.....................
(9,968,951)
(129,077,198)
(65,823,992)
Net
unrealized
appreciation
(depreciation)
.......
$2,906,436,381
$913,000,653
$1,623,236,499
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Purchases
..............................
$488,569,019
$708,354,578
$1,105,050,448
Sales
..................................
$613,006,518
$748,332,892
$1,164,380,944
Shares
Issuer
Acquisition
Date
Cost
Value
Franklin
Growth
Opportunities
Fund
255,039
Avidxchange
,
Inc.
............................
7/31/20
$
12,499,971
$
12,499,971
2,610,594
ClearMotion
,
Inc.,
C
..........................
11/06/17
5,499,999
6,809,870
3,698,772
ClearMotion
,
Inc.,
D
..........................
12/21/18
10,000,000
10,567,181
642,459
Confluent,
Inc.,
E
............................
4/13/20
9,616,776
9,616,776
920,577
Fanatics,
Inc.,
E
.............................
8/13/20
15,916,776
15,767,643
5.
Income
Taxes
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
67
franklintempleton.com
Semiannual
Report
Shares
Issuer
Acquisition
Date
Cost
Value
Franklin
Growth
Opportunities
Fund
(continued)
230,802
Figs,
Inc.
..................................
10/23/20
$
17,756,521
$
17,756,521
201,294
Gitlab
,
Inc.,
E
...............................
9/11/19
3,749,986
8,051,760
207,551
HashiCorp
,
Inc.,
E
...........................
3/06/20
12,004,812
14,792,293
1,673,284
Legalzoom.com,
Inc
..........................
7/20/18
16,479,338
22,391,396
1,196,245
Marqeta
,
Inc.
...............................
8/20/20
10,353,396
10,919,384
181,494
Marqeta
,
Inc.,
A
.............................
10/09/20
2,172,357
2,087,181
19,136
Marqeta
,
Inc.,
B
.............................
10/21/20
229,632
229,632
509,182
Optoro
,
Inc.,
E
..............................
7/24/18
10,020,702
13,113,596
2,362,202
Proterra
,
Inc.,
144A,
5
........................
9/21/16
-
1/13/17
11,896,616
35,150,615
596,775
Proterra
,
Inc.,
144A,
6
........................
6/07/17
3,306,052
8,880,277
780,667
Proterra
,
Inc.,
7
.............................
5/21/18
-
9/18/18
5,094,960
11,616,672
289,016
Proterra
,
Inc.,
8
.............................
8/02/19
1,996,378
4,300,686
928,488
Sweetgreen
,
Inc.,
H
..........................
11/09/18
12,107,484
14,767,846
100,835
Sweetgreen
,
Inc.,
I
...........................
9/16/19
1,724,278
1,781,490
1,753,060
Talkdesk
,
Inc.,
C
............................
7/15/20
11,517,955
11,517,955
805,800
Tanium,
Inc.,
G
..............................
9/14/15
4,000,233
8,336,143
504,854
Tempus
Labs,
Inc.,
F
.........................
5/29/19
12,499,983
17,772,425
126,131
Tempus
Labs,
Inc.,
G
.........................
2/06/20
4,837,427
5,090,745
5,028,735
Wheels
Up
Partners
LLC,
D
....................
5/16/19
-
8/02/19
17,499,998
20,826,898
Total
Restricted
Securities
(Value
is
5.89%
of
Net
Assets)
.............
$212,781,630
$284,644,956
Shares
Issuer
Acquisition
Date
Cost
Value
Franklin
Small
Cap
Growth
Fund
343,750
Alkami
Technology,
Inc.,
F
.....................
9/24/20
$
5,500,000
$
5,500,000
1,297,305
Allbirds
,
Inc.,
E
..............................
9/22/20
14,999,998
14,999,998
3,698,772
ClearMotion
,
Inc.,
D
..........................
12/21/18
10,000,000
10,567,181
1,431,280
Legalzoom.com,
Inc
..........................
7/20/18
14,095,961
19,152,970
1,199,415
Marqeta
,
Inc.
...............................
8/20/20
10,000,003
10,948,320
508,130
Optoro
,
Inc.,
E
..............................
7/24/18
9,999,998
13,086,502
2,000,000
Paya
Holdings,
Inc.
..........................
10/16/20
20,000,000
21,940,000
1,787,047
Proterra
,
Inc.,
144A,
5
........................
9/21/16
-
1/13/17
8,999,998
26,592,053
1,310,834
Proterra
,
Inc.,
144A,
6
........................
6/07/17
-
1/02/18
7,261,842
19,505,792
536,367
Proterra
,
Inc.,
7
.............................
5/21/18
3,500,556
7,981,379
596,471
Rent
the
Runway,
Inc.,
144A,
F
.................
3/21/19
13,333,328
12,797,090
203,515
Rent
the
Runway,
Inc.,
G
......................
4/30/20
3,000,006
3,606,110
1,542,673
Smule
,
Inc.,
144A,
G
.........................
5/31/16
11,099,995
10,412,764
352,675
Smule
,
Inc.,
144A,
H
.........................
4/27/17
2,999,995
2,809,136
383,435
Sweetgreen
,
Inc.,
H
..........................
11/09/18
4,999,993
6,098,635
41,641
Sweetgreen
,
Inc.,
I
...........................
9/16/19
712,061
735,687
361,111
Tula
eTechnology
,
Inc.
........................
11/01/18
3,611,111
Tula
Technology,
Inc.,
E
.......................
9/08/17
6,500,000
6,919,423
8.
Restricted
Securities
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
68
franklintempleton.com
Semiannual
Report
9.
Holdings
of
5%
Voting
Securities
of
Portfolio
Companies
The
1940
Act
defines
"affiliated
companies"
to
include
investments
in
portfolio
companies
in
which
a
fund
owns
5%
or
more
of
the
outstanding
voting
securities.
During
the
period
ended
October
31,
2020,
investments
in
“affiliated
companies”
were
as
follows:
Shares
Issuer
Acquisition
Date
Cost
Value
Franklin
Small
Cap
Growth
Fund
(continued)
4,310,344
Wheels
Up
Partners
LLC,
D
....................
5/16/19
-
8/02/19
$
14,999,997
$
17,851,626
Total
Restricted
Securities
(Value
is
6.78%
of
Net
Assets)
.............
$162,003,731
$211,504,666
Principal
Amount
*
/
Shares
/
Warrants
Issuer
Acquisition
Date
Cost
Value
Franklin
Small-Mid
Cap
Growth
Fund
405,100
Alkami
Technology,
Inc.,
F
.....................
9/24/20
$
6,481,600
$
6,481,600
772,477
Allbirds
,
Inc.,
E
..............................
9/22/20
8,931,711
8,931,711
775,014
Fanatics,
Inc.,
E
.............................
8/13/20
13,399,992
13,274,440
1,070,236
Marqeta
,
Inc.
...............................
8/20/20
8,922,985
9,769,168
511,298
Phononic
Devices,
Inc.,
12/01/29
................
1/17/20
47
1,127,996
2,970,061
Phononic
Devices,
Inc.,
F
......................
6/06/19
7,499,998
5,912,774
523,663
Phononic
Devices,
Inc.,
Term
Loan,
A,
12%,
PIK,
1/17/24
..................................
1/21/20
513,890
480,267
107,694
Phononic
,
Inc.,
Term
Loan
Advance,
B,
12%,
PIK,
7/31/26
..................................
8/25/20
105,505
97,377
1,416,913
Proterra
,
Inc.,
144A,
5
........................
9/21/16
7,135,914
21,084,294
Total
Restricted
Securities
(Value
is
1.52%
of
Net
Assets)
.............
$52,991,642
$67,159,627
*
In
U.S.
dollars
unless
otherwise
indicated.
8.
Restricted
Securities
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
69
franklintempleton.com
Semiannual
Report
10.
Credit
Facility
The
Funds,
together
with
other
U.S.
registered
and
foreign
investment
funds
(collectively,
Borrowers),
managed
by
Franklin
Templeton,
are
borrowers
in
a
joint
syndicated
senior
unsecured
credit
facility
totaling
$2
billion
(Global
Credit
Facility)
which
matures
on
February
5,
2021.
This
Global
Credit
Facility
provides
a
source
of
funds
to
the
Borrowers
for
temporary
and
emergency
purposes,
including
the
ability
to
meet
future
unanticipated
or
unusually
large
redemption
requests. 
Under
the
terms
of
the
Global
Credit
Facility,
the
Funds
shall,
in
addition
to
interest
charged
on
any
borrowings
made
by
the
Funds
and
other
costs
incurred
by
the
Funds,
pay
their
share
of
fees
and
expenses
incurred
in
connection
with
the
implementation
and
maintenance
of
the
Global
Credit
Facility,
based
upon
their
relative
share
of
the
aggregate
net
assets
of
all
of
the
Borrowers,
including
an
annual
commitment
fee
of
0.15%
based
upon
the
unused
portion
of
the
Global
Credit
Facility.
These
fees
are
reflected
in
other
expenses
in
the
Statements
of
Operations.
During
the
period
ended
October
31,
2020,
the Funds
did
not
use
the
Global
Credit
Facility.
11.
Fair
Value
Measurements
The Funds
follow
a
fair
value
hierarchy
that
distinguishes
between
market
data
obtained
from
independent
sources
(observable
inputs)
and
the Funds'
own
market
assumptions
(unobservable
inputs).
These
inputs
are
used
in
determining
the
value
of
the Funds' financial
instruments
and
are
summarized
in
the
following
fair
value
hierarchy:
Level
1
quoted
prices
in
active
markets
for
identical
financial
instruments
Level
2
other
significant
observable
inputs
(including
quoted
prices
for
similar
financial
instruments,
interest
rates,
prepayment
speed,
credit
risk,
etc.)
Level
3
significant
unobservable
inputs
(including
the Funds'
own
assumptions
in
determining
the
fair
value
of
financial
instruments)
Value
at
Beginning
of
Period
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Period
Number
of
Shares
Held
at
End
of
Period
Investment
Income
Franklin
Growth
Opportunities
Fund
Non-Controlled
Affiliates
Dividends
Avidxchange
,
Inc.
........
$
$
12,499,971
$
$
$
$
12,499,971
255,039
$
Talkdesk
,
Inc.,
C
.........
11,517,955
11,517,955
1,753,060
Total
Affiliated
Securities
(Value
is
0.5%
*
of
Net
Assets)
$—
$24,017,926
$—
$24,017,926
$—
Franklin
Small
Cap
Growth
Fund
Non-Controlled
Affiliates
Dividends
Paya
Holdings,
Inc.
.......
20,000,000
a
1,940,000
21,940,000
2,000,000
Total
Affiliated
Securities
(Value
is
0.7%
*
of
Net
Assets)
$—
$20,000,000
$—
1,940,000
$21,940,000
$—
a
May
include
accretion,
amortization,
partnership
adjustments,
and/or
corporate
actions.
9.
Holdings
of
5%
Voting
Securities
of
Portfolio
Companies
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
70
franklintempleton.com
Semiannual
Report
The
input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level.
A
summary
of
inputs
used
as
of
October
31,
2020,
in
valuing
the
Funds’
assets
and
liabilities
carried
at
fair
value,
is
as
follows:
Level
1
Level
2
Level
3
Total
Franklin
Growth
Opportunities
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Auto
Components
......................
$
18,653,447
$
$
$
18,653,447
Automobiles
..........................
31,860,024
31,860,024
Beverages
...........................
52,649,218
52,649,218
Biotechnology
.........................
104,096,240
104,096,240
Capital
Markets
........................
246,955,202
246,955,202
Chemicals
...........................
58,596,124
58,596,124
Commercial
Services
&
Supplies
...........
13,990,022
22,391,396
36,381,418
Entertainment
.........................
23,757,968
23,757,968
Equity
Real
Estate
Investment
Trusts
(REITs)
.
141,809,555
141,809,555
Food
Products
........................
61,938,181
61,938,181
Health
Care
Equipment
&
Supplies
.........
337,185,047
337,185,047
Health
Care
Providers
&
Services
..........
103,617,433
103,617,433
Health
Care
Technology
.................
101,373,259
101,373,259
Hotels,
Restaurants
&
Leisure
.............
47,984,708
47,984,708
Industrial
Conglomerates
................
79,049,597
79,049,597
Insurance
............................
2,595,951
2,595,951
Interactive
Media
&
Services
..............
162,960,130
162,960,130
Internet
&
Direct
Marketing
Retail
..........
449,831,172
10,919,384
460,750,556
IT
Services
...........................
626,520,989
626,520,989
Leisure
Products
.......................
28,183,783
28,183,783
Life
Sciences
Tools
&
Services
............
20,205,959
27,001,112
47,207,071
Media
...............................
45,239,500
45,239,500
Pharmaceuticals
.......................
80,750,832
80,750,832
Professional
Services
...................
247,274,840
247,274,840
Road
&
Rail
..........................
44,847,852
44,847,852
Semiconductors
&
Semiconductor
Equipment
.
173,550,319
173,550,319
Software
.............................
908,970,791
12,499,971
921,470,762
Specialty
Retail
........................
9,961,820
9,961,820
Technology
Hardware,
Storage
&
Peripherals
.
180,397,131
180,397,131
Textiles,
Apparel
&
Luxury
Goods
..........
31,817,358
17,756,521
49,573,879
Wireless
Telecommunication
Services
.......
62,899,425
62,899,425
Preferred
Stocks
........................
221,077,684
221,077,684
Short
Term
Investments
...................
19,889,482
19,889,482
Total
Investments
in
Securities
...........
$4,519,413,359
$27,001,112
$284,644,956
$4,831,059,427
Franklin
Small
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Aerospace
&
Defense
...................
169,493,011
169,493,011
Airlines
..............................
52,994,100
52,994,100
Banks
...............................
73,549,247
73,549,247
Biotechnology
.........................
347,193,994
347,193,994
Capital
Markets
........................
92,175,876
92,175,876
Chemicals
...........................
37,575,568
37,575,568
Commercial
Services
&
Supplies
...........
38,614,099
19,152,970
57,767,069
Communications
Equipment
..............
59,711,259
59,711,259
Construction
&
Engineering
...............
61,995,121
61,995,121
Consumer
Finance
.....................
26,481,467
26,481,467
Diversified
Consumer
Services
............
30,744,551
30,744,551
9.
Holdings
of
5%
Voting
Securities
of
Portfolio
Companies
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
71
franklintempleton.com
Semiannual
Report
Level
1
Level
2
Level
3
Total
Franklin
Small
Cap
Growth
Fund
(continued)
Assets:
Investments
in
Securities:
Common
Stocks:
Electronic
Equipment,
Instruments
&
Components
........................
$
11,309,190
$
$
$
11,309,190
Equity
Real
Estate
Investment
Trusts
(REITs)
.
41,679,266
41,679,266
Food
&
Staples
Retailing
.................
39,595,990
39,595,990
Food
Products
........................
66,949,189
66,949,189
Health
Care
Equipment
&
Supplies
.........
200,585,782
200,585,782
Health
Care
Providers
&
Services
..........
53,230,321
53,230,321
Health
Care
Technology
.................
95,915,805
95,915,805
Hotels,
Restaurants
&
Leisure
.............
157,452,695
157,452,695
Household
Durables
....................
67,403,291
67,403,291
Insurance
............................
36,077,015
36,077,015
Internet
&
Direct
Marketing
Retail
..........
10,948,320
10,948,320
IT
Services
...........................
157,715,145
21,940,000
179,655,145
Life
Sciences
Tools
&
Services
............
39,908,679
39,908,679
Machinery
............................
38,942,200
38,942,200
Personal
Products
.....................
23,067,348
23,067,348
Pharmaceuticals
.......................
94,489,693
94,489,693
Semiconductors
&
Semiconductor
Equipment
.
167,521,171
167,521,171
Software
.............................
263,767,946
263,767,946
Specialty
Retail
........................
195,662,233
195,662,233
Textiles,
Apparel
&
Luxury
Goods
..........
25,994,427
25,994,427
Trading
Companies
&
Distributors
..........
65,606,590
65,606,590
Preferred
Stocks
........................
159,463,376
a
159,463,376
Short
Term
Investments
...................
133,711,784
133,711,784
Total
Investments
in
Securities
...........
$2,967,114,053
$—
$211,504,666
$3,178,618,719
Franklin
Small-Mid
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Aerospace
&
Defense
...................
49,087,414
49,087,414
Airlines
..............................
18,579,100
18,579,100
Banks
...............................
17,721,873
17,721,873
Biotechnology
.........................
166,972,937
166,972,9,37
Capital
Markets
........................
192,311,153
192,311,153
Chemicals
...........................
19,470,326
19,470,326
Commercial
Services
&
Supplies
...........
46,641,930
46,641,930
Communications
Equipment
..............
9,290,295
9,290,295
Construction
Materials
..................
38,354,400
38,354,400
Containers
&
Packaging
.................
52,955,000
52,955,000
Electronic
Equipment,
Instruments
&
Components
........................
105,056,195
105,056,195
Entertainment
.........................
122,464,522
122,464,522
Equity
Real
Estate
Investment
Trusts
(REITs)
.
83,547,135
83,547,135
Food
&
Staples
Retailing
.................
18,708,500
18,708,500
Health
Care
Equipment
&
Supplies
.........
277,504,245
277,504,245
Health
Care
Providers
&
Services
..........
93,189,431
93,189,431
Health
Care
Technology
.................
80,129,342
34,116,654
114,245,996
Hotels,
Restaurants
&
Leisure
.............
225,978,622
225,978,622
Household
Durables
....................
43,088,681
43,088,681
Household
Products
....................
40,270,484
40,270,484
Interactive
Media
&
Services
..............
104,550,594
104,550,594
Internet
&
Direct
Marketing
Retail
..........
39,736,691
9,769,168
49,505,859
IT
Services
...........................
503,337,908
503,337,908
11.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
72
franklintempleton.com
Semiannual
Report
A
reconciliation
in
which
Level
3
inputs
are
used
in
determining
fair
value
is
presented
when
there
are
significant
Level
3
assets
and/or
liabilities
at
the
beginning
and/or
end
of
the period.
At
October
31,
2020,
the
reconciliation is
as follows:
Level
1
Level
2
Level
3
Total
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
Assets:
Investments
in
Securities:
Common
Stocks:
Leisure
Products
.......................
$
20,410,892
$
$
$
20,410,892
Life
Sciences
Tools
&
Services
............
159,285,101
159,285,101
Machinery
............................
95,547,330
95,547,330
Personal
Products
.....................
19,648,947
19,648,947
Pharmaceuticals
.......................
88,963,164
88,963,164
Professional
Services
...................
215,036,208
215,036,208
Road
&
Rail
..........................
57,294,876
57,294,876
Semiconductors
&
Semiconductor
Equipment
.
282,146,358
282,146,358
Software
.............................
693,817,683
693,817,683
Specialty
Retail
........................
116,676,390
116,676,390
Textiles,
Apparel
&
Luxury
Goods
..........
40,893,840
40,893,840
Trading
Companies
&
Distributors
..........
32,163,120
32,163,120
Preferred
Stocks
........................
55,684,819
55,684,819
Warrants
..............................
1,127,996
1,127,996
Senior
Floating
Rate
Interests
...............
577,644
577,644
Short
Term
Investments
...................
195,339,818
195,339,818
Total
Investments
in
Securities
...........
$4,366,170,505
$—
$101,276,281
$4,467,446,786
a
Includes
securities
determined
to
have
no
value
at
October
31,
2020.
Balance
at
Beginning
of
Period
Purchases
Sales
Transfer
Into
Level
3
a
Transfer
Out
of
Level
3
Cost
Basis
Adjust-
ments
b
Net
Realized
Gain
(Loss)
Net
Unr
ealized
Appreciatio
n
(
Depreciation
)
Balance
at
End
of
Period
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Period
End
a
a
a
a
a
a
a
a
a
a
a
Franklin
Growth
Opportunities
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Commercial
Services
&
Supplies
........
$
20,046,660
$
$
$
$
$
$
$
2,344,736
$
22,391,396
$
2,344,736
Internet
&
Direct
Marketing
Retail
...
10,353,395
565,989
10,919,384
565,989
Software
..........
43,653,245
12,499,971
(52,300,561)
8,647,316
12,499,971
8,647,316
Textiles,
Apparel
&
Luxury
Goods
.........
17,756,521
17,756,521
Preferred
Stocks
:
Airlines
..........
17,193,220
3,633,678
20,826,898
3,633,678
Automobiles
.......
33,649,056
26,299,194
59,948,250
26,299,194
Commercial
Services
&
Supplies
........
13,293,475
(179,879)
13,113,596
(179,879)
Food
&
Staples
Retailing
15,056,118
1,493,218
16,549,336
1,493,218
Health
Care
Providers
&
Services
........
20,693,106
2,170,064
22,863,170
2,170,064
Internet
&
Direct
Marketing
Retail
...
18,318,765
(234,309)
18,084,456
(234,309)
IT
Services
........
12,004,812
2,787,481
14,792,293
2,787,481
11.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
73
franklintempleton.com
Semiannual
Report
Balance
at
Beginning
of
Period
Purchases
Sales
Transfer
Into
Level
3
a
Transfer
Out
of
Level
3
Cost
Basis
Adjust-
ments
b
Net
Realized
Gain
(Loss)
Net
Unrealized
Appreciation
(Depreciation)
Balance
at
End
of
Period
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Period
End
a
a
a
a
a
a
a
a
a
a
a
Franklin
Growth
Opportunities
Fund
(continued)
Assets:
Investments
in
Securities:
Preferred
Stocks:
Software
..........
$
38,260,725
$
11,517,955
$
$
$
$
$
$
5,121,005
$
54,899,685
$
5,121,005
Total
Investments
in
Securities
.
$213,850,417
$70,446,607
$—
$—
$(52,300,561)
$—
$—
$52,648,493
$284,644,956
$52,648,493
Franklin
Small
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Commercial
Services
&
Supplies
........
17,147,349
2,005,621
19,152,970
2,005,621
Hotels,
Restaurants
&
Leisure
.........
60,602,791
(74,522,452)
47,970,632
(34,050,971)
Internet
&
Direct
Marketing
Retail
...
10,000,003
948,317
10,948,320
948,317
IT
Services
........
20,000,000
1,940,000
21,940,000
1,940,000
Warrants
:
Hotels,
Restaurants
&
Leisure
.........
637,467
(1,551,306)
1,551,301
(637,462)
Preferred
Stocks
:
Airlines
..........
14,737,045
3,114,581
17,851,626
3,114,581
Auto
Components
....
7,165,798
c
(246,375)
6,919,423
c
(246,375)
Automobiles
.......
30,354,762
23,724,462
54,079,224
23,724,462
Commercial
Services
&
Supplies
........
13,266,009
(179,507)
13,086,502
(179,507)
Food
&
Staples
Retailing
6,217,673
616,649
6,834,322
616,649
Software
..........
23,409,805
5,500,000
379,276
29,289,081
379,276
Specialty
Retail
.....
14,399,688
2,003,512
16,403,200
2,003,512
Textiles,
Apparel
&
Luxury
Goods
.........
14,999,998
14,999,998
Escrows
and
Litigation
Trusts
...........
c
c
Total
Investments
in
Securities
.
$187,938,387
$50,500,001
$(76,073,758)
$—
$—
$—
$49,521,933
$(381,897)
$211,504,666
$34,306,536
Franklin
Small-Mid
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Health
Care
Technology
2,877,086
(2,019,803)
33,339,500
1,709,746
(1,789,875)
34,116,654
(1,789,875)
Hotels,
Restaurants
&
Leisure
.........
48,788,058
c
(42,128,919)
20,809,223
(27,468,362)
Internet
&
Direct
Marketing
Retail
...
8,922,986
846,182
9,769,168
846,182
Warrants
:
Hotels,
Restaurants
&
Leisure
.........
140,884
(1,034,479)
973,870
(80,275)
Semiconductors
&
Semiconductor
Equipment
.......
628,432
499,564
1,127,996
499,564
Preferred
Stocks
:
Automobiles
.......
11,834,651
9,249,644
21,084,29
5
9,249,644
11.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
74
franklintempleton.com
Semiannual
Report
Significant
unobservable
valuation
inputs
for
material
Level
3 assets
and/or
liabilities and
impact
to
fair
value
as
a
result
of
changes
in
unobservable
valuation
inputs
as
of
October
31,
2020,
are
as
follows:
Balance
at
Beginning
of
Period
Purchases
Sales
Transfer
Into
Level
3
a
Transfer
Out
of
Level
3
Cost
Basis
Adjust-
ments
b
Net
Realized
Gain
(Loss)
Net
Unrealized
Appreciation
(Depreciation)
Balance
at
End
of
Period
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Period
End
a
a
a
a
a
a
a
a
a
a
a
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
Assets:
Investments
in
Securities:
Preferred
Stocks:
Internet
&
Direct
Marketing
Retail
...
$
$
13,399,992
$
$
$
$
$
$
(125,552)
$
13,274,440
$
(125,552)
Semiconductors
&
Semiconductor
Equipment
.......
3,875,755
2,037,018
5,912,77
3
2,037,018
Software
..........
23,281,742
6,481,600
(27,893,645)
4,611,903
6,481,600
Textiles,
Apparel
&
Luxury
Goods
.........
8,931,711
8,931,711
Senior
Floating
Rate
Interests
:
Semiconductors
&
Semiconductor
Equipment
.......
394,282
138,23
2
231
44,899
577,644
44,899
Escrows
and
Litigation
Trusts
...........
c
c
Total
Investments
in
Securities
.
$88,943,804
$40,751,607
$(45,183,201)
$33,339,500
$(27,893,645)
$231
$23,492,839
$(12,174,854)
$101,276,281
$10,761,880
a
Transferred
into
level
3
as
a
result
of
the
unavailability
of
a
quoted
market
price
in
an
active
market
for
identical
securities
or
as
a
result
of
the
unreliability
of
the
foreign
exchange
rate
and
other
significant
observable
valuation
inputs.
May
include
amounts
related
to
a
corporate
action.
b
May
include
accretion,
amortization,
partnership
adjustments,
and/or
other
cost
basis
adjustments.
c
Includes
securities
determined
to
have
no
value.
Description
Fair
Value
at
End
of
Period
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
a
Impact
to
Fair
Value
if
Input
Increases
b
Franklin
Growth
Opportunities
Fund
Assets:
Investments
in
Securities:
Common
Stock:
Commercial
Services
and
Supplies
..................
$22,391,396
Discounted
cash
flow
Discount
for
lack
of
marketability
9.3%
Decrease
c
Discount
rate
11.4%
Decrease
d
Long
term
growth
rate
4.0%
Increase
d
Preferred
Stocks:
Airlines
...............
20,826,898
Discounted
cash
flow
Discount
for
lack
of
marketability
13.2%
Decrease
c
Discount
rate
10.6%
Decrease
d
Long
term
growth
rate
3.0%
Increase
c
11.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
75
franklintempleton.com
Semiannual
Report
Description
Fair
Value
at
End
of
Period
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
a
Impact
to
Fair
Value
if
Input
Increases
b
Automobiles
............
55,647,564
Discounted
cash
flow
Discount
for
lack
of
marketability
11.1%
Decrease
c
Discount
rate
11.4%
Decrease
Terminal
Multiple
23.5x
Increase
Market
comparables
EV
/
revenue
10.8x
Increase
c
Commercial
Services
&
Supplies
..................
13,113,596
Discounted
cash
flow
Discount
for
lack
of
marketability
9.5%
Decrease
c
Discount
rate
19.6%
Decrease
C
Long
term
growth
rate
5.0%
Increase
Food
&
Staples
Retailing
..
14,767,846
Discounted
cash
flow
Discount
for
lack
of
marketability
8.1%
Decrease
Discount
rate
12.4%
Decrease
Terminal
Multiple
32.5x
Increase
c
Market
comparables
EV
/
revenue
4.1x
Increase
c
Health
Care
Providers
&
Services
..................
22,863,170
Discounted
cash
flow
Discount
for
lack
of
marketability
10.0%
Decrease
Discount
rate
9.4%
Decrease
d
Long
term
growth
rate
5.0%
Increase
c
Internet
&
Direct
Marketing
Retail
....................
15,767,643
Market
comparables
EV
/
EBITA
multiple
28.2x
Increase
c
EV
/
revenue
multiple
3.2x
Increase
c
Discount
for
lack
of
marketability
15.5%
Decrease
c
IT
Services
............
14,792,293
Discounted
cash
flow
Discount
for
lack
of
marketability
12.3%
Decrease
c
EV
/
revenue
23.1x
31.2x
(27.2x)
Increase
Software
..............
25,713,194
Discounted
cash
flow
Discount
for
lack
of
marketability
13.0%
-
18.8%
(16.9%)
Decrease
c
Discount
rate
9.0%
-
10.7%
(10.1%)
Decrease
c
Long
term
growth
rate
2.0%
Increase
Terminal
Multiple
26.9x
Increase
d
All
Other
Investments
.........
78,761,356
Total
.......................
$284,644,956
Franklin
Small
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stock:
Commercial
Services
and
Supplies
..................
$19,152,970
Discounted
cash
flow
Discount
for
lack
of
marketability
9.3%
Decrease
c
11.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
76
franklintempleton.com
Semiannual
Report
Description
Fair
Value
at
End
of
Period
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
a
Impact
to
Fair
Value
if
Input
Increases
b
Discount
rate
11.4%
Decrease
d
Long
term
growth
rate
4.0%
Increase
d
Preferred
Stocks:
Airlines
...............
17,851,626
Discounted
cash
flow
Discount
for
lack
of
marketability
13.2%
Decrease
c
Discount
rate
10.6%
Decrease
d
Long
term
growth
rate
3.0%
Increase
c
Auto
Components
.......
6,919,423
Market
comparables
EV
/
EBITDA
multiple
17.5x
-
22.2x
(20.6x)
Increase
EV
/
revenue
multiple
12.3x
Decrease
Discount
for
lack
of
marketability
8.4%
Increase
c
Automobiles
............
54,079,224
Discounted
cash
flow
Discount
for
lack
of
marketability
11.1%
Decrease
c
Discount
rate
11.4%
Decrease
Terminal
Multiple
23.5x
Increase
Market
comparables
EV
/
revenue
10.8x
Increase
c
Commercial
Services
&
Supplies
..................
13,086,502
Discounted
cash
flow
Discount
for
lack
of
marketability
9.5%
Decrease
c
Discount
rate
19.6%
Decrease
C
Long
term
growth
rate
5.0%
Increase
Food
&
Staples
Retailing
..
6,098,635
Discounted
cash
flow
Discount
for
lack
of
marketability
8.1%
Decrease
Discount
rate
12.4%
Decrease
Terminal
Multiple
32.5x
Increase
c
Market
comparables
EV
/
revenue
4.1%
Increase
c
Software
...............
20,979,945
Discounted
cash
flow
Discount
for
lack
of
marketability
18.8
Decrease
c
Discount
rate
10.7
Decrease
c
Long
term
growth
rate
2.0%
Increase
Market
comparables
Discount
for
lack
of
marketability
6.2%
Decrease
c
EV
/
revenue
3.4x
Increase
Specialty
Retail
.........
16,403,200
Discounted
cash
flow
Discount
for
lack
of
marketability
16.7%
Decrease
c
Discount
rate
13.6%
Decrease
d
Long
term
growth
rate
4.0%
Increase
c
All
Other
Investments
............
56,933,141
e.f 
Total
.........................
$211,504,666
11.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
77
franklintempleton.com
Semiannual
Report
12.
New
Accounting
Pronouncements
In
March
2020,
the
Financial
Accounting
Standards
Board
issued
Accounting
Standards
Update
(ASU)
No.
2020-04,
Reference
Rate
Reform
(Topic
848)
Facilitation
of
the
Effects
of
Reference
Rate
Reform
on
Financial
Reporting.
The
amendments
in
the
ASU
provides
optional
temporary
financial
reporting
relief
from
the
effect
of
certain
types
of
contract
modifications
due
to
the
planned
discontinuation
of
the
London
Interbank
Offered
Rate
(LIBOR)
and
other
interbank-offered
Description
Fair
Value
at
End
of
Period
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
a
Impact
to
Fair
Value
if
Input
Increases
b
Franklin
Small-Mid
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stock:
Internet
&
Direct
Marketing
Retail
.....................
$13,274,440
Market
comparables
EV
/
EBITDA
multiple
28.2x
Increase
c
EV
/
revenue
multiple
3.2x
Increase
c
Discount
for
lack
of
marketability
15.5%
Decrease
c
Preferred
Stocks:
Automobiles
............
21,084,294
Discounted
cash
flow
Discount
for
lack
of
marketability
11.1%
Decrease
c
Discount
rate
11.4%
Decrease
Terminal
multiple
23.5x
Increase
Market
comparables
EV
/
revenue
10.8x
Increase
c
Semiconductors
&
Semiconductor
Equipment
.....
$5,912,774
Discounted
cash
flow
Discount
rate
16.3%
Decrease
Discount
for
lack
of
marketability
14.6%
Decrease
c
Terminal
multiple
18.0x
Increase
Market
comparables
EV
/
revenue
6.4x
6.9x
(6.7x)
Increase
All
Other
Investments
..........
61,004,773
Total
.......................
$101,276,281
a
Weighted
based
on
the
relative
fair
value
of
the
financial
instruments.
b
Represents
the
directional
change
in
the
fair
value
that
would
result
from
a
significant
and
reasonable
increase
in
the
corresponding
input.
A
significant
and
reasonable
decrease
in
the
input
would
have
the
opposite
effect.
Significant
impacts,
if
any,
to
fair
value
and/or
net
assets
have
been
indicated.
c
Represents
a
significant
impact
to
fair
value
but
not
net
assets.
d
Represents
a
significant
impact
to
fair
value
and
net
assets.
e
Includes
fair
value
of
immaterial
assets
and/or
liabilities
developed
using
various
valuation
techniques
and
unobservable
inputs.
May
also
include
values
derived
using
private
transaction
prices
or
non-public
third
party
pricing
information
which
is
unobservable.
f
Includes
securities
determined
to
have
no
value
at
October
31,
2020.
Abbreviations
List
EBITDA
-
Earnings
before
interest,
taxes,
depreciation
and
amortization
EV
-
Enterprise
value
11.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
(unaudited)
78
franklintempleton.com
Semiannual
Report
based
reference
rates
as
of
the
end
of
2021.
The
ASU
is
effective
for
certain
reference
rate-related
contract
modifications
that
occur
during
the
period
March
12,
2020
through
December
31,
2022.
Management
has
reviewed
the
requirements
and
believes
the
adoption
of
this
ASU
will
not
have
a
material
impact
on
the
financial
statements.
13.
Subsequent
Events
The
Funds
have
evaluated
subsequent
events
through
the
issuance
of
the
financial
statements
and
determined
that
no
events
have
occurred
that
require
disclosure.
Abbreviations
Selected
Portfolio
ADR
American
Depositary
Receipts
LIBOR
London
Inter-Bank
Offered
Rate
PIK
Payment-In-Kind
Currency
USD
United
States
Dollar
12.
New
Accounting
Pronouncements
(continued)
Franklin
Strategic
Series
Shareholder
Information
79
franklintempleton.com
Semiannual
Report
Liquidity
Risk
Management
Program
Funds
no
HLIM
Each
of
the
Funds
has
adopted
and
implemented
a
written
Liquidity
Risk
Management
Program
(the
“LRMP”)
as
required
by
Rule
22e-4
under
the
Investment
Company
Act
of
1940
(the
“Liquidity
Rule”).
The
LRMP
is
designed
to
assess
and
manage
each
Fund’s
liquidity
risk,
which
is
defined
as
the
risk
that
the
Fund
could
not
meet
requests
to
redeem
shares
issued
by
the
Fund
without
significant
dilution
of
remaining
investors’
interests
in
the
Fund.
In
accordance
with
the
Liquidity
Rule,
the
LRMP
includes
policies
and
procedures
that
provide
for:
(1)
assessment,
management,
and
review
(no
less
frequently
than
annually)
of
each
Fund’s
liquidity
risk;
(2)
classification
of
each
Fund’s
portfolio
holdings
into
one
of
four
liquidity
categories
(Highly
Liquid,
Moderately
Liquid,
Less
Liquid,
and
Illiquid);
(3)
for
Funds
that
do
not
primarily
hold
assets
that
are
Highly
Liquid,
establishing
and
maintaining
a
minimum
percentage
of
the
Fund’s
net
assets
in
Highly
Liquid
investments
(called
a
“Highly
Liquid
Investment
Minimum”
or
“HLIM”);
and
(4)
prohibiting
the
Fund’s
acquisition
of
Illiquid
investments
that
would
result
in
the
Fund
holding
more
than
15%
of
its
net
assets
in
Illiquid
assets.
The
LRMP
also
requires
reporting
to
the
Securities
and
Exchange
Commission
(“SEC”)
(on
a
non-public
basis)
and
to
the
Board
if
the
Fund’s
holdings
of
Illiquid
assets
exceed
15%
of
the
Fund’s
net
assets.
Funds
with
HLIMs
must
have
procedures
for
addressing
HLIM
shortfalls,
including
reporting
to
the
Board
and,
with
respect
to
HLIM
shortfalls
lasting
more
than
seven
consecutive
calendar
days,
reporting
to
the
SEC
(on
a
non-public
basis).
The
Funds’
Board
of
Trustees
approved
the
appointment
of
the
Director
of
Liquidity
Risk
within
the
Investment
Risk
Management
Group
(the
“IRMG”)
as
the
Administrator
of
the
LRMP.
The
IRMG
maintains
the
Investment
Liquidity
Committee
(the
“ILC”)
to
provide
oversight
and
administration
of
policies
and
procedures
governing
liquidity
risk
management
for
FT
products
and
portfolios.
The
ILC
includes
representatives
from
Franklin
Templeton’s
Risk,
Trading,
Global
Compliance,
Investment
Compliance,
Investment
Operations,
Valuation
Committee
and
Product
Management
groups.
In
assessing
and
managing
each
Fund’s
liquidity
risk,
the
ILC
considers,
as
relevant,
a
variety
of
factors,
including
the
Fund’s
investment
strategy
and
the
liquidity
of
its
portfolio
investments
during
both
normal
and
reasonably
foreseeable
stressed
conditions;
its
short
and
long-term
cash
flow
projections;
and
its
cash
holdings
and
access
to
other
funding
sources
including
the
Funds’
interfund
lending
facility
and
line
of
credit.
Classification
of
the
Fund’s
portfolio
holdings
in
the
four
liquidity
categories
is
based
on
the
number
of
days
it
is
reasonably
expected
to
take
to
convert
the
investment
to
cash
(for
Highly
Liquid
and
Moderately
Liquid
holdings)
or
sell
or
dispose
of
the
investment
(for
Less
Liquid
and
Illiquid
investments),
in
current
market
conditions
without
significantly
changing
the
investment’s
market
value.
Each
Fund
primarily
holds
liquid
assets
that
are
defined
under
the
Liquidity
Rule
as
"Highly
Liquid
Investments,"
and
therefore
is
not
required
to
establish
an
HLIM.
Highly
Liquid
Investments
are
defined
as
cash
and
any
investment
reasonably
expected
to
be
convertible
to
cash
in
current
market
conditions
in
three
business
days
or
less
without
the
conversion
to
cash
significantly
changing
the
market
value
of
the
investment.
At
meetings
of
the
Funds’
Board
of
Trustees
held
in
May
2020,
the
Program
Administrator
provided
a
written
report
to
the
Board
addressing
the
adequacy
and
effectiveness
of
the
program
during
the
period
December
1,
2018
to
December
31,
2019.
The
Program
Administrator
report
concluded
that
(i.)
the
LRMP,
as
adopted
and
implemented,
remains
reasonably
designed
to
assess
and
manage
each
Fund’s
liquidity
risk;
(ii.)
the
LRMP,
including
the
Highly
Liquid
Investment
Minimum
(“HLIM”)
where
applicable,
was
implemented
and
operated
effectively
to
achieve
the
goal
of
assessing
and
managing
each
Fund’s
liquidity
risk;
and
(iii.)
each
Fund
was
able
to
meet
requests
for
redemption
without
significant
dilution
of
remaining
investors’
interests
in
the
Fund.
At
the
same
time,
the
Program
Administrator
also
presented
the
Fund
Board
of
Trustees
an
update
on
liquidity
during
the
first
quarter
of
2020
in
relation
to
the
COVID-19
pandemic.
Proxy
Voting
Policies
and
Procedures
The
Trust’s
investment
manager
has
established
Proxy
Voting
Policies
and
Procedures
(Policies)
that
the
Trust
uses
to
determine
how
to
vote
proxies
relating
to
portfolio
securities.
Shareholders
may
view
the
Trust’s
complete
Policies
online
at
franklintempleton.com.
Alternatively,
shareholders
may
request
copies
of
the
Policies
free
of
charge
by
calling
the
Proxy
Group
collect
at
(954)
527-
7678
or
by
sending
a
written
request
to:
Franklin
Templeton
Companies,
LLC,
300
S.E.
2nd
Street,
Fort
Lauderdale,
FL
33301,
Attention:
Proxy
Group.
Copies
of
the
Trust’s
Franklin
Strategic
Series
Shareholder
Information
80
franklintempleton.com
Semiannual
Report
proxy
voting
records
are
also
made
available
online
at
franklintempleton.com
and
posted
on
the
U.S.
Securities
and
Exchange
Commission’s
website
at
sec.gov
and
reflect
the
most
recent
12-month
period
ended
June
30.
Quarterly
Statement
of
Investments
The
Trust
files
a
complete
statement
of
investments
with
the
U.S.
Securities
and
Exchange
Commission
for
the
first
and
third
quarters
for
each
fiscal
year
as
an
exhibit
to
its
report
on
Form
N-PORT.
Shareholders
may
view
the
filed
Form
N-PORT
by
visiting
the
Commission’s
website
at
sec.
gov.
The
filed
form
may
also
be
viewed
and
copied
at
the
Commission’s
Public
Reference
Room
in
Washington,
DC.
Information
regarding
the
operations
of
the
Public
Reference
Room
may
be
obtained
by
calling
(800)
SEC-0330.
Householding
of
Reports
and
Prospectuses
You
will
receive
each
Fund’s
financial
reports
every
six
months
as
well
as
an
annual
updated
summary
prospectus
(prospectus
available
upon
request).
To
reduce
Fund
expenses,
we
try
to
identify
related
shareholders
in
a
household
and
send
only
one
copy
of
the
financial
reports
and
summary
prospectus.
This
process,
called
“householding,”
will
continue
indefinitely
unless
you
instruct
us
otherwise.
If
you
prefer
not
to
have
these
documents
householded,
please
call
us
at
(800)
632-2301.
At
any
time
you
may
view
current
prospectuses/summary
prospectuses
and
financial
reports
on
our
website.
If
you
choose,
you
may
receive
these
documents
through
electronic
delivery.
FSS1
S
12/20
©
2020
Franklin
Templeton
Investments.
All
rights
reserved.
Authorized
for
distribution
only
when
accompanied
or
preceded
by
a
summary
prospectus
and/or
prospectus.
Investors
should
carefully
consider
a
fund’s
investment
goals,
risks,
charges
and
expenses
before
investing.
A
prospectus
contains
this
and
other
information;
please
read
it
carefully
before
investing.
To
help
ensure
we
provide
you
with
quality
service,
all
calls
to
and
from
our
service
areas
are
monitored
and/or
recorded.
Semiannual
Report
and
Shareholder
Letter
Franklin
Strategic
Series
Investment
Manager
Distributor
Shareholder
Services
Franklin
Advisers,
Inc.
Franklin
Templeton
Distributors,
Inc.
(800)
DIAL
BEN
®
/
342-5236
franklintempleton.com
(800)
632-2301
SEMIANNUAL
REPORT
AND
SHAREHOLDER
LETTER
Franklin
Strategic
Series
October
31,
2020
Sign
up
for
electronic
delivery
at
franklintempleton.com/edelivery
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Internet
Delivery
of
Fund
Reports
Unless
You
Request
Paper
Copies
:
Effective
January
1,
2021,
as
permitted
by
the
SEC,
paper
copies
of
the
Fund’s
shareholder
reports
will
no
longer
be
sent
by
mail,
unless
you
specifically
request
them
from
the
Fund
or
your
financial
intermediary.
Instead,
the
reports
will
be
made
available
on
a
website,
and
you
will
be
notified
by
mail
each
time
a
report
is
posted
and
provided
with
a
website
link
to
access
the
report.
If
you
already
elected
to
receive
shareholder
reports
electronically,
you
will
not
be
affected
by
this
change
and
you
need
not
take
any
action.
If
you
have
not
signed
up
for
electronic
delivery,
we
would
encourage
you
to
join
fellow
shareholders
who
have.
You
may
elect
to
receive
shareholder
reports
and
other
communications
electronically
from
the
Fund
by
calling
(800)
632-2301
or
by
contacting
your
financial
intermediary.
You
may
elect
to
continue
to
receive
paper
copies
of
all
your
future
shareholder
reports
free
of
charge
by
contacting
your
financial
intermediary
or,
if
you
invest
directly
with
a
Fund,
calling
(800)
632-2301
to
let
the
Fund
know
of
your
request.
Your
election
to
receive
reports
in
paper
will
apply
to
all
funds
held
in
your
account.
Not
FDIC
Insured
May
Lose
Value
No
Bank
Guarantee
franklintempleton.com
Not
part
of
the
semiannual
report
1
Shareholder
Letter
Dear
Shareholder:
During
the
six
months
ended
October
31,
2020,
first-
and
second-quarter
2020
data
reported
during
the
period
indicated
that
the
U.S.
economy
contracted
in
response
to
the
novel
coronavirus
(COVID-19)
pandemic.
In
the
third
quarter,
the
economy
recovered
substantially
based
on
increased
business
and
residential
investment
and
consumer
spending.
Before
the
reporting
period,
the
U.S.
Federal
Reserve
(Fed),
in
its
efforts
to
support
U.S.
economic
activity,
lowered
the
federal
funds
rate
twice
in
March
2020
and
implemented
broad
quantitative
easing
measures
to
support
credit
markets.
During
the
reporting
period,
the
Fed
held
its
key
rate
unchanged
at
0.25%,
but
continued
quantitative
easing
and
adjusted
its
policy
in
August
2020
to
allow
more
flexibility
to
keep
interest
rates
low,
while
maintaining
a
2%
average
inflation
target.
U.S.
equity
prices
rose
considerably
during
the
period,
helped
by
monetary
and
fiscal
actions
and
optimism
about
the
economy,
which
propelled
valuations
to
all-time
highs
in
September
before
stocks
trended
lower
amid
renewed
investor
concerns.
In
this
environment,
U.S.
stocks,
as
measured
by
the
Standard
&
Poor’s
®
500
Index,
posted
a
strong
positive
total
return
for
the
six-month
period.
We
are
committed
to
our
long-term
perspective
and
disciplined
investment
approach
as
we
conduct
a
rigorous,
fundamental
analysis
of
securities
with
a
regular
emphasis
on
investment
risk
management.
We
believe
active,
professional
investment
management
serves
investors
well.
We
also
recognize
the
important
role
of
financial
advisors
in
today’s
markets
and
encourage
investors
to
continue
to
seek
their
advice.
Amid
changing
markets
and
economic
conditions,
we
are
confident
investors
with
a
well-diversified
portfolio
and
a
patient,
long-term
outlook
should
be
well-positioned
for
the
years
ahead.
In
addition,
Franklin
Strategic
Series
semiannual
report
includes
more
detail
about
prevailing
conditions
and
a
discussion
about
investment
decisions
during
the
period.
All
securities
markets
fluctuate,
as
do
mutual
fund
share
prices.
We
thank
you
for
investing
with
Franklin
Templeton,
welcome
your
questions
and
comments,
and
look
forward
to
serving
your
future
investment
needs.
Sincerely,
Edward
Perks,
CFA
President
and
Chief
Executive
Officer
Investment
Management
Franklin
Strategic
Series
This
letter
reflects
our
analysis
and
opinions
as
of
October
31,
2020
,
unless
otherwise
indicated.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
fund.
Statements
of
fact
are
from
sources
considered
reliable.
CFA
®
is
a
trademark
owned
by
CFA
Institute.
franklintempleton.com
Semiannual
Report
2
Contents
Semiannual
Report
Economic
and
Market
Overview
....................
3
Franklin
Biotechnology
Discovery
Fund
..............
4
Franklin
Natural
Resources
Fund
...................
10
Financial
Highlights
and
Statements
of
Investments
...
16
Financial
Statements
.............................
30
Notes
to
Financial
Statements
.....................
34
Shareholder
Information
..........................
47
Visit
franklintempleton.com
for
fund
updates,
to
access
your
account,
or
to
find
helpful
financial
planning
tools.
3
franklintempleton.com
Semiannual
Report
SEMIANNUAL
REPORT
Economic
and
Market
Overview
U.S.
equities,
as
measured
by
the
Standard
&
Poor’s
500
Index
(S&P
500
®
),
advanced
significantly
during
the
six
months
ended
October
31,
2020,
as
markets
continued
to
recover
from
the
disruption
caused
by
the
novel
coronavirus
(COVID-19)
pandemic.
The
nascent
equity
market
recovery
that
began
in
late
March
gained
momentum
during
the
period,
supported
by
monetary
and
fiscal
measures,
which
drove
stocks,
as
measured
by
the
S&P
500,
to
all-time
price
highs
in
early
September,
before
retreating
in
the
period’s
final
months.
The
U.S.
Federal
Reserve
(Fed)
continued
its
efforts
to
support
the
U.S.
economy
by
maintaining
the
federal
funds
target
rate
at
a
range
of
0.00%–0.25%,
expanding
quantitative
easing
measures
aimed
at
ensuring
credit
flows
to
borrowers
and
supporting
credit
markets
with
unlimited
amounts
of
bond
purchasing.
Furthermore,
the
Fed
signaled
that
interest
rates
would
potentially
remain
low,
even
if
inflation
persistently
exceeded
the
Fed’s
2%
target.
Pandemic-related
restrictions
implemented
prior
to
the
period
caused
stiff
economic
headwinds.
The
longest
U.S.
economic
expansion
in
history
ended
in
February
2020,
according
to
the
National
Bureau
of
Economic
Research,
and
the
country
slipped
into
a
deep
recession
with
second-
quarter
2020
gross
domestic
product
(GDP)
posting
a
record
annualized
decline.
Optimism
about
an
economic
rebound
amid
the
government’s
fiscal
and
monetary
stimulus,
along
with
rising
retail
sales
and
resilient
consumer
spending,
drove
a
sharp
equity
rally
throughout
much
of
the
summer.
Improving
economic
activity
led
third-quarter
GDP
to
expand
at
a
record
annualized
pace,
while
declining
jobless
claims
drove
the
unemployment
rate
from
a
pandemic
high
of
14.7%
in
April
to
6.9%
in
October.
1
Optimism
about
treatments
and
potential
vaccines
for
COVID-19
also
supported
stock
prices.
However,
stocks
declined
in
the
period’s
last
two
months
amid
investor
concerns
that
the
economic
recovery
was
stalling,
as
new
job
growth
slowed
and
unemployment
claims
remained
high.
Concerns
that
possible
new
restrictions
due
to
rising
COVID-19
cases
could
disrupt
the
economic
recovery,
the
government’s
lack
of
consensus
about
additional
stimulus
and
uncertainties
surrounding
the
upcoming
presidential
election
also
tempered
investor
enthusiasm.
The
foregoing
information
reflects
our
analysis
and
opinions
as
of
October
31,
2020.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
fund.
Statements
of
fact
are
from
sources
considered
reliable.
1.
Source:
Bureau
of
Labor
Statistics.
4
franklintempleton.com
Semiannual
Report
Franklin
Biotechnology
Discovery
Fund
This
semiannual
report
for
Franklin
Biotechnology
Discovery
Fund
covers
the
period
ended
October
31,
2020
.
Your
Fund’s
Goal
and
Main
Investments
The
Fund
seeks
capital
appreciation.
The
Fund
invests
at
least
80%
of
its
net
assets
in
securities
of
biotechnology
companies
and
discovery
research
firms
located
in
the
U.S.
and
other
countries.
Performance
Overview
The
Fund’s
Class
A
shares
posted
a
+12.54%
cumulative
total
return
for
the
six
months
under
review.
In
comparison,
the
NASDAQ
Biotechnology
Index
®
,
which
tracks
U.S.
and
international-based
biotechnology
stocks,
posted
a
+5.34%
total
return.
1
Also
in
comparison,
the
Standard
&
Poor’s
500
Index
(S&P
500),
which
is
a
broad
measure
of
the
U.S.
stock
market,
posted
a
+13.29%
total
return.
1
You
can
find
the
Fund’s
long-term
performance
data
in
the
Performance
Summary
beginning
on
page
7
.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Investment
Strategy
We
are
research-driven,
fundamental
investors,
pursuing
a
growth
strategy.
As
bottom-up
investors
focusing
primarily
on
individual
securities,
we
choose
companies
that
have
identifiable
drivers
of
future
earnings
growth
and
that
present,
in
our
opinion,
the
best
trade-off
between
potential
earnings
growth,
business
and
financial
risk,
and
valuation.
Also,
in
seeking
sustainable
growth
characteristics,
we
look
for
companies
that
we
believe
can
produce
sustainable
earnings
growth
and
cash
flow
growth
or
the
potential
to
generate
income.
We
rely
on
a
team
of
analysts
to
help
provide
in-depth
industry
expertise
and
use
both
qualitative
and
quantitative
analysis
to
evaluate
companies
for
distinct
and
sustainable
competitive
advantages
likely
to
lead
to
growth
in
earnings
and/or
share
price.
Competitive
advantages,
such
as
a
particular
product
niche,
proven
technology,
sound
financial
position
and
strong
management,
are
all
factors
we
believe
may
contribute
to
strong
growth
potential.
Manager’s
Discussion
During
the
six
months
under
review,
the
biotechnology
industry
experienced
relatively
low
levels
of
volatility.
However,
please
keep
in
mind
that
volatility
is
not
uncommon
in
the
biotechnology
industry,
and
we
seek
to
take
advantage
of
short-term
volatility
by
initiating
positions
or
adding
to
existing
holdings
in
companies
we
believe
are
undervalued.
The
Fund’s
absolute
returns
were
boosted
by
a
considerable
rally
across
biotechnology
holdings,
which
made
up
a
majority
of
the
portfolio.
The
Fund
began
the
period
with
an
elevated
cash
position,
most
of
which
was
deployed
into
new
or
additional
purchases
of
biotechnology
and
pharmaceutical
stocks.
Company-specific
successes
tied
to
clinical
trials,
product
launches,
and
merger-and-acquisition
(M&A)
activity
had
a
dramatic
positive
impact
on
the
equity
values
of
numerous
holdings,
including
vaccine
developer
Novavax.
The
company’s
share
continued
rising
steeply
through
July
as
the
company
appeared
closer
to
producing
a
COVID-19
vaccine,
which
has
attracted
substantial
U.S.
government
funding.
The
company’s
history
of
developing
effective
vaccines
for
the
seasonal
flu,
malaria,
Ebola
and
other
diseases
made
it
a
leading
candidate,
in
our
view,
to
produce
the
first
COVID-19
vaccine.
In
August,
the
company
began
to
give
back
some
of
its
robust
summer
gains
due
to
intensifying
competition
in
the
COVID-19
vaccine
development
race,
a
trend
that
continued
through
period-end
as
investors
concluded
that
some
of
Novavax’s
competitors
were
more
likely
to
be
first
to
market.
Portfolio
Composition
10/31/20
%
of
Total
Net
Assets
Biotechnology
80.0%
Pharmaceuticals
11.7%
Life
Sciences
Tools
&
Services
3.6%
Capital
Markets
1.1%
Other
0.1%
Short-Term
Investments
&
Other
Net
Assets
3.5%
1.
Source:
Morningstar.
The
indexes
are
unmanaged
and
include
reinvestment
of
any
income
or
distributions.
They
do
not
reflect
any
fees,
expenses
or
sales
charges.
One
cannot
invest
directly
in
an
index,
and
an
index
is
not
representative
of
the
Fund’s
portfolio.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
The
dollar
value,
number
of
shares
or
principal
amount,
and
names
of
all
portfolio
holdings
are
listed
in
the
Fund’s
Statement
of
Investments
(SOI).
The
SOI
begins
on
page
20
.
Franklin
Biotechnology
Discovery
Fund
5
franklintempleton.com
Semiannual
Report
Forte
Therapeutics
also
contributed
to
absolute
returns.
The
clinical-stage
biopharmaceutical
company,
which
focuses
on
skin
diseases,
made
significant
gains
following
its
mid-June
initial
public
offering.
The
company
also
settled
its
previously
announced
merger
with
cancer
Tocagen,
a
developer
of
cancer
treatments.
We
believe
the
merger
is
a
transformative
event
that
will
provide
the
opportunity
to
achieve
significant
growth
as
it
continues
to
advance
its
clinical
program
for
a
live
biotherapeutic
for
the
treatment
of
inflammatory
skin
diseases.
Forte
presents
an
attractive
business
opportunity
with
a
unique
product
pipeline
that
has
considerable
market
potential,
as
well
as
significant
value-driving
clinical
milestones.
In
particular,
there
is
a
genuine
unmet
need
for
safe
and
effective
eczema
therapies
for
children,
which
Forte
is
developing.
The
company
also
provided
an
upbeat
second-quarter
update
as
it
successfully
concluded
its
merger
with
Tocagen
and
otherwise
continued
to
grow
its
development
capabilities
while
improving
business
operations.
The
single
most
positive
influence
on
absolute
returns
came
from
our
comparatively
larger
position
in
Immunomedics
(not
held
at
period-end).
Immunomedics
is
a
commercial-
stage
biotechnology
firm
focused
on
the
discovery
and
development
of
antibody
drug
conjugate
drugs
for
cancer.
Their
lead
drug,
Trodelvy,
is
approved
to
treat
multiple
types
of
breast
cancer
and
is
in
development
to
treat
bladder,
ovarian,
uterine
and
other
cancers.
We
were
positive
on
Trodelvy’s
commercial
prospects
across
different
cancer
types
and
had
viewed
the
Immunomedics
as
a
likely
M&A
target,
which
came
to
fruition
in
mid-September
when
Gilead
Sciences
(also
a
Fund
holding)
agreed
to
acquire
the
company.
Similar
to
Gilead
management’s
view,
we
believe
Trodelvy’s
launch
to
treat
triple
negative
breast
cancer
(TNBC)
will
exceed
expectations
and
become
the
new
standard
of
care
due
its
strong
clinical
profile
and
the
high
unmet
need
for
new
TNBC
therapies.
Furthermore,
we
believe
the
upcoming
clinical
trial
readout
for
other
breast
cancer
types
will
be
encouraging
and
enable
label
expansion
to
even
larger
markets.
Other
key
contributors
in
the
biotechnology
industry
included
Argenx,
Mirati
Therapeutics,
Insmed,
Fate
Therapeutics
and
CRISPR
Therapeutics
in
the
biotechnology
industry.
In
pharmaceuticals
Horizon
Pharma
contributed
as
well.
In
contrast,
the
pharmaceuticals
industry
slightly
detracted
from
absolute
returns.
The
most
substantial
detractors
were
Reata
Pharmaceuticals
and
Aerie
Pharmaceuticals
(not
held
at
period-end),
the
latter
of
which
specializes
in
ophthalmic
drugs
for
glaucoma
and
other
eye
diseases.
Biopharmaceutical
developer
Reata,
which
focuses
on
oral
antioxidative
and
anti-inflammatory
drugs
for
rare
kidney
and
neurological
diseases,
lost
share
price
after
receiving
mixed
feedback
from
the
U.S.
Food
and
Drug
Administration
(FDA)
on
their
ability
to
file
two
drugs—bardoxolone
and
omaveloxolone—for
regulatory
review.
While
the
feedback
on
bardoxolone
was
positive,
the
FDA’s
request
for
additional
data
on
omaveloxolone
was
a
negative
surprise.
We
continue
to
believe
that
omaveloxolone
is
a
game-changing
drug
for
Friedreich’s
Ataxia,
a
rare
genetic
disease,
and
that
it
will
eventually
receive
FDA
approval,
but
it
remains
unclear
how
long
the
delay
will
extend.
That
said,
we
view
bardoxolone
as
the
key
value
driver
for
the
stock,
and
we
continue
to
expect
a
positive
regulatory
outcome
for
bardoxolone’s
first
indication
in
Alport
Syndrome,
a
kidney
disease.
Other
notable
detractors
were
found
in
biotechnology.
The
Fund
had
substantial
positions
in
Gilead
Sciences,
Vertex
Pharmaceuticals
and
Biogen,
all
of
which
posted
declines.
Gilead’s
drug
remdesivir
was
the
first
to
be
granted
an
emergency
use
authorization
by
the
FDA
as
a
treatment
for
COVID-19,
but
this
leading-role
success
was
not
enough
to
lift
the
share
price
over
the
semiannual
period.
Gilead’s
share
value
declined
from
that
early-May
approval,
though
it
was
eventually
used
to
treat
U.S.
president
Donald
Trump’s
coronavirus
symptoms
in
October,
and
was
still
generating
Top
10
Holdings
10/31/20
Company
Industry
,
Country
%
of
Total
Net
Assets
a
a
Gilead
Sciences,
Inc.
6.6%
Biotechnology,
United
States
Regeneron
Pharmaceuticals,
Inc.
6.3%
Biotechnology,
United
States
Vertex
Pharmaceuticals,
Inc.
5.3%
Biotechnology,
United
States
Amgen,
Inc.
5.2%
Biotechnology,
United
States
Iovance
Biotherapeutics
,
Inc.
4.0%
Biotechnology,
United
States
Illumina,
Inc.
3.6%
Life
Sciences
Tools
&
Services,
United
States
Horizon
Therapeutics
plc
3.1%
Pharmaceuticals,
United
States
Biogen,
Inc.
3.0%
Biotechnology,
United
States
PTC
Therapeutics,
Inc.
3.0%
Biotechnology,
United
States
GW
Pharmaceuticals
plc
2.9%
Pharmaceuticals,
United
Kingdom
Franklin
Biotechnology
Discovery
Fund
6
franklintempleton.com
Semiannual
Report
significant
sales.
Investors
began
to
overlook
remdesivir
as
the
promise
around
a
vaccine
gathered
steam,
leaving
Gilead
in
what
some
investors
saw
as
a
more
minor
role
for
the
next
phase
of
COVID-19
treatment
and
prevention.
Worries
over
its
hepatitis
C
business,
which
was
shrinking
well
before
the
pandemic,
were
a
secondary
influence
in
the
selloff.
Furthermore,
the
pandemic
appeared
to
suppress
the
sales
of
other
select
drugs
in
Gilead’s
lineup
due
to
patient-access
setbacks
under
government-mandated
social
distancing
restrictions,
while
the
company
also
faced
competition
from
generic
drugmakers
which
created
headwinds
for
its
pulmonary
hypertension
drug
and
angina
drug.
Our
smaller
positions
in
Global
Blood
Therapeutics
and
Constellation
Pharmaceuticals
(not
held
at
period-end)
also
suffered
significant
declines
within
the
biotechnology
industry.
Thank
you
for
your
continued
participation
in
Franklin
Biotechnology
Discovery
Fund.
We
look
forward
to
serving
your
future
investment
needs.
Evan
McCulloch,
CFA
Lead
Portfolio
Manager
Wendy
Lam,
Ph.D.
Akiva
Felt
Portfolio
Management
Team
The
foregoing
information
reflects
our
analysis,
opinions
and
portfolio
holdings
as
of
October
31,
2020,
the
end
of
the
reporting
period.
The
way
we
implement
our
main
investment
strategies
and
the
resulting
portfolio
holdings
may
change
depending
on
factors
such
as
market
and
economic
conditions.
These
opinions
may
not
be
relied
upon
as
investment
advice
or
an
offer
for
a
particular
security.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
the
Fund.
Statements
of
fact
are
from
sources
considered
reliable,
but
the
investment
manager
makes
no
representation
or
warranty
as
to
their
completeness
or
accuracy.
Although
historical
performance
is
no
guarantee
of
future
results,
these
insights
may
help
you
understand
our
investment
management
philosophy.
Performance
Summary
as
of
October
31,
2020
Franklin
Biotechnology
Discovery
Fund
7
franklintempleton.com
Semiannual
Report
The
performance
table
does
not
reflect
any
taxes
that
a
shareholder
would
pay
on
Fund
dividends,
capital
gain
distributions,
if
any,
or
any
realized
gains
on
the
sale
of
Fund
shares.
Total
return
reflects
reinvestment
of
the
Fund’s
dividends
and
capital
gain
distributions,
if
any,
and
any
unrealized
gains
or
losses.
Your
dividend
income
will
vary
depending
on
dividends
or
interest
paid
by
securities
in
the
Fund’s
portfolio,
adjusted
for
operating
expenses
of
each
class.
Capital
gain
distributions
are
net
profits
realized
from
the
sale
of
portfolio
securities.
Performance
as
of
10/31/20
1
Cumulative
total
return
excludes
sales
charges.
Average
annual
total
return
includes
maximum
sales
charges.
Sales
charges
will
vary
depending
on
the
size
of
the
investment
and
the
class
of
share
purchased.
The
maximum
is
5.50%
and
the
minimum
is
0%.
Class
A
:
5.50%
maximum
initial
sales
charge;
Advisor
Class:
no
sales
charges.
For
other
share
classes,
visit
franklintempleton.com.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Share
Class
Cumulative
Total
Return
2
Average
Annual
Total
Return
3
A
4
6-Month
+12.54%
+6.36%
1-Year
+28.04%
+21.00%
5-Year
+30.22%
+4.24%
10-Year
+344.88%
+15.44%
Advisor
6-Month
+12.68%
+12.69%
1-Year
+28.37%
+28.37%
5-Year
+31.85%
+5.68%
10-Year
+356.75%
+16.40%
See
page
8
for
Performance
Summary
footnotes.
Franklin
Biotechnology
Discovery
Fund
Performance
Summary
8
franklintempleton.com
Semiannual
Report
Each
class
of
shares
is
available
to
certain
eligible
investors
and
has
different
annual
fees
and
expenses,
as
described
in
the
prospectus.
All
investments
involve
risks,
including
possible
loss
of
principal.
The
Fund
is
a
nondiversified
fund
that
concentrates
in
a
single
sector,
which
involves
risks
such
as
patent
considerations,
product
liability,
government
regulatory
requirements,
and
regulatory
approval
for
new
drugs
and
medical
products.
Biotechnol-
ogy
companies
often
are
small
and/or
relatively
new.
Smaller
companies
can
be
particularly
sensitive
to
changes
in
economic
conditions
and
have
less
certain
growth
prospects
than
larger,
more
established
companies
and
can
be
volatile,
especially
over
the
short
term.
The
Fund
may
also
invest
in
foreign
companies,
which
involve
special
risks,
including
currency
fluctuations
and
political
uncertainty.
Unexpected
events
and
their
aftermaths,
such
as
the
spread
of
deadly
dis-
eases;
natural,
environmental
or
man-made
disasters;
financial,
political
or
social
disruptions;
terrorism
and
war;
and
other
tragedies
or
catastrophes,
can
cause
investor
fear
and
panic,
which
can
adversely
affect
the
economies
of
many
companies,
sectors,
nations,
regions
and
the
market
in
general,
in
ways
that
cannot
necessarily
be
foreseen.
The
Fund’s
prospectus
also
includes
a
description
of
the
main
investment
risks.
1.
The
Fund
has
a
fee
waiver
associated
with
any
investment
it
makes
in
a
Franklin
Templeton
money
fund
and/or
other
Franklin
Templeton
fund,
contractually
guaranteed
through
8/31/21.
Fund
investment
results
reflect
the
fee
waiver;
without
this
reduction,
the
results
would
have
been
lower.
2.
Cumulative
total
return
represents
the
change
in
value
of
an
investment
over
the
periods
indicated.
3.
Average
annual
total
return
represents
the
average
annual
change
in
value
of
an
investment
over
the
periods
indicated.
Return
for
less
than
one
year,
if
any,
has
not
been
annualized.
4.
Prior
to
9/10/18,
these
shares
were
offered
at
a
higher
initial
sales
charge
of
5.75%,
thus
actual
returns
(with
sales
charges)
would
have
differed.
Average
annual
total
returns
(with
sales
charges)
have
been
restated
to
reflect
the
current
maximum
initial
sales
charge
of
5.50%.
5.
Figures
are
as
stated
in
the
Fund’s
current
prospectus
and
may
differ
from
the
expense
ratios
disclosed
in
the
Your
Fund’s
Expenses
and
Financial
Highlights
sections
in
this
report.
In
periods
of
market
volatility,
assets
may
decline
significantly,
causing
total
annual
Fund
operating
expenses
to
become
higher
than
the
figures
shown.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
Total
Annual
Operating
Expenses
5
Share
Class
With
Fee
Waiver
Without
Fee
Waiver
A
1.03%
1.05%
Advisor
0.78%
0.80%
Your
Fund’s
Expenses
Franklin
Biotechnology
Discovery
Fund
9
franklintempleton.com
Semiannual
Report
As
a
Fund
shareholder,
you
can
incur
two
types
of
costs:
(1)
transaction
costs,
including
sales
charges
(loads)
on
Fund
purchases
and
redemptions;
and
(2)
ongoing
Fund
costs,
including
management
fees,
distribution
and
service
(12b-1)
fees,
and
other
Fund
expenses.
All
mutual
funds
have
ongoing
costs,
sometimes
referred
to
as
operating
expenses.
The
table
below
shows
ongoing
costs
of
investing
in
the
Fund
and
can
help
you
understand
these
costs
and
compare
them
with
those
of
other
mutual
funds.
The
table
assumes
a
$1,000
investment
held
for
the
six
months
indicated.
Actual
Fund
Expenses
The
table
below
provides
information
about
actual
account
values
and
actual
expenses
in
the
columns
under
the
heading
“Actual.”
In
these
columns
the
Fund’s
actual
return,
which
includes
the
effect
of
Fund
expenses,
is
used
to
calculate
the
“Ending
Account
Value”
for
each
class
of
shares.
You
can
estimate
the
expenses
you
paid
during
the
period
by
following
these
steps
(
of
course,
your
account
value
and
expenses
will
differ
from
those
in
this
illustration
):
Divide
your
account
value
by
$1,000
(
if
your
account
had
an
$8,600
value,
then
$8,600
÷
$1,000
=
8.6).
Then
multiply
the
result
by
the
number
in
the
row
for
your
class
of
shares
under
the
headings
“Actual”
and
“Expenses
Paid
During
Period”
(
if
Actual
Expenses
Paid
During
Period
were
$7.50,
then
8.6
x
$7.50
=
$64.
50
).
In
this
illustration,
the
actual
expenses
paid
this
period
are
$64.50.
Hypothetical
Example
for
Comparison
with
Other
Funds
Under
the
heading
“Hypothetical”
in
the
table,
information
is
provided
about
hypothetical
account
values
and
hypothetical
expenses
based
on
the
Fund’s
actual
expense
ratio
and
an
assumed
rate
of
return
of
5%
per
year
before
expenses,
which
is
not
the
Fund’s
actual
return.
This
information
may
not
be
used
to
estimate
the
actual
ending
account
balance
or
expenses
you
paid
for
the
period,
but
it
can
help
you
compare
ongoing
costs
of
investing
in
the
Fund
with
those
of
other
funds.
To
do
so,
compare
this
5%
hypothetical
example
for
the
class
of
shares
you
hold
with
the
5%
hypothetical
examples
that
appear
in
the
shareholder
reports
of
other
funds.
Please
note
that
expenses
shown
in
the
table
are
meant
to
highlight
ongoing
costs
and
do
not
reflect
any
transactional
costs.
Therefore,
information
under
the
heading
“Hypothetical”
is
useful
in
comparing
ongoing
costs
only,
and
will
not
help
you
compare
total
costs
of
owning
different
funds.
In
addition,
if
transactional
costs
were
included,
your
total
costs
would
have
been
higher.
1.
Expenses
are
equal
to
the
annualized
expense
ratio
for
the
six-month
period
as
indicated
above—in
the
far
right
column—multiplied
by
the
simple
average
account
value
over
the
period
indicated,
and
then
multiplied
by
184/365
to
reflect
the
one-half
year
period.
2.
Reflects
expenses
after
fee
waivers
and
expense
reimbursements.
Does
not
include
acquired
fund
fees
and
expenses.
Actual
(actual
return
after
expenses)
Hypothetical
(5%
annual
return
before
expenses)
Share
Class
Beginning
Account
Value
5/1/20
Ending
Account
Value
10/31/20
Expenses
Paid
During
Period
5/1/20–10/31/20
1,2
Ending
Account
Value
10/31/20
Expenses
Paid
During
Period
5/1/20–10/31/20
1,2
a
Net
Annualized
Expense
Ratio
2
A
$1,000
$1,125.53
$5.21
$1,020.31
$4.95
0.97%
C
$1,000
$1,121.33
$9.20
$1,016.54
$8.74
1.72%
R6
$1,000
$1,127.46
$3.39
$1,022.01
$3.23
0.63%
Advisor
$1,000
$1,126.92
$3.87
$1,021.56
$3.68
0.72%
10
franklintempleton.com
Semiannual
Report
Franklin
Natural
Resources
Fund
This
semiannual
report
for
Franklin
Natural
Resources
Fund
covers
the
period
ended
October
31,
2020
.
Your
Fund’s
Goal
and
Main
Investments
The
Fund
seeks
to
provide
high
total
return.
Total
return
consists
of
capital
appreciation
and
current
dividend
and
interest
income.
Under
normal
market
conditions,
the
Fund
invests
at
least
80%
of
its
net
assets
in
equity
and
debt
securities
of
companies
that
own,
produce,
refine,
process,
transport
or
market
natural
resources,
as
well
as
those
that
provide
related
services.
Performance
Overview
The
Fund’s
Class
A
shares
posted
a
-4.56%
cumulative
total
return
for
the
six
months
under
review.
In
comparison,
the
Standard
&
Poor’s
(S&P
®
)
North
American
Natural
Resources
Sector
Index,
which
tracks
companies
involved
in
industries
such
as
mining,
energy,
timber
and
forestry
services,
and
the
production
of
pulp
and
paper,
posted
a
-6.58%
total
return.
1
Also
in
comparison,
the
Standard
&
Poor’s
500
Index
(S&P
500),
which
is
a
broad
measure
of
the
U.S.
stock
market,
posted
a
+13.29%
total
return.
1
Please
note
index
performance
information
is
provided
for
reference
and
we
do
not
attempt
to
track
any
index
but
rather
undertake
investments
on
the
basis
of
fundamental
research.
The
Fund’s
strategy,
which
focuses
on
companies
with
higher
long-term
growth
potential,
differs
from
the
natural
resources
index’s
large
weighting
in
income-oriented
companies
that
we
believe
typically
provide
more
limited
opportunities
for
growth.
This
difference
may
occasionally
lead
to
wide
performance
discrepancies,
especially
in
periods
when
investors
focus
on
short-term
safety
and
yield
or,
conversely,
when
investors
focus
more
heavily
on
companies
with
stronger
growth
prospects
and
greater
commodity
price
leverage.
You
can
find
the
Fund’s
long-term
performance
data
in
the
Performance
Summary
beginning
on
page
13
.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Investment
Strategy
We
are
research-driven,
fundamental
investors,
pursuing
a
growth
strategy.
As
bottom-up
investors
focusing
primarily
on
individual
securities,
we
choose
companies
that
have
identifiable
drivers
of
future
earnings
growth
and
that
present,
in
our
opinion,
the
best
trade-off
between
potential
earnings
growth,
business
and
financial
risk,
and
valuation.
Also,
in
seeking
sustainable
growth
characteristics,
we
look
for
companies
that
we
believe
can
produce
sustainable
earnings
growth
and
cash
flow
growth
or
the
potential
to
generate
income.
We
rely
on
a
team
of
analysts
to
help
provide
in-depth
industry
expertise
and
use
both
qualitative
and
quantitative
analysis
to
evaluate
companies
for
distinct
and
sustainable
competitive
advantages
likely
to
lead
to
growth
in
earnings
and/or
share
price.
Competitive
advantages,
such
as
a
particular
product
niche,
proven
technology,
sound
financial
position
and
strong
management,
are
all
factors
we
believe
may
contribute
to
strong
growth
potential.
Sector
Overview
Global
commodity
prices
rose
during
the
six
months
ended
October
31,
2020.
Energy
and
industrial
metals
benefited
from
increased
economic
activity
following
the
lifting
of
the
most
restrictive
lockdowns
put
in
place
to
contain
the
novel
coronavirus
(COVID-19)
pandemic.
The
economic
recovery
in
China,
the
world’s
largest
consumer
of
many
raw
materials,
has
played
an
important
role
in
lifting
commodity
prices.
Precious
metals
also
rose
in
value
as
many
investors
sought
perceived
safe-haven
assets.
Geographic
Composition
10/31/20
%
of
Total
Net
Assets
North
America
75.3%
Europe
9.0%
Australia
&
New
Zealand
6.9%
Latin
America
&
Caribbean
5.7%
Middle East & Africa
2.5%
Short-Term
Investments
&
Other
Net
Assets
0.6%
1.
Source:
Morningstar.
The
indexes
are
unmanaged
and
include
reinvestment
of
any
income
or
distributions.
They
do
not
reflect
any
fees,
expenses
or
sales
charges.
One
cannot
invest
directly
in
an
index,
and
an
index
is
not
representative
of
the
Fund’s
portfolio.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
The
dollar
value,
number
of
shares
or
principal
amount,
and
names
of
all
portfolio
holdings
are
listed
in
the
Fund’s
Statement
of
Investments
(SOI).
The
SOI
begins
on
page
27
.
Franklin
Natural
Resources
Fund
11
franklintempleton.com
Semiannual
Report
Crude
oil
prices
rose
significantly
during
the
period
after
reaching
historically
low
levels
in
early
2020.
Prices
increased
significantly
in
May
and
June
due
to
increased
demand
from
a
recovering
Chinese
economy
along
with
production
curtailments
by
the
Organization
of
the
Petroleum
Exporting
Countries
and
certain
non-member
countries.
Some
of
these
gains
were
given
back
late
in
the
period
due
to
weakening
adherence
to
the
production
cuts
by
certain
countries,
anticipation
of
renewed
COVID-19
lockdowns
in
Europe
and
the
U.S.,
and
reduced
expectations
for
oil
demand
in
the
remaining
months
of
2020
and
into
2021.
U.S.
natural
gas
prices
also
rose
significantly
during
the
period,
despite
some
volatility.
Prices
were
supported
by
recovering
exports
of
liquified
natural
gas
(LNG),
decreased
gas
drilling
in
the
U.S.
and
a
faster-than-expected
recovery
in
demand
from
U.S.
businesses
after
the
most
restrictive
COVID-19-related
lockdowns
were
lifted.
Prices
were
held
in
check
by
relatively
mild
summer
weather,
which
reduced
electricity
demand
for
air
conditioning,
and
high
inventory
levels.
Prices
rose
in
October,
however,
due
to
investor
expectations
that
heating
demand
in
the
coming
winter
may
reduce
inventories.
Precious
metals
prices
increased
as
well
during
the
period.
The
price
of
gold
continued
its
relatively
steady,
long-term
upward
trend,
despite
some
volatility.
Demand
increased
as
many
investors
sought
perceived-safe
havens
out
of
fear
that
equities
would
decline
due
to
economic
lockdowns
and
inflationary
pressures
from
aggressive
monetary
and
fiscal
stimulus
measures.
COVID-19-related
mine
closures
hampered
production,
further
supporting
prices.
Silver
prices
rose
significantly
for
similar
reasons,
along
with
the
metal’s
application
in
infrastructure
and
green
energy
construction,
which
some
analysts
expected
to
increase
in
the
U.S.
following
the
presidential
election.
Platinum
and
palladium
prices
also
increased.
Palladium,
a
key
component
in
pollution-control
devices
for
automobiles,
benefited
from
a
recovery
in
car
sales
in
China
and
elsewhere.
Industrial
metal
prices
also
rose
during
the
period.
Copper
benefited
from
decreased
supply
due
to
pandemic-related
mine
closures
in
Chile
and
demand
from
China.
Iron
ore
prices
also
rose
as
a
result
of
decreased
supply
due
to
mine
closures,
particularly
in
Brazil,
and
demand
from
China,
where
steel
producers
ramped
up
output
to
meet
the
needs
of
the
country’s
large
construction
and
manufacturing
sectors.
Manager’s
Discussion
Natural
resources
equities
declined
during
the
period,
hurt
by
the
ongoing
COVID-19
pandemic
and
government
efforts
to
contain
the
spread
of
the
virus.
Oil
companies
have
been
hit
particularly
hard
by
public
health
measures
severely
restricting
mobility
and
business
activity,
which
have
decreased
fuel
demand.
Political
uncertainty
around
the
U.S.
presidential
election
has
also
hurt
the
energy
sector,
with
investors
concerned
about
the
impact
of
a
Joe
Biden
administration,
which
could
be
relatively
more
antagonistic
toward
U.S.
oil
and
gas
producers
and
favorable
to
renewable
energy.
The
production
cut
agreement
between
OPEC
and
other
oil
producing
non-member
countries
did
allow
a
partial
recovery
among
energy
equities,
and
the
sector
stands
to
benefit
greatly
from
the
anticipated
development
of
a
vaccine,
which
would
hopefully
allow
global
economic
activity
to
normalize.
Mining
equities,
in
contrast,
performed
well
during
the
period.
China’s
economic
recovery,
partially
stoked
by
government
stimulus,
stimulated
rising
demand
for
industrial
metals.
Low
fuel
costs,
supply
curtailments
and
declining
inventories
further
benefited
mining
companies.
In
this
environment,
overweightings
in
the
diversified
metals
and
mining
and
copper
industries
contributed
to
relative
performance.
U.K-based
BHP
Group
and
Australia-based
Rio
Tinto
were
significant
contributors
in
the
former,
while
Chile-based
Antofagasta
and
Canada-based
Lundin
Mining
contributed
in
the
latter.
Portfolio
Composition
10/31/20
%
of
Total
Net
Assets
Oil
&
Gas
Exploration
&
Production
20.2%
Integrated
Oil
&
Gas
14.9%
Gold
12.8%
Oil
&
Gas
Equipment
&
Services
9.7%
Diversified
Metals
&
Mining
9.1%
Copper
7.9%
Oil
&
Gas
Storage
&
Transportation
7.5%
Oil
&
Gas
Refining
&
Marketing
5.3%
Industrial
Gases
2.3%
Fertilizers
&
Agricultural
Chemicals
1.5%
Construction
Materials
1.1%
Packaged
Foods
&
Meats
1.1%
Other
6.0%
Short-Term
Investments
&
Other
Net
Assets
0.6%
Franklin
Natural
Resources
Fund
12
franklintempleton.com
Semiannual
Report
An
underweighting
in
the
integrated
oil
and
gas
industry
helped
relative
performance
as
well.
Underweighted
positions
in
Exxon
Mobil
and
Chevron
were
significant
relative
contributors
in
the
industry,
which
was
hurt
by
soft
demand
for
transportation
fuels
and
LNG.
Elsewhere,
off-benchmark
positions
in
fertilizer
and
agriculture
and
industrial
gases
also
contributed
to
relative
results.
In
contrast,
underweighted
allocation
in
paper
packaging
and
a
lack
of
holdings
in
metal
and
glass
containers
hurt
relative
results
as
these
industries
proved
to
be
relatively
insulated
from
the
pandemic’s
economic
effects.
An
underweighting
in
gold,
which
included
a
lack
of
positions
in
multiple
major
gold
miners,
also
hurt
relative
results.
Gold
equities
performed
well
on
an
absolute
basis
as
investors
sought
safe
havens
from
low
interest
rates,
a
weakening
dollar
and
growing
inflation
concerns.
Elsewhere,
other
relative
detractors
included
a
lack
of
position
in
a
major
construction
materials
firm
along
with
positions
in
U.K.
oil
services
firm
TechnipFMC
and
U.S.
oil
and
gas
exploration
firm
Concho
Resources.
It
is
important
to
recognize
the
effect
of
currency
movements
on
the
Fund’s
performance.
In
general,
if
the
value
of
the
U.S.
dollar
goes
up
compared
with
a
foreign
currency,
an
investment
traded
in
that
foreign
currency
will
go
down
in
value
because
it
will
be
worth
fewer
U.S.
dollars.
This
can
have
a
negative
effect
on
Fund
performance.
Conversely,
when
the
U.S.
dollar
weakens
in
relation
to
a
foreign
currency,
an
investment
traded
in
that
foreign
currency
will
increase
in
value,
which
can
contribute
to
Fund
performance.
For
the
six
months
ended
October
31,
2020,
the
U.S.
dollar
declined
in
value
relative
to
most
currencies.
As
a
result,
the
Fund’s
performance
was
positively
affected
by
the
portfolio’s
significant
investment
in
securities
with
non-U.S.
currency
exposure.
However,
one
cannot
expect
the
same
result
in
future
periods.
Whether
the
U.S.
dollar
goes
up
or
weakens
compared
with
foreign
currencies,
company-specific
factors
may
offset
the
effects
of
the
currency
movements
on
the
value
of
individual
investments
and,
possibly,
the
Fund’s
performance
overall.
Thank
you
for
your
continued
participation
in
Franklin
Natural
Resources
Fund.
We
look
forward
to
serving
your
future
investment
needs.
Frederick
G.
Fromm,
CFA
Matthew
J.
Adams,
CFA
Stephen
M.
Land,
CFA
Portfolio
Management
Team
The
foregoing
information
reflects
our
analysis,
opinions
and
portfolio
holdings
as
of
October
31,
2020
,
the
end
of
the
reporting
period.
The
way
we
implement
our
main
investment
strategies
and
the
resulting
portfolio
holdings
may
change
depending
on
factors
such
as
market
and
economic
conditions.
These
opinions
may
not
be
relied
upon
as
investment
advice
or
an
offer
for
a
particular
security.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
the
Fund.
Statements
of
fact
are
from
sources
considered
reliable,
but
the
investment
manager
makes
no
representation
or
warranty
as
to
their
completeness
or
accuracy.
Although
historical
performance
is
no
guarantee
of
future
results,
these
insights
may
help
you
understand
our
investment
management
philosophy.
Top
10
Holdings
10/31/20
Company
Industry
,
Country
%
of
Total
Net
Assets
a
a
Chevron
Corp.
4.1%
Oil,
Gas
&
Consumable
Fuels,
United
States
Barrick
Gold
Corp.
4.0%
Metals
&
Mining,
Canada
BHP
Group
plc
3.9%
Metals
&
Mining,
Australia
Cabot
Oil
&
Gas
Corp.
3.9%
Oil,
Gas
&
Consumable
Fuels,
United
States
Newmont
Corp.
3.9%
Metals
&
Mining,
United
States
Antofagasta
plc
3.1%
Metals
&
Mining,
Chile
TOTAL
SE
3.0%
Oil,
Gas
&
Consumable
Fuels,
France
Exxon
Mobil
Corp.
3.0%
Oil,
Gas
&
Consumable
Fuels,
United
States
ConocoPhillips
2.7%
Oil,
Gas
&
Consumable
Fuels,
United
States
Williams
Cos.,
Inc.
(The)
2.7%
Oil,
Gas
&
Consumable
Fuels,
United
States
Performance
Summary
as
of
October
31,
2020
Franklin
Natural
Resources
Fund
13
franklintempleton.com
Semiannual
Report
The
performance
table
does
not
reflect
any
taxes
that
a
shareholder
would
pay
on
Fund
dividends,
capital
gain
distributions,
if
any,
or
any
realized
gains
on
the
sale
of
Fund
shares.
Total
return
reflects
reinvestment
of
the
Fund’s
dividends
and
capital
gain
distributions,
if
any,
and
any
unrealized
gains
or
losses.
Your
dividend
income
will
vary
depending
on
dividends
or
interest
paid
by
securities
in
the
Fund’s
portfolio,
adjusted
for
operating
expenses
of
each
class.
Capital
gain
distributions
are
net
profits
realized
from
the
sale
of
portfolio
securities.
Performance
as
of
10/31/20
Cumulative
total
return
excludes
sales
charges.
Average
annual
total
return
includes
maximum
sales
charges.
Sales
charges
will
vary
depending
on
the
size
of
the
investment
and
the
class
of
share
purchased.
The
maximum
is
5.50%
and
the
minimum
is
0%.
Class
A
:
5.50%
maximum
initial
sales
charge;
Advisor
Class:
no
sales
charges.
For
other
share
classes,
visit
franklintempleton.com.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Share
Class
Cumulative
Total
Return
1
Average
Annual
Total
Return
2
A
3
6-Month
-4.56
%
-9.86%
1-Year
-32.34%
-36.07%
5-Year
-42.13%
-11.37%
10-Year
-58.48%
-8.93%
Advisor
6-Month
-4.47%
-4.54%
1-Year
-32.20%
-32.20%
5-Year
-41.42%
-10.14%
10-Year
-57.35%
-8.17%
See
page
14
for
Performance
Summary
footnotes.
Franklin
Natural
Resources
Fund
Performance
Summary
14
franklintempleton.com
Semiannual
Report
Each
class
of
shares
is
available
to
certain
eligible
investors
and
has
different
annual
fees
and
expenses,
as
described
in
the
prospectus.
All
investments
involve
risks,
including
possible
loss
of
principal.
Investing
in
a
fund
concentrating
in
the
natural
resources
sector
involves
special
risks,
includ-
ing
increased
susceptibility
to
adverse
economic
and
regulatory
developments
affecting
the
sector.
Growth
stock
prices
may
fall
dramatically
if
the
company
fails
to
meet
projections
of
earnings
or
revenue;
their
prices
may
be
more
volatile
than
other
securities,
particularly
over
the
short
term.
Smaller
companies
can
be
particularly
sensitive
to
changes
in
economic
conditions
and
have
less
certain
growth
prospects
than
larger,
more
established
companies
and
can
be
volatile,
especially
over
the
short
term.
The
Fund
may
also
invest
in
foreign
companies,
which
involve
special
risks,
including
currency
fluctuations
and
political
uncertainty.
Unexpected
events
and
their
aftermaths,
such
as
the
spread
of
deadly
diseases;
natural,
environmental
or
man-made
disasters;
financial,
political
or
social
disruptions;
terrorism
and
war;
and
other
tragedies
or
catastrophes,
can
cause
investor
fear
and
panic,
which
can
adversely
affect
the
economies
of
many
companies,
sectors,
nations,
regions
and
the
market
in
general,
in
ways
that
cannot
necessarily
be
foreseen.
The
Fund’s
prospectus
also
includes
a
description
of
the
main
investment
risks.
1.
Cumulative
total
return
represents
the
change
in
value
of
an
investment
over
the
periods
indicated.
2.
Average
annual
total
return
represents
the
average
annual
change
in
value
of
an
investment
over
the
periods
indicated.
Return
for
less
than
one
year,
if
any,
has
not
been
annualized.
3.
Prior
to
9/10/18,
these
shares
were
offered
at
a
higher
initial
sales
charge
of
5.75%,
thus
actual
returns
(with
sales
charges)
would
have
differed.
Average
annual
total
returns
(with
sales
charges)
have
been
restated
to
reflect
the
current
maximum
initial
sales
charge
of
5.50%.
4.
Figures
are
as
stated
in
the
Fund’s
current
prospectus
and
may
differ
from
the
expense
ratios
disclosed
in
the
Your
Fund’s
Expenses
and
Financial
Highlights
sections
in
this
report.
In
periods
of
market
volatility,
assets
may
decline
significantly,
causing
total
annual
Fund
operating
expenses
to
become
higher
than
the
figures
shown.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
Total
Annual
Operating
Expenses
4
Share
Class
A
1.17%
Advisor
0.92%
Your
Fund’s
Expenses
Franklin
Natural
Resources
Fund
15
franklintempleton.com
Semiannual
Report
As
a
Fund
shareholder,
you
can
incur
two
types
of
costs:
(1)
transaction
costs,
including
sales
charges
(loads)
on
Fund
purchases
and
redemptions;
and
(2)
ongoing
Fund
costs,
including
management
fees,
distribution
and
service
(12b-1)
fees,
and
other
Fund
expenses.
All
mutual
funds
have
ongoing
costs,
sometimes
referred
to
as
operating
expenses.
The
table
below
shows
ongoing
costs
of
investing
in
the
Fund
and
can
help
you
understand
these
costs
and
compare
them
with
those
of
other
mutual
funds.
The
table
assumes
a
$1,000
investment
held
for
the
six
months
indicated.
Actual
Fund
Expenses
The
table
below
provides
information
about
actual
account
values
and
actual
expenses
in
the
columns
under
the
heading
“Actual.”
In
these
columns
the
Fund’s
actual
return,
which
includes
the
effect
of
Fund
expenses,
is
used
to
calculate
the
“Ending
Account
Value”
for
each
class
of
shares.
You
can
estimate
the
expenses
you
paid
during
the
period
by
following
these
steps
(
of
course,
your
account
value
and
expenses
will
differ
from
those
in
this
illustration
):
Divide
your
account
value
by
$1,000
(
if
your
account
had
an
$8,600
value,
then
$8,600
÷
$1,000
=
8.6).
Then
multiply
the
result
by
the
number
in
the
row
for
your
class
of
shares
under
the
headings
“Actual”
and
“Expenses
Paid
During
Period”
(
if
Actual
Expenses
Paid
During
Period
were
$7.50,
then
8.6
x
$7.50
=
$64.
50
).
In
this
illustration,
the
actual
expenses
paid
this
period
are
$64.50.
Hypothetical
Example
for
Comparison
with
Other
Funds
Under
the
heading
“Hypothetical”
in
the
table,
information
is
provided
about
hypothetical
account
values
and
hypothetical
expenses
based
on
the
Fund’s
actual
expense
ratio
and
an
assumed
rate
of
return
of
5%
per
year
before
expenses,
which
is
not
the
Fund’s
actual
return.
This
information
may
not
be
used
to
estimate
the
actual
ending
account
balance
or
expenses
you
paid
for
the
period,
but
it
can
help
you
compare
ongoing
costs
of
investing
in
the
Fund
with
those
of
other
funds.
To
do
so,
compare
this
5%
hypothetical
example
for
the
class
of
shares
you
hold
with
the
5%
hypothetical
examples
that
appear
in
the
shareholder
reports
of
other
funds.
Please
note
that
expenses
shown
in
the
table
are
meant
to
highlight
ongoing
costs
and
do
not
reflect
any
transactional
costs.
Therefore,
information
under
the
heading
“Hypothetical”
is
useful
in
comparing
ongoing
costs
only,
and
will
not
help
you
compare
total
costs
of
owning
different
funds.
In
addition,
if
transactional
costs
were
included,
your
total
costs
would
have
been
higher.
1.
Expenses
are
equal
to
the
annualized
expense
ratio
for
the
six-month
period
as
indicated
above—in
the
far
right
column—multiplied
by
the
simple
average
account
value
over
the
period
indicated,
and
then
multiplied
by
184/365
to
reflect
the
one-half
year
period.
2.
Reflects
expenses
after
fee
waivers
and
expense
reimbursements.
Does
not
include
acquired
fund
fees
and
expenses.
Actual
(actual
return
after
expenses)
Hypothetical
(5%
annual
return
before
expenses)
Share
Class
Beginning
Account
Value
5/1/20
Ending
Account
Value
10/31/20
Expenses
Paid
During
Period
5/1/20–10/31/20
1,2
Ending
Account
Value
10/31/20
Expenses
Paid
During
Period
5/1/20–10/31/20
1,2
a
Net
Annualized
Expense
Ratio
2
A
$1,000
$953.71
$6.32
$1,018.73
$6.53
1.28%
C
$1,000
$950.23
$10.00
$1,014.95
$10.33
2.03%
R6
$1,000
$956.94
$3.62
$1,021.50
$3.74
0.7
3%
Advisor
$1,000
$954.64
$5.10
$1,019.99
$5.27
1.03%
Franklin
Strategic
Series
Financial
Highlights
Franklin
Biotechnology
Discovery
Fund
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
16
.
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
A
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$150.48
$138.85
$146.14
$147.22
$128.19
$182.30
Income
from
investment
operations
a
:
Net
investment
income
(loss)
b
........
(0.53)
(0.69)
(0.99)
(0.80)
(0.79)
(0.94)
Net
realized
and
unrealized
gains
(losses)
19.40
26.48
(1.75)
3.32
25.75
(39.39)
Total
from
investment
operations
........
18.87
25.79
(2.74)
2.52
24.96
(40.33)
Less
distributions
from:
Net
investment
income
..............
(1.73)
Net
realized
gains
.................
(14.16)
(4.55)
(3.60)
(4.20)
(13.78)
Total
distributions
...................
(14.16)
(4.55)
(3.60)
(5.93)
(13.78)
Net
asset
value,
end
of
period
..........
$169.35
$150.48
$138.85
$146.14
$147.22
$128.19
Total
return
c
.......................
12.54%
18.52%
(1.60)%
1.69%
20.02%
(23.55)%
Ratios
to
average
net
assets
d
Expenses
before
waiver
and
payments
by
affiliates
..........................
0.98%
1.03%
1.02%
1.05%
1.04%
0.99%
Expenses
net
of
waiver
and
payments
by
affiliates
e
..........................
0.97%
1.01%
1.00%
1.03%
1.02%
0.98%
Net
investment
income
(loss)
..........
(0.62)%
(0.49)%
(0.67)%
(0.53)%
(0.58)%
(0.56)%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$1,077,405
$960,305
$924,611
$1,081,883
$1,176,687
$1,074,903
Portfolio
turnover
rate
................
24.20
%
32.92%
28.62%
26.95%
34.12%
22.13%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable,
and
is
not
annualized
for
periods
less
than
one
year.
d
Ratios
are
annualized
for
periods
less
than
one
year.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Biotechnology
Discovery
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
17
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
C
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$143.00
$133.51
$141.75
$143.98
$125.99
$180.67
Income
from
investment
operations
a
:
Net
investment
income
(loss)
b
........
(1.12)
(1.70)
(2.03)
(1.90)
(1.81)
(2.11)
Net
realized
and
unrealized
gains
(losses)
18.45
25.35
(1.66)
3.27
25.29
(38.79)
Total
from
investment
operations
........
17.33
23.65
(3.69)
1.37
23.48
(40.90)
Less
distributions
from:
Net
investment
income
..............
(1.29)
Net
realized
gains
.................
(14.16)
(4.55)
(3.60)
(4.20)
(13.78)
Total
distributions
...................
(14.16)
(4.55)
(3.60)
(5.49)
(13.78)
Net
asset
value,
end
of
period
..........
$160.33
$143.00
$133.51
$141.75
$143.98
$125.99
Total
return
c
.......................
12.12%
17.62%
(2.33)%
0.93%
19.14%
(24.09)%
Ratios
to
average
net
assets
d
Expenses
before
waiver
and
payments
by
affiliates
..........................
1.73%
1.78%
1.77%
1.80%
1.79%
1.71%
Expenses
net
of
waiver
and
payments
by
affiliates
e
..........................
1.72%
1.76%
1.75%
1.78%
1.77%
1.70%
Net
investment
income
(loss)
..........
(1.37)%
(1.24)%
(1.42)%
(1.28)%
(1.33)%
(1.28)%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$57,507
$48,363
$46,508
$58,433
$53,935
$17,562
Portfolio
turnover
rate
................
24.20%
32.92%
28.62%
26.95%
34.12%
22.13%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable,
and
is
not
annualized
for
periods
less
than
one
year.
d
Ratios
are
annualized
for
periods
less
than
one
year.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Biotechnology
Discovery
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
18
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
R6
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$156.99
$143.83
$150.65
$151.03
$131.37
$185.75
Income
from
investment
operations
a
:
Net
investment
income
(loss)
b
........
(0.25)
(0.18)
(0.46)
(0.17)
(0.25)
(0.32)
Net
realized
and
unrealized
gains
(losses)
20.24
27.50
(1.81)
3.39
26.41
(40.28)
Total
from
investment
operations
........
19.99
27.32
(2.27)
3.22
26.16
(40.60)
Less
distributions
from:
Net
investment
income
..............
(2.30)
Net
realized
gains
.................
(14.16)
(4.55)
(3.60)
(4.20)
(13.78)
Total
distributions
...................
(14.16)
(4.55)
(3.60)
(6.50)
(13.78)
Net
asset
value,
end
of
period
..........
$176.98
$156.99
$143.83
$150.65
$151.03
$131.37
Total
return
c
.......................
12.73%
18.95%
(1.24)%
2.11%
20.50%
(23.24)%
Ratios
to
average
net
assets
d
Expenses
before
waiver
and
payments
by
affiliates
..........................
0.70%
0.74%
0.70%
0.65%
0.63%
0.60%
Expenses
net
of
waiver
and
payments
by
affiliates
e
..........................
0.63%
0.64%
0.63%
0.61%
0.61%
0.59%
Net
investment
income
(loss)
..........
(0.28)%
(0.12)%
(0.30)%
(0.11)%
(0.17)%
(0.17)%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$10,677
$9,484
$6,164
$8,307
$8,891
$5,568
Portfolio
turnover
rate
................
24.20%
32.92%
28.62%
26.95%
34.12%
22.13%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
is
not
annualized
for
periods
less
than
one
year.
d
Ratios
are
annualized
for
periods
less
than
one
year.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Biotechnology
Discovery
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
19
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Advisor
Class
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$155.30
$142.56
$149.54
$150.20
$130.67
$185.12
Income
from
investment
operations
a
:
Net
investment
income
(loss)
b
........
(0.33)
(0.34)
(0.63)
(0.45)
(0.46)
(0.55)
Net
realized
and
unrealized
gains
(losses)
20.02
27.24
(1.80)
3.39
26.27
(40.12)
Total
from
investment
operations
........
19.69
26.90
(2.43)
2.94
25.81
(40.67)
Less
distributions
from:
Net
investment
income
..............
(2.08)
Net
realized
gains
.................
(14.16)
(4.55)
(3.60)
(4.20)
(13.78)
Total
distributions
...................
(14.16)
(4.55)
(3.60)
(6.28)
(13.78)
Net
asset
value,
end
of
period
..........
$174.99
$155.30
$142.56
$149.54
$150.20
$130.67
Total
return
c
.......................
12.68%
18.82%
(1.36)%
1.94%
20.32%
(23.36)%
Ratios
to
average
net
assets
d
Expenses
before
waiver
and
payments
by
affiliates
..........................
0.73%
0.78%
0.77%
0.80%
0.79%
0.75%
Expenses
net
of
waiver
and
payments
by
affiliates
e
..........................
0.72%
0.76%
0.75%
0.78%
0.77%
0.74%
Net
investment
income
(loss)
..........
(0.37)%
(0.24)%
(0.42)%
(0.28)%
(0.33)%
(0.32)%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$194,840
$159,348
$153,874
$180,219
$159,894
$93,263
Portfolio
turnover
rate
................
24.20%
32.92%
28.62%
26.95%
34.12%
22.13%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
is
not
annualized
for
periods
less
than
one
year.
d
Ratios
are
annualized
for
periods
less
than
one
year.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Statement
of
Investments,
October
31,
2020
Franklin
Biotechnology
Discovery
Fund
franklintempleton.com
Semiannual
Report
20
2
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
96.4%
Biotechnology
80.0%
a
89bio,
Inc.
...........................................
United
States
284,400
$
6,586,704
a
ACADIA
Pharmaceuticals,
Inc.
...........................
United
States
294,600
13,684,170
a
Acceleron
Pharma,
Inc.
.................................
United
States
158,700
16,596,846
a,b
ADMA
Biologics,
Inc.
...................................
United
States
437,264
870,155
a,b
Akouos
,
Inc.
.........................................
United
States
157,600
3,059,016
a
Albireo
Pharma,
Inc.
...................................
United
States
102,400
3,231,744
a
Alector
,
Inc.
..........................................
United
States
331,600
3,120,356
a
Alexion
Pharmaceuticals,
Inc.
............................
United
States
260,000
29,936,400
a
Alnylam
Pharmaceuticals,
Inc.
............................
United
States
52,300
6,431,331
a
ALX
Oncology
Holdings,
Inc.
.............................
United
States
86,100
3,401,811
Amgen,
Inc.
.........................................
United
States
318,700
69,138,778
a,b
Applied
Molecular
Transport,
Inc.
.........................
United
States
59,800
1,757,522
a
Applied
Therapeutics,
Inc.
...............................
United
States
154,857
2,519,523
a
Arcus
Biosciences,
Inc.
.................................
United
States
311,000
6,779,800
a
Argenx
SE,
ADR
......................................
Netherlands
57,325
14,224,052
a
Ascendis
Pharma
A/S,
ADR
.............................
Denmark
214,400
35,022,240
a
Assembly
Biosciences,
Inc.
..............................
United
States
381,295
5,620,288
a
Athenex
,
Inc.
.........................................
United
States
406,200
4,630,680
a
Autolus
Therapeutics
plc,
ADR
...........................
United
Kingdom
232,430
2,512,568
a
Biogen,
Inc.
.........................................
United
States
159,875
40,299,691
a
BioMarin
Pharmaceutical,
Inc.
............................
United
States
142,456
10,603,000
a
Black
Diamond
Therapeutics,
Inc.
.........................
United
States
127,800
4,026,978
a
Bluebird
Bio,
Inc.
......................................
United
States
30,900
1,597,839
a
Blueprint
Medicines
Corp.
...............................
United
States
117,200
11,987,216
a,b
Bridgebio
Pharma,
Inc.
.................................
United
States
118,800
4,559,544
a
Cardiff
Oncology,
Inc.
..................................
United
States
174,312
2,757,616
a
Codiak
Biosciences,
Inc.
................................
United
States
107,500
926,650
a
CRISPR
Therapeutics
AG
...............................
Switzerland
166,314
15,270,952
a
Deciphera
Pharmaceuticals,
Inc.
..........................
United
States
572,854
33,265,632
c,d
Dyne
Therapeutics,
Inc.
................................
United
States
115,139
2,172,481
a
Dyne
Therapeutics,
Inc.
................................
United
States
100,400
2,076,272
a,b
Equillium
,
Inc.
........................................
United
States
294,800
1,871,980
a
Fate
Therapeutics,
Inc.
.................................
United
States
456,793
20,281,609
a
Forte
Biosciences,
Inc.
.................................
United
States
445,464
16,998,906
Gilead
Sciences,
Inc.
..................................
United
States
1,511,900
87,916,985
a
Global
Blood
Therapeutics,
Inc.
...........................
United
States
391,500
20,702,520
a
Gossamer
Bio,
Inc.
....................................
United
States
361,833
3,003,214
a
Heron
Therapeutics,
Inc.
................................
United
States
1,739,677
28,374,132
a,b
Inhibrx
,
Inc.
..........................................
United
States
84,100
1,433,064
a
Insmed
,
Inc.
.........................................
United
States
890,600
29,336,364
c,d
Intarcia
Therapeutics,
Inc.,
DD
...........................
United
States
80,195
a
Iovance
Biotherapeutics
,
Inc.
.............................
United
States
1,502,101
53,594,964
a
iTeos
Therapeutics,
Inc.
................................
United
States
36,700
835,659
a
KalVista
Pharmaceuticals,
Inc.
...........................
United
States
103,300
1,777,793
a
Kezar
Life
Sciences,
Inc.
................................
United
States
853,550
4,370,176
a
Kronos
Bio,
Inc.
......................................
United
States
82,400
2,314,616
a
Legend
Biotech
Corp.,
ADR
.............................
United
States
196,800
5,091,216
a
LogicBio
Therapeutics,
Inc.
..............................
United
States
661,200
3,649,824
c,d
Metacrine
,
Inc.
.......................................
United
States
260,919
2,163,123
a
Metacrine
,
Inc.
.......................................
United
States
251,900
2,292,290
a
Mirati
Therapeutics,
Inc.
................................
United
States
108,715
23,606,375
a
Neurocrine
Biosciences,
Inc.
.............................
United
States
163,800
16,162,146
a,b
Nkarta
,
Inc.
..........................................
United
States
238,955
6,860,398
a
Novavax
,
Inc.
........................................
United
States
360,800
29,120,168
a
PMV
Pharmaceuticals,
Inc.
..............................
United
States
83,100
2,912,655
a
Praxis
Precision
Medicines,
Inc.
..........................
United
States
103,600
3,626,000
a
Protara
Therapeutics,
Inc.
...............................
United
States
145,500
2,610,270
a
PTC
Therapeutics,
Inc.
.................................
United
States
765,900
39,972,321
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Biotechnology
Discovery
Fund
franklintempleton.com
Semiannual
Report
21
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Biotechnology
(continued)
a
Regeneron
Pharmaceuticals,
Inc.
.........................
United
States
154,909
$
84,202,336
a,b
Repare
Therapeutics,
Inc.
...............................
Canada
38,100
1,029,843
a
REVOLUTION
Medicines,
Inc.
...........................
United
States
148,900
4,495,291
a
Rocket
Pharmaceuticals,
Inc.
............................
United
States
467,071
13,049,964
a
Sage
Therapeutics,
Inc.
................................
United
States
101,070
7,416,517
a
Sarepta
Therapeutics,
Inc.
..............................
United
States
65,400
8,888,514
a
Scholar
Rock
Holding
Corp.
.............................
United
States
41,500
1,614,350
a
Seagen
,
Inc.
.........................................
United
States
234,900
39,181,320
a
Sutro
Biopharma,
Inc.
..................................
United
States
155,900
2,004,874
c,d
Taysha
Gene
Therapies,
Inc.
.............................
United
States
138,156
2,623,877
a
Taysha
Gene
Therapies,
Inc.
.............................
United
States
166,100
3,454,880
a
Trillium
Therapeutics,
Inc.
...............................
Canada
952,690
11,860,991
a
Ultragenyx
Pharmaceutical,
Inc.
..........................
United
States
162,100
16,291,050
a
Vaxcyte
,
Inc.
.........................................
United
States
172,000
6,427,640
a
Vertex
Pharmaceuticals,
Inc.
.............................
United
States
343,100
71,488,316
a,b
Viela
Bio,
Inc.
........................................
United
States
138,300
4,413,153
a
Zentalis
Pharmaceuticals,
Inc.
............................
United
States
135,700
5,372,363
a
Zymeworks
,
Inc.
......................................
Canada
471,320
18,438,039
1,071,799,941
Capital
Markets
1.1%
a
ARYA
Sciences
Acquisition
Corp.
III
.......................
United
States
212,500
2,176,000
a
FS
Development
Corp.,
A
...............................
United
States
211,300
2,113,000
a
Health
Sciences
Acquisitions
Corp.
2
.......................
United
States
171,600
1,873,872
a
Panacea
Acquisition
Corp.
..............................
United
States
345,800
3,665,480
a
Therapeutics
Acquisition
Corp.,
A
.........................
United
States
429,800
5,673,360
15,501,712
Life
Sciences
Tools
&
Services
3.6%
a
Illumina,
Inc.
.........................................
United
States
165,000
48,295,500
a
Pharmaceuticals
11.7%
a
Athira
Pharma,
Inc.
....................................
United
States
168,664
3,046,072
c,d
Athira
Pharma,
Inc.
....................................
United
States
407,548
6,580,931
a
Collegium
Pharmaceutical,
Inc.
...........................
United
States
345,350
6,157,590
a,b
EyePoint
Pharmaceuticals,
Inc.
...........................
United
States
5,923,300
2,215,907
a
GW
Pharmaceuticals
plc,
ADR
...........................
United
Kingdom
437,300
39,361,373
a
Horizon
Therapeutics
plc
................................
United
States
545,749
40,892,973
a,b
Pliant
Therapeutics,
Inc.
................................
United
States
149,100
3,223,542
a
Reata
Pharmaceuticals,
Inc.,
A
...........................
United
States
251,200
29,317,552
a,b
Relmada
Therapeutics,
Inc.
..............................
United
States
91,266
2,822,857
a
Revance
Therapeutics,
Inc.
..............................
United
States
275,500
7,129,940
Royalty
Pharma
plc,
A
..................................
United
States
150,300
5,516,010
a,b
VYNE
Therapeutics,
Inc.
................................
United
States
2,882,600
4,612,160
a
Zogenix
,
Inc.
.........................................
United
States
276,583
5,896,750
156,773,657
Total
Common
Stocks
(Cost
$776,137,647)
.....................................
1,292,370,810
Escrows
and
Litigation
Trusts
0.1%
c
True
North
Therapeutics,
Inc.,
Escrow
Account
...............
United
States
759,880
1,005,744
Total
Escrows
and
Litigation
Trusts
(Cost
$2,090,611)
...........................
1,005,744
Total
Long
Term
Investments
(Cost
$778,228,258)
...............................
1,293,376,554
a
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Biotechnology
Discovery
Fund
franklintempleton.com
Semiannual
Report
22
See
Abbreviations
on
page
46
.
Short
Term
Investments
5.6%
a
a
Country
Shares
a
Value
a
Money
Market
Funds
3.9%
e,f
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
........
United
States
51,932,000
$
51,932,000
Total
Money
Market
Funds
(Cost
$51,932,000)
..................................
51,932,000
a
a
a
a
a
g
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
1.7%
Money
Market
Funds
1.7%
e,f
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio
...........
United
States
22,593,784
22,593,784
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$22,593,784)
...........................................................
22,593,784
Total
Short
Term
Investments
(Cost
$74,525,784
)
................................
74,525,784
a
Total
Investments
(Cost
$852,754,042)
102.1%
..................................
$1,367,902,338
Other
Assets,
less
Liabilities
(2.1)%
...........................................
(27,473,620)
Net
Assets
100.0%
...........................................................
$1,340,428,718
a
Non-income
producing.
b
A
portion
or
all
of
the
security
is
on
loan
at
October
31,
2020.
See
Note
1(c)
c
Fair
valued
using
significant
unobservable
inputs.
See
Note
11
regarding
fair
value
measurements.
d
See
Note
9
regarding
restricted
securities.
e
See
Note
3(f)
regarding
investments
in
affiliated
management
investment
companies.
f
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
g
See
Note
1(c)
regarding
securities
on
loan.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Natural
Resources
Fund
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
23
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
A
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$13.60
$23.58
$27.96
$25.11
$25.02
$31.46
Income
from
investment
operations
a
:
Net
investment
income
b
.............
0.14
0.34
0.31
0.39
c
0.20
0.29
Net
realized
and
unrealized
gains
(losses)
(0.76)
(9.96)
(4.20)
2.77
0.17
(6.55)
Total
from
investment
operations
........
(0.62)
(9.62)
(3.89)
3.16
0.37
(6.26)
Less
distributions
from:
Net
investment
income
..............
(0.36)
(0.49)
(0.31)
(0.28)
(0.18)
Net
asset
value,
end
of
period
..........
$12.98
$13.60
$23.58
$27.96
$25.11
$25.02
Total
return
d
.......................
(4.56
)%
(41.30)%
(13.69)%
12.74%
1.37%
(19.80)%
Ratios
to
average
net
assets
e
Expenses
before
waiver
and
payments
by
affiliates
..........................
1.29%
1.17%
1.03%
1.13%
1.06%
1.14%
Expenses
net
of
waiver
and
payments
by
affiliates
..........................
1.28%
f
1.17%
f,g
1.03%
f,g
1.13%
f,g
1.05%
f
1.13%
Net
investment
income
...............
1.91%
1.75%
1.21%
1.56%
c
0.79%
1.22%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$111,479
$123,467
$247,362
$344,695
$398,703
$461,596
Portfolio
turnover
rate
................
29.17%
25.60%
29.83%
29.98%
29.74%
35.77%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Net
investment
income
per
share
includes
approximately
$0.16
per
share
related
to
income
received
in
the
form
of
special
dividends
in
connection
with
certain
Fund
hold-
ings.
Excluding
this
amount,
the
ratio
of
net
investment
income
to
average
net
assets
would
have
been
0.91%.
d
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable,
and
is
not
annualized
for
periods
less
than
one
year.
e
Ratios
are
annualized
for
periods
less
than
one
year.
f
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
g
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Natural
Resources
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
24
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
C
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$13.25
$22.82
$27.17
$24.28
$24.25
$30.46
Income
from
investment
operations
a
:
Net
investment
income
b
.............
0.08
0.19
0.11
0.20
c
0.01
0.11
Net
realized
and
unrealized
gains
(losses)
(0.73)
(9.70)
(4.07)
2.69
0.15
(6.31)
Total
from
investment
operations
........
(0.65)
(9.51)
(3.96)
2.89
0.16
(6.20)
Less
distributions
from:
Net
investment
income
..............
(0.06)
(0.39)
(0.13)
(0.01)
Net
asset
value,
end
of
period
..........
$12.60
$13.25
$22.82
$27.17
$24.28
$24.25
Total
return
d
.......................
(4.91)%
(41.71)%
(14.37)%
11.90%
0.63%
(20.37)%
Ratios
to
average
net
assets
e
Expenses
before
waiver
and
payments
by
affiliates
..........................
2.04%
1.92%
1.78%
1.88%
1.81%
1.87%
Expenses
net
of
waiver
and
payments
by
affiliates
..........................
2.03%
f
1.92%
f,g
1.78%
f,g
1.88%
f,g
1.80%
f
1.86%
Net
investment
income
...............
1.16%
2.00%
0.46%
0.81%
c
0.04%
0.49%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$19,232
$23,391
$49,620
$83,814
$96,835
$107,724
Portfolio
turnover
rate
................
29.17%
25.60%
29.83%
29.98%
29.74%
35.77%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Net
investment
income
per
share
includes
approximately
$0.16
per
share
related
to
income
received
in
the
form
of
special
dividends
in
connection
with
certain
Fund
hold-
ings.
Excluding
this
amount,
the
ratio
of
net
investment
income
to
average
net
assets
would
have
been
0.16%.
d
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable,
and
is
not
annualized
for
periods
less
than
one
year.
e
Ratios
are
annualized
for
periods
less
than
one
year.
f
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
g
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Natural
Resources
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
25
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
R6
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$14.63
$25.22
$29.79
$26.87
$26.73
$33.62
Income
from
investment
operations
a
:
Net
investment
income
b
.............
0.19
0.54
0.45
0.57
c
0.47
0.51
Net
realized
and
unrealized
gains
(losses)
(0.82)
(10.76)
(4.49)
2.95
0.04
(7.06)
Total
from
investment
operations
........
(0.63)
(10.22)
(4.04)
3.52
0.51
(6.55)
Less
distributions
from:
Net
investment
income
..............
(0.37)
(0.53)
(0.60)
(0.37)
(0.34)
Net
asset
value,
end
of
period
..........
$14.00
$14.63
$25.22
$29.79
$26.87
$26.73
Total
return
d
.......................
(4.31)%
(41.02)%
(13.31)%
13.37%
1.89%
(19.31)%
Ratios
to
average
net
assets
e
Expenses
before
waiver
and
payments
by
affiliates
..........................
0.92%
0.72%
0.62%
0.64%
0.83%
0.60%
Expenses
net
of
waiver
and
payments
by
affiliates
..........................
0.73%
f
0.66%
f
0.59%
f
0.57%
f
0.54%
f
0.55%
Net
investment
income
...............
2.47%
2.26%
1.65%
2.12%
c
1.30%
1.80%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$894
$839
$15,627
$15,866
$218
$15
Portfolio
turnover
rate
................
29.17%
25.60%
29.83%
29.98%
29.74%
35.77%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Net
investment
income
per
share
includes
approximately
$0.16
per
share
related
to
income
received
in
the
form
of
special
dividends
in
connection
with
certain
Fund
hold-
ings.
Excluding
this
amount,
the
ratio
of
net
investment
income
to
average
net
assets
would
have
been
1.47%.
d
Total
Return
is
not
annualized
for
periods
less
than
one
year.
e
Ratios
are
annualized
for
periods
less
than
one
year.
f
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Natural
Resources
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
26
In
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Advisor
Class
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$14.54
$25.20
$29.80
$26.81
$26.71
$26.71
Income
from
investment
operations
a
:
Net
investment
income
b
.............
0.17
0.41
0.40
0.49
c
0.29
0.36
Net
realized
and
unrealized
gains
(losses)
(0.82)
(10.64)
(4.49)
2.95
0.17
(7.00)
Total
from
investment
operations
........
(0.65)
(10.23)
(4.09)
3.44
0.46
(6.64)
Less
distributions
from:
Net
investment
income
..............
(0.43)
(0.51)
(0.45)
(0.36)
(0.28)
Net
asset
value,
end
of
period
..........
$13.89
$14.54
$25.20
$29.80
$26.81
$26.71
Total
return
d
.......................
(4.47)%
(41.15)%
(13.50)%
13.04%
1.64%
(19.60)%
Ratios
to
average
net
assets
e
Expenses
before
waiver
and
payments
by
affiliates
..........................
1.04%
0.92%
0.78%
0.88%
0.81%
0.87%
Expenses
net
of
waiver
and
payments
by
affiliates
..........................
1.03%
f
0.92%
f,g
0.78%
f,g
0.88%
f,g
0.80%
f
0.86%
Net
investment
income
...............
2.17%
2.00%
1.46%
1.81%
c
1.04%
1.49%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$25,482
$28,334
$62,639
$78,443
$94,070
$90,185
Portfolio
turnover
rate
................
29.17%
25.60%
29.83%
29.98%
29.74%
35.77%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Net
investment
income
per
share
includes
approximately
$0.16
per
share
related
to
income
received
in
the
form
of
special
dividends
in
connection
with
certain
Fund
hold-
ings.
Excluding
this
amount,
the
ratio
of
net
investment
income
to
average
net
assets
would
have
been
1.16%.
d
Total
Return
is
not
annualized
for
periods
less
than
one
year.
e
Ratios
are
annualized
for
periods
less
than
one
year.
f
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
g
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Statement
of
Investments,
October
31,
2020
Franklin
Natural
Resources
Fund
franklintempleton.com
Semiannual
Report
27
a
a
Country
Shares
a
Value
a
Common
Stocks
99.4%
Agricultural
Products
0.4%
a
Darling
Ingredients,
Inc.
................................
United
States
15,000
$
645,000
a
Application
Software
0.4%
a
Aspen
Technology,
Inc.
.................................
United
States
6,300
691,803
a
Construction
Materials
1.1%
Martin
Marietta
Materials,
Inc.
............................
United
States
6,700
1,784,545
Copper
7.9%
Antofagasta
plc
.......................................
Chile
362,400
4,831,753
First
Quantum
Minerals
Ltd.
.............................
Zambia
121,600
1,397,460
Freeport-McMoRan,
Inc.
................................
United
States
169,900
2,946,066
a
Imperial
Metals
Corp.
..................................
Canada
181,600
413,037
Lundin
Mining
Corp.
...................................
Chile
447,200
2,702,267
12,290,583
Diversified
Chemicals
0.3%
Huntsman
Corp.
......................................
United
States
22,400
544,096
Diversified
Metals
&
Mining
9.1%
Anglo
American
plc
....................................
South
Africa
104,000
2,439,890
BHP
Group
plc,
ADR
...................................
Australia
159,600
6,203,652
a
Glencore
plc
.........................................
Australia
569,200
1,148,078
Rio
Tinto
plc,
ADR
.....................................
Australia
55,600
3,156,412
Teck
Resources
Ltd.,
B
.................................
Canada
104,100
1,367,874
14,315,906
Electrical
Components
&
Equipment
0.1%
a
Array
Technologies,
Inc.
................................
United
States
6,500
239,525
a
Environmental
&
Facilities
Services
0.8%
US
Ecology,
Inc.
......................................
United
States
39,500
1,205,540
Fertilizers
&
Agricultural
Chemicals
1.5%
Corteva
,
Inc.
.........................................
United
States
35,900
1,183,982
Nutrien
Ltd.
..........................................
Canada
26,900
1,094,292
2,278,274
Gold
12.8%
Agnico
Eagle
Mines
Ltd.
................................
Canada
21,100
1,670,483
Alamos
Gold,
Inc.,
A
...................................
Canada
272,300
2,487,533
B2Gold
Corp.
........................................
Canada
305,000
1,962,055
Barrick
Gold
Corp.
....................................
Canada
232,291
6,209,138
Newcrest
Mining
Ltd.
...................................
Australia
20,200
418,897
Newmont
Corp.
.......................................
United
States
96,915
6,090,139
a
SSR
Mining,
Inc.
......................................
Canada
72,200
1,336,422
20,174,667
Heavy
Electrical
Equipment
0.5%
a
TPI
Composites,
Inc.
...................................
United
States
21,500
712,080
a
Industrial
Gases
2.3%
Air
Products
and
Chemicals,
Inc.
..........................
United
States
6,200
1,712,688
Linde
plc
............................................
United
Kingdom
8,500
1,872,890
3,585,578
Integrated
Oil
&
Gas
14.9%
Chevron
Corp.
.......................................
United
States
92,900
6,456,550
Exxon
Mobil
Corp.
.....................................
United
States
145,200
4,736,424
Occidental
Petroleum
Corp.
.............................
United
States
154,700
1,412,411
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Natural
Resources
Fund
franklintempleton.com
Semiannual
Report
28
a
a
Country
Shares
a
Value
a
Common
Stocks
(continued)
Integrated
Oil
&
Gas
(continued)
Royal
Dutch
Shell
plc,
ADR,
A
............................
Netherlands
84,821
$
2,167,177
Suncor
Energy,
Inc.
....................................
Canada
348,100
3,927,296
TOTAL
SE,
ADR
......................................
France
157,410
4,774,245
23,474,103
Oil
&
Gas
Drilling
0.8%
Helmerich
&
Payne,
Inc.
................................
United
States
55,400
823,798
Patterson-UTI
Energy,
Inc.
..............................
United
States
177,200
453,632
1,277,430
Oil
&
Gas
Equipment
&
Services
9.7%
Baker
Hughes
Co.
.....................................
United
States
126,600
1,869,882
Cactus,
Inc.,
A
........................................
United
States
45,800
778,600
a
ChampionX
Corp.
.....................................
United
States
169,300
1,477,989
Halliburton
Co.
.......................................
United
States
119,735
1,444,004
Liberty
Oilfield
Services,
Inc.,
A
...........................
United
States
142,300
950,564
a
NexTier
Oilfield
Solutions,
Inc.
............................
United
States
403,422
762,468
a
Nine
Energy
Service,
Inc.
...............................
United
States
278,226
297,702
a
Oceaneering
International,
Inc.
...........................
United
States
143,900
587,112
a
Oil
States
International,
Inc.
.............................
United
States
201,966
502,895
a
Ranger
Energy
Services,
Inc.
............................
United
States
169,957
416,395
Schlumberger
NV
.....................................
United
States
208,147
3,109,716
Schoeller-Bleckmann
Oilfield
Equipment
AG
.................
Austria
32,500
787,618
a
Select
Energy
Services,
Inc.,
A
...........................
United
States
291,519
880,387
TechnipFMC
plc
......................................
United
Kingdom
245,900
1,359,827
15,225,159
Oil
&
Gas
Exploration
&
Production
20.2%
Cabot
Oil
&
Gas
Corp.
.................................
United
States
343,616
6,112,929
a
Cairn
Energy
plc
......................................
United
Kingdom
748,125
1,347,026
Canadian
Natural
Resources
Ltd.
.........................
Canada
161,100
2,563,669
Concho
Resources,
Inc.
................................
United
States
88,357
3,667,699
ConocoPhillips
.......................................
United
States
148,492
4,249,841
EOG
Resources,
Inc.
..................................
United
States
112,500
3,852,000
EQT
Corp.
..........................................
United
States
53,700
813,018
Hess
Corp.
..........................................
United
States
65,000
2,419,300
Parsley
Energy,
Inc.,
A
.................................
United
States
156,810
1,569,668
Pioneer
Natural
Resources
Co.
...........................
United
States
33,624
2,675,125
a
WPX
Energy,
Inc.
.....................................
United
States
530,300
2,444,683
31,714,958
Oil
&
Gas
Refining
&
Marketing
5.3%
Marathon
Petroleum
Corp.
..............................
United
States
93,300
2,752,350
New
Fortress
Energy,
Inc.
...............................
United
States
18,100
653,953
Phillips
66
...........................................
United
States
52,200
2,435,652
Valero
Energy
Corp.
...................................
United
States
66,900
2,583,009
8,424,964
Oil
&
Gas
Storage
&
Transportation
7.5%
Enbridge,
Inc.
........................................
Canada
60,247
1,660,407
Kinder
Morgan,
Inc.
....................................
United
States
98,100
1,167,390
ONEOK,
Inc.
.........................................
United
States
24,900
722,100
Targa
Resources
Corp.
.................................
United
States
83,500
1,340,175
TC
Energy
Corp.
......................................
Canada
63,400
2,501,764
Williams
Cos.,
Inc.
(The)
................................
United
States
218,600
4,194,934
11,586,770
Franklin
Strategic
Series
Statement
of
Investments
Franklin
Natural
Resources
Fund
franklintempleton.com
Semiannual
Report
29
See
Abbreviations
on
page
46
.
a
a
Country
Shares
a
Value
a
Common
Stocks
(continued)
Packaged
Foods
&
Meats
1.1%
a
Nomad
Foods
Ltd.
....................................
United
Kingdom
71,100
$
1,724,175
a
Paper
Packaging
0.7%
Packaging
Corp.
of
America
.............................
United
States
9,000
1,030,410
Semiconductor
Equipment
0.3%
a
SolarEdge
Technologies,
Inc.
............................
United
States
1,700
438,073
a
Steel
0.9%
Vale
SA,
ADR
........................................
Brazil
139,000
1,469,230
Trading
Companies
&
Distributors
0.8%
a
Univar
Solutions,
Inc.
..................................
United
States
73,800
1,224,342
a
Total
Common
Stocks
(Cost
$177,326,720)
.....................................
156,057,211
Warrants
a
a
a
a
a
Warrants
0.0%
Integrated
Oil
&
Gas
0.0%
a
Occidental
Petroleum
Corp.
,
8/03/27
.......................
United
States
17,900
44,213
Total
Warrants
(Cost
$88,605)
.................................................
44,213
Total
Long
Term
Investments
(Cost
$177,415,325)
...............................
156,101,424
a
Short
Term
Investments
0.9%
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Money
Market
Funds
0.9%
b,c
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
........
United
States
1,355,057
1,355,057
Total
Money
Market
Funds
(Cost
$1,355,057)
...................................
1,355,057
Total
Short
Term
Investments
(Cost
$1,355,057
)
.................................
1,355,057
a
Total
Investments
(Cost
$178,770,382)
100.3%
..................................
$157,456,481
Other
Assets,
less
Liabilities
(0.3)%
...........................................
(369,154)
Net
Assets
100.0%
...........................................................
$157,087,327
Rounds
to
less
than
0.1%
of
net
assets.
a
Non-income
producing.
b
See
Note
3(f)
regarding
investments
in
affiliated
management
investment
companies.
c
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
Franklin
Strategic
Series
Financial
Statements
Statements
of
Assets
and
Liabilities
October
31,
2020
(unaudited)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
30
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Assets:
Investments
in
securities:
Cost
-
Unaffiliated
issuers
..................................................
$778,228,258
$177,415,325
Cost
-
Non-controlled
affiliates
(Note
3
f
)
.......................................
74,525,784
1,355,057
Value
-
Unaffiliated
issuers
(Includes
securities
loaned
$19,879,848
and
$—
respectively)
.
$1,293,376,554
$156,101,424
Value
-
Non-controlled
affiliates
(Note
3
f
)
.......................................
74,525,784
1,355,057
Foreign
currency,
at
value
(cost
$–
and
$32,766
respectively)
.........................
32,766
Receivables:
Investment
securities
sold
..................................................
13,224,092
522,213
Capital
shares
sold
.......................................................
1,260,390
146,576
Dividends
and
interest
....................................................
43,863
182,098
Other
assets
.............................................................
1,102
80
Total
assets
.........................................................
1,382,431,785
158,340,214
Liabilities:
Payables:
Investment
securities
purchased
.............................................
16,768,457
296,392
Capital
shares
redeemed
..................................................
1,342,266
680,354
Management
fees
........................................................
724,343
82,382
Distribution
fees
.........................................................
291,022
42,196
Transfer
agent
fees
.......................................................
212,823
95,802
Trustees'
fees
and
expenses
................................................
704
Funds
advanced
by
custodian
................................................
147
Payable
upon
return
of
securities
loaned
........................................
22,593,784
Accrued
expenses
and
other
liabilities
..........................................
70,225
55,057
Total
liabilities
........................................................
42,003,067
1,252,887
Net
assets,
at
value
................................................
$1,340,428,718
$157,087,327
Net
assets
consist
of:
Paid-in
capital
............................................................
$633,381,321
$408,097,119
Total
distributable
earnings
(losses)
............................................
707,047,397
(251,009,792)
Net
assets,
at
value
................................................
$1,340,428,718
$157,087,327
Franklin
Strategic
Series
Financial
Statements
Statements
of
Assets
and
Liabilities
(continued)
October
31,
2020
(unaudited)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
31
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Class
A:
Net
assets,
at
value
......................................................
$1,077,405,411
$111,479,437
Shares
outstanding
.......................................................
6,361,875
8,591,061
Net
asset
value
per
share
a
.................................................
$169.35
$12.98
Maximum
offering
price
per
share
(net
asset
value
per
share
÷
94.50%
and
94.50%,
respectively)
............................................................
$179.21
$13.74
Class
C:
Net
assets,
at
value
......................................................
$57,506,758
$19,231,655
Shares
outstanding
.......................................................
358,678
1,526,819
Net
asset
value
and
maximum
offering
price
per
share
a
............................
$160.33
$12.60
Class
R6:
Net
assets,
at
value
......................................................
$10,676,640
$894,190
Shares
outstanding
.......................................................
60,326
63,891
Net
asset
value
and
maximum
offering
price
per
share
............................
$176.98
$14.00
Advisor
Class:
Net
assets,
at
value
......................................................
$194,839,909
$25,482,045
Shares
outstanding
.......................................................
1,113,404
1,834,318
Net
asset
value
and
maximum
offering
price
per
share
............................
$174.99
$13.89
a
Redemption
price
is
equal
to
net
asset
value
less
contingent
deferred
sales
charges,
if
applicable.
Franklin
Strategic
Series
Financial
Statements
Statements
of
Operations
for
the
period
ended
October
31,
2020
(unaudited)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
32
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Investment
income:
Dividends:
(net
of
foreign
taxes
of
$108,154
and
$–
respectively)
Unaffiliated
issuers
.......................................................
$2,130,090
$2,914,710
Income
from
securities
loaned:
Unaffiliated
entities
(net
of
fees
and
rebates)
....................................
270,354
1,061
Total
investment
income
..................................................
2,400,444
2,915,771
Expenses:
Management
fees
(Note
3
a
)
..................................................
4,010,944
519,048
Distribution
fees:
(Note
3c
)
Class
A
...............................................................
1,375,071
160,427
Class
C
...............................................................
288,342
118,431
Transfer
agent
fees:
(Note
3e
)
Class
A
...............................................................
656,117
211,882
Class
C
...............................................................
34,363
39,089
Class
R6
..............................................................
4,498
1,033
Advisor
Class
...........................................................
119,167
48,395
Custodian
fees
(Note
4
)
.....................................................
20,319
6,123
Reports
to
shareholders
.....................................................
40,727
17,208
Registration
and
filing
fees
...................................................
86,910
63,552
Professional
fees
..........................................................
29,795
29,030
Trustees'
fees
and
expenses
.................................................
7,057
1,912
Other
...................................................................
14,271
8,139
Total
expenses
........................................................
6,687,581
1,224,269
Expense
reductions
(Note
4
)
..............................................
(2,411)
(247)
Expenses
waived/paid
by
affiliates
(Note
3
f
and
3
g
)
.............................
(77,212)
(3,334)
Net
expenses
........................................................
6,607,958
1,220,688
Net
investment
income
(loss)
...........................................
(4,207,514)
1,695,083
Realized
and
unrealized
gains
(losses):
Net
realized
gain
(loss)
from:
Investments:
Unaffiliated
issuers
.....................................................
150,712,041
(39,567,005)
Foreign
currency
transactions
...............................................
(95,049)
Net
realized
gain
(loss)
.................................................
150,712,041
(39,662,054)
Net
change
in
unrealized
appreciation
(depreciation)
on:
Investments:
Unaffiliated
issuers
.....................................................
3,038,198
28,680,830
Translation
of
other
assets
and
liabilities
denominated
in
foreign
currencies
.............
2,172,507
Net
change
in
unrealized
appreciation
(depreciation)
...........................
3,038,198
30,853,337
Net
realized
and
unrealized
gain
(loss)
...........................................
153,750,239
(8,808,717)
Net
increase
(decrease)
in
net
assets
resulting
from
operations
.........................
$149,542,725
$(7,113,634)
Franklin
Strategic
Series
Financial
Statements
Statements
of
Changes
in
Net
Assets
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
33
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
Increase
(decrease)
in
net
assets:
Operations:
Net
investment
income
(loss)
.......
$(4,207,514)
$(5,334,586)
$1,695,083
$4,504,278
Net
realized
gain
(loss)
............
150,712,041
96,628,087
(39,662,054)
(39,172,430)
Net
change
in
unrealized
appreciation
(depreciation)
.................
3,038,198
98,772,198
30,853,337
(90,505,249)
Net
increase
(decrease)
in
net
assets
resulting
from
operations
.
149,542,725
190,065,699
(7,113,634)
(125,173,401)
Distributions
to
shareholders:
Class
A
........................
(85,259,141)
(3,164,483)
Class
C
........................
(4,306,918)
(111,347)
Class
R6
.......................
(645,173)
(13,751)
Advisor
Class
...................
(13,979,384)
(833,185)
Total
distributions
to
shareholders
.....
(104,190,616)
(4,122,766)
Capital
share
transactions:
(Note
2
)
Class
A
........................
(4,162,643)
(34,210,659)
(6,839,162)
(34,646,355)
Class
C
........................
3,289,955
(1,170,193)
(3,392,460)
(9,393,999)
Class
R6
.......................
38,024
2,793,619
97,889
(12,686,535)
Advisor
Class
...................
14,221,105
(6,945,668)
(1,695,745)
(13,195,013)
Total
capital
share
transactions
.......
13,386,441
(39,532,901)
(11,829,478)
(69,921,902)
Net
increase
(decrease)
in
net
assets
.....................
162,929,166
46,342,182
(18,943,112)
(199,218,069)
Net
assets:
Beginning
of
period
................
1,177,499,552
1,131,157,370
176,030,439
375,248,508
End
of
period
.....................
$1,340,428,718
$1,177,499,552
$157,087,327
$176,030,439
Franklin
Strategic
Series
Notes
to
Financial
Statements
34
franklintempleton.com
Semiannual
Report
1.
Organization
and
Significant
Accounting
Policies
Franklin
Strategic
Series (Trust)
is
registered
under
the
Investment
Company
Act
of
1940
(1940
Act)
as
an
open-
end
management
investment
company,
consisting
of
ten
separate
funds, two
of
which
are
included
in
this
report
(Funds)
and
applies
the
specialized
accounting
and
reporting
guidance
in
U.S.
Generally
Accepted
Accounting
Principles
(U.S.
GAAP).
The
Funds
offer four classes
of
shares: Class A,
Class
C,
Class R6
and
Advisor
Class. Each
class
of
shares
may
differ
by
its initial
sales
load,
contingent
deferred
sales
charges,
voting
rights
on
matters
affecting
a
single
class,
its
exchange
privilege
and
fees
due
to
differing
arrangements
for
distribution
and
transfer
agent
fees.
The
following
summarizes
the Funds'
significant
accounting
policies. 
a.
Financial
Instrument
Valuation 
The Funds'
investments
in
financial
instruments
are
carried
at
fair
value
daily.
Fair
value
is
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
on
the
measurement
date.
The Funds calculate the
net
asset
value
(NAV)
per
share
each
business
day
as
of
4
p.m.
Eastern
time
or
the
regularly
scheduled
close
of
the
New
York
Stock
Exchange
(NYSE),
whichever
is
earlier.
Under
compliance
policies
and
procedures
approved
by
the
Trust's
Board
of
Trustees
(the
Board),
the
Funds' administrator
has
responsibility
for
oversight
of
valuation,
including
leading
the
cross-functional
Valuation
Committee
(VC).
The
Funds
may
utilize
independent
pricing
services,
quotations
from
securities
and
financial
instrument
dealers,
and
other
market
sources
to
determine
fair
value. 
Equity
securities
listed
on
an
exchange
or
on
the
NASDAQ
National
Market
System
are
valued
at
the
last
quoted
sale
price
or
the
official
closing
price of
the
day,
respectively.
Foreign
equity
securities
are
valued
as
of
the
close
of
trading
on
the
foreign
stock
exchange
on
which
the
security
is
primarily
traded,
or
as
of
4
p.m.
Eastern
time.
The
value
is
then
converted
into
its
U.S.
dollar
equivalent
at
the
foreign
exchange
rate
in
effect
at
4
p.m.
Eastern
time
on
the
day
that
the
value
of
the
security
is
determined.
Over-the-counter
(OTC)
securities
are
valued
within
the
range
of
the
most
recent
quoted
bid
and
ask
prices.
Securities
that
trade
in
multiple
markets
or
on
multiple
exchanges
are
valued
according
to
the
broadest
and
most
representative
market.
Certain
equity
securities
are
valued
based
upon
fundamental
characteristics
or
relationships
to
similar
securities. 
Investments
in open-end mutual
funds
are
valued
at
the
closing
NAV.
The
Funds
have
procedures
to
determine
the
fair
value
of
financial
instruments
for
which
market
prices
are
not
reliable
or
readily
available.
Under
these
procedures,
the
Funds
primarily
employ
a
market-based
approach
which
may
use
related
or
comparable
assets
or
liabilities,
recent
transactions,
market
multiples,
book
values,
and
other
relevant
information
for
the
investment
to
determine
the
fair
value
of
the
investment.
An
income-based
valuation
approach
may
also
be
used
in
which
the
anticipated
future
cash
flows
of
the
investment
are
discounted
to
calculate
fair
value.
Discounts
may
also
be
applied
due
to
the
nature
or
duration
of
any
restrictions
on
the
disposition
of
the
investments.
Due
to
the
inherent
uncertainty
of
valuations
of
such
investments,
the
fair
values
may
differ
significantly
from
the
values
that
would
have
been
used
had
an
active
market
existed.
Trading
in
securities
on
foreign
securities
stock
exchanges
and
OTC
markets
may
be
completed
before
4
p.m.
Eastern
time.
In
addition,
trading
in
certain
foreign
markets
may
not
take
place
on
every
Funds'
business
day.
Occasionally,
events
occur
between
the
time
at
which
trading
in
a
foreign
security
is
completed
and
4
p.m.
Eastern
time
that
might
call
into
question
the
reliability
of
the
value
of
a
portfolio
security
held
by
the
Fund.
As
a
result,
differences
may
arise
between
the
value
of
the
Funds'
portfolio
securities
as
determined
at
the
foreign
market
close
and
the
latest
indications
of
value
at
4
p.m.
Eastern
time.
In
order
to
minimize
the
potential
for
these
differences,
an
independent
pricing
service
may
be
used
to
adjust
the
value
of
the
Funds'
securities
to
the
latest
indications
of
fair
value
at
4
p.m.
Eastern
time.
At
October
31,
2020,
certain
securities
may
have
been
fair
valued
using
these
procedures,
in
which
case
the
securities
were
categorized
as
Level
2
inputs
within
the
fair
value
hierarchy.
See
the
Fair
Value
Measurements
note
for
more
information.
When
the
last
day
of
the
reporting
period
is
a
non-business
day,
certain
foreign
markets
may
be
open
on
those
days
that
the
Funds'
NAV
is
not
calculated,
which
could
result
in
differences
between
the
value
of
the
Funds'
portfolio
securities
on
the
last
business
day
and
the
last
calendar
day
Franklin
Strategic
Series
Notes
to
Financial
Statements
35
franklintempleton.com
Semiannual
Report
of
the
reporting
period.
Any
security
valuation
changes
due
to
an
open
foreign
market
are
adjusted
and
reflected
by
the
Funds
for
financial
reporting
purposes.
b.
Foreign
Currency
Translation 
Portfolio
securities
and
other
assets
and
liabilities
denominated
in
foreign
currencies
are
translated
into
U.S.
dollars
based
on
the
exchange
rate
of
such
currencies
against
U.S.
dollars
on
the
date
of
valuation.
The
Funds
may
enter
into
foreign
currency
exchange
contracts
to
facilitate
transactions
denominated
in
a
foreign
currency.
Purchases
and
sales
of
securities,
income
and
expense
items
denominated
in
foreign
currencies
are
translated
into
U.S.
dollars
at
the
exchange
rate
in
effect
on
the
transaction
date.
Portfolio
securities
and
assets
and
liabilities
denominated
in
foreign
currencies
contain
risks
that
those
currencies
will
decline
in
value
relative
to
the
U.S.
dollar.
Occasionally,
events
may
impact
the
availability
or
reliability
of
foreign
exchange
rates
used
to
convert
the
U.S.
dollar
equivalent
value.
If
such
an
event
occurs,
the
foreign
exchange
rate
will
be
valued
at
fair
value
using
procedures
established
and
approved
by
the
Board.
The
Funds
do
not
separately
report
the
effect
of
changes
in
foreign
exchange
rates
from
changes
in
market
prices
on
securities
held.
Such
changes
are
included
in
net
realized
and
unrealized
gain
or
loss
from
investments
in
the
Statements
of
Operations.
Realized
foreign
exchange
gains
or
losses
arise
from
sales
of
foreign
currencies,
currency
gains
or
losses
realized
between
the
trade
and
settlement
dates
on
securities
transactions
and
the
difference
between
the
recorded
amounts
of
dividends,
interest,
and
foreign
withholding
taxes
and
the
U.S.
dollar
equivalent
of
the
amounts
actually
received
or
paid.
Net
unrealized
foreign
exchange
gains
and
losses
arise
from
changes
in
foreign
exchange
rates
on
foreign
denominated
assets
and
liabilities
other
than
investments
in
securities
held
at
the
end
of
the
reporting
period.
c.
Securities
Lending
Certain
or
all
Funds
participate
in
an
agency
based
securities
lending
program
to
earn
additional
income.
The
Fund
receives
collateral
in
the
form
of
cash
and/or
U.S.
Government
and
Agency
securities
against
the
loaned
securities
in
an
amount
equal
to
at
least
102%
of
the
fair
value
of
the
loaned
securities.
Collateral
is
maintained
over
the
life
of
the
loan
in
an
amount
not
less
than
100%
of
the
fair
value
of
loaned
securities,
as
determined
at
the
close
of
Fund
business
each
day;
any
additional
collateral
required
due
to
changes
in
security
values
is
delivered
to
the
Fund
on
the
next
business
day.
Any
cash
collateral
received
is
deposited
into
a
joint
cash
account
with
other
funds
and
is
used
to
invest
in
a
money
market
fund
managed
by
Franklin
Advisers,
Inc.,
an
affiliate
of
the
Funds,
and/or
uninvested
cash
as
included
in
due
from
custodian
in
the
Statements
of
Assets
and
Liabilities.
The
Fund
may
receive
income
from
the
investment
of
cash
collateral,
in
addition
to
lending
fees
and
rebates
paid
by
the
borrower.
Income
from
securities
loaned,
net
of
fees
paid
to
the
securities
lending
agent
and/or
third-party
vendor,
is
reported
separately
in
the
Statements
of
Operations.
The
Fund
bears
the
market
risk
with
respect
to any
cash collateral
investment,
securities
loaned,
and
the
risk
that
the
agent
may
default
on
its
obligations
to
the
Fund.
If
the
borrower
defaults
on
its
obligation
to
return
the
securities
loaned,
the
Fund
has
the
right
to
repurchase
the
securities
in
the
open
market
using
the
collateral
received.
The
securities
lending
agent
has
agreed
to
indemnify
the
Fund
in
the
event
of
default
by
a
third
party
borrower.
At
October
31,
2020,
the
Franklin
Natural
Resources
Fund
had
no
securities
on
loan.
d.
Income
and
Deferred
Taxes
It
is each
Fund's
policy
to
qualify
as
a
regulated
investment
company
under
the
Internal
Revenue
Code. Each
Fund
intends
to
distribute
to
shareholders
substantially
all
of
its
taxable
income
and
net
realized
gains
to
relieve
it
from
federal
income
and
excise
taxes.
As
a
result,
no
provision
for
U.S.
federal
income
taxes
is
required.
The
Funds
may
be
subject
to
foreign
taxation
related
to
income
received,
capital
gains
on
the
sale
of
securities
and
certain
foreign
currency
transactions
in
the
foreign
jurisdictions
in
which
the
Funds
invest.
Foreign
taxes,
if
any,
are
recorded
based
on
the
tax
regulations
and
rates
that
exist
in
the
foreign
markets
in
which
the
Funds
invest.
When
a
capital
gain
tax
is
determined
to
apply,
certain
or
all
Funds
1.
Organization
and
Significant
Accounting
Policies
(continued)
a.
Financial
Instrument
Valuation 
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
36
franklintempleton.com
Semiannual
Report
record
an
estimated
deferred
tax
liability
in
an
amount
that
would
be
payable
if
the
securities
were
disposed
of
on
the
valuation
date.
Each
Fund
may
recognize
an
income
tax
liability
related
to
its
uncertain
tax
positions
under
U.S.
GAAP
when
the
uncertain
tax
position
has
a
less
than
50%
probability
that
it
will
be
sustained
upon
examination
by
the
tax
authorities
based
on
its
technical
merits.
As
of
October
31,
2020, each
Fund
has
determined
that
no
tax
liability
is
required
in
its
financial
statements
related
to
uncertain
tax
positions
for
any
open
tax
years
(or
expected
to
be
taken
in
future
tax
years).
Open
tax
years
are
those
that
remain
subject
to
examination
and
are
based
on
the
statute
of
limitations
in
each
jurisdiction
in
which
the
Fund
invests. 
e.
Security
Transactions,
Investment
Income,
Expenses
and
Distributions
Security
transactions
are
accounted
for
on
trade
date.
Realized
gains
and
losses
on
security
transactions
are
determined
on
a
specific
identification
basis.
Interest
income
and
estimated
expenses
are
accrued
daily.
Dividend
income
is
recorded
on
the
ex-dividend
date
except
for
certain
dividends
from
securities
where
the
dividend
rate
is
not
available.
In
such
cases,
the
dividend
is
recorded
as
soon
as
the
information
is
received
by
the
Funds.
Distributions
to shareholders
are
recorded
on
the
ex-dividend
date.
Distributable
earnings
are
determined
according
to
income
tax
regulations
(tax
basis)
and
may
differ
from
earnings
recorded
in
accordance
with
U.S.
GAAP.
These
differences
may
be
permanent
or
temporary.
Permanent
differences
are
reclassified
among
capital
accounts
to
reflect
their
tax
character.
These
reclassifications
have
no
impact
on
net
assets
or
the
results
of
operations.
Temporary
differences
are
not
reclassified,
as
they
may
reverse
in
subsequent
periods.
Common
expenses
incurred
by
the
Trust
are
allocated
among
the
Funds
based
on
the
ratio
of
net
assets
of
each
Fund
to
the
combined
net
assets
of
the
Trust
or
based
on
the
ratio
of
number
of
shareholders
of
each
Fund
to
the
combined
number
of
shareholders
of
the
Trust.
Fund
specific
expenses
are
charged
directly
to
the
Fund
that
incurred
the
expense.
Realized
and
unrealized
gains
and
losses
and
net
investment
income,
excluding
class
specific
expenses,
are
allocated
daily
to
each
class
of
shares
based
upon
the
relative
proportion
of
net
assets
of
each
class.
Differences
in
per
share
distributions
by
class
are
generally
due
to
differences
in
class
specific
expenses.
f.
Accounting
Estimates
The
preparation
of
financial
statements
in
accordance
with
U.S.
GAAP
requires
management
to
make
estimates
and
assumptions
that
affect
the
reported
amounts
of
assets
and
liabilities
at
the
date
of
the
financial
statements
and
the
amounts
of
income
and
expenses
during
the
reporting
period.
Actual
results
could
differ
from
those
estimates.
g.
Guarantees
and
Indemnifications
Under
the
Trust's
organizational
documents,
its
officers
and
trustees
are
indemnified
by
the
Trust
against
certain
liabilities
arising
out
of
the
performance
of
their
duties
to
the
Trust.
Additionally,
in
the
normal
course
of
business,
the
Trust,
on
behalf
of
the
Funds,
enters
into
contracts
with
service
providers
that
contain
general
indemnification
clauses.
The
Trust's
maximum
exposure
under
these
arrangements
is
unknown
as
this
would
involve
future
claims
that
may
be
made
against
the
Trust
that
have
not
yet
occurred.
Currently,
the
Trust
expects
the
risk
of
loss
to
be
remote.
1.
Organization
and
Significant
Accounting
Policies
(continued)
d.
Income
and
Deferred
Taxes
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
37
franklintempleton.com
Semiannual
Report
2.
Shares
of
Beneficial
Interest
At
October
31,
2020,
there
were
an
unlimited
number
of
shares
authorized
(without
par
value).
Transactions
in
the
Funds'
shares
were
as
follows:
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Shares
Amount
Shares
Amount
Class
A
Class
A
Shares:
Six
Months
ended
October
31,
2020
Shares
sold
a
...................................
509,123
$86,238,376
934,461
$13,376,715
Shares
redeemed
...............................
(528,848)
(90,401,019)
(1,420,631)
(20,215,877)
Net
increase
(decrease)
..........................
(19,725)
$(4,162,643)
(486,170)
$(6,839,162)
Year
ended
April
30,
2020
Shares
sold
a
...................................
790,060
$113,642,349
2,038,606
$29,732,882
Shares
issued
in
reinvestment
of
distributions
..........
537,057
81,305,070
148,428
3,105,113
Shares
redeemed
...............................
(1,604,682)
(229,158,078)
(3,601,621)
(67,484,350)
Net
increase
(decrease)
..........................
(277,565)
$(34,210,659)
(1,414,587)
$(34,646,355)
Class
C
Class
C
Shares:
Six
Months
ended
October
31,
2020
Shares
sold
...................................
67,499
$10,902,353
151,039
$2,032,901
Shares
issued
in
reinvestment
of
distributions
..........
Shares
redeemed
a
..............................
(47,025)
(7,612,398)
(389,150)
(5,425,361)
Net
increase
(decrease)
..........................
20,474
$3,289,955
(238,111)
$(3,392,460)
Year
ended
April
30,
2020
Shares
sold
...................................
66,779
$9,196,211
417,343
$5,926,617
Shares
issued
in
reinvestment
of
distributions
..........
29,739
4,290,371
5,386
110,099
Shares
redeemed
a
..............................
(106,671)
(14,656,775)
(831,954)
(15,430,715)
Net
increase
(decrease)
..........................
(10,153)
$(1,170,193)
(409,225)
$(9,393,999)
Class
R6
Class
R6
Shares:
Six
Months
ended
October
31,
2020
Shares
sold
...................................
16,535
$2,949,115
13,919
$212,696
Shares
redeemed
...............................
(16,617)
(2,911,091)
(7,363)
(114,807)
Net
increase
(decrease)
..........................
(82)
$38,024
6,556
$97,889
Year
ended
April
30,
2020
Shares
sold
...................................
35,149
$5,389,737
96,853
$2,098,343
Shares
issued
in
reinvestment
of
distributions
..........
4,090
645,154
613
13,751
Shares
redeemed
...............................
(21,691)
(3,241,272)
(659,867)
(14,798,629)
Net
increase
(decrease)
..........................
17,548
$2,793,619
(562,401)
$(12,686,535)
Advisor
Class
Franklin
Strategic
Series
Notes
to
Financial
Statements
38
franklintempleton.com
Semiannual
Report
3.
Transactions
with
Affiliates
Franklin
Resources,
Inc.
is
the
holding
company
for
various
subsidiaries
that
together
are
referred
to
as
Franklin
Templeton.
Certain
officers
and
trustees
of
the
Trust
are
also
officers
and/or
directors
of
the
following
subsidiaries:
a.
Management
Fees
Franklin
Biotechnology
Discovery
Fund
pays
an
investment
management
fee
to
Advisers
based
on
the
average
daily
net
assets
of
the
Fund
as
follows:
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Shares
Amount
Shares
Amount
Advisor
Class
Shares:
Six
Months
ended
October
31,
2020
Shares
sold
...................................
291,878
$50,830,801
401,424
$6,176,865
Shares
redeemed
...............................
(204,548)
(36,609,696)
(515,280)
(7,872,610)
Net
increase
(decrease)
..........................
87,330
$14,221,105
(113,856)
$(1,695,745)
Year
ended
April
30,
2020
Shares
sold
...................................
256,733
$38,219,541
849,335
$14,059,870
Shares
issued
in
reinvestment
of
distributions
..........
80,467
12,560,088
36,902
824,379
Shares
redeemed
...............................
(390,486)
(57,725,297)
(1,423,757)
(28,079,262)
Net
increase
(decrease)
..........................
(53,286)
$(6,945,668)
(537,520)
$(13,195,013)
a
May
include
a
portion
of
Class
C
shares
that
were
automatically
converted
to
Class
A.
Subsidiary
Affiliation
Franklin
Advisers,
Inc.
(Advisers)
Investment
manager
Franklin
Templeton
Services,
LLC
(FT
Services)
Administrative
manager
Franklin
Templeton
Distributors,
Inc.
(Distributors)
Principal
underwriter
Franklin
Templeton
Investor
Services,
LLC
(Investor
Services)
Transfer
agent
Annualized
Fee
Rate
Net
Assets
0.775%
Up
to
and
including
$100
million
0.650%
Over
$100
million,
up
to
and
including
$200
million
0.635%
Over
$200
million,
up
to
and
including
$250
million
0.585%
Over
$250
million,
up
to
and
including
$700
million
0.550%
Over
$700
billion,
up
to
and
including
$1.2
billion
0.525%
Over
$1.2
billion,
up
to
and
including
$7.5
billion
0.515%
Over
$7.5
billion,
up
to
and
including
$10
billion
0.505%
Over
$10
billion,
up
to
and
including
$12.5
billion
0.495%
Over
$12.5
billion,
up
to
and
including
$15
billion
0.475%
In
excess
of
$15
billion
2.
Shares
of
Beneficial
Interest
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
39
franklintempleton.com
Semiannual
Report
Franklin
Natural
Resources
Fund
pays
an
investment
management
fee
to
Advisers
based
on
the
average
daily
net
assets
of
the
Fund
as
follows:
For
the
period
ended
October
31,
2020,
each
Fund's
annualized
gross
effective
investment
management
fee
rate
based
on
average
daily
net
assets
was
as
follows:
b.
Administrative
Fees
Under
an
agreement
with
Advisers,
FT
Services
provides
administrative
services
to
the
Funds.
The
fee
is
paid
by
Advisers
based
on
the
Funds’
average
daily
net
assets,
and
is
not
an
additional
expense
of
the
Funds.
c.
Distribution
Fees
The
Board
has
adopted
distribution
plans
for
each
share
class,
with
the
exception
of
Class
R6
and
Advisor
Class
shares,
pursuant
to
Rule
12b-1
under
the
1940
Act.
Under
the
Funds’
Class
A
reimbursement
distribution
plans,
the
Funds
reimburse
Distributors
for
costs
incurred
in
connection
with
the
servicing,
sale
and
distribution
of each
Fund's
shares
up
to
the
maximum
annual
plan
rate
for
each
class.
Under
the
Class
A
reimbursement
distribution
plans,
costs
exceeding
the
maximum
for
the
current
plan
year
cannot
be
reimbursed
in
subsequent
periods.
In
addition,
under
the
Funds’
Class
C
compensation
distribution
plans,
the
Funds
pay
Distributors
for
costs
incurred
in
connection
with
the
servicing,
sale
and
distribution
of
each
Fund's
shares
up
to
the
maximum
annual
plan
rate
for
each
class.
The
plan
year,
for
purposes
of
monitoring
compliance
with
the
maximum
annual
plan
rates,
is
February
1
through
January
31
for
each
Fund.
The
maximum
annual
plan
rates,
based
on
the
average
daily
net
assets,
for
each
class,
are
as
follows:
The
Board
has
set
the
current
rate
at
0.25%
per
year
for
Class
A
shares
until
further
notice
and
approval
by
the
Board.
Annualized
Fee
Rate
Net
Assets
0.625%
Up
to
and
including
$100
million
0.500%
Over
$100
million,
up
to
and
including
$250
million
0.450%
Over
$250
million,
up
to
and
including
$7.5
billion
0.440%
Over
$7.5
billion,
up
to
and
including
$10
billion
0.430%
Over
$10
billion,
up
to
and
including
$12.5
billion
0.420%
Over
$12.5
billion,
up
to
and
including
$15
billion
0.400%
In
excess
of
$15
billion
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Gross
effective
investment
management
fee
rate
........
0.585%
0.569%
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Reimbursement
Plans:
Class
A
...............................
0.35%
0.35%
Class
C
...............................
1.00%
1.00%
3.
Transactions
with
Affiliates
(continued)
a.
Management
Fees
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
40
franklintempleton.com
Semiannual
Report
d.
Sales
Charges/Underwriting
Agreements
Front-end
sales
charges
and
contingent
deferred
sales
charges
(CDSC)
do
not
represent
expenses
of
the
Funds.
These
charges
are
deducted
from
the
proceeds
of
sales
of
fund
shares
prior
to
investment
or
from
redemption
proceeds
prior
to
remittance,
as
applicable.
Distributors
has
advised
the
Funds
of
the
following
commission
transactions
related
to
the
sales
and
redemptions
of
the
Funds'
shares
for
the
period:
e.
Transfer
Agent
Fees
Each
class
of
shares
pays
transfer
agent
fees
to
Investor
Services
for
its
performance
of
shareholder
servicing
obligations.
The
fees
are
based
on
an
annualized
asset
based
fee
of
0.02%
plus
a
transaction
based
fee.
In
addition,
each
class
reimburses
Investor
Services
for
out
of
pocket
expenses
incurred
and,
except
for
Class
R6,
reimburses
shareholder
servicing
fees
paid
to
third
parties.
These
fees
are
allocated
daily
based
upon
their
relative
proportion
of
such
classes'
aggregate
net
assets.
Class
R6
pays
Investor
Services
transfer
agent
fees
specific
to
that
class.
For
the
period
ended
October
31,
2020,
the
Funds
paid
transfer
agent
fees
as
noted
in
the
Statements
of
Operations
of
which
the
following
amounts
were
retained
by
Investor
Services:
f.
Investments
in
Affiliated
Management
Investment
Companies
Certain
or
all
Funds
invest
in
one
or
more
affiliated
management
investment
companies
for
purposes
other
than
exercising
a
controlling
influence
over
the
management
or
policies.
Management
fees
paid
by
the
Funds
are
waived
on
assets
invested
in
the
affiliated
management
investment
companies,
as
noted
in
the
Statements
of
Operations,
in
an
amount
not
to
exceed
the
management
and
administrative
fees
paid
directly
or
indirectly
by
each
affiliate.
During
the
period
ended
October
31,
2020,
investments
in
affiliated
management
investment
companies
were
as
follows:
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Sales
charges
retained
net
of
commissions
paid
to
unaffiliated
brokers/dealers
..................
$119,309
$15,316
CDSC
retained
...........................
$6,237
$805
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Transfer
agent
fees
........................
$321,452
$113,479
a
Value
at
Beginning
of
Period
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Period
Number
of
Shares
Held
at
End
of
Period
Investment
Income
a
a
a
a
a
a
a
a
a
Franklin
Biotechnology
Discovery
Fund
Non-Controlled
Affiliates
Dividends
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
.........
$102,836,782
$222,983,926
$(273,888,708)
$—
$—
$51,932,000
51,932,000
$—
3.
Transactions
with
Affiliates
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
41
franklintempleton.com
Semiannual
Report
g.
Waiver
and
Expense
Reimbursements
Investor
Services
has
contractually
agreed
in
advance
to
waive
or
limit
its
fees
so
that
the
Class
R6
transfer
agent
fees
do
not
exceed
0.03%
based
on
the
average
net
assets
of
the
class
until
August
31,
2021.
4.
Expense
Offset
Arrangement
The
Funds
have entered
into
an
arrangement
with
their
custodian
whereby
credits
realized
as
a
result
of
uninvested
cash
balances
are
used
to
reduce
a
portion
of
the
Funds'
custodian
expenses. During
the period
ended
October
31,
2020 the
custodian
fees
were
reduced
as
noted
in
the
Statements
of
Operations.
5.
Income
Taxes
For
tax
purposes,
capital
losses
may
be
carried
over
to
offset
future
capital
gains.
At
April
30,
2020,
the
capital
loss
carryforwards
were
as
follows:
For
tax
purposes,
the
Funds
may
elect
to
defer
any
portion
of
a
post-October
capital
loss
or
late-year
ordinary
loss
to
the
first
day
of
the
following
fiscal
year.
At
April
30,
2020,
Franklin
Biotechnology
Discovery
Fund
deferred
losses
of
$2,197,521.
a
Value
at
Beginning
of
Period
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Period
Number
of
Shares
Held
at
End
of
Period
Investment
Income
a
a
a
a
a
a
a
a
a
Franklin
Biotechnology
Discovery
Fund
(continued)
Non-Controlled
Affiliates
Income
from
securities
loaned
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
.........
$39,742,135
$207,482,022
$(224,630,373)
$
$
$22,593,784
22,593,784
$—
Total
Affiliated
Securities
....
$142,578,917
$430,465,948
$(498,519,081)
$—
$—
$74,525,784
$—
Franklin
Natural
Resources
Fund
Non-Controlled
Affiliates
Dividends
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
.........
$6,778,486
$23,957,526
$(29,380,955)
$—
$—
$1,355,057
1,355,057
$—
Total
Affiliated
Securities
....
$6,778,486
$23,957,526
$(29,380,955)
$—
$—
$1,355,057
$—
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
1
1
1
Capital
loss
carryforwards
not
subject
to
expiration:
Short
term
.............................
$
$
15,911,665
Long
term
.............................
174,175,055
Total
capital
loss
carryforwards
............
$—
$190,086,720
3.
Transactions
with
Affiliates
(continued)
f.
Investments
in
Affiliated
Management
Investment
Companies
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
42
franklintempleton.com
Semiannual
Report
At
October
31,
2020,
the
cost
of
investments
and
net
unrealized
appreciation
(depreciation)
for
income
tax
purposes
were
as
follows:
Differences
between
income
and/or
capital
gains
as
determined
on
a
book
basis
and
a
tax
basis
are
primarily
due
to
differing
treatment
of
wash
sales.
6.
Investment
Transactions
Purchases
and
sales
of
investments
(excluding
short
term
securities)
for
the
period
ended
October
31,
2020,
were
as
follows:
7.
Concentration
of
Risk
Investing
in
foreign
securities
may
include
certain
risks
and
considerations
not
typically
associated
with
investing
in
U.S.
securities,
such
as
fluctuating
currency
values
and
changing
local,
regional
and
global
economic,
political
and
social
conditions,
which
may
result
in
greater
market
volatility.
Current
political
and
financial
uncertainty
surrounding
the
European
Union
may
increase
market
volatility
and
the
economic
risk
of
investing
in
securities
in
Europe.
In
addition,
certain
foreign
securities
may
not
be
as
liquid
as
U.S.
securities.
8.
Novel
Coronavirus
Pandemic 
The
global
outbreak
of
the
novel
coronavirus
disease,
known
as
COVID-19, has
caused
adverse
effects
on
many
companies,
sectors,
nations,
regions
and
the
markets
in
general, and
may
continue for
an unpredictable duration.
The
effects
of
this
pandemic
may
materially
impact
the
value
and
performance
of
the
Funds, their ability
to
buy
and
sell
fund
investments
at
appropriate
valuations
and their ability
to
achieve their investment
objectives.
9.
Restricted
Securities
Certain
or
all
Funds
invest
in
securities
that
are
restricted
under
the
Securities
Act
of
1933
(1933
Act).
Restricted
securities
are
often
purchased
in
private
placement
transactions,
and
cannot
be
sold
without
prior
registration
unless
the
sale
is
pursuant
to
an
exemption
under
the
1933
Act.
Disposal
of
these
securities
may
require
greater
effort
and
expense,
and
prompt
sale
at
an
acceptable
price
may
be
difficult.
The
Funds
may
have
registration
rights
for
restricted
securities.
The
issuer
generally
incurs
all
registration
costs.
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
a
a
a
Cost
of
investments
.......................
$852,754,042
$178,770,382
Unrealized
appreciation
.....................
$560,377,725
$23,665,438
Unrealized
depreciation
.....................
(45,229,429)
(44,979,339)
Net
unrealized
appreciation
(depreciation)
.......
$515,148,296
$(21,313,901)
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Purchases
..............................
$368,552,426
$50,342,115
Sales
..................................
$305,755,220
$54,142,685
5.
Income
Taxes
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
43
franklintempleton.com
Semiannual
Report
At
October
31,
2020,
investments
in
restricted
securities,
excluding
securities
exempt
from
registration
under
the
1933
Act,
were
as
follows:
10.
Credit
Facility
The
Funds,
together
with
other
U.S.
registered
and
foreign
investment
funds
(collectively,
Borrowers),
managed
by
Franklin
Templeton,
are
borrowers
in
a
joint
syndicated
senior
unsecured
credit
facility
totaling
$2
billion
(Global
Credit
Facility)
which
matures
on
February
5,
2021.
This
Global
Credit
Facility
provides
a
source
of
funds
to
the
Borrowers
for
temporary
and
emergency
purposes,
including
the
ability
to
meet
future
unanticipated
or
unusually
large
redemption
requests.
Under
the
terms
of
the
Global
Credit
Facility,
the
Funds
shall,
in
addition
to
interest
charged
on
any
borrowings
made
by
the
Funds
and
other
costs
incurred
by
the
Funds,
pay
their
share
of
fees
and
expenses
incurred
in
connection
with
the
implementation
and
maintenance
of
the
Global
Credit
Facility,
based
upon
their
relative
share
of
the
aggregate
net
assets
of
all
of
the
Borrowers,
including
an
annual
commitment
fee
of
0.15%
based
upon
the
unused
portion
of
the
Global
Credit
Facility.
These
fees
are
reflected
in
other
expenses
in
the
Statements
of
Operations.
During
the
period
ended
October
31,
2020,
the Funds
did
not
use
the
Global
Credit
Facility.
11.
Fair
Value
Measurements
The Funds
follow
a
fair
value
hierarchy
that
distinguishes
between
market
data
obtained
from
independent
sources
(observable
inputs)
and
the Funds'
own
market
assumptions
(unobservable
inputs).
These
inputs
are
used
in
determining
the
value
of
the Funds' financial
instruments
and
are
summarized
in
the
following
fair
value
hierarchy:
Level
1
quoted
prices
in
active
markets
for
identical
financial
instruments
Level
2
other
significant
observable
inputs
(including
quoted
prices
for
similar
financial
instruments,
interest
rates,
prepayment
speed,
credit
risk,
etc.)
Level
3
significant
unobservable
inputs
(including
the Funds'
own
assumptions
in
determining
the
fair
value
of
financial
instruments)
Shares
Issuer
Acquisition
Date
Cost
Value
Franklin
Biotechnology
Discovery
Fund
407,548
a
Athira
Pharma
Inc
...........................
5/29/20
$
2,976,236
$
6,580,931
115,139
b
Dyne
Therapeutics
Inc
........................
8/07/20
1,073,538
2,172,481
80,195
Intarcia
Therapeutics
Inc
......................
3/26/14
2,597,516
260,919
c
Metacrine
Inc
...............................
6/04/18
2,821,056
2,163,123
138,156
d
Taysha
Gene
Therapies
Inc
....................
7/28/20
2,155,719
2,623,877
Total
Restricted
Securities
(Value
is
1.00%
of
Net
Assets)
.............
$11,624,065
$13,540,412
a
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$3,046,072
as
of
October
31,
2020.
b
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$2,076,272
as
of
October
31,
2020.
c
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$2,292,290
as
of
October
31,
2020.
d
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$3,454,880
as
of
October
31,
2020.
9.
Restricted
Securities
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
44
franklintempleton.com
Semiannual
Report
The
input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level.
A
summary
of
inputs
used
as
of
October
31,
2020,
in
valuing
the
Fund's
assets
and
liabilities
carried
at
fair
value,
is
as
follows:
55
Level
1
Level
2
Level
3
Total
Franklin
Biotechnology
Discovery
Fund
Assets:
Investments
in
Securities:
a
Common
Stocks
:
Biotechnology
.........................
$
1,064,840,460
$
$
6,959,481
b
$
1,071,799,941
Capital
Markets
........................
15,501,712
15,501,712
Life
Sciences
Tools
&
Services
............
48,295,500
48,295,500
Pharmaceuticals
.......................
150,192,726
6,580,931
156,773,657
Escrows
and
Litigation
Trusts
...............
1,005,744
1,005,744
Short
Term
Investments
...................
74,525,784
74,525,784
Total
Investments
in
Securities
...........
$1,353,356,182
$—
$14,546,156
$1,367,902,338
Level
1
Level
2
Level
3
Total
Franklin
Natural
Resources
Fund
Assets:
Investments
in
Securities:
a
Common
Stocks
:
Agricultural
Products
....................
$
645,000
$
$
$
645,000
Application
Software
....................
691,803
691,803
Construction
Materials
..................
1,784,545
1,784,545
Copper
..............................
7,458,830
4,831,753
12,290,583
Diversified
Chemicals
...................
544,096
544,096
Diversified
Metals
&
Mining
...............
10,727,938
3,587,968
14,315,906
Electrical
Components
&
Equipment
........
239,525
239,525
Environmental
&
Facilities
Services
.........
1,205,540
1,205,540
Fertilizers
&
Agricultural
Chemicals
.........
2,278,274
2,278,274
Gold
................................
19,755,770
418,897
20,174,667
Heavy
Electrical
Equipment
..............
712,080
712,080
Industrial
Gases
.......................
3,585,578
3,585,578
Integrated
Oil
&
Gas
....................
23,474,103
23,474,103
Oil
&
Gas
Drilling
......................
1,277,430
1,277,430
Oil
&
Gas
Equipment
&
Services
...........
14,437,541
787,618
15,225,159
Oil
&
Gas
Exploration
&
Production
.........
31,714,958
31,714,958
Oil
&
Gas
Refining
&
Marketing
............
8,424,964
8,424,964
Oil
&
Gas
Storage
&
Transportation
.........
11,586,770
11,586,770
Packaged
Foods
&
Meats
................
1,724,175
1,724,175
Paper
Packaging
......................
1,030,410
1,030,410
Semiconductor
Equipment
...............
438,073
438,073
Steel
................................
1,469,230
1,469,230
Trading
Companies
&
Distributors
..........
1,224,342
1,224,342
Warrants
..............................
44,213
44,213
Short
Term
Investments
...................
1,355,057
1,355,057
Total
Investments
in
Securities
...........
$147,830,245
$9,626,236
$—
$157,456,481
a
For
detailed
categories,
see
the
accompanying
Statement
of
Investments.
b
Includes
securities
determined
to
have
no
value
at
October
31,
2020.
11.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
45
franklintempleton.com
Semiannual
Report
A
reconciliation
in
which
Level
3
inputs
are
used
in
determining
fair
value
is
presented
when
there
are
significant
Level
3
assets
and/or
liabilities
at
the
beginning
and/or
end
of
the period.
At
October
31,
2020,
the
reconciliation is
as follows:
Significant
unobservable
valuation
inputs
for
material
Level
3 assets
and/or
liabilities and
impact
to
fair
value
as
a
result
of
changes
in
unobservable
valuation
inputs
as
of
October
31,
2020,
are
as
follows:
a
Weighted
based
on
the
relative
fair
value
of
the
financial
instruments.
b
Represents
the
directional
change
in
the
fair
value
that
would
result
from
a
significant
and
reasonable
increase
in
the
corresponding
input.
A
significant
and
reasonable
decrease
in
the
input
would
have
the
opposite
effect.
Significant
impacts,
if
any,
to
fair
value
and/or
net
assets
have
been
indicated.
c
Represents
a
significant
impact
to
fair
value
but
not
net
assets.
d
Includes
fair
value
of
immaterial
assets
and/or
liabilities
developed
using
various
valuation
techniques
and
unobservable
inputs.
May
also
include
values
derived
using
private
transaction
prices
or
non-public
third
party
pricing
information
which
is
unobservable.
e
Includes
securities
determined
to
have
no
value
at
October
31,
2020.
Balance
at
Beginning
of
Period
Purchases
Sales
Transfer
Into
Level
3
Transfer
Out
of
Level
3
Cost
Basis
Adjust-
ments
a
Net
Realized
Gain
(Loss)
Net
Unr
ealized
Appreciatio
n
(
Depreciation
)
Balance
at
End
of
Period
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Period
End
a
a
a
a
a
a
a
a
a
a
a
Franklin
Biotechnology
Discovery
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Biotechnology
......
$
2,747,737
$
6,050,313
$
$
$
$
$
982,488
$
6,959,481
$
982,488
Pharmaceuticals
....
2,976,236
3,604,695
6,580,931
3,604,695
Escrows
and
Litigation
Trusts
...........
958,814
46,930
1,005,744
46,930
Total
Investments
in
Securities
$3,706,551
$9,026,549
$—
$—
4,634,113
$14,546,156
4,634,113
a
May
include
accretion,
amortization,
partnership
adjustments,
and/or
other
cost
basis
adjustments.
Description
Fair
Value
at
End
of
Period
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
a
Impact
to
Fair
Value
if
Input
Increases
b
Franklin
Biotechnology
Discovery
Fund
Assets:
Investments
in
Securities:
Common
Stocks:
Biotechnology
............
$6,959,481
Market
comparables
Discount
for
lack
of
marketability
8.7%
-
8.9%
(8.8%)
Decrease
Pharmaceuticals
..........
6,580,931
Market
comparables
Discount
for
lack
of
marketability
10.6%
Decrease
c
All
other
Investments
..........
1,005,744
d.e
Total
.......................
$14,546,156
11.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
46
franklintempleton.com
Semiannual
Report
12.
New
Accounting
Pronouncements
In
March
2020,
the
Financial
Accounting
Standards
Board
issued
Accounting
Standards
Update
(ASU)
No.
2020-04,
Reference
Rate
Reform
(Topic
848)
Facilitation
of
the
Effects
of
Reference
Rate
Reform
on
Financial
Reporting.
The
amendments
in
the
ASU
provides
optional
temporary
financial
reporting
relief
from
the
effect
of
certain
types
of
contract
modifications
due
to
the
planned
discontinuation
of
the
London
Interbank
Offered
Rate
and
other
interbank-offered
based
reference
rates
as
of
the
end
of
2021.
The
ASU
is
effective
for
certain
reference
rate-related
contract
modifications
that
occur
during
the
period
March
12,
2020
through
December
31,
2022. Management
has
reviewed
the
requirements
and
believes
the
adoption
of
this
ASU
will
not
have
a
material
impact
on
the
financial
statements.
13.
Subsequent
Events
The
Funds
have
evaluated
subsequent
events
through
the
issuance
of
the
financial
statements
and
determined
that
no
events
have
occurred
that
require
disclosure.
Abbreviations
Selected
Portfolio
ADR
American
Depositary
Receipt
Franklin
Strategic
Series
Shareholder
Information
47
franklintempleton.com
Semiannual
Report
Liquidity
Risk
Management
Program
Funds
no
HLIM
Each
of
the
Funds
has
adopted
and
implemented
a
written
Liquidity
Risk
Management
Program
(the
“LRMP”)
as
required
by
Rule
22e-4
under
the
Investment
Company
Act
of
1940
(the
“Liquidity
Rule”).
The
LRMP
is
designed
to
assess
and
manage
each
Fund’s
liquidity
risk,
which
is
defined
as
the
risk
that
the
Fund
could
not
meet
requests
to
redeem
shares
issued
by
the
Fund
without
significant
dilution
of
remaining
investors’
interests
in
the
Fund.
In
accordance
with
the
Liquidity
Rule,
the
LRMP
includes
policies
and
procedures
that
provide
for:
(1)
assessment,
management,
and
review
(no
less
frequently
than
annually)
of
each
Fund’s
liquidity
risk;
(2)
classification
of
each
Fund’s
portfolio
holdings
into
one
of
four
liquidity
categories
(Highly
Liquid,
Moderately
Liquid,
Less
Liquid,
and
Illiquid);
(3)
for
Funds
that
do
not
primarily
hold
assets
that
are
Highly
Liquid,
establishing
and
maintaining
a
minimum
percentage
of
the
Fund’s
net
assets
in
Highly
Liquid
investments
(called
a
“Highly
Liquid
Investment
Minimum”
or
“HLIM”);
and
(4)
prohibiting
the
Fund’s
acquisition
of
Illiquid
investments
that
would
result
in
the
Fund
holding
more
than
15%
of
its
net
assets
in
Illiquid
assets.
The
LRMP
also
requires
reporting
to
the
Securities
and
Exchange
Commission
(“SEC”)
(on
a
non-public
basis)
and
to
the
Board
if
the
Fund’s
holdings
of
Illiquid
assets
exceed
15%
of
the
Fund’s
net
assets.
Funds
with
HLIMs
must
have
procedures
for
addressing
HLIM
shortfalls,
including
reporting
to
the
Board
and,
with
respect
to
HLIM
shortfalls
lasting
more
than
seven
consecutive
calendar
days,
reporting
to
the
SEC
(on
a
non-public
basis).
The
Funds’
Board
of
Trustees
approved
the
appointment
of
the
Director
of
Liquidity
Risk
within
the
Investment
Risk
Management
Group
(the
“IRMG”)
as
the
Administrator
of
the
LRMP.
The
IRMG
maintains
the
Investment
Liquidity
Committee
(the
“ILC”)
to
provide
oversight
and
administration
of
policies
and
procedures
governing
liquidity
risk
management
for
FT
products
and
portfolios.
The
ILC
includes
representatives
from
Franklin
Templeton’s
Risk,
Trading,
Global
Compliance,
Investment
Compliance,
Investment
Operations,
Valuation
Committee
and
Product
Management
groups.
In
assessing
and
managing
each
Fund’s
liquidity
risk,
the
ILC
considers,
as
relevant,
a
variety
of
factors,
including
the
Fund’s
investment
strategy
and
the
liquidity
of
its
portfolio
investments
during
both
normal
and
reasonably
foreseeable
stressed
conditions;
its
short
and
long-term
cash
flow
projections;
and
its
cash
holdings
and
access
to
other
funding
sources
including
the
Funds’
interfund
lending
facility
and
line
of
credit.
Classification
of
the
Fund’s
portfolio
holdings
in
the
four
liquidity
categories
is
based
on
the
number
of
days
it
is
reasonably
expected
to
take
to
convert
the
investment
to
cash
(for
Highly
Liquid
and
Moderately
Liquid
holdings)
or
sell
or
dispose
of
the
investment
(for
Less
Liquid
and
Illiquid
investments),
in
current
market
conditions
without
significantly
changing
the
investment’s
market
value.
Each
Fund
primarily
holds
liquid
assets
that
are
defined
under
the
Liquidity
Rule
as
"Highly
Liquid
Investments,"
and
therefore
is
not
required
to
establish
an
HLIM.
Highly
Liquid
Investments
are
defined
as
cash
and
any
investment
reasonably
expected
to
be
convertible
to
cash
in
current
market
conditions
in
three
business
days
or
less
without
the
conversion
to
cash
significantly
changing
the
market
value
of
the
investment.
At
meetings
of
the
Funds’
Board
of
Trustees
held
in
May
2020,
the
Program
Administrator
provided
a
written
report
to
the
Board
addressing
the
adequacy
and
effectiveness
of
the
program
during
the
period
December
1,
2018
to
December
31,
2019.
The
Program
Administrator
report
concluded
that
(i.)
the
LRMP,
as
adopted
and
implemented,
remains
reasonably
designed
to
assess
and
manage
each
Fund’s
liquidity
risk;
(ii.)
the
LRMP,
including
the
Highly
Liquid
Investment
Minimum
(“HLIM”)
where
applicable,
was
implemented
and
operated
effectively
to
achieve
the
goal
of
assessing
and
managing
each
Fund’s
liquidity
risk;
and
(iii.)
each
Fund
was
able
to
meet
requests
for
redemption
without
significant
dilution
of
remaining
investors’
interests
in
the
Fund.
At
the
same
time,
the
Program
Administrator
also
presented
the
Fund
Board
of
Trustees
an
update
on
liquidity
during
the
first
quarter
of
2020
in
relation
to
the
COVID-19
pandemic.
Proxy
Voting
Policies
and
Procedures
The
Trust’s
investment
manager
has
established
Proxy
Voting
Policies
and
Procedures
(Policies)
that
the
Trust
uses
to
determine
how
to
vote
proxies
relating
to
portfolio
securities.
Shareholders
may
view
the
Trust’s
complete
Policies
online
at
franklintempleton.com.
Alternatively,
shareholders
may
request
copies
of
the
Policies
free
of
charge
by
calling
the
Proxy
Group
collect
at
(954)
527-
7678
or
by
sending
a
written
request
to:
Franklin
Templeton
Companies,
LLC,
300
S.E.
2nd
Street,
Fort
Lauderdale,
FL
33301,
Attention:
Proxy
Group.
Copies
of
the
Trust’s
Franklin
Strategic
Series
Shareholder
Information
48
franklintempleton.com
Semiannual
Report
proxy
voting
records
are
also
made
available
online
at
franklintempleton.com
and
posted
on
the
U.S.
Securities
and
Exchange
Commission’s
website
at
sec.gov
and
reflect
the
most
recent
12-month
period
ended
June
30.
Quarterly
Statement
of
Investments
The
Trust
files
a
complete
statement
of
investments
with
the
U.S.
Securities
and
Exchange
Commission
for
the
first
and
third
quarters
for
each
fiscal
year
as
an
exhibit
to
its
report
on
Form
N-PORT.
Shareholders
may
view
the
filed
Form
N-PORT
by
visiting
the
Commission’s
website
at
sec.
gov.
The
filed
form
may
also
be
viewed
and
copied
at
the
Commission’s
Public
Reference
Room
in
Washington,
DC.
Information
regarding
the
operations
of
the
Public
Reference
Room
may
be
obtained
by
calling
(800)
SEC-0330.
Householding
of
Reports
and
Prospectuses
You
will
receive
each
Fund’s
financial
reports
every
six
months
as
well
as
an
annual
updated
summary
prospectus
(prospectus
available
upon
request).
To
reduce
Fund
expenses,
we
try
to
identify
related
shareholders
in
a
household
and
send
only
one
copy
of
the
financial
reports
and
summary
prospectus.
This
process,
called
“householding,”
will
continue
indefinitely
unless
you
instruct
us
otherwise.
If
you
prefer
not
to
have
these
documents
householded,
please
call
us
at
(800)
632-2301.
At
any
time
you
may
view
current
prospectuses/summary
prospectuses
and
financial
reports
on
our
website.
If
you
choose,
you
may
receive
these
documents
through
electronic
delivery.
FSS2
S
12/20
©
2020
Franklin
Templeton
Investments.
All
rights
reserved.
Authorized
for
distribution
only
when
accompanied
or
preceded
by
a
summary
prospectus
and/or
prospectus.
Investors
should
carefully
consider
a
fund’s
investment
goals,
risks,
charges
and
expenses
before
investing.
A
prospectus
contains
this
and
other
information;
please
read
it
carefully
before
investing.
To
help
ensure
we
provide
you
with
quality
service,
all
calls
to
and
from
our
service
areas
are
monitored
and/or
recorded.
Seminnual
Report
and
Shareholder
Letter
Franklin
Strategic
Series
Investment
Manager
Distributor
Shareholder
Services
Franklin
Advisers,
Inc.
Franklin
Templeton
Distributors,
Inc.
(800)
DIAL
BEN
®
/
342-5236
franklintempleton.com
(800)
632-2301
Semiannual
Report
and
Shareholder
Letter
Franklin
Strategic
Income
Fund
A
Series
of
Franklin
Strategic
Series
October
31,
2020
Sign
up
for
electronic
delivery
at
franklintempleton.com/edelivery
Internet
Delivery
of
Fund
Reports
Unless
You
Request
Paper
Copies
:
Effective
January
1,
2021,
as
permitted
by
the
SEC,
paper
copies
of
the
Fund’s
shareholder
reports
will
no
longer
be
sent
by
mail,
unless
you
specifically
request
them
from
the
Fund
or
your
financial
intermediary.
Instead,
the
reports
will
be
made
available
on
a
website,
and
you
will
be
notified
by
mail
each
time
a
report
is
posted
and
provided
with
a
website
link
to
access
the
report.
If
you
already
elected
to
receive
shareholder
reports
electronically,
you
will
not
be
affected
by
this
change
and
you
need
not
take
any
action.
If
you
have
not
signed
up
for
electronic
delivery,
we
would
encourage
you
to
join
fellow
shareholders
who
have.
You
may
elect
to
receive
shareholder
reports
and
other
communications
electronically
from
the
Fund
by
calling
(800)
632-2301
or
by
contacting
your
financial
intermediary.
You
may
elect
to
continue
to
receive
paper
copies
of
all
your
future
shareholder
reports
free
of
charge
by
contacting
your
financial
intermediary
or,
if
you
invest
directly
with
a
Fund,
calling
(800)
632-2301
to
let
the
Fund
know
of
your
request.
Your
election
to
receive
reports
in
paper
will
apply
to
all
funds
held
in
your
account.
Not
FDIC
Insured
May
Lose
Value
No
Bank
Guarantee
franklintempleton.com
Not
part
of
the
semiannual
report
1
Shareholder
Letter
Dear
Shareholder:
During
the
six
months
ended
October
31,
2020,
first-
and
second-quarter
2020
data
reported
during
the
period
indicated
that
the
U.S.
economy
contracted
in
response
to
the
novel
coronavirus
(COVID-19)
pandemic.
In
the
third
quarter,
the
economy
recovered
substantially
based
on
increased
business
and
residential
investment
and
consumer
spending.
Before
the
reporting
period,
the
U.S.
Federal
Reserve
(Fed),
in
its
efforts
to
support
U.S.
economic
activity,
lowered
the
federal
funds
rate
twice
in
March
2020
and
implemented
broad
quantitative
easing
measures
to
support
credit
markets.
During
the
reporting
period,
the
Fed
held
its
key
rate
unchanged
at
0.25%,
but
continued
quantitative
easing
and
adjusted
its
policy
in
August
2020
to
allow
more
flexibility
to
keep
interest
rates
low,
while
maintaining
a
2%
average
inflation
target.
U.S.
equity
prices
rose
considerably
during
the
period,
helped
by
monetary
and
fiscal
actions
and
optimism
about
the
economy,
which
propelled
valuations
to
all-time
highs
in
September
before
stocks
trended
lower
amid
renewed
investor
concerns.
In
this
environment,
investment-grade
bonds,
as
measured
by
the
Bloomberg
Barclays
U.S.
Aggregate
Bond
Index,
posted
a
positive
total
return
for
the
six-month
period.
We
are
committed
to
our
long-term
perspective
and
disciplined
investment
approach
as
we
conduct
a
rigorous,
fundamental
analysis
of
securities
with
a
regular
emphasis
on
investment
risk
management.
We
believe
active,
professional
investment
management
serves
investors
well.
We
also
recognize
the
important
role
of
financial
advisors
in
today’s
markets
and
encourage
investors
to
continue
to
seek
their
advice.
Amid
changing
markets
and
economic
conditions,
we
are
confident
investors
with
a
well-diversified
portfolio
and
a
patient,
long-term
outlook
should
be
well-positioned
for
the
years
ahead.
In
addition,
Franklin
Strategic
Series’
semiannual
report
includes
more
detail
about
prevailing
conditions
and
a
discussion
about
investment
decisions
during
the
period.
All
securities
markets
fluctuate,
as
do
mutual
fund
share
prices.
We
thank
you
for
investing
with
Franklin
Templeton,
welcome
your
questions
and
comments,
and
look
forward
to
serving
your
future
investment
needs.
Sincerely,
Edward
Perks,
CFA
President
and
Chief
Executive
Officer
Investment
Management
Franklin
Strategic
Series
This
letter
reflects
our
analysis
and
opinions
as
of
October
31,
2020
,
unless
otherwise
indicated.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
fund.
Statements
of
fact
are
from
sources
considered
reliable.
CFA
®
is
a
trademark
owned
by
CFA
Institute.
franklintempleton.com
Semiannual
Report
2
Contents
Semiannual
Report
Franklin
Strategic
Income
Fund
3
Performance
Summary
6
Your
Fund’s
Expenses
8
Consolidated
Financial
Highlights
and
Consolidated
Statement
of
Investments
9
Consolidated
Financial
Statements
44
Notes
to
Consolidated
Financial
Statements
48
Shareholder
Information
70
Visit
franklintempleton.com
for
fund
updates,
to
access
your
account,
or
to
find
helpful
financial
planning
tools.
3
franklintempleton.com
Semiannual
Report
SEMIANNUAL
REPORT
Franklin
Strategic
Income
Fund
This
semiannual
report
for
Franklin
Strategic
Income
Fund
covers
the
period
ended
October
31,
2020
.
Your
Fund’s
Goal
and
Main
Investments
The
Fund
seeks
to
earn
a
high
level
of
current
income.
A
secondary
goal
is
capital
appreciation
over
the
long
term.
The
Fund
uses
an
active
asset
allocation
process
and
under
normal
market
conditions
invests
at
least
65%
of
its
assets
in
U.S.
and
foreign
debt
securities,
including
those
in
emerging
markets.
The
Fund
may
invest
in
all
varieties
of
fixed,
variable
and
floating
rate
income
securities,
including
bonds,
U.S.
and
foreign
government
and
agency
securities,
corporate
loans
(and
loan
participations),
mortgage-backed
securities
and
other
asset-backed
securities.
Performance
Overview
The
Fund’s
Class
A
shares
posted
a
+8.38%
cumulative
total
return
for
the
six
months
under
review.
In
comparison,
the
Bloomberg
Barclays
U.S.
Aggregate
Bond
Index,
which
represents
the
U.S.
investment-grade
fixed
rate
taxable
bond
market,
posted
a
+1.27%
total
return.
1
The
Lipper
Multi-Sector
Income
Funds
Classification
Average,
which
consists
of
funds
chosen
by
Lipper
that
seek
current
income
by
allocating
assets
among
different
fixed
income
securities
sectors,
with
a
significant
portion
rated
below
investment
grade,
posted
a
+7.86%
total
return.
2
You
can
find
more
of
the
Fund’s
performance
data
in
the
Performance
Summary
beginning
on
page
6
.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Economic
and
Market
Overview
The
U.S.
bond
market,
as
measured
by
the
Bloomberg
Barclays
U.S.
Aggregate
Bond
Index,
posted
modest
total
returns
during
the
six
months
ended
October
31,
2020,
as
markets
adjusted
to
the
disruption
caused
by
the
novel
coronavirus
(COVID-19)
pandemic.
Prior
to
the
period,
investor
flight
to
perceived
safety
had
driven
the
10-year
U.S.
Treasury
yield
(which
move
inversely
to
price)
to
intraday
record
lows,
while
corporate
bond
yields
increased,
reflecting
increased
credit
risk
amid
widespread
economic
disruption.
Throughout
the
reporting
period,
however,
U.S.
Federal
Reserve
(Fed)
support
and
the
gradual
reopening
of
the
economy
reduced
many
investors’
concerns
about
solvency,
and
corporate
bonds
rebounded
significantly.
This
advance
was
tempered
somewhat
in
late
August,
as
the
rebounding
economy
and
a
change
in
the
Fed’s
long-
standing
inflation
policy
led
yields
on
most
bonds
to
rise.
The
Fed
maintained
the
federal
funds
target
rate
at
a
range
of
0.00%–0.25%
and
continued
its
program
of
unlimited,
open-ended
purchasing
of
government-backed
and
corporate
bonds
to
help
keep
markets
functioning,
significantly
expanding
its
balance
sheet.
Furthermore,
the
Fed
signaled
that
interest
rates
would
potentially
remain
low,
even
if
inflation
persistently
exceeded
the
Fed’s
2%
target.
U.S.
Treasury
bonds,
as
measured
by
the
Bloomberg
Barclays
U.S.
Treasury
Index,
declined
slightly
during
the
period.
The
10-year
U.S.
Treasury
yield
recovered
from
a
new
record
closing
low
in
early
August
2020
and
rose
slightly
for
the
period,
remaining
historically
low
despite
the
widening
U.S.
federal
budget
deficit
and
a
massive
increase
in
issuance.
Mortgage-backed
securities
(MBS),
as
measured
by
the
Bloomberg
Barclays
MBS
Index,
ended
the
period
relatively
flat
despite
Fed
support,
as
lower
interest
rates
led
to
accelerated
prepayments
from
mortgage
refinancing.
U.S.
corporate
bond
performance
varied
based
on
credit
rating,
reflecting
the
recovery
of
credit
markets
following
the
initial
COVID-19
shock.
As
Fed
support
tempered
many
investors’
concerns
about
credit
quality,
prices
for
corporate
bonds
rebounded,
particularly
for
the
lower-rated
segment.
1.
Source:
Morningstar.
2.
Source:
Lipper,
a
Thomson
Reuters
Company.
For
the
six-month
period
ended
10/31/20,
this
category
consisted
of
351
funds.
Lipper
calculations
do
not
include
sales
charges
or
expense
subsidization
by
a
fund’s
manager.
Fund
performance
relative
to
the
average
may
have
differed
if
these
or
other
factors
had
been
considered.
The
indexes
are
unmanaged
and
include
reinvestment
of
any
income
or
distributions.
They
do
not
reflect
any
fees,
expenses
or
sales
charges.
One
cannot
invest
directly
in
an
index,
and
an
index
is
not
representative
of
the
Fund’s
portfolio.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
The
dollar
value,
number
of
shares
or
principal
amount,
and
names
of
all
portfolio
holdings
are
listed
in
the
Fund’s
Consolidated
Statement
of
Investments
(SOI).
The
Consolidated
SOI
begins
on
page
14
.
Franklin
Strategic
Income
Fund
4
franklintempleton.com
Semiannual
Report
Consequently,
high-yield
corporate
bonds,
as
represented
by
the
Bloomberg
Barclays
U.S.
Corporate
High
Yield
Bond
Index,
advanced
significantly.
Investment-grade
corporate
bonds,
as
represented
by
the
Bloomberg
Barclays
U.S.
Corporate
Bond
Index,
also
posted
solid
performance.
Investment
Strategy
We
use
an
active
asset
allocation
strategy
to
try
to
achieve
the
Fund’s
investment
goals.
We
employ
a
top-down
analysis
of
macroeconomic
trends
combined
with
a
bottom-
up
fundamental
analysis
of
market
sectors,
industries
and
issuers
to
try
to
take
advantage
of
varying
sector
reactions
to
economic
events.
We
regularly
enter
into
various
currency-
related
transactions
involving
derivative
instruments,
including
currency
and
cross
currency
forwards,
currency
swaps,
currency
and
currency
index
futures
contracts
and
currency
options.
We
may
also
enter
into
interest-rate
and
credit-related
transactions
involving
derivative
instruments,
including
interest-rate,
fixed
income
total
return
and
credit
default
swaps
and
interest
rate
and/or
bond
futures
contracts.
Manager’s
Discussion
During
the
six-month
period,
financial
markets
were
volatile
but
recovered
from
the
sharp
decline
experienced
earlier
in
the
year
as
a
Fed
backstop
for
credit
markets
bolstered
investor
confidence.
Amid
signs
of
economic
progress,
investors
weighed
the
generally
positive
data
against
rising
COVID-19
cases,
lack
of
progress
on
fiscal
stimulus
negotiations
and
uncertainty
leading
up
to
the
presidential
election,
which
exacerbated
market
volatility.
Despite
the
heightened
state
of
market
uncertainty,
fixed
income
spreads
still
managed
to
end
the
period
largely
narrower.
In
this
environment,
most
fixed
income
sectors
posted
positive
total
returns
and
outpaced
similar
maturity
U.S.
Treasuries
which
underperformed
with
negative
total
returns.
The
Fund’s
largest
allocations
were
in
high
yield
(HY)
and
investment-grade
(IG)
corporate
bonds,
which
were
the
primary
contributors
to
performance.
Additionally,
senior
secured
floating-rate
bank
loans
and
collateralized
loan
obligation
exposure
benefited
absolute
results.
We
increased
our
HY
exposure
over
the
period.
The
sector
offers
what
we
consider
an
interesting
juxtaposition
between
average
valuations
and
a
challenging
economic
backdrop,
and
while
we
believe
volatility
could
remain
elevated
in
the
near-term,
the
technical
environment
has
remained
generally
supportive
and
we
view
HY
as
an
attractive
asset
class
in
the
continued
low-rate
environment.
We
also
slightly
increased
our
IG
exposure
while
paring
senior
secured
floating-rate
loan
exposure.
While
we
remain
generally
positive
on
the
IG
corporate
bond
sector,
the
opportunity
set
has
become
less
compelling
to
us
given
tighter
valuations
and
continued
near-term
economic
and
policy
uncertainty,
particularly
as
COVID-19
cases
have
surged.
Our
allocation
to
non-agency
residential
mortgage-backed
securities
(RMBS)
also
added
to
portfolio
returns
as
markets
continue
to
recover
from
the
distressed
levels
seen
in
the
first
quarter.
A
majority
of
RMBS
exposure
in
the
portfolio
is
in
credit
risk
transfer
securities
(CRTs).
We
believe
RMBS
issuance
should
remain
light
for
2020,
particularly
in
CRTs
and
we
continue
to
believe
we
could
see
an
overall
strong
housing
market,
supported
by
limited
home
supply
coupled
with
strong
demand
and
historically
low
mortgage
rates.
We
pared
exposure
amid
strength
in
the
market
over
the
period.
Sovereign
emerging
markets
securities
and
Treasury
Inflation
Protected-Securities
(TIPS)
performance
contributed
to
returns.
We
reduced
TIPS
exposure
over
the
period
as
inflation
expectations
have
continued
to
recover
since
their
March
lows.
Foreign
currency
exposure
detracted
from
performance
as
gains
mainly
from
our
long
Japanese
yen,
South
African
rand
and
Mexican
peso
positions
were
offset
by
negative
returns
mainly
from
our
short
Australian
dollar,
Singapore
dollar
and
Canadian
dollar
positions.
Portfolio
Composition
10/31/20
%
of
Total
Net
Assets
Corporate
Bonds
46.4%
Asset-Backed
Securities
19.7%
Foreign
Government
and
Agency
Securities
14.3%
Mortgage-Backed
Securities
7.7%
U.S.
Government
and
Agency
Securities
4.3%
Senior
Floating
Rate
Interests
4.1%
Management
Investment
Companies
2.8%
Municipal
Bonds
1.6%
Other
1.0%
Short-Term
Investments
&
Other
Net
Assets
(1.9)%
Franklin
Strategic
Income
Fund
5
franklintempleton.com
Semiannual
Report
Thank
you
for
your
participation
in
Franklin
Strategic
Income
Fund.
We
look
forward
to
continuing
to
serve
your
investment
needs.
Sonal
Desai,
Ph.D.
Co-Lead
Portfolio
Manager
Patricia
O’Connor,
CFA
Co-Lead
Portfolio
Manager
William
Chong,
CFA,
FRM
Co-Lead
Portfolio
Manager
David
Yuen,
CFA,
FRM
Co-Lead
Portfolio
Manager
The
foregoing
information
reflects
our
analysis,
opinions
and
portfolio
holdings
as
of
October
31,
2020
,
the
end
of
the
reporting
period.
The
way
we
implement
our
main
investment
strategies
and
the
resulting
portfolio
holdings
may
change
depending
on
factors
such
as
market
and
economic
conditions.
These
opinions
may
not
be
relied
upon
as
investment
advice
or
an
offer
for
a
particular
security.
The
information
is
not
a
complete
analysis
of
every
aspect
of
any
market,
country,
industry,
security
or
the
Fund.
Statements
of
fact
are
from
sources
considered
reliable,
but
the
investment
manager
makes
no
representation
or
warranty
as
to
their
completeness
or
accuracy.
Although
historical
performance
is
no
guarantee
of
future
results,
these
insights
may
help
you
understand
our
investment
management
philosophy.
Performance
Summary
as
of
October
31,
2020
Franklin
Strategic
Income
Fund
6
franklintempleton.com
Semiannual
Report
The
performance
tables
do
not
reflect
any
taxes
that
a
shareholder
would
pay
on
Fund
dividends,
capital
gain
distributions,
if
any,
or
any
realized
gains
on
the
sale
of
Fund
shares.
Total
return
reflects
reinvestment
of
the
Fund’s
dividends
and
capital
gain
distributions,
if
any,
and
any
unrealized
gains
or
losses.
Your
dividend
income
will
vary
depending
on
dividends
or
interest
paid
by
securities
in
the
Fund’s
portfolio,
adjusted
for
operating
expenses
of
each
class.
Capital
gain
distributions
are
net
profits
realized
from
the
sale
of
portfolio
securities.
Performance
as
of
10/31/20
1
Cumulative
total
return
excludes
sales
charges.
Average
annual
total
return
includes
maximum
sales
charges.
Sales
charges
will
vary
depending
on
the
size
of
the
investment
and
the
class
of
share
purchased.
The
maximum
is
3.75%
and
the
minimum
is
0%.
Class
A
:
3.75%
maximum
initial
sales
charge;
Advisor
Class:
no
sales
charges.
For
other
share
classes,
visit
franklintempleton.com.
Performance
data
represent
past
performance,
which
does
not
guarantee
future
results.
Investment
return
and
principal
value
will
fluctuate,
and
you
may
have
a
gain
or
loss
when
you
sell
your
shares.
Current
performance
may
differ
from
figures
shown.
For
most
recent
month-end
performance,
go
to
franklintempleton.com
or
call
(800)
342-5236
.
Share
Class
Cumulative
Total
Return
2
Average
Annual
Total
Return
3
A
4
6-Month
+8.38%
+4.29%
1-Year
+0.44%
-3.30%
5-Year
+16.17%
+2.26%
10-Year
+38.36%
+2.90%
Advisor
6-Month
+8.51%
+8.51%
1-Year
+0.69%
+0.69%
5-Year
+17.61%
+3.30%
10-Year
+41.81%
+3.56%
30-Day
Standardized
Yield
6
Share
Class
Distribution
Rate
5
(with
fee
waiver)
(without
fee
waiver)
A
4.37%
2.71%
2.69%
Advisor
4.82%
3.06%
3.04%
See
page
7
for
Performance
Summary
footnotes.
Franklin
Strategic
Income
Fund
Performance
Summary
7
franklintempleton.com
Semiannual
Report
Each
class
of
shares
is
available
to
certain
eligible
investors
and
has
different
annual
fees
and
expenses,
as
described
in
the
prospectus.
All
investments
involve
risks,
including
possible
loss
of
principal.
Bond
prices
generally
move
in
the
opposite
direction
of
interest
rates.
Thus,
as
prices
of
bonds
in
the
Fund
adjust
to
a
rise
in
interest
rates,
the
Fund’s
share
price
may
decline.
Changes
in
the
financial
strength
of
a
bond
issuer
or
in
a
bond’s
credit
rating
may
affect
its
value.
High
yields
reflect
the
higher
credit
risks
associated
with
certain
lower
rated
securities
held
in
the
portfolio.
Floating-rate
loans
and
high-yield
corporate
bonds
are
rated
below
investment
grade
and
are
subject
to
greater
risk
of
default,
which
could
result
in
loss
of
principal—a
risk
that
may
be
heightened
in
a
slowing
economy.
The
risks
of
foreign
securities
include
currency
fluctuations
and
political
uncertainty.
Investments
in
developing
markets
involve
heightened
risks
related
to
the
same
factors,
in
addition
to
those
associated
with
their
relatively
small
size
and
lesser
liquidity.
Investing
in
derivative
securities
and
the
use
of
foreign
currency
techniques
involve
special
risks
as
such
may
not
achieve
the
anticipated
benefits
and/or
may
result
in
losses
to
the
Fund.
Unexpected
events
and
their
aftermaths,
such
as
the
spread
of
deadly
diseases;
natural,
environmental
or
man-made
disasters;
financial,
political
or
social
disruptions;
terrorism
and
war;
and
other
tragedies
or
catastrophes,
can
cause
investor
fear
and
panic,
which
can
adversely
affect
the
economies
of
many
companies,
sectors,
nations,
regions
and
the
market
in
general,
in
ways
that
cannot
necessarily
be
foreseen.
The
Fund’s
prospectus
also
includes
a
description
of
the
main
investment
risks.
1.
The
Fund
has
a
fee
waiver
associated
with
any
investment
it
makes
in
a
Franklin
Templeton
money
fund
and/or
other
Franklin
Templeton
fund,
contractually
guaranteed
through
8/31/21.
Fund
investment
results
reflect
the
fee
waiver;
without
this
waiver,
the
results
would
have
been
lower.
2.
Cumulative
total
return
represents
the
change
in
value
of
an
investment
over
the
periods
indicated.
3.
Average
annual
total
return
represents
the
average
annual
change
in
value
of
an
investment
over
the
periods
indicated.
Return
for
less
than
one
year,
if
any,
has
not
been
annualized.
4.
Prior
to
3/1/19,
these
shares
were
offered
at
a
higher
initial
sales
charge
of
4.25%,
thus
actual
returns
(with
sales
charges)
would
have
differed.
Average
annual
total
returns
(with
sales
charges)
have
been
restated
to
reflect
the
current
maximum
initial
sales
charge
of
3.75%.
5.
Distribution
rate
is
based
on
the
sum
of
the
respective
class’s
dividend
distributions
over
the
past
six
months
and
the
maximum
offering
price
(NAV
for
Advisor
Class)
per
share
on
10/31/20.
6.
The
Fund’s
30-day
standardized
yield
is
calculated
over
a
trailing
30-day
period
using
the
yield
to
maturity
on
bonds
and/or
the
dividends
accrued
on
stocks.
It
may
not
equal
the
Fund’s
actual
income
distribution
rate,
which
reflects
the
Fund’s
past
dividends
paid
to
shareholders.
7.
Figures
are
as
stated
in
the
Fund’s
current
prospectus
and
may
differ
from
the
expense
ratios
disclosed
in
the
Your
Fund’s
Expenses
and
Consolidated
Financial
Highlights
sections
in
this
report.
In
periods
of
market
volatility,
assets
may
decline
significantly,
causing
total
annual
Fund
operating
expenses
to
become
higher
than
the
figures
shown.
See
www.franklintempletondatasources.com
for
additional
data
provider
information.
Distributions
(5/1/20–10/31/20)
Share
Class
Net
Investment
Income
A
$0.1745
C
$0.1546
R
$0.1628
R6
$0.1920
Advisor
$0.1861
Total
Annual
Operating
Expenses
7
Share
Class
With
Fee
Waiver
Without
Fee
Waiver
A
0.88%
0.90%
Advisor
0.63%
0.65%
Your
Fund’s
Expenses
Franklin
Strategic
Income
Fund
8
franklintempleton.com
Semiannual
Report
As
a
Fund
shareholder,
you
can
incur
two
types
of
costs:
(1)
transaction
costs,
including
sales
charges
(loads)
on
Fund
purchases
and
redemptions;
and
(2)
ongoing
Fund
costs,
including
management
fees,
distribution
and
service
(12b-1)
fees,
and
other
Fund
expenses.
All
mutual
funds
have
ongoing
costs,
sometimes
referred
to
as
operating
expenses.
The
table
below
shows
ongoing
costs
of
investing
in
the
Fund
and
can
help
you
understand
these
costs
and
compare
them
with
those
of
other
mutual
funds.
The
table
assumes
a
$1,000
investment
held
for
the
six
months
indicated.
Actual
Fund
Expenses
The
table
below
provides
information
about
actual
account
values
and
actual
expenses
in
the
columns
under
the
heading
“Actual.”
In
these
columns
the
Fund’s
actual
return,
which
includes
the
effect
of
Fund
expenses,
is
used
to
calculate
the
“Ending
Account
Value”
for
each
class
of
shares.
You
can
estimate
the
expenses
you
paid
during
the
period
by
following
these
steps
(
of
course,
your
account
value
and
expenses
will
differ
from
those
in
this
illustration
):
Divide
your
account
value
by
$1,000
(
if
your
account
had
an
$8,600
value,
then
$8,600
÷
$1,000
=
8.6
).
Then
multiply
the
result
by
the
number
in
the
row
for
your
class
of
shares
under
the
headings
“Actual”
and
“Expenses
Paid
During
Period”
(
if
Actual
Expenses
Paid
During
Period
were
$7.50,
then
8.6
x
$7.50
=
$64.50
).
In
this
illustration,
the
actual
expenses
paid
this
period
are
$64.50.
Hypothetical
Example
for
Comparison
with
Other
Funds
Under
the
heading
“Hypothetical”
in
the
table,
information
is
provided
about
hypothetical
account
values
and
hypothetical
expenses
based
on
the
Fund’s
actual
expense
ratio
and
an
assumed
rate
of
return
of
5%
per
year
before
expenses,
which
is
not
the
Fund’s
actual
return.
This
information
may
not
be
used
to
estimate
the
actual
ending
account
balance
or
expenses
you
paid
for
the
period,
but
it
can
help
you
compare
ongoing
costs
of
investing
in
the
Fund
with
those
of
other
funds.
To
do
so,
compare
this
5%
hypothetical
example
for
the
class
of
shares
you
hold
with
the
5%
hypothetical
examples
that
appear
in
the
shareholder
reports
of
other
funds.
Please
note
that
expenses
shown
in
the
table
are
meant
to
highlight
ongoing
costs
and
do
not
reflect
any
transactional
costs.
Therefore,
information
under
the
heading
“Hypothetical”
is
useful
in
comparing
ongoing
costs
only,
and
will
not
help
you
compare
total
costs
of
owning
different
funds.
In
addition,
if
transactional
costs
were
included,
your
total
costs
would
have
been
higher.
1.
Expenses
are
equal
to
the
annualized
expense
ratio
for
the
six-month
period
as
indicated
above—in
the
far
right
column—multiplied
by
the
simple
average
account
value
over
the
period
indicated,
and
then
multiplied
by
184/365
to
reflect
the
one-half
year
period.
2.
Reflects
expenses
after
fee
waivers
and
expense
reimbursements.
Does
not
include
acquired
fund
fees
and
expenses.
Actual
(actual
return
after
expenses)
Hypothetical
(5%
annual
return
before
expenses)
Share
Class
Beginning
Account
Value
5/1/20
Ending
Account
Value
10/31/20
Expenses
Paid
During
Period
5/1/20–10/31/20
1,2
Ending
Account
Value
10/31/20
Expenses
Paid
During
Period
5/1/20–10/31/20
1,2
a
Net
Annualized
Expense
Ratio
2
A
$1,000
$1,083.80
$4.47
$1,020.91
$4.34
0.86%
C
$1,000
$1,081.46
$6.58
$1,018.89
$6.38
1.26%
R
$1,000
$1,082.81
$5.87
$1,019.57
$5.69
1.11%
R6
$1,000
$1,085.75
$2.70
$1,022.62
$2.62
0.51%
Advisor
$1,000
$1,085.06
$3.17
$1,022.16
$3.08
0.61
%
Franklin
Strategic
Series
Consolidated
Financial
Highlights
Franklin
Strategic
Income
Fund
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
9
2
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
A
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$8.67
$9.61
$9.61
$9.84
$9.32
$10.04
Income
from
investment
operations
a
:
Net
investment
income
b
.............
0.24
0.38
0.42
0.39
0.39
0.42
Net
realized
and
unrealized
gains
(losses)
0.48
(0.90)
c
(0.32)
0.30
(0.74)
Total
from
investment
operations
........
0.72
(0.52)
0.42
0.07
0.69
(0.32)
Less
distributions
from:
Net
investment
income
and
net
foreign
currency
gains
....................
(0.17)
(0.42)
(0.42)
(0.30)
(0.17)
(0.40)
Net
asset
value,
end
of
period
..........
$9.22
$8.67
$9.61
$9.61
$9.84
$9.32
Total
return
d
.......................
8.38%
(5.72)%
4.52%
0.64%
7.50%
(3.14)%
Ratios
to
average
net
assets
e
Expenses
before
waiver
and
payments
by
affiliates
..........................
0.87%
0.88%
0.89%
0.90%
0.88%
0.88%
Expenses
net
of
waiver
and
payments
by
affiliates
f
..........................
0.86%
0.86%
0.84%
0.85%
0.82%
0.84%
Net
investment
income
...............
5.13%
4.01%
4.39%
3.93%
4.08%
4.44%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$2,837,732
$2,686,523
$3,131,799
$3,291,002
$3,833,786
$4,500,752
Portfolio
turnover
rate
................
69.48%
118.64%
116.21%
g
115.94%
140.83%
88.04%
Portfolio
turnover
rate
excluding
mortgage
dollar
rolls
h
........................
34.18%
86.69%
39.01%
g
47.40%
87.33%
48.33%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Amount
rounds
to
less
than
$0.01
per
share.
d
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable,
and
is
not
annualized
for
periods
less
than
one
year.
e
Ratios
are
annualized
for
periods
less
than
one
year.
f
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
g
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
h
See
Note
1(j)
regarding
mortgage
dollar
rolls.
Franklin
Strategic
Series
Consolidated
Financial
Highlights
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
10
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
C
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$8.67
$9.61
$9.60
$9.84
$9.31
$10.04
Income
from
investment
operations
a
:
Net
investment
income
b
.............
0.22
0.34
0.38
0.35
0.35
0.38
Net
realized
and
unrealized
gains
(losses)
0.48
(0.90)
0.01
(0.33)
0.31
(0.75)
Total
from
investment
operations
........
0.70
(0.56)
0.39
0.02
0.66
(0.37)
Less
distributions
from:
Net
investment
income
and
net
foreign
currency
gains
....................
(0.15)
(0.38)
(0.38)
(0.26)
(0.13)
(0.36)
Net
asset
value,
end
of
period
..........
$9.22
$8.67
$9.61
$9.60
$9.84
$9.31
Total
return
c
.......................
8.15%
(6.11)%
4.19%
0.14%
7.19%
(3.64)%
Ratios
to
average
net
assets
d
Expenses
before
waiver
and
payments
by
affiliates
..........................
1.27%
1.28%
1.29%
1.30%
1.28%
1.28%
Expenses
net
of
waiver
and
payments
by
affiliates
e
..........................
1.26%
1.26%
1.24%
1.25%
1.22%
1.24%
Net
investment
income
...............
4.71%
3.61%
3.99%
3.53%
3.68%
4.04%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$448,600
$518,795
$716,327
$1,078,890
$1,385,981
$1,645,852
Portfolio
turnover
rate
................
69.48%
118.64%
116.21%
f
115.94%
140.83%
88.04%
Portfolio
turnover
rate
excluding
mortgage
dollar
rolls
g
........................
34.18%
86.69%
39.01%
f
47.40%
87.33%
48.33%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable,
and
is
not
annualized
for
periods
less
than
one
year.
d
Ratios
are
annualized
for
periods
less
than
one
year.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
g
See
Note
1(j)
regarding
mortgage
dollar
rolls.
Franklin
Strategic
Series
Consolidated
Financial
Highlights
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
11
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
R
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$8.63
$9.57
$9.57
$9.81
$9.28
$10.01
Income
from
investment
operations
a
:
Net
investment
income
b
.............
0.22
0.36
0.39
0.36
0.37
0.39
Net
realized
and
unrealized
gains
(losses)
0.49
(0.91)
0.01
(0.33)
0.31
(0.74)
Total
from
investment
operations
........
0.71
(0.55)
0.40
0.03
0.68
(0.35)
Less
distributions
from:
Net
investment
income
and
net
foreign
currency
gains
....................
(0.16)
(0.39)
(0.40)
(0.27)
(0.15)
(0.38)
Net
asset
value,
end
of
period
..........
$9.18
$8.63
$9.57
$9.57
$9.81
$9.28
Total
return
c
.......................
8.28%
(5.98)%
4.28%
0.29%
7.38%
(3.50)%
Ratios
to
average
net
assets
d
Expenses
before
waiver
and
payments
by
affiliates
..........................
1.12%
1.13%
1.14%
1.15%
1.13%
1.13%
Expenses
net
of
waiver
and
payments
by
affiliates
e
..........................
1.12%
f
1.11%
1.09%
1.10%
1.07%
1.09%
Net
investment
income
...............
4.88%
3.76%
4.14%
3.68%
3.83%
4.19%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$62,764
$62,063
$85,458
$105,692
$146,552
$181,671
Portfolio
turnover
rate
................
69.48%
118.64%
116.21%
g
115.94%
140.83%
88.04%
Portfolio
turnover
rate
excluding
mortgage
dollar
rolls
h
........................
34.18%
86.69%
39.01%
g
47.04%
87.33%
48.33%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
is
not
annualized
for
periods
less
than
one
year.
d
Ratios
are
annualized
for
periods
less
than
one
year.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
g
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
h
See
Note
1(j)
regarding
mortgage
dollar
rolls.
Franklin
Strategic
Series
Consolidated
Financial
Highlights
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
12
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Class
R6
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$8.68
$9.63
$9.62
$9.86
$9.33
$10.05
Income
from
investment
operations
a
:
Net
investment
income
b
.............
0.25
0.43
0.45
0.43
0.43
0.46
Net
realized
and
unrealized
gains
(losses)
0.49
(0.93)
0.02
(0.34)
0.31
(0.74)
Total
from
investment
operations
........
0.74
(0.50)
0.47
0.09
0.74
(0.28)
Less
distributions
from:
Net
investment
income
and
net
foreign
currency
gains
....................
(0.19)
(0.45)
(0.46)
(0.33)
(0.21)
(0.44)
Net
asset
value,
end
of
period
..........
$9.23
$8.68
$9.63
$9.62
$9.86
$9.33
Total
return
c
.......................
8.58%
(5.46)%
5.03%
0.95%
8.03%
(2.76)%
Ratios
to
average
net
assets
d
Expenses
before
waiver
and
payments
by
affiliates
..........................
0.54%
0.52%
0.51%
0.50%
0.48%
0.49%
Expenses
net
of
waiver
and
payments
by
affiliates
e
..........................
0.52%
0.49%
0.45%
0.45%
0.42%
0.45%
Net
investment
income
...............
5.48%
4.38%
4.78%
4.33%
4.48%
4.83%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$126,054
$133,575
$307,287
$433,068
$369,106
$286,503
Portfolio
turnover
rate
................
69.48%
118.64%
116.21%
f
115.94%
140.83%
88.04%
Portfolio
turnover
rate
excluding
mortgage
dollar
rolls
g
........................
34.18%
86.69%
39.01%
f
47.40%
87.33%
48.33%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
is
not
annualized
for
periods
less
than
one
year.
d
Ratios
are
annualized
for
periods
less
than
one
year.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
g
See
Note
1(j)
regarding
mortgage
dollar
rolls.
Franklin
Strategic
Series
Consolidated
Financial
Highlights
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
13
a
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
2019
2018
2017
2016
Advisor
Class
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
period)
Net
asset
value,
beginning
of
period
.....
$8.68
$9.62
$9.62
$9.85
$9.33
$10.05
Income
from
investment
operations
a
:
Net
investment
income
b
.............
0.25
0.40
0.44
0.41
0.42
0.44
Net
realized
and
unrealized
gains
(losses)
0.49
(0.90)
c
(0.32)
0.30
(0.74)
Total
from
investment
operations
........
0.74
(0.50)
0.44
0.09
0.72
(0.30)
Less
distributions
from:
Net
investment
income
and
net
foreign
currency
gains
....................
(0.19)
(0.44)
(0.44)
(0.32)
(0.20)
(0.42)
Net
asset
value,
end
of
period
..........
$9.23
$8.68
$9.62
$9.62
$9.85
$9.33
Total
return
d
.......................
8.51%
(5.47)%
4.88%
0.79%
7.76%
(2.89)%
Ratios
to
average
net
assets
e
Expenses
before
waiver
and
payments
by
affiliates
..........................
0.62%
0.63%
0.64%
0.65%
0.63%
0.63%
Expenses
net
of
waiver
and
payments
by
affiliates
f
..........................
0.61%
0.61%
0.59%
0.60%
0.57%
0.59%
Net
investment
income
...............
5.37%
4.26%
4.64%
4.18%
4.33%
4.69%
Supplemental
data
Net
assets,
end
of
period
(000’s)
........
$508,743
$517,522
$608,317
$933,747
$1,070,103
$904,899
Portfolio
turnover
rate
................
69.48%
118.64%
116.21%
g
115.94%
140.83%
88.04%
Portfolio
turnover
rate
excluding
mortgage
dollar
rolls
h
........................
34.18%
86.69%
39.01%
g
47.40%
87.33%
48.33%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Amount
rounds
to
less
than
$0.01
per
share.
d
Total
return
is
not
annualized
for
periods
less
than
one
year.
e
Ratios
are
annualized
for
periods
less
than
one
year.
f
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
g
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
h
See
Note
1(j)
regarding
mortgage
dollar
rolls.
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited),
October
31,
2020
Franklin
Strategic
Income
Fund
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
14
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
0.2%
Aerospace
&
Defense
0.0%
a,b,c
Remington
Outdoor
Co.,
Inc.
.............................
United
States
1,322,439
$
b
Energy
Equipment
&
Services
0.0%
b
Weatherford
International
plc
.............................
United
States
151,545
316,729
b
Entertainment
0.0%
d
AMC
Entertainment
Holdings,
Inc.
.........................
United
States
14,125
33,335
Hotels,
Restaurants
&
Leisure
0.0%
a,b,e
Turtle
Bay
Resort
LLC
..................................
United
States
5,579,939
122,759
b
Machinery
0.1%
a,b
Birch
Permian
Holdings,
Inc.
.............................
United
States
46,176
230,880
a,b
Birch
Permian
Holdings,
Inc.
.............................
United
States
359,948
1,754,746
1,985,626
Media
0.0%
b
Clear
Channel
Outdoor
Holdings,
Inc.
......................
United
States
285,564
255,294
b
iHeartMedia
,
Inc.,
A
....................................
United
States
115,084
945,991
a,b
iHeartMedia
,
Inc.,
B
...................................
United
States
1,941
14,838
1,216,123
Multiline
Retail
0.0%
a,b,f
K2016470219
South
Africa
Ltd.,
A
.........................
South
Africa
125,940,079
a,b,f
K2016470219
South
Africa
Ltd.,
B
.........................
South
Africa
12,532,821
Oil,
Gas
&
Consumable
Fuels
0.0%
Amplify
Energy
Corp.
..................................
United
States
5,288
3,439
Riviera
Resources,
Inc.
.................................
United
States
84,462
25,718
29,157
Paper
&
Forest
Products
0.1%
a,b,f
Appvion
Operations,
Inc.
................................
United
States
331,326
4,917,645
Verso
Corp.,
A
........................................
United
States
38,905
302,681
5,220,326
Road
&
Rail
0.0%
a
Onsite
Rental
Group
Operations
Pty.
Ltd.
...................
Australia
2,551,511
Specialty
Retail
0.0%
Party
City
Holdings,
Inc.
................................
United
States
117,385
233,596
Total
Common
Stocks
(Cost
$40,124,717)
......................................
9,157,651
Management
Investment
Companies
2.8%
Capital
Markets
2.8%
g
Franklin
Floating
Rate
Income
Fund
.......................
United
States
15,243,687
110,821,608
Total
Management
Investment
Companies
(Cost
$152,217,419)
...................
110,821,608
Warrants
Warrants
0.0%
Diversified
Financial
Services
0.0%
a,b
Chaparral
Energy,
Inc.,
10/01/24
..........................
United
States
18
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
15
a
a
Country
Warrants
a
Value
a
a
a
a
a
a
Warrants
(continued)
Media
0.0%
b
iHeartMedia
,
Inc.,
5/01/39
...............................
United
States
1
$
9
Oil,
Gas
&
Consumable
Fuels
0.0%
a,b
Battalion
Oil
Corp.,
A,
10/08/22
...........................
United
States
10,639
84
a,b
Battalion
Oil
Corp.,
B,
10/08/22
...........................
United
States
13,300
43
a,b
Battalion
Oil
Corp.,
C,
10/08/22
...........................
United
States
17,100
17
144
Paper
&
Forest
Products
0.0%
b
Verso
Corp.,
7/25/23
...................................
United
States
4,095
2,109
Software
&
Services
0.0%
a,b
WorkCapital
BSD
SARL,
2/13/26
..........................
Brazil
6,000,000
750,000
Total
Warrants
(Cost
$750,023)
................................................
752,262
Principal
Amount
*
Convertible
Bonds
0.0%
Wireless
Telecommunication
Services
0.0%
h,i,j
Digicel
Group
0.5
Ltd.
,
Sub.
Bond
,
144A,
PIK,
7
%
,
Perpetual
.....
Bermuda
599,324
80,293
Total
Convertible
Bonds
(Cost
$106,476)
.......................................
80,293
Corporate
Bonds
46.4%
Aerospace
&
Defense
0.1%
j
TransDigm
,
Inc.
,
Senior
Secured
Note
,
144A,
6.25
%
,
3/15/26
....
United
States
5,000,000
5,218,775
Air
Freight
&
Logistics
0.2%
FedEx
Corp.
,
Senior
Bond
,
4.05
%
,
2/15/48
..................
United
States
1,200,000
1,381,602
United
Parcel
Service,
Inc.
,
Senior
Bond
,
5.3
%
,
4/01/50
........
United
States
5,400,000
7,774,330
9,155,932
Airlines
0.3%
j
Delta
Air
Lines,
Inc.
/
SkyMiles
IP
Ltd.
,
Senior
Secured
Note
,
144A,
4.5
%
,
10/20/25
.....................................
United
States
10,400,000
10,563,571
Auto
Components
0.7%
j
Allison
Transmission,
Inc.
,
Senior
Bond
,
144A,
5.875
%
,
6/01/29
..
United
States
7,000,000
7,652,715
Dana,
Inc.
,
Senior
Note
,
5.625
%
,
6/15/28
...................
United
States
12,400,000
13,036,554
Goodyear
Tire
&
Rubber
Co.
(The)
,
Senior
Note
,
4.875
%
,
3/15/27
.
United
States
9,000,000
8,750,295
29,439,564
Banks
2.1%
j
Akbank
T.A.S.
,
Senior
Note
,
144A,
5.125
%
,
3/31/25
...........
Turkey
12,400,000
11,490,956
Bank
of
America
Corp.
,
Senior
Bond,
3.248%,
10/21/27
.........................
United
States
5,000,000
5,518,063
Senior
Note,
3.5%,
4/19/26
............................
United
States
5,800,000
6,504,162
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
16
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Corporate
Bonds
(continued)
Banks
(continued)
j
BDO
Unibank
,
Inc.
,
Senior
Note
,
Reg
S,
2.95
%
,
3/06/23
........
Philippines
1,550,000
$
1,611,709
j
BNP
Paribas
SA
,
Senior
Note
,
144A,
2.219%
to
6/09/25,
FRN
thereafter
,
6/09/26
...................................
France
4,400,000
4,554,634
j
China
Construction
Bank
Corp.
,
Sub.
Note
,
Reg
S,
4.25%
to
2/27/24,
FRN
thereafter
,
2/27/29
...............................
China
8,000,000
8,547,910
i
Comerica,
Inc.
,
Junior
Sub.
Bond
,
5.625%
to
10/01/25,
FRN
thereafter
,
Perpetual
.................................
United
States
3,000,000
3,210,000
HSBC
Holdings
plc
,
Senior
Bond,
2.848%
to
6/04/30,
FRN
thereafter,
6/04/31
.....
United
Kingdom
8,300,000
8,590,395
Senior
Bond,
2.357%
to
8/18/30,
FRN
thereafter,
8/18/31
.....
United
Kingdom
2,900,000
2,882,316
Industrial
&
Commercial
Bank
of
China
Ltd.
,
Senior
Note
,
3.538
%
,
11/08/27
..........................................
China
8,500,000
9,366,830
JPMorgan
Chase
&
Co.
,
Senior
Bond
,
2.522%
to
4/22/30,
FRN
thereafter
,
4/22/31
...................................
United
States
9,400,000
9,918,390
Lloyds
Banking
Group
plc
,
Senior
Note
,
3.87%
to
7/09/24,
FRN
thereafter
,
7/09/25
...................................
United
Kingdom
1,600,000
1,746,588
SVB
Financial
Group
,
Senior
Note
,
3.125
%
,
6/05/30
...........
United
States
2,700,000
2,952,736
Wells
Fargo
&
Co.
,
Senior
Note
,
2.188%
to
4/30/25,
FRN
thereafter
,
4/30/26
...........................................
United
States
7,700,000
8,013,665
84,908,354
Beverages
0.5%
Anheuser-Busch
InBev
Worldwide,
Inc.
,
Senior
Bond
,
3.5
%
,
6/01/30
Belgium
16,400,000
18,533,383
Biotechnology
0.6%
j
AbbVie,
Inc.
,
Senior
Note,
144A,
3.8%,
3/15/25
.......................
United
States
8,000,000
8,892,407
Senior
Note,
144A,
2.95%,
11/21/26
.....................
United
States
5,900,000
6,447,642
Senior
Note,
144A,
3.2%,
11/21/29
......................
United
States
6,000,000
6,627,692
21,967,741
Building
Products
0.7%
j
Carrier
Global
Corp.
,
Senior
Note
,
144A,
2.722
%
,
2/15/30
.......
United
States
16,000,000
16,751,185
j
Cornerstone
Building
Brands,
Inc.
,
Senior
Note
,
144A,
8
%
,
4/15/26
United
States
9,000,000
9,371,250
26,122,435
Capital
Markets
1.0%
Goldman
Sachs
Group,
Inc.
(The)
,
Senior
Note
,
3.75
%
,
2/25/26
..
United
States
15,000,000
16,875,070
Morgan
Stanley
,
Senior
Bond,
3.591%
to
7/22/27,
FRN
thereafter,
7/22/28
.....
United
States
10,000,000
11,253,137
Senior
Note,
3.875%,
1/27/26
..........................
United
States
10,000,000
11,359,172
39,487,379
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
17
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Corporate
Bonds
(continued)
Chemicals
2.8%
j
Alpek
SAB
de
CV
,
Senior
Note
,
144A,
4.25
%
,
9/18/29
..........
Mexico
8,000,000
$
8,219,920
h,j
Anagram
International,
Inc.
/
Anagram
Holdings
LLC
,
Secured
Note
,
144A,
PIK,
10
%
,
8/15/26
..............................
United
States
623,545
513,385
j
Braskem
Netherlands
Finance
BV
,
Senior
Bond
,
144A,
4.5
%
,
1/31/30
...........................................
Brazil
12,400,000
11,467,520
j
CNAC
HK
Finbridge
Co.
Ltd.
,
Senior
Note
,
Reg
S,
4.875
%
,
3/14/25
China
7,800,000
8,608,865
EI
du
Pont
de
Nemours
and
Co.
,
Senior
Bond
,
2.3
%
,
7/15/30
....
United
States
14,500,000
15,167,004
j
Element
Solutions,
Inc.
,
Senior
Note
,
144A,
3.875
%
,
9/01/28
.....
United
States
7,000,000
6,925,625
j
Gates
Global
LLC
/
Gates
Corp.
,
Senior
Note
,
144A,
6.25
%
,
1/15/26
United
States
12,500,000
12,864,625
j
Ingevity
Corp.
,
Senior
Note
,
144A,
3.875
%
,
11/01/28
...........
United
States
3,900,000
3,966,593
j
Neon
Holdings,
Inc.
,
Senior
Secured
Note
,
144A,
10.125
%
,
4/01/26
United
States
5,000,000
5,312,500
Olin
Corp.
,
Senior
Bond
,
5.125
%
,
9/15/27
...................
United
States
9,000,000
9,146,250
j
SABIC
Capital
II
BV
,
Senior
Note
,
144A,
4.5
%
,
10/10/28
........
Saudi
Arabia
5,500,000
6,494,659
j
Syngenta
Finance
NV
,
Senior
Note
,
144A,
4.892
%
,
4/24/25
......
Switzerland
8,000,000
8,677,670
j
TPC
Group,
Inc.
,
Senior
Secured
Note
,
144A,
10.5
%
,
8/01/24
....
United
States
11,000,000
9,206,780
Westlake
Chemical
Corp.
,
Senior
Note
,
3.375
%
,
6/15/30
........
United
States
2,500,000
2,681,936
j
Yara
International
ASA
,
Senior
Note
,
144A,
3.148
%
,
6/04/30
.....
Brazil
1,400,000
1,493,303
110,746,635
Commercial
Services
&
Supplies
0.4%
j
Prime
Security
Services
Borrower
LLC
/
Prime
Finance,
Inc.
,
Senior
Secured
Note
,
144A,
3.375
%
,
8/31/27
....................
United
States
13,000,000
12,561,250
RELX
Capital,
Inc.
,
Senior
Note
,
3
%
,
5/22/30
................
United
Kingdom
1,500,000
1,621,657
14,182,907
Communications
Equipment
0.3%
j
CommScope
Technologies
LLC
,
Senior
Note
,
144A,
6
%
,
6/15/25
..
United
States
12,652,000
12,560,020
Construction
&
Engineering
0.0%
j
Rutas
2
and
7
Finance
Ltd.
,
Senior
Secured
Bond
,
144A,
Zero
Cpn
.,
9/30/36
...........................................
United
States
1,200,000
846,000
Construction
Materials
0.3%
j
Cemex
SAB
de
CV
,
Senior
Secured
Bond
,
144A,
5.7
%
,
1/11/25
...
Mexico
13,000,000
13,364,000
Consumer
Finance
0.6%
j
FirstCash
,
Inc.
,
Senior
Note
,
144A,
4.625
%
,
9/01/28
...........
United
States
12,700,000
12,914,313
OneMain
Finance
Corp.
,
Senior
Bond,
5.375%,
11/15/29
.........................
United
States
3,300,000
3,399,000
Senior
Note,
6.625%,
1/15/28
..........................
United
States
5,700,000
6,243,210
22,556,523
Containers
&
Packaging
1.7%
j
Ardagh
Packaging
Finance
plc
/
Ardagh
Holdings
USA,
Inc.
,
Senior
Note,
144A,
6%,
2/15/25
........................
United
States
3,167,000
3,277,053
Senior
Note,
144A,
5.25%,
8/15/27
......................
United
States
3,700,000
3,813,627
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
18
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Corporate
Bonds
(continued)
Containers
&
Packaging
(continued)
Bemis
Co.,
Inc.
,
Senior
Note
,
2.63
%
,
6/19/30
................
United
States
2,100,000
$
2,202,478
Crown
Americas
LLC
/
Crown
Americas
Capital
Corp.
VI
,
Senior
Note
,
4.75
%
,
2/01/26
.................................
United
States
7,100,000
7,391,526
j
Mauser
Packaging
Solutions
Holding
Co.
,
Senior
Note
,
144A,
7.25
%
,
4/15/25
...........................................
United
States
15,000,000
14,489,250
j
Owens-Brockway
Glass
Container,
Inc.
,
Senior
Note
,
144A,
5.875
%
,
8/15/23
...........................................
United
States
10,000,000
10,540,000
j
Reynolds
Group
Issuer,
Inc.
/
Reynolds
Group
Issuer
LLC
/
Reynolds
Group
Issuer
Luxembourg
SA
,
Senior
Secured
Note,
144A,
5.125%,
7/15/23
..............
United
States
484,000
490,292
Senior
Secured
Note,
144A,
4%,
10/15/27
.................
United
States
4,600,000
4,674,750
j
Sealed
Air
Corp.
,
Senior
Note,
144A,
4.875%,
12/01/22
....................
United
States
4,000,000
4,217,500
Senior
Note,
144A,
5.125%,
12/01/24
....................
United
States
11,300,000
12,366,438
WRKCo
,
Inc.
,
Senior
Bond
,
3
%
,
6/15/33
....................
United
States
3,600,000
3,836,396
67,299,310
Distributors
0.1%
j
Resideo
Funding,
Inc.
,
Senior
Note
,
144A,
6.125
%
,
11/01/26
.....
United
States
5,000,000
4,837,500
Diversified
Financial
Services
0.4%
k
Cia
Securitizadora
de
Creditos
Financeiros
Vert-Fintech
,
12
,
Senior
Secured
Note
,
FRN
,
5.96
%
,
(
BZDIOVRA
+
5.75
%
),
2/14/24
....
Brazil
11,513,000
BRL
2,262,669
j
MPH
Acquisition
Holdings
LLC
,
Senior
Note
,
144A,
5.75
%
,
11/01/28
United
States
13,000,000
12,756,250
15,018,919
Diversified
Telecommunication
Services
1.4%
j
Altice
France
Holding
SA
,
Senior
Note
,
144A,
6
%
,
2/15/28
......
Luxembourg
9,100,000
8,745,100
j
Altice
France
SA
,
Senior
Secured
Note
,
144A,
5.5
%
,
1/15/28
....
France
2,500,000
2,535,937
AT&T,
Inc.
,
Senior
Note,
2.95%,
7/15/26
...........................
United
States
6,000,000
6,542,009
Senior
Note,
2.3%,
6/01/27
............................
United
States
2,900,000
3,013,480
Bell
Canada,
Inc.
,
Senior
Bond
,
4.464
%
,
4/01/48
..............
Canada
1,400,000
1,747,163
j
CCO
Holdings
LLC
/
CCO
Holdings
Capital
Corp.
,
Senior
Bond,
144A,
5.375%,
5/01/25
.....................
United
States
13,000,000
13,367,250
Senior
Bond,
144A,
4.5%,
8/15/30
.......................
United
States
2,000,000
2,080,010
Senior
Bond,
144A,
4.5%,
5/01/32
.......................
United
States
10,000,000
10,337,500
TELUS
Corp.
,
Senior
Bond
,
4.6
%
,
11/16/48
..................
Canada
1,000,000
1,240,750
j
Virgin
Media
Secured
Finance
plc
,
Senior
Secured
Bond
,
144A,
4.5
%
,
8/15/30
......................................
United
Kingdom
5,600,000
5,696,600
55,305,799
Electric
Utilities
2.3%
j
CGNPC
International
Ltd.
,
Senior
Note
,
Reg
S,
3.75
%
,
12/11/27
..
China
3,289,000
3,623,590
Duke
Energy
Corp.
,
Senior
Bond,
2.45%,
6/01/30
...........................
United
States
3,800,000
3,978,388
Senior
Bond,
3.75%,
9/01/46
...........................
United
States
1,600,000
1,801,763
Exelon
Corp.
,
Senior
Bond,
4.05%,
4/15/30
...........................
United
States
13,400,000
15,516,997
Senior
Bond,
4.45%,
4/15/46
...........................
United
States
1,400,000
1,696,612
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
19
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Corporate
Bonds
(continued)
Electric
Utilities
(continued)
Southern
Co.
(The)
,
Senior
Bond
,
3.25
%
,
7/01/26
.............
United
States
24,200,000
$
26,951,810
j
State
Grid
Overseas
Investment
2016
Ltd.
,
Senior
Note
,
144A,
3.5
%
,
5/04/27
...........................................
China
15,800,000
17,569,207
j
Three
Gorges
Finance
I
Cayman
Islands
Ltd.
,
Senior
Note
,
144A,
3.15
%
,
6/02/26
.....................................
China
12,800,000
13,868,800
j
TNB
Global
Ventures
Capital
Bhd.
,
Senior
Note
,
Reg
S,
3.244
%
,
10/19/26
..........................................
Malaysia
3,775,000
4,064,411
Virginia
Electric
and
Power
Co.
,
Senior
Bond
,
6.35
%
,
11/30/37
...
United
States
820,000
1,209,998
90,281,576
Electronic
Equipment,
Instruments
&
Components
0.8%
CDW
LLC
/
CDW
Finance
Corp.
,
Senior
Note
,
3.25
%
,
2/15/29
....
United
States
10,000,000
10,000,000
Flex
Ltd.
,
Senior
Note,
3.75%,
2/01/26
...........................
United
States
12,300,000
13,471,064
Senior
Note,
4.875%,
5/12/30
..........................
United
States
7,100,000
8,218,624
FLIR
Systems,
Inc.
,
Senior
Note
,
2.5
%
,
8/01/30
...............
United
States
2,100,000
2,166,497
33,856,185
Energy
Equipment
&
Services
0.2%
Baker
Hughes
a
GE
Co.
LLC
/
Baker
Hughes
Co-Obligor,
Inc.
,
Senior
Note
,
4.486
%
,
5/01/30
...........................
United
States
700,000
794,589
j
Nabors
Industries
Ltd.
,
Senior
Note
,
144A,
7.25
%
,
1/15/26
......
United
States
6,000,000
2,351,250
j
Schlumberger
Holdings
Corp.
,
Senior
Note
,
144A,
3.9
%
,
5/17/28
..
United
States
3,800,000
4,062,222
j
Weatherford
International
Ltd.
,
Senior
Note
,
144A,
11
%
,
12/01/24
.
United
States
4,591,000
2,727,697
9,935,758
Entertainment
0.9%
j
AMC
Entertainment
Holdings,
Inc.
,
h
Secured
Note,
144A,
PIK,
12%,
6/15/26
..................
United
States
4,791,000
162,894
Senior
Secured
Note,
144A,
10.5%,
4/24/26
...............
United
States
565,000
290,975
j
Live
Nation
Entertainment,
Inc.
,
Senior
Note
,
144A,
4.75
%
,
10/15/27
United
States
4,400,000
4,054,886
Netflix,
Inc.
,
Senior
Bond
,
4.375
%
,
11/15/26
.................
United
States
11,800,000
12,830,803
Walt
Disney
Co.
(The)
,
Senior
Note
,
2.2
%
,
1/13/28
............
United
States
4,800,000
5,020,326
j
WMG
Acquisition
Corp.
,
Senior
Secured
Bond
,
144A,
3
%
,
2/15/31
.
United
States
12,100,000
11,525,250
33,885,134
Equity
Real
Estate
Investment
Trusts
(REITs)
1.0%
AvalonBay
Communities,
Inc.
,
Senior
Bond
,
2.45
%
,
1/15/31
.....
United
States
4,500,000
4,755,736
MPT
Operating
Partnership
LP
/
MPT
Finance
Corp.
,
Senior
Bond,
5.25%,
8/01/26
...........................
United
States
4,200,000
4,368,000
Senior
Bond,
5%,
10/15/27
............................
United
States
5,700,000
5,974,882
j
Park
Intermediate
Holdings
LLC
/
PK
Domestic
Property
LLC
/
PK
Finance
Co-Issuer
,
Senior
Secured
Note
,
144A,
5.875
%
,
10/01/28
United
States
8,600,000
8,444,125
j
SBA
Communications
Corp.
,
Senior
Note
,
144A,
3.875
%
,
2/15/27
.
United
States
9,000,000
9,157,500
j
VICI
Properties
LP
/
VICI
Note
Co.,
Inc.
,
Senior
Bond,
144A,
4.125%,
8/15/30
.....................
United
States
1,300,000
1,317,875
Senior
Note,
144A,
3.75%,
2/15/27
......................
United
States
7,500,000
7,531,650
41,549,768
Food
&
Staples
Retailing
0.2%
j
Cencosud
SA
,
Senior
Note
,
144A,
4.375
%
,
7/17/27
............
Chile
8,700,000
9,442,951
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
20
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Corporate
Bonds
(continued)
Food
Products
1.1%
B&G
Foods,
Inc.
,
Senior
Note
,
5.25
%
,
9/15/27
...............
United
States
9,000,000
$
9,323,460
j
China
Mengniu
Dairy
Co.
Ltd.
,
Senior
Note
,
Reg
S,
4.25
%
,
8/07/23
China
392,000
420,748
j
Chobani
LLC
/
Chobani
Finance
Corp.,
Inc.
,
Senior
Secured
Note
,
144A,
4.625
%
,
11/15/28
...............................
United
States
5,000,000
5,029,000
j
Kraft
Heinz
Foods
Co.
,
Senior
Bond,
144A,
4.25%,
3/01/31
......................
United
States
2,000,000
2,171,161
Senior
Note,
144A,
3.875%,
5/15/27
.....................
United
States
11,500,000
12,171,231
j
MHP
Lux
SA
,
Senior
Note
,
144A,
6.95
%
,
4/03/26
.............
Ukraine
8,000,000
8,060,800
j
Post
Holdings,
Inc.
,
Senior
Bond
,
144A,
4.625
%
,
4/15/30
.......
United
States
6,700,000
6,884,250
44,060,650
Gas
Utilities
0.1%
Piedmont
Natural
Gas
Co.,
Inc.
,
Senior
Bond
,
3.35
%
,
6/01/50
....
United
States
2,800,000
2,988,646
Health
Care
Providers
&
Services
1.2%
Anthem,
Inc.
,
Senior
Bond,
2.25%,
5/15/30
...........................
United
States
3,650,000
3,763,876
Senior
Bond,
3.7%,
9/15/49
............................
United
States
1,400,000
1,584,397
Centene
Corp.
,
j
Senior
Note,
144A,
5.375%,
6/01/26
.....................
United
States
7,600,000
8,006,296
Senior
Note,
4.25%,
12/15/27
..........................
United
States
3,000,000
3,164,445
Senior
Note,
4.625%,
12/15/29
.........................
United
States
2,300,000
2,507,069
Senior
Note,
3.375%,
2/15/30
..........................
United
States
1,400,000
1,456,329
CHS/Community
Health
Systems,
Inc.
,
Senior
Secured
Note
,
6.25
%
,
3/31/23
...........................................
United
States
8,000,000
7,940,000
Cigna
Corp.
,
Senior
Bond
,
4.9
%
,
12/15/48
...................
United
States
1,200,000
1,546,310
CVS
Health
Corp.
,
Senior
Bond
,
4.3
%
,
3/25/28
...............
United
States
5,800,000
6,725,740
HCA,
Inc.
,
Senior
Bond
,
5.875
%
,
2/15/26
...................
United
States
3,000,000
3,393,750
Orlando
Health
Obligated
Group
,
3.777
%
,
10/01/28
............
United
States
3,870,000
4,309,210
Quest
Diagnostics,
Inc.
,
Senior
Bond
,
2.8
%
,
6/30/31
...........
United
States
2,100,000
2,248,090
46,645,512
Hotels,
Restaurants
&
Leisure
1.7%
j
1011778
BC
ULC
/
New
Red
Finance,
Inc.
,
Secured
Bond,
144A,
4%,
10/15/30
......................
Canada
9,000,000
8,955,000
Secured
Note,
144A,
5%,
10/15/25
......................
Canada
3,880,000
3,978,358
j
Caesars
Entertainment,
Inc.
,
Senior
Secured
Note
,
144A,
6.25
%
,
7/01/25
...........................................
United
States
3,700,000
3,803,600
j
Caesars
Resort
Collection
LLC
/
CRC
Finco
,
Inc.
,
Senior
Secured
Note
,
144A,
5.75
%
,
7/01/25
............................
United
States
1,500,000
1,540,320
j
Golden
Nugget,
Inc.
,
Senior
Note
,
144A,
6.75
%
,
10/15/24
.......
United
States
13,200,000
11,193,864
j
International
Game
Technology
plc
,
Senior
Secured
Note
,
144A,
5.25
%
,
1/15/29
.....................................
United
States
13,000,000
12,890,865
j
KFC
Holding
Co./Pizza
Hut
Holdings
LLC/Taco
Bell
of
America
LLC
,
Senior
Note
,
144A,
5.25
%
,
6/01/26
.......................
United
States
5,100,000
5,279,520
MGM
Resorts
International
,
Senior
Note
,
4.75
%
,
10/15/28
.......
United
States
10,000,000
9,793,750
j
Wynn
Las
Vegas
LLC
/
Wynn
Las
Vegas
Capital
Corp.
,
Senior
Bond
,
144A,
5.5
%
,
3/01/25
.................................
United
States
9,800,000
9,401,875
66,837,152
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
21
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Corporate
Bonds
(continued)
Household
Durables
0.8%
KB
Home
,
Senior
Bond,
7.5%,
9/15/22
............................
United
States
5,000,000
$
5,469,925
Senior
Note,
7%,
12/15/21
............................
United
States
5,000,000
5,209,375
Mohawk
Industries,
Inc.
,
Senior
Note
,
3.625
%
,
5/15/30
.........
United
States
14,300,000
15,538,126
j
Williams
Scotsman
International,
Inc.
,
Senior
Secured
Note
,
144A,
4.625
%
,
8/15/28
.....................................
United
States
7,500,000
7,637,063
33,854,489
Household
Products
0.3%
j
Energizer
Holdings,
Inc.
,
Senior
Note
,
144A,
4.375
%
,
3/31/29
....
United
States
8,500,000
8,593,500
j
Kimberly-Clark
de
Mexico
SAB
de
CV
,
Senior
Bond
,
144A,
2.431
%
,
7/01/31
...........................................
Mexico
2,200,000
2,231,625
j
Spectrum
Brands,
Inc.
,
Senior
Bond
,
144A,
5.5
%
,
7/15/30
.......
United
States
2,300,000
2,465,312
13,290,437
Independent
Power
and
Renewable
Electricity
Producers
1.6%
j
Calpine
Corp.
,
Senior
Bond,
144A,
5%,
2/01/31
........................
United
States
4,300,000
4,396,535
Senior
Note,
144A,
5.125%,
3/15/28
.....................
United
States
4,000,000
4,130,080
Senior
Note,
144A,
4.625%,
2/01/29
.....................
United
States
6,500,000
6,572,865
Clearway
Energy
Operating
LLC
,
Senior
Note
,
5.75
%
,
10/15/25
..
United
States
12,800,000
13,432,000
j
Colbun
SA
,
Senior
Note,
144A,
3.95%,
10/11/27
.....................
Chile
7,500,000
8,328,825
Senior
Note,
144A,
3.15%,
3/06/30
......................
Chile
2,900,000
3,036,010
j
InterGen
NV
,
Senior
Secured
Bond
,
144A,
7
%
,
6/30/23
.........
Netherlands
10,900,000
10,341,375
j
Talen
Energy
Supply
LLC
,
Senior
Note,
144A,
10.5%,
1/15/26
......................
United
States
3,000,000
2,085,000
Senior
Secured
Note,
144A,
7.25%,
5/15/27
...............
United
States
10,800,000
10,840,500
63,163,190
Insurance
1.0%
Aflac,
Inc.
,
Senior
Note
,
3.6
%
,
4/01/30
.....................
United
States
12,000,000
13,917,073
j
Alliant
Holdings
Intermediate
LLC
/
Alliant
Holdings
Co-Issuer
,
Senior
Note
,
144A,
6.75
%
,
10/15/27
...........................
United
States
2,000,000
2,103,380
Arch
Capital
Group
Ltd.
,
Senior
Bond
,
3.635
%
,
6/30/50
.........
United
States
10,000,000
10,791,539
j
Five
Corners
Funding
Trust
II
,
Senior
Note
,
144A,
2.85
%
,
5/15/30
.
United
States
9,100,000
9,795,084
Willis
North
America,
Inc.
,
Senior
Note
,
2.95
%
,
9/15/29
.........
United
States
3,500,000
3,813,935
40,421,011
Interactive
Media
&
Services
0.4%
j
Tencent
Holdings
Ltd.
,
Senior
Note
,
144A,
2.39
%
,
6/03/30
.......
China
17,100,000
17,310,722
Internet
&
Direct
Marketing
Retail
0.3%
JD.com,
Inc.
,
Senior
Note
,
3.375
%
,
1/14/30
..................
China
12,200,000
13,160,456
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
22
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Corporate
Bonds
(continued)
IT
Services
0.9%
j
Cablevision
Lightpath
LLC
,
Senior
Secured
Note
,
144A,
3.875
%
,
9/15/27
...........................................
United
States
9,200,000
$
9,142,500
Fiserv,
Inc.
,
Senior
Bond
,
2.65
%
,
6/01/30
...................
United
States
6,300,000
6,694,204
j
Gartner,
Inc.
,
Senior
Note
,
144A,
4.5
%
,
7/01/28
...............
United
States
7,000,000
7,316,470
j
Presidio
Holdings,
Inc.
,
Senior
Secured
Note
,
144A,
4.875
%
,
2/01/27
United
States
12,000,000
12,339,360
35,492,534
Machinery
0.6%
j
Manitowoc
Co.,
Inc.
(The)
,
Secured
Note
,
144A,
9
%
,
4/01/26
....
United
States
7,000,000
7,198,345
j
Navistar
International
Corp.
,
Senior
Note
,
144A,
6.625
%
,
11/01/25
United
States
3,300,000
3,416,160
j
Vertical
US
Newco,
Inc.
,
Senior
Secured
Note
,
144A,
5.25
%
,
7/15/27
Germany
9,000,000
9,279,675
Westinghouse
Air
Brake
Technologies
Corp.
,
Senior
Note
,
3.2
%
,
6/15/25
...........................................
United
States
1,900,000
2,026,032
21,920,212
Marine
0.3%
j
ICTSI
Treasury
BV
,
Senior
Note
,
Reg
S,
4.625
%
,
1/16/23
.......
Philippines
12,000,000
12,612,180
Media
2.9%
j
Altice
Financing
SA
,
Senior
Secured
Bond
,
144A,
7.5
%
,
5/15/26
..
Luxembourg
4,000,000
4,180,000
Charter
Communications
Operating
LLC
/
Charter
Communications
Operating
Capital
,
Senior
Secured
Bond
,
2.8
%
,
4/01/31
.......
United
States
16,300,000
16,834,640
j
Clear
Channel
International
BV
,
Senior
Secured
Note
,
144A,
6.625
%
,
8/01/25
.....................................
United
States
1,300,000
1,324,375
Clear
Channel
Worldwide
Holdings,
Inc.
,
Senior
Note,
9.25%,
2/15/24
...........................
United
States
10,362,000
8,993,957
j
Senior
Secured
Note,
144A,
5.125%,
8/15/27
..............
United
States
3,200,000
3,108,000
Comcast
Corp.
,
Senior
Bond
,
4.75
%
,
3/01/44
................
United
States
1,400,000
1,843,489
j
CSC
Holdings
LLC
,
Senior
Note
,
144A,
5.5
%
,
5/15/26
..........
United
States
16,000,000
16,640,000
j
Diamond
Sports
Group
LLC
/
Diamond
Sports
Finance
Co.
,
Senior
Note,
144A,
6.625%,
8/15/27
.....................
United
States
4,500,000
1,873,125
Senior
Secured
Note,
144A,
5.375%,
8/15/26
..............
United
States
4,300,000
2,512,812
DISH
DBS
Corp.
,
Senior
Note,
5%,
3/15/23
.............................
United
States
3,500,000
3,517,500
Senior
Note,
5.875%,
11/15/24
.........................
United
States
6,100,000
6,145,750
Senior
Note,
7.375%,
7/01/28
..........................
United
States
3,600,000
3,631,500
Fox
Corp.
,
Senior
Note
,
3.5
%
,
4/08/30
.....................
United
States
4,000,000
4,480,825
j
Gray
Television,
Inc.
,
Senior
Note
,
144A,
4.75
%
,
10/15/30
.......
United
States
10,300,000
10,171,250
iHeartCommunications
,
Inc.
,
Senior
Note
,
8.375
%
,
5/01/27
......
United
States
1,199,371
1,171,863
j
Nexstar
Broadcasting,
Inc.
,
Senior
Note
,
144A,
4.75
%
,
11/01/28
..
United
States
8,000,000
8,075,000
j
Sinclair
Television
Group,
Inc.
,
Senior
Bond
,
144A,
5.5
%
,
3/01/30
.
United
States
3,900,000
3,672,981
j
Univision
Communications,
Inc.
,
Senior
Secured
Note
,
144A,
5.125
%
,
2/15/25
.....................................
United
States
16,000,000
15,750,000
113,927,067
Metals
&
Mining
0.9%
j
CSN
Islands
XI
Corp.
,
Senior
Note
,
144A,
6.75
%
,
1/28/28
.......
Brazil
8,000,000
7,887,920
j
FMG
Resources
August
2006
Pty.
Ltd.
,
Senior
Note
,
144A,
5.125
%
,
5/15/24
...........................................
Australia
7,700,000
8,252,552
j
Novelis
Corp.
,
Senior
Bond
,
144A,
5.875
%
,
9/30/26
...........
United
States
14,000,000
14,463,820
j
SunCoke
Energy
Partners
LP
/
SunCoke
Energy
Partners
Finance
Corp.
,
Senior
Note
,
144A,
7.5
%
,
6/15/25
..................
United
States
4,400,000
3,946,250
34,550,542
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
23
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Corporate
Bonds
(continued)
Multiline
Retail
0.1%
Dollar
Tree,
Inc.
,
Senior
Bond
,
4.2
%
,
5/15/28
.................
United
States
1,700,000
$
1,989,308
a,h,j
K2016470219
South
Africa
Ltd.
,
Senior
Secured
Note
,
144A,
PIK,
3
%
,
12/31/22
.......................................
South
Africa
10,283,232
a,h,j
K2016470260
South
Africa
Ltd.
,
Senior
Secured
Note
,
144A,
PIK,
25
%
,
12/31/22
......................................
South
Africa
3,001,471
15,007
2,004,315
Multi-Utilities
0.2%
Dominion
Energy,
Inc.
,
C
,
Senior
Note
,
3.375
%
,
4/01/30
........
United
States
8,500,000
9,579,330
Oil,
Gas
&
Consumable
Fuels
4.5%
j
Aker
BP
ASA
,
Senior
Bond,
144A,
4%,
1/15/31
........................
Norway
4,400,000
4,312,186
Senior
Note,
144A,
4.75%,
6/15/24
......................
Norway
5,900,000
6,069,010
Apache
Corp.
,
Senior
Note,
4.625%,
11/15/25
.........................
United
States
5,600,000
5,327,000
Senior
Note,
4.875%,
11/15/27
.........................
United
States
5,000,000
4,700,000
Canadian
Natural
Resources
Ltd.
,
Senior
Bond
,
2.95
%
,
7/15/30
..
Canada
3,700,000
3,628,671
Cenovus
Energy,
Inc.
,
Senior
Note
,
5.375
%
,
7/15/25
...........
Canada
11,900,000
12,552,016
Cheniere
Corpus
Christi
Holdings
LLC
,
Senior
Secured
Note
,
5.875
%
,
3/31/25
.....................................
United
States
6,400,000
7,249,358
Cheniere
Energy
Partners
LP
,
Senior
Secured
Note
,
5.25
%
,
10/01/25
..........................................
United
States
11,900,000
12,126,100
Comstock
Resources,
Inc.
,
Senior
Note
,
9.75
%
,
8/15/26
........
United
States
6,500,000
6,857,500
j
CVR
Energy,
Inc.
,
Senior
Note
,
144A,
5.25
%
,
2/15/25
..........
United
States
5,000,000
3,653,125
Energy
Transfer
Operating
LP
,
Senior
Note
,
4.05
%
,
3/15/25
......
United
States
1,300,000
1,367,995
EnLink
Midstream
LLC
,
Senior
Bond
,
5.375
%
,
6/01/29
.........
United
States
10,900,000
9,352,200
h,j
EnQuest
plc
,
Senior
Note
,
144A,
Reg
S,
PIK,
7
%
,
10/15/23
......
United
Kingdom
10,664,175
5,670,083
Enterprise
Products
Operating
LLC
,
Senior
Bond
,
4.8
%
,
2/01/49
..
United
States
1,200,000
1,390,771
EOG
Resources,
Inc.
,
Senior
Note
,
4.375
%
,
4/15/30
...........
United
States
1,000,000
1,177,182
Exxon
Mobil
Corp.
,
Senior
Bond
,
2.61
%
,
10/15/30
.............
United
States
4,700,000
4,991,116
j
Martin
Midstream
Partners
LP
/
Martin
Midstream
Finance
Corp.
,
Secured
Note,
144A,
11.5%,
2/28/25
.....................
United
States
16,387,122
14,953,249
Senior
Secured
Note,
144A,
10%,
2/29/24
.................
United
States
3,608,495
3,653,601
MPLX
LP
,
Senior
Note
,
2.65
%
,
8/15/30
.....................
United
States
15,000,000
14,454,767
Occidental
Petroleum
Corp.
,
Senior
Bond,
6.45%,
9/15/36
...........................
United
States
5,000,000
4,057,500
Senior
Note,
8.875%,
7/15/30
..........................
United
States
6,800,000
6,668,250
j
Rattler
Midstream
LP
,
Senior
Note
,
144A,
5.625
%
,
7/15/25
......
United
States
8,200,000
8,440,875
j
Sabine
Pass
Liquefaction
LLC
,
Senior
Secured
Note
,
144A,
4.5
%
,
5/15/30
...........................................
United
States
10,000,000
11,191,234
j
Seven
Generations
Energy
Ltd.
,
Senior
Note
,
144A,
5.375
%
,
9/30/25
Canada
1,700,000
1,624,103
Sunoco
LP
/
Sunoco
Finance
Corp.
,
Senior
Note
,
4.875
%
,
1/15/23
United
States
5,900,000
5,965,755
Williams
Cos.,
Inc.
(The)
,
Senior
Bond
,
3.5
%
,
11/15/30
.........
United
States
16,400,000
17,618,608
179,052,255
Paper
&
Forest
Products
0.1%
Suzano
Austria
GmbH
,
Senior
Bond
,
3.75
%
,
1/15/31
...........
Brazil
3,700,000
3,814,145
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
24
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Corporate
Bonds
(continued)
Pharmaceuticals
1.0%
j
Bausch
Health
Americas,
Inc.
,
Senior
Note
,
144A,
8.5
%
,
1/31/27
..
United
States
5,000,000
$
5,474,175
j
Bausch
Health
Cos.,
Inc.
,
Senior
Bond
,
144A,
6.125
%
,
4/15/25
...
United
States
3,100,000
3,189,900
j
Bayer
US
Finance
II
LLC
,
Senior
Bond
,
144A,
4.375
%
,
12/15/28
..
Germany
11,700,000
13,485,827
j
Endo
Dac
/
Endo
Finance
LLC
/
Endo
Finco
,
Inc.
,
Secured
Note,
144A,
9.5%,
7/31/27
......................
United
States
6,580,000
7,070,769
Senior
Note,
144A,
6%,
6/30/28
........................
United
States
6,537,000
5,056,370
j
Par
Pharmaceutical,
Inc.
,
Senior
Secured
Note
,
144A,
7.5
%
,
4/01/27
United
States
1,716,000
1,821,208
j
Royalty
Pharma
plc
,
Senior
Bond
,
144A,
3.3
%
,
9/02/40
.........
United
States
5,300,000
5,202,097
41,300,346
Real
Estate
Management
&
Development
0.7%
j
China
Overseas
Finance
Cayman
VI
Ltd.
,
Senior
Note
,
Reg
S,
5.95
%
,
5/08/24
.....................................
China
7,500,000
8,581,013
j
Five
Point
Operating
Co.
LP
/
Five
Point
Capital
Corp.
,
Senior
Note
,
144A,
7.875
%
,
11/15/25
...............................
United
States
8,000,000
8,015,000
j
Howard
Hughes
Corp.
(The)
,
Senior
Note
,
144A,
5.375
%
,
8/01/28
.
United
States
10,000,000
10,081,250
26,677,263
Road
&
Rail
1.3%
Burlington
Northern
Santa
Fe
LLC
,
Senior
Bond
,
4.15
%
,
4/01/45
..
United
States
3,600,000
4,391,448
CSX
Corp.
,
Senior
Bond
,
4.1
%
,
3/15/44
....................
United
States
1,600,000
1,887,228
j
DAE
Funding
LLC
,
Senior
Note,
144A,
4.5%,
8/01/22
.......................
United
Arab
Emirates
2,000,000
2,015,000
Senior
Note,
144A,
5%,
8/01/24
........................
United
Arab
Emirates
14,000,000
14,026,250
j
Kazakhstan
Temir
Zholy
Finance
BV
,
Senior
Bond
,
144A,
6.95
%
,
7/10/42
...........................................
Kazakhstan
17,300,000
23,765,529
a,h
Onsite
Rental
Group
Operations
Pty.
Ltd.
,
PIK,
6.1
%
,
10/26/23
...
Australia
4,655,176
4,101,072
50,186,527
Semiconductors
&
Semiconductor
Equipment
0.3%
j
ON
Semiconductor
Corp.
,
Senior
Note
,
144A,
3.875
%
,
9/01/28
...
United
States
12,900,000
13,141,875
Software
0.3%
j
Blackboard,
Inc.
,
Secured
Note
,
144A,
10.375
%
,
11/15/24
.......
United
States
4,200,000
4,255,125
j
NortonLifeLock
,
Inc.
,
Senior
Note
,
144A,
5
%
,
4/15/25
..........
United
States
7,500,000
7,657,200
11,912,325
Specialty
Retail
0.4%
AutoNation,
Inc.
,
Senior
Bond
,
4.75
%
,
6/01/30
...............
United
States
1,900,000
2,228,957
L
Brands,
Inc.
,
Senior
Bond,
5.25%,
2/01/28
...........................
United
States
5,500,000
5,427,812
j
Senior
Note,
144A,
6.625%,
10/01/30
....................
United
States
1,600,000
1,683,000
j
Lithia
Motors,
Inc.
,
Senior
Bond
,
144A,
4.375
%
,
1/15/31
........
United
States
5,000,000
5,171,875
j,k
Party
City
Holdings,
Inc.
,
Senior
Secured
Note
,
144A,
FRN
,
5.75
%
,
(
6-month
USD
LIBOR
+
5
%
),
7/15/25
.....................
United
States
1,153,545
813,249
15,324,893
Textiles,
Apparel
&
Luxury
Goods
0.3%
j
Hanesbrands,
Inc.
,
Senior
Bond
,
144A,
4.875
%
,
5/15/26
........
United
States
10,000,000
10,827,800
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
25
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Corporate
Bonds
(continued)
Thrifts
&
Mortgage
Finance
1.1%
MGIC
Investment
Corp.
,
Senior
Note
,
5.25
%
,
8/15/28
..........
United
States
7,000,000
$
7,205,625
j
PennyMac
Financial
Services,
Inc.
,
Senior
Note
,
144A,
5.375
%
,
10/15/25
..........................................
United
States
11,500,000
11,740,925
j
Quicken
Loans
LLC
/
Quicken
Loans
Co-Issuer,
Inc.
,
Senior
Bond,
144A,
3.875%,
3/01/31
.....................
United
States
4,600,000
4,536,750
Senior
Note,
144A,
3.625%,
3/01/29
.....................
United
States
8,100,000
7,993,688
j
United
Shore
Financial
Services
LLC
,
Senior
Note
,
144A,
5.5
%
,
11/15/25
..........................................
United
States
11,400,000
11,553,330
43,030,318
Tobacco
0.5%
Altria
Group,
Inc.
,
Senior
Note
,
3.4
%
,
5/06/30
................
United
States
12,400,000
13,478,052
BAT
Capital
Corp.
,
Senior
Bond,
4.54%,
8/15/47
...........................
United
Kingdom
600,000
629,995
Senior
Note,
3.557%,
8/15/27
..........................
United
Kingdom
2,700,000
2,912,979
j
Imperial
Brands
Finance
plc
,
Senior
Note
,
144A,
3.875
%
,
7/26/29
.
United
Kingdom
2,200,000
2,423,592
Reynolds
American,
Inc.
,
Senior
Note
,
4.45
%
,
6/12/25
..........
United
Kingdom
1,900,000
2,147,413
21,592,031
Trading
Companies
&
Distributors
0.7%
j
Beacon
Roofing
Supply,
Inc.
,
Senior
Note
,
144A,
4.875
%
,
11/01/25
United
States
12,000,000
11,793,780
j
Herc
Holdings,
Inc.
,
Senior
Note
,
144A,
5.5
%
,
7/15/27
..........
United
States
5,300,000
5,459,000
j
WESCO
Distribution,
Inc.
,
Senior
Note,
144A,
7.125%,
6/15/25
.....................
United
States
4,700,000
5,070,477
Senior
Note,
144A,
7.25%,
6/15/28
......................
United
States
5,500,000
6,028,523
28,351,780
Wireless
Telecommunication
Services
1.2%
h,j
Digicel
Group
0.5
Ltd.
,
Senior
Note
,
144A,
PIK,
8
%
,
4/01/25
.....
Bermuda
1,107,585
368,949
Hughes
Satellite
Systems
Corp.
,
Senior
Note
,
6.625
%
,
8/01/26
...
United
States
8,000,000
8,693,480
Sprint
Communications,
Inc.
,
Senior
Note
,
6
%
,
11/15/22
........
United
States
10,000,000
10,716,200
T-Mobile
USA,
Inc.
,
Senior
Note,
5.125%,
4/15/25
..........................
United
States
6,000,000
6,168,690
j
Senior
Secured
Bond,
144A,
3.3%,
2/15/51
................
United
States
4,800,000
4,642,368
j
Senior
Secured
Note,
144A,
3.875%,
4/15/30
..............
United
States
13,400,000
15,069,774
j
Vmed
O2
UK
Financing
I
plc
,
Senior
Secured
Bond
,
144A,
4.25
%
,
1/31/31
...........................................
United
Kingdom
3,400,000
3,408,500
49,067,961
Total
Corporate
Bonds
(Cost
$1,847,118,640)
...................................
1,847,164,083
k,l
Senior
Floating
Rate
Interests
4.1%
Aerospace
&
Defense
0.0%
h
Alloy
FinCo
Ltd.,
Facility
Term
Loan,
B,
0.5%,
PIK,
(3-month
USD
LIBOR
+
0.5%),
3/06/25
...............................
Jersey
2,938,441
780,656
Airlines
0.0%
Delta
Air
Lines,
Inc.
/
SkyMiles
IP
Ltd.,
Initial
Term
Loan,
4.75%,
(6-month
USD
LIBOR
+
3.75%),
10/20/27
.................
United
States
568,379
567,313
JetBlue
Airways
Corp.,
Term
Loan,
6.25%,
(3-month
USD
LIBOR
+
5.25%),
6/17/24
.....................................
United
States
235,574
234,931
802,244
a
a
a
a
a
a
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
26
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
k,l
Senior
Floating
Rate
Interests
(continued)
Auto
Components
0.1%
Adient
US
LLC,
Initial
Term
Loan,
4.422%,
(3-month
USD
LIBOR
+
4.25%;
1-month
USD
LIBOR
+
4.25%),
5/06/24
.............
United
States
4,680,849
$
4,624,679
m
Highline
Aftermarket
Acquisition
LLC,
First
Lien,
Term
Loan,
TBD,
10/20/27
..........................................
United
States
228,432
223,577
4,848,256
a
a
a
a
a
a
Automobiles
0.0%
Thor
Industries,
Inc.,
Initial
USD
Term
Loan,
3.938%,
(1-month
USD
LIBOR
+
3.75%),
2/01/26
..............................
United
States
1,780,712
1,771,808
Biotechnology
0.1%
Grifols
Worldwide
Operations
Ltd.,
Dollar
Term
Loan,
B,
2.094%,
(1-
week
USD
LIBOR
+
2%),
11/15/27
.......................
Ireland
2,230,154
2,179,006
Capital
Markets
0.0%
Russell
Investments
US
Institutional
Holdco,
Inc.,
Initial
Term
Loan,
3.75%,
(3-month
USD
LIBOR
+
2.75%),
6/01/23
.............
United
States
630,769
626,959
Chemicals
0.0%
Axalta
Coating
Systems
Dutch
Holding
B
BV
(Axalta
Coating
Systems
U.S.
Holdings,
Inc.),
Dollar
Term
Loan,
B3,
1.97%,
(3-month
USD
LIBOR
+
1.75%),
6/01/24
..................
Netherlands
1,887,232
1,836,117
Commercial
Services
&
Supplies
0.1%
Harsco
Corp.,
Term
Loan,
B2,
3.25%,
(1-month
USD
LIBOR
+
2.25%),
12/06/24
....................................
United
States
2,040,990
2,035,030
Prime
Security
Services
Borrower
LLC,
First
Lien,
2019
Refinancing
Term
Loan,
B1,
4.25%,
(3-month
USD
LIBOR
+
3.25%;
1-month
USD
LIBOR
+
3.25%),
9/23/26
..........................
United
States
2,493,087
2,465,227
4,500,257
a
a
a
a
a
a
Containers
&
Packaging
0.0%
Berry
Global,
Inc.,
Term
Loan,
Y,
2.147%,
(1-month
USD
LIBOR
+
2%),
7/01/26
.......................................
United
States
1,484,944
1,439,853
Diversified
Financial
Services
0.1%
First
Eagle
Holdings,
Inc.,
2020
Refinancing
Term
Loan,
2.72%,
(3-month
USD
LIBOR
+
2.5%),
2/01/27
...................
United
States
2,069,786
2,015,599
Jefferies
Finance
LLC,
2020
Term
Loan,
4.5%,
(1-month
USD
LIBOR
+
3.75%),
9/30/27
...................................
United
States
801,473
794,460
2,810,059
a
a
a
a
a
a
Electric
Utilities
0.0%
EFS
Cogen
Holdings
I
LLC,
Term
Loan,
4.5%,
(3-month
USD
LIBOR
+
3.5%),
10/01/27
...................................
United
States
1,160,000
1,152,930
Entertainment
0.0%
Diamond
Sports
Group
LLC,
Term
Loan,
3.4%,
(1-month
USD
LIBOR
+
3.25%),
8/24/26
..............................
United
States
2,970,000
1,862,442
Food
&
Staples
Retailing
0.1%
Aramark
Intermediate
HoldCo
Corp.,
U.S.
Term
Loan,
B4,
1.898%,
(1-month
USD
LIBOR
+
1.75%),
1/15/27
..................
United
States
3,880,500
3,726,502
Food
Products
0.3%
B&G
Foods,
Inc.,
Term
Loan,
B4,
2.648%,
(1-month
USD
LIBOR
+
2.5%),
10/10/26
.....................................
United
States
689,010
686,340
CSM
Bakery
Solutions
Ltd.,
Second
Lien,
Term
Loan,
11%,
(3-month
USD
LIBOR
+
10%),
7/05/21
...........................
United
States
7,846,051
7,511,721
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
27
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
k,l
Senior
Floating
Rate
Interests
(continued)
Food
Products
(continued)
JBS
USA
Lux
SA,
New
Term
Loan,
2.148%,
(1-month
USD
LIBOR
+
2%),
5/01/26
.......................................
Luxembourg
2,243,128
$
2,194,643
10,392,704
a
a
a
a
a
a
Health
Care
Providers
&
Services
0.1%
m,n
CNT
Holdings
I
Corp.,
First
Lien,
Term
Loan
Facility,
TBD,
10/16/27
United
States
116,829
115,685
DaVita,
Inc.,
Term
Loan,
B1,
1.898%,
(1-month
USD
LIBOR
+
1.75%),
8/12/26
.....................................
United
States
1,985,000
1,945,300
n
Navicure
,
Inc.,
First
Lien,
Initial
Term
Loan,
4.148%,
(1-month
USD
LIBOR
+
4%),
10/22/26
...............................
United
States
520,000
508,516
2,569,501
a
a
a
a
a
a
Hotels,
Restaurants
&
Leisure
0.1%
Caesars
Resort
Collection
LLC,
Term
Loan
,
B,
2.898%,
(1-month
USD
LIBOR
+
2.75%),
12/23/24
.........
United
States
2,977,041
2,799,669
B1,
4.649%,
(1-month
USD
LIBOR
+
4.5%),
7/21/25
..........
United
States
114,883
111,544
2,911,213
a
a
a
a
a
a
Household
Products
1.0%
a
FGI
Operating
Co.
LLC,
Last
Out
Initial
Term
Loan,
13%,
(3-month
USD
LIBOR
+
10%;
3-month
USD
LIBOR
+
11%),
5/17/21
.....
United
States
28,662,305
28,662,305
a,h,o
FGI
Operating
Co.
LLC,
Term
Loan,
PIK,
(3-month
USD
LIBOR
+
11%),
5/16/22
......................................
United
States
15,104,489
9,828,738
38,491,043
a
a
a
a
a
a
IT
Services
0.4%
Aventiv
Technologies
LLC,
First
Lien,
Initial
Term
Loan,
5.5%,
(3-month
USD
LIBOR
+
4.5%),
11/01/24
..................
United
States
2,462,025
2,073,419
Aventiv
Technologies
LLC,
Second
Lien,
Initial
Term
Loan,
9.25%,
(6-month
USD
LIBOR
+
8.25%),
11/01/25
..................
United
States
7,588,688
4,766,189
m,n
Barracuda
Networks,
Inc.,
Term
Loan,
TBD,
2/12/25
...........
United
States
377,855
372,187
n
Milano
Acquisition
Corp.,
Term
Loan,
B,
4.75%,
(3-month
USD
LIBOR
+
4%),
10/01/27
...............................
United
States
330,000
325,326
Pitney
Bowes,
Inc.,
Incremental
Term
Loan,
B,
5.65%,
(1-month
USD
LIBOR
+
5.5%),
1/07/25
...............................
United
States
3,654,399
3,612,830
WEX,
Inc.,
Term
Loan,
B3,
2.398%,
(1-month
USD
LIBOR
+
2.25%),
5/15/26
...........................................
United
States
4,108,167
3,974,652
15,124,603
a
a
a
a
a
a
Leisure
Products
0.1%
NASCAR
Holdings
LLC,
Initial
Term
Loan,
2.902%,
(1-month
USD
LIBOR
+
2.75%),
10/19/26
.............................
United
States
3,108,741
3,032,421
Machinery
0.1%
Altra
Industrial
Motion
Corp.,
Term
Loan,
2.148%,
(1-month
USD
LIBOR
+
2%),
10/01/25
...............................
United
States
2,126,255
2,090,045
Navistar,
Inc.,
Term
Loan,
B,
3.65%,
(1-month
USD
LIBOR
+
3.5%),
11/06/24
..........................................
United
States
1,497,026
1,486,173
3,576,218
a
a
a
a
a
a
Media
0.1%
CSC
Holdings
LLC,
March
2017
Refinancing
Term
Loan,
2.398%,
(1-month
USD
LIBOR
+
2.25%),
7/17/25
..................
United
States
987,212
955,745
Gray
Television,
Inc.,
Term
Loan,
C,
2.649%,
(1-month
USD
LIBOR
+
2.5%),
1/02/26
......................................
United
States
339,690
331,538
Nexstar
Broadcasting,
Inc.,
Term
Loan,
B4,
2.899%,
(1-month
USD
LIBOR
+
2.75%),
9/18/26
..............................
United
States
958,343
936,301
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
28
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
k,l
Senior
Floating
Rate
Interests
(continued)
Media
(continued)
m,n
Virgin
Media
Bristol
LLC,
Term
Loan,
Q,
TBD,
1/31/29
..........
United
States
1,888,138
$
1,855,096
4,078,680
a
a
a
a
a
a
Multiline
Retail
0.0%
Harbor
Freight
Tools
USA,
Inc.,
Initial
Term
Loan
(2020),
4%,
(1-month
USD
LIBOR
+
3.25%),
10/19/27
.................
United
States
1,867,139
1,843,688
Oil,
Gas
&
Consumable
Fuels
0.3%
Buckeye
Partners
LP,
Initial
Term
Loan,
2.897%,
(1-month
USD
LIBOR
+
2.75%),
11/01/26
.............................
United
States
1,561,587
1,536,492
n,p
Fieldwood
Energy
LLC,
Debtor-in-possession
Facility
Term
Loan,
3.675%,
(1-month
USD
LIBOR;
1-month
USD
LIBOR
+
8.75%),
8/04/21
...........................................
United
States
386,753
388,687
o
Fieldwood
Energy
LLC,
First
Lien,
Closing
Date
Term
Loan,
(3-month
USD
LIBOR
+
5.25%),
4/11/22
..........................
United
States
32,439,645
7,136,722
UTEX
Industries,
Inc.,
Debtor-in-possession
Term
Loan,
10%,
(1-month
USD
LIBOR
+
9%),
2/08/21
.....................
United
States
137,013
137,698
o
UTEX
Industries,
Inc.,
First
Lien,
Initial
Term
Loan,
(3-month
USD
LIBOR
+
5%),
5/21/21
................................
United
States
2,138,576
658,682
o
UTEX
Industries,
Inc.,
Second
Lien,
Initial
Term
Loan,
(3-month
USD
LIBOR
+
7.25%),
5/20/22
..............................
United
States
955,410
23,885
9,882,166
a
a
a
a
a
a
Paper
&
Forest
Products
0.1%
Appvion
Operations,
Inc.,
Term
Loan,
7%,
(3-month
USD
LIBOR
+
6%),
6/12/26
.......................................
United
States
4,823,297
4,738,889
Pharmaceuticals
0.1%
Catalent
Pharma
Solutions,
Inc.,
Dollar
Term
Loan,
B2,
3.25%,
(1-month
USD
LIBOR
+
2.25%),
5/18/26
..................
United
States
2,162,734
2,157,782
Real
Estate
Management
&
Development
0.1%
Cushman
&
Wakefield
U.S.
Borrower
LLC,
Replacement
Term
Loan,
2.898%,
(1-month
USD
LIBOR
+
2.75%),
8/21/25
............
United
States
3,165,351
3,038,737
Road
&
Rail
0.2%
Avis
Budget
Car
Rental
LLC,
New
Term
Loan,
B,
2.4%,
(1-month
USD
LIBOR
+
2.25%),
8/06/27
..........................
United
States
1,666,401
1,509,134
a
Onsite
Rental
Group
Operations
Pty.
Ltd.,
Term
Loan,
B,
5.5%,
(1-month
USD
LIBOR
+
4.5%),
10/26/22
..................
Australia
3,404,855
3,129,152
Ventia
Midco
Pty.
Ltd.,
2017
Refinancing
USD
Term
Loan,
B,
5%,
(3-month
USD
LIBOR
+
4%),
5/21/26
.....................
Australia
2,283,412
2,254,869
6,893,155
a
a
a
a
a
a
Semiconductors
&
Semiconductor
Equipment
0.1%
ON
Semiconductor
Corp.,
2019
New
Replacement
Term
Loan,
B4,
2.148%,
(1-month
USD
LIBOR
+
2%),
9/19/26
..............
United
States
1,980,000
1,941,113
Software
0.5%
Aristocrat
Leisure
Ltd.,
Term
Loan,
B3,
1.959%,
(3-month
USD
LIBOR
+
1.75%),
10/19/24
.............................
Australia
1,000,348
976,340
n
Mitchell
International,
Inc.,
First
Lien,
Amendment
No.
2
New
Term
Loan
Facility,
4.75%,
(1-month
USD
LIBOR
+
4.25%),
11/29/24
.
United
States
410,000
398,520
a
WorkCapital
BSD
SARL,
Term
Loan,
16.254%,
(1-month
USD
LIBOR
+
16%),
11/02/22
..............................
United
States
20,000,000
19,911,128
21,285,988
a
a
a
a
a
a
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
29
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
k,l
Senior
Floating
Rate
Interests
(continued)
Technology
Hardware,
Storage
&
Peripherals
0.0%
m
Amentum
Government
Services
Holdings
LLC,
Incremental
Term
Loan,
TBD,
1/29/27
..................................
United
States
330,000
$
323,813
Cardtronics
USA,
Inc.,
Initial
Term
Loan,
5%,
(1-month
USD
LIBOR
+
4%),
6/29/27
.......................................
United
States
1,005,179
1,006,435
1,330,248
a
a
a
a
a
a
Total
Senior
Floating
Rate
Interests
(Cost
$206,974,996)
.........................
161,625,238
q
Marketplace
Loans
0.2%
Diversified
Financial
Services
0.2%
a
Lending
Club
-
LCX
PM,
8.46%
-
20.74%,
9/04/23
-
10/22/25
.....
United
States
2,147,066
2,146,500
a
Lending
Club
-
LCX,
6.46%
-
28.8%,
5/31/22
-
3/17/25
.........
United
States
4,020,853
3,694,034
a
Upgrade,
14.19%
-
30.51%,
11/05/22
-
2/20/25
...............
United
States
2,026,999
1,802,543
7,643,077
a
a
a
a
a
a
Total
Marketplace
Loans
(Cost
$8,194,918)
.....................................
7,643,077
r
Loan
Participations
and
Assignments
0.5%
b,j
Russian
Railways
Via
RZD
Capital
plc,
Senior
Note,
Reg
S,
5.7%,
4/05/22
...........................................
Russia
17,600,000
18,699,014
Total
Loan
Participations
and
Assignments
(Cost
$18,158,659)
...................
18,699,014
Foreign
Government
and
Agency
Securities
14.3%
j
African
Export-Import
Bank
(The)
,
Senior
Note
,
144A,
3.994
%
,
9/21/29
...........................................
Supranational
s
19,100,000
19,749,400
j
Angola
Government
Bond
,
Senior
Note
,
144A,
8.25
%
,
5/09/28
...
Angola
28,800,000
22,738,320
j
Banque
Centrale
de
Tunisie
,
Senior
Note
,
Reg
S,
5.625
%
,
2/17/24
Tunisia
24,800,000
EUR
24,903,313
j
Banque
Ouest
Africaine
de
Developpement
,
Senior
Note
,
144A,
5
%
,
7/27/27
...........................................
Supranational
s
11,500,000
12,374,000
j
Belarus
Government
Bond
,
Senior
Note,
144A,
7.625%,
6/29/27
......................
Belarus
11,400,000
11,346,420
Senior
Bond,
144A,
6.2%,
2/28/30
.......................
Belarus
12,300,000
11,659,219
Brazil
Notas
do
Tesouro
Nacional
,
10%,
1/01/23
.......................................
Brazil
34,402,000
BRL
6,580,791
t
Index
Linked,
6%,
5/15/23
.............................
Brazil
65,409,448
BRL
12,809,480
Colombia
Government
Bond
,
Senior
Bond,
3.875%,
4/25/27
..........................
Colombia
14,000,000
15,187,340
Senior
Bond,
9.85%,
6/28/27
...........................
Colombia
55,750,000,000
COP
18,701,641
Senior
Bond,
4.5%,
3/15/29
............................
Colombia
2,800,000
3,152,968
Senior
Bond,
5%,
6/15/45
.............................
Colombia
20,700,000
24,110,325
j
Dominican
Republic
Government
Bond
,
Senior
Note
,
144A,
8.9
%
,
2/15/23
...........................................
Dominican
Republic
838,300,000
DOP
14,508,727
Ecopetrol
SA
,
Senior
Bond
,
4.125
%
,
1/16/25
.................
Colombia
8,200,000
8,612,050
i,j
Electricite
de
France
SA
,
Junior
Sub.
Bond,
144A,
5.25%
to
1/29/23,
FRN
thereafter,
Perpetual
..........................................
France
25,000,000
25,927,250
Junior
Sub.
Bond,
144A,
5.625%
to
1/22/24,
FRN
thereafter,
Perpetual
..........................................
France
5,000,000
5,253,475
Equinor
ASA
,
Senior
Note
,
2.375
%
,
5/22/30
.................
Norway
7,000,000
7,287,483
j
Export-Import
Bank
of
India
,
Senior
Note
,
144A,
3.875
%
,
2/01/28
.
India
16,000,000
16,890,080
j
Gabon
Government
Bond
,
144A,
6.375%,
12/12/24
...............................
Gabon
10,443,918
9,977,858
Senior
Bond,
144A,
6.625%,
2/06/31
.....................
Gabon
17,150,000
15,362,831
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
30
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Foreign
Government
and
Agency
Securities
(continued)
Indonesia
Government
Bond
,
FR34,
12.8%,
6/15/21
................................
Indonesia
129,210,000,000
IDR
$
9,353,921
FR39,
11.75%,
8/15/23
...............................
Indonesia
29,150,000,000
IDR
2,347,248
FR44,
10%,
9/15/24
..................................
Indonesia
8,340,000,000
IDR
662,239
FR56,
8.375%,
9/15/26
...............................
Indonesia
363,988,000,000
IDR
27,750,196
j
Senior
Bond,
144A,
4.35%,
1/08/27
......................
Indonesia
8,100,000
9,283,693
j
Senior
Note,
144A,
3.85%,
7/18/27
.......................
Indonesia
22,000,000
24,666,398
j
Iraq
Government
Bond
,
Senior
Bond
,
144A,
5.8
%
,
1/15/28
......
Iraq
25,687,500
22,220,921
j
Israel
Electric
Corp.
Ltd.
,
Senior
Secured
Bond
,
144A,
Reg
S,
4.25
%
,
8/14/28
...........................................
Israel
9,200,000
10,581,242
j
Kazakhstan
Government
Bond
,
Senior
Bond
,
144A,
4.875
%
,
10/14/44
..........................................
Kazakhstan
17,700,000
23,539,938
Mexico
Government
Bond
,
Senior
Note,
4.15%,
3/28/27
...........................
Mexico
32,700,000
36,480,937
Senior
Note,
3.75%,
1/11/28
............................
Mexico
4,000,000
4,336,660
j
Panama
Notas
del
Tesoro
,
Senior
Note
,
144A,
3.75
%
,
4/17/26
...
Panama
6,400,000
6,933,536
Peru
Government
Bond
,
Senior
Bond
,
6.55
%
,
3/14/37
..........
Peru
8,600,000
13,044,437
j
Russia
Government
Bond
,
Senior
Note,
144A,
4.875%,
9/16/23
......................
Russia
6,800,000
7,457,560
Senior
Note,
Reg
S,
4.75%,
5/27/26
......................
Russia
12,000,000
13,739,400
South
Africa
Government
Bond
,
Senior
Bond
,
7
%
,
2/28/31
......
South
Africa
365,000,000
ZAR
18,373,574
j
Turkiye
Vakiflar
Bankasi
TAO
,
Covered
Note
,
Reg
S,
2.375
%
,
5/04/21
...........................................
Turkey
3,900,000
EUR
4,499,900
j
Ukraine
Government
Bond
,
Senior
Note,
144A,
7.75%,
9/01/23
.......................
Ukraine
4,355,000
4,542,465
Senior
Note,
144A,
7.75%,
9/01/24
.......................
Ukraine
4,355,000
4,518,792
Senior
Bond,
144A,
7.375%,
9/25/32
.....................
Ukraine
6,000,000
5,774,520
u
VRI,
GDP
Linked
Security,
Senior
Bond,
144A,
Reg
S,
5/31/40
..
Ukraine
9,990,000
8,685,606
t
Uruguay
Government
Bond
,
Index
Linked,
Senior
Bond
,
3.7
%
,
6/26/37
...........................................
Uruguay
918,721,097
UYU
23,886,749
Total
Foreign
Government
and
Agency
Securities
(Cost
$599,478,482)
............
569,812,903
U.S.
Government
and
Agency
Securities
4.3%
U.S.
Treasury
Bonds
,
7.125%,
2/15/23
.....................................
United
States
3,000,000
3,477,188
6.25%,
8/15/23
.....................................
United
States
4,000,000
4,675,000
6.875%,
8/15/25
.....................................
United
States
1,000,000
1,308,828
U.S.
Treasury
Notes
,
1.5%,
11/30/21
......................................
United
States
30,000,000
30,440,625
t
0.625%,
1/15/24
.....................................
United
States
22,950,000
27,031,797
t
0.125%,
7/15/24
.....................................
United
States
38,840,000
44,708,049
0.25%,
6/30/25
.....................................
United
States
41,000,000
40,807,813
t
0.375%,
7/15/25
.....................................
United
States
17,700,000
20,907,154
Total
U.S.
Government
and
Agency
Securities
(Cost
$166,890,947)
................
173,356,454
Asset-Backed
Securities
19.7%
Capital
Markets
0.1%
v
Merrill
Lynch
Mortgage
Investors
Trust
,
2005-A6
,
2A3
,
FRN
,
0.529
%
,
(
1-month
USD
LIBOR
+
0.38
%
),
8/25/35
..................
United
States
352,979
354,021
j,v
Mountain
View
CLO
XIV
Ltd.
,
2019-1A
,
C
,
144A,
FRN
,
3.137
%
,
(
3-month
USD
LIBOR
+
2.9
%
),
4/15/29
...................
United
States
4,500,000
4,410,075
4,764,096
a
A
a
a
a
a
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
31
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Asset-Backed
Securities
(continued)
Consumer
Finance
0.5%
v
Citibank
Credit
Card
Issuance
Trust
,
2017-A7
,
A7
,
FRN
,
0.51
%
,
(
1-month
USD
LIBOR
+
0.37
%
),
8/08/24
..................
United
States
20,069,000
$
20,165,977
Diversified
Financial
Services
10.3%
j,v
AMMC
CLO
XI
Ltd.
,
2012-11A,
BR2,
144A,
FRN,
1.814%,
(3-month
USD
LIBOR
+
1.6%),
4/30/31
......................................
United
States
3,000,000
2,917,150
2012-11A,
CR2,
144A,
FRN,
2.114%,
(3-month
USD
LIBOR
+
1.9%),
4/30/31
......................................
United
States
1,000,000
912,442
j,v
Antares
CLO
Ltd.
,
2018-1A
,
B
,
144A,
FRN
,
1.868
%
,
(
3-month
USD
LIBOR
+
1.65
%
),
4/20/31
..............................
United
States
17,500,000
16,462,498
j,v
Ares
L
CLO
Ltd.
,
2018-50A
,
B
,
144A,
FRN
,
1.937
%
,
(
3-month
USD
LIBOR
+
1.7
%
),
1/15/32
...............................
United
States
15,700,000
15,417,102
j,v
Ares
LII
CLO
Ltd.
,
2019-52A,
A2,
144A,
FRN,
1.866%,
(3-month
USD
LIBOR
+
1.65%),
4/22/31
.....................................
United
States
2,522,358
2,513,304
2019-52A,
C,
144A,
FRN,
2.896%,
(3-month
USD
LIBOR
+
2.68%),
4/22/31
.....................................
United
States
1,000,000
994,259
j,v
BCC
Middle
Market
CLO
LLC
,
2018-1A
,
A2
,
144A,
FRN
,
2.368
%
,
(
3-month
USD
LIBOR
+
2.15
%
),
10/20/30
.................
United
States
6,300,000
6,016,020
j,v
BlueMountain
CLO
Ltd.
,
2012-2A,
BR2,
144A,
FRN,
1.703%,
(3-month
USD
LIBOR
+
1.45%),
11/20/28
....................................
United
States
6,710,000
6,561,654
2012-2A,
CR2,
144A,
FRN,
2.253%,
(3-month
USD
LIBOR
+
2%),
11/20/28
..........................................
United
States
2,730,000
2,615,892
2014-2A,
CR2,
144A,
FRN,
2.418%,
(3-month
USD
LIBOR
+
2.2%),
10/20/30
.....................................
United
States
3,800,000
3,702,152
2016-3A,
CR,
144A,
FRN,
2.48%,
(3-month
USD
LIBOR
+
2.2%),
11/15/30
..........................................
United
States
300,000
289,641
2018-1A,
D,
144A,
FRN,
3.264%,
(3-month
USD
LIBOR
+
3.05%),
7/30/30
...........................................
United
States
5,000,000
4,383,893
j,v
BlueMountain
Fuji
EUR
CLO
V
DAC
,
5A
,
B
,
144A,
FRN
,
1.55
%
,
(
3-month
EURIBOR
+
1.55
%
),
1/15/33
....................
Ireland
6,200,000
EUR
7,106,797
j,v
BlueMountain
Fuji
US
CLO
III
Ltd.
,
2017-3A
,
C
,
144A,
FRN
,
1.937
%
,
(
3-month
USD
LIBOR
+
1.7
%
),
1/15/30
...................
United
States
1,250,000
1,176,621
j
BRAVO
Residential
Funding
Trust
,
2019-1,
A1C,
144A,
3.5%,
3/25/58
.......................
United
States
7,204,496
7,451,356
w
2019-2,
A3,
144A,
FRN,
3.5%,
10/25/44
...................
United
States
8,552,159
9,049,034
j,v
Burnham
Park
CLO
Ltd.
,
2016-1A
,
BR
,
144A,
FRN
,
1.718
%
,
(
3-month
USD
LIBOR
+
1.5
%
),
10/20/29
..................
United
States
3,500,000
3,423,135
j,v
Buttermilk
Park
CLO
Ltd.
,
2018-1A
,
C
,
144A,
FRN
,
2.337
%
,
(
3-month
USD
LIBOR
+
2.1
%
),
10/15/31
..................
United
States
9,730,950
9,454,712
j,v
Carlyle
Global
Market
Strategies
CLO
Ltd.
,
2013-3A,
BR,
144A,
FRN,
1.937%,
(3-month
USD
LIBOR
+
1.7%),
10/15/30
..........................................
United
States
300,000
281,640
2014-2RA,
B,
144A,
FRN,
2.105%,
(3-month
USD
LIBOR
+
1.825%),
5/15/31
....................................
United
States
580,000
547,651
2014-4RA,
C,
144A,
FRN,
3.137%,
(3-month
USD
LIBOR
+
2.9%),
7/15/30
...........................................
United
States
3,000,000
2,586,333
j,v
Carlyle
GMS
Finance
MM
CLO
LLC
,
2015-1A
,
A2R
,
144A,
FRN
,
2.437
%
,
(
3-month
USD
LIBOR
+
2.2
%
),
10/15/31
............
United
States
12,000,000
11,630,311
j,v
Catamaran
CLO
Ltd.
,
2014-2A
,
BR
,
144A,
FRN
,
3.168
%
,
(
3-month
USD
LIBOR
+
2.95
%
),
10/18/26
.........................
United
States
11,770,000
11,638,351
j
CF
Hippolyta
LLC
,
2020-1
,
A1
,
144A,
1.69
%
,
7/15/60
..........
United
States
4,234,866
4,290,343
j,k,w
CIM
Trust
,
2019-INV1,
A1,
144A,
FRN,
4%,
2/25/49
..................
United
States
7,616,826
7,909,159
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
32
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Asset-Backed
Securities
(continued)
Diversified
Financial
Services
(continued)
j,k,w
CIM
Trust,
(continued)
2019-INV2,
A3,
144A,
FRN,
4%,
5/25/49
..................
United
States
9,801,167
$
10,138,578
j,v
Cole
Park
CLO
Ltd.
,
2015-1A
,
BR
,
144A,
FRN
,
1.818
%
,
(
3-month
USD
LIBOR
+
1.6
%
),
10/20/28
..........................
United
States
3,530,000
3,469,071
j,k,w
Consumer
Loan
Underlying
Bond
Certificate
Issuer
Trust
I
,
2018-14,
PT,
144A,
FRN,
9.91%,
9/16/41
..................
United
States
1,787,531
1,689,559
2018-29,
PT,
144A,
FRN,
28.565%,
12/15/43
...............
United
States
1,304,596
1,090,489
2019-26,
PT,
144A,
FRN,
20.123%,
8/15/44
................
United
States
5,054,975
4,307,534
2019-31,
PT,
144A,
FRN,
19.138%,
9/15/44
................
United
States
4,612,870
3,952,531
2019-37,
PT,
144A,
FRN,
20.068%,
10/17/44
...............
United
States
4,747,020
4,207,236
2019-42,
PT,
144A,
FRN,
19.334%,
11/15/44
...............
United
States
5,128,246
4,426,734
2019-51,
PT,
144A,
FRN,
17.231%,
1/15/45
................
United
States
5,557,832
4,838,663
2019-52,
PT,
144A,
FRN,
17.6%,
1/15/45
..................
United
States
5,522,395
4,845,489
2019-S1,
PT,
144A,
FRN,
15.295%,
4/15/44
................
United
States
3,576,536
3,004,915
2019-S2,
PT,
144A,
FRN,
15.2%,
5/16/44
..................
United
States
2,684,525
2,240,213
2019-S3,
PT,
144A,
FRN,
14.692%,
6/15/44
................
United
States
3,500,697
2,952,643
2019-S4,
PT,
144A,
FRN,
12.487%,
8/15/44
................
United
States
4,033,809
3,419,550
2019-S5,
PT,
144A,
FRN,
13.461%,
9/15/44
................
United
States
3,859,218
3,449,892
2019-S6,
PT,
144A,
FRN,
11.881%,
10/17/44
...............
United
States
3,835,533
3,301,012
2019-S7,
PT,
144A,
FRN,
11.349%,
12/15/44
...............
United
States
3,355,259
2,917,990
2019-S8,
PT,
144A,
FRN,
10.753%,
1/15/45
................
United
States
4,111,285
3,565,808
2020-2,
PT,
144A,
FRN,
17.326%,
3/15/45
.................
United
States
5,434,651
4,700,441
2020-7,
PT,
144A,
FRN,
17.023%,
4/17/45
.................
United
States
3,440,361
2,991,188
w
CWABS
Asset-Backed
Certificates
Trust
,
2005-11
,
AF4
,
FRN
,
5.21
%
,
3/25/34
...........................................
United
States
627,882
630,874
j,v
Dryden
38
Senior
Loan
Fund
,
2015-38A
,
CR
,
144A,
FRN
,
2.237
%
,
(
3-month
USD
LIBOR
+
2
%
),
7/15/30
.....................
United
States
7,186,000
6,945,318
j,v
Dryden
42
Senior
Loan
Fund
,
2016-42A
,
DR
,
144A,
FRN
,
3.167
%
,
(
3-month
USD
LIBOR
+
2.93
%
),
7/15/30
..................
United
States
8,400,000
7,793,724
j,v
Dryden
55
CLO
Ltd.
,
2018-55A
,
D
,
144A,
FRN
,
3.087
%
,
(
3-month
USD
LIBOR
+
2.85
%
),
4/15/31
..........................
United
States
3,000,000
2,668,167
j,v
Eaton
Vance
CLO
Ltd.
,
2014-1RA
,
C
,
144A,
FRN
,
2.337
%
,
(
3-month
USD
LIBOR
+
2.1
%
),
7/15/30
...........................
United
States
1,972,575
1,917,865
j,v
Galaxy
XVIII
CLO
Ltd.
,
2018-28A
,
C
,
144A,
FRN
,
2.187
%
,
(
3-month
USD
LIBOR
+
1.95
%
),
7/15/31
..........................
United
States
3,070,000
2,951,642
j,v
Galaxy
XXVII
CLO
Ltd.
,
2018-27A
,
C
,
144A,
FRN
,
2.08
%
,
(
3-month
USD
LIBOR
+
1.8
%
),
5/16/31
...........................
United
States
3,600,000
3,460,609
j,v
HPS
Loan
Management
Ltd.
,
13A-18
,
C
,
144A,
FRN
,
2.387
%
,
(
3-month
USD
LIBOR
+
2.15
%
),
10/15/30
.................
United
States
4,950,000
4,776,920
j,v
LCM
XVI
LP
,
16A
,
BR2
,
144A,
FRN
,
1.987
%
,
(
3-month
USD
LIBOR
+
1.75
%
),
10/15/31
..................................
United
States
13,525,832
13,354,763
j,v
LCM
XVII
LP
,
17A,
BRR,
144A,
FRN,
1.837%,
(3-month
USD
LIBOR
+
1.6%),
10/15/31
..........................................
United
States
4,590,000
4,450,717
17A,
CRR,
144A,
FRN,
2.337%,
(3-month
USD
LIBOR
+
2.1%),
10/15/31
..........................................
United
States
4,240,000
4,071,039
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
33
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Asset-Backed
Securities
(continued)
Diversified
Financial
Services
(continued)
j,v
LCM
XVIII
LP
,
18A
,
DR
,
144A,
FRN
,
3.018
%
,
(
3-month
USD
LIBOR
+
2.8
%
),
4/20/31
....................................
United
States
6,860,000
$
5,986,588
j,v
Madison
Park
Euro
Funding
VIII
DAC
,
8A
,
BRN
,
144A,
FRN
,
1.7
%
,
(
3-month
EURIBOR
+
1.7
%
),
4/15/32
.....................
Ireland
4,100,000
EUR
4,746,447
j,w
Mill
City
Mortgage
Loan
Trust
,
2018-4
,
A1B
,
144A,
FRN
,
3.5
%
,
4/25/66
...........................................
United
States
15,221,926
16,164,860
j,v
Neuberger
Berman
CLO
XVIII
Ltd.
,
2014-18A
,
CR2
,
144A,
FRN
,
3.209
%
,
(
3-month
USD
LIBOR
+
3
%
),
10/21/30
.............
United
States
500,000
449,520
j,v
Neuberger
Berman
CLO
XXII
Ltd.
,
2016-22A
,
CR
,
144A,
FRN
,
2.418
%
,
(
3-month
USD
LIBOR
+
2.2
%
),
10/17/30
............
United
States
2,129,630
2,076,421
j,v
NZCG
Funding
Ltd.
,
2015-1A
,
A2R
,
144A,
FRN
,
1.784
%
,
(
3-month
USD
LIBOR
+
1.55
%
),
2/26/31
..........................
United
States
15,500,000
15,237,146
j,v
Octagon
Investment
Partners
28
Ltd.
,
2016-1A,
A2R,
144A,
FRN,
1.665%,
(3-month
USD
LIBOR
+
1.45%),
10/24/30
....................................
United
States
5,000,000
4,924,494
2016-1A,
BR,
144A,
FRN,
2.015%,
(3-month
USD
LIBOR
+
1.8%),
10/24/30
..........................................
United
States
3,914,730
3,862,056
j,v
Octagon
Investment
Partners
36
Ltd.
,
2018-1A
,
A1
,
144A,
FRN
,
1.207
%
,
(
3-month
USD
LIBOR
+
0.97
%
),
4/15/31
............
United
States
7,475,000
7,368,505
j,v
Octagon
Investment
Partners
37
Ltd.
,
2018-2A
,
C
,
144A,
FRN
,
3.065
%
,
(
3-month
USD
LIBOR
+
2.85
%
),
7/25/30
............
United
States
4,000,000
3,684,607
j,v
Octagon
Investment
Partners
38
Ltd.
,
2018-1A
,
C
,
144A,
FRN
,
3.168
%
,
(
3-month
USD
LIBOR
+
2.95
%
),
7/20/30
............
United
States
5,000,000
4,598,620
j,v
Octagon
Investment
Partners
XVI
Ltd.
,
2013-1A
,
DR
,
144A,
FRN
,
3.218
%
,
(
3-month
USD
LIBOR
+
3
%
),
7/17/30
..............
United
States
6,000,000
5,416,476
j,v
Octagon
Investment
Partners
XXIII
Ltd.
,
2015-1A
,
BR
,
144A,
FRN
,
1.437
%
,
(
3-month
USD
LIBOR
+
1.2
%
),
7/15/27
.............
United
States
4,590,000
4,469,736
v
Opteum
Mortgage
Acceptance
Corp.
,
2005-4
,
1APT
,
FRN
,
0.459
%
,
(
1-month
USD
LIBOR
+
0.31
%
),
11/25/35
..................
United
States
950,529
954,672
j,k,w
Prosper
Pass-Thru
Trust
III
,
2020-PT1,
A,
144A,
FRN,
8.796%,
3/15/26
.................
United
States
3,500,511
3,433,396
2020-PT2,
A,
144A,
FRN,
9.444%,
4/15/26
.................
United
States
3,801,819
3,733,453
2020-PT3,
A,
144A,
FRN,
7.183%,
5/15/26
.................
United
States
1,040,229
1,055,622
j,k,w
Provident
Funding
Mortgage
Trust
,
2019-1,
A2,
144A,
FRN,
3%,
12/25/49
....................
United
States
6,024,189
6,215,054
2020-1,
A3,
144A,
FRN,
3%,
2/25/50
.....................
United
States
5,564,889
5,669,376
j,v
Strata
CLO
I
Ltd.
,
2018-1A
,
B
,
144A,
FRN
,
2.437
%
,
(
3-month
USD
LIBOR
+
2.2
%
),
1/15/31
...............................
United
States
14,100,000
13,359,628
j,k
Upgrade
Master
Pass-Thru
Trust
,
w
2019-PT1,
A,
144A,
FRN,
12.429%,
6/15/25
................
United
States
2,028,960
1,825,080
2019-PT2,
A,
144A,
7.727%,
2/15/26
.....................
United
States
2,950,813
2,893,648
j,v
Voya
CLO
Ltd.
,
2013-2A,
A2AR,
144A,
FRN,
1.615%,
(3-month
USD
LIBOR
+
1.4%),
4/25/31
......................................
United
States
2,200,000
2,127,889
2013-2A,
BR,
144A,
FRN,
2.065%,
(3-month
USD
LIBOR
+
1.85%),
4/25/31
.....................................
United
States
5,770,000
5,507,004
2014-1A,
CR2,
144A,
FRN,
3.018%,
(3-month
USD
LIBOR
+
2.8%),
4/18/31
......................................
United
States
8,000,000
6,990,365
2015-2A,
BR,
144A,
FRN,
1.709%,
(3-month
USD
LIBOR
+
1.5%),
7/23/27
...........................................
United
States
9,290,000
9,148,273
2016-1A,
BR,
144A,
FRN,
2.018%,
(3-month
USD
LIBOR
+
1.8%),
1/20/31
...........................................
United
States
590,000
563,414
410,324,974
a
a
a
a
a
a
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
34
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Asset-Backed
Securities
(continued)
Thrifts
&
Mortgage
Finance
8.8%
v
FHLMC
Structured
Agency
Credit
Risk
Debt
Notes
,
2013-DN2,
M2,
FRN,
4.399%,
(1-month
USD
LIBOR
+
4.25%),
11/25/23
..........................................
United
States
9,290,229
$
8,557,630
2014-DN1,
M2,
FRN,
2.349%,
(1-month
USD
LIBOR
+
2.2%),
2/25/24
...........................................
United
States
870,135
871,204
2014-DN2,
M3,
FRN,
3.749%,
(1-month
USD
LIBOR
+
3.6%),
4/25/24
...........................................
United
States
18,523,984
17,577,709
2014-DN3,
M3,
FRN,
4.149%,
(1-month
USD
LIBOR
+
4%),
8/25/24
...........................................
United
States
720,337
728,636
2014-DN4,
M3,
FRN,
4.699%,
(1-month
USD
LIBOR
+
4.55%),
10/25/24
..........................................
United
States
8,595,791
8,765,722
2014-HQ1,
M3,
FRN,
4.249%,
(1-month
USD
LIBOR
+
4.1%),
8/25/24
...........................................
United
States
1,609,999
1,631,851
2014-HQ2,
M2,
FRN,
2.349%,
(1-month
USD
LIBOR
+
2.2%),
9/25/24
...........................................
United
States
1,365,538
1,366,209
2014-HQ3,
M3,
FRN,
4.899%,
(1-month
USD
LIBOR
+
4.75%),
10/25/24
..........................................
United
States
3,005,844
3,049,722
2015-DNA1,
M3,
FRN,
3.449%,
(1-month
USD
LIBOR
+
3.3%),
10/25/27
..........................................
United
States
2,559,798
2,645,345
2015-DNA3,
M3,
FRN,
4.849%,
(1-month
USD
LIBOR
+
4.7%),
4/25/28
...........................................
United
States
17,296,896
18,094,978
2015-HQ1,
M3,
FRN,
3.949%,
(1-month
USD
LIBOR
+
3.8%),
3/25/25
...........................................
United
States
1,485,220
1,489,559
2015-HQA1,
M3,
FRN,
4.849%,
(1-month
USD
LIBOR
+
4.7%),
3/25/28
...........................................
United
States
13,874,756
14,458,758
2016-DNA2,
M3,
FRN,
4.799%,
(1-month
USD
LIBOR
+
4.65%),
10/25/28
..........................................
United
States
12,505,853
13,044,403
2017-DNA1,
M2,
FRN,
3.399%,
(1-month
USD
LIBOR
+
3.25%),
7/25/29
...........................................
United
States
7,063,901
7,296,751
2017-DNA2,
M2,
FRN,
3.599%,
(1-month
USD
LIBOR
+
3.45%),
10/25/29
..........................................
United
States
5,868,312
6,058,653
2017-DNA3,
M2,
FRN,
2.649%,
(1-month
USD
LIBOR
+
2.5%),
3/25/30
...........................................
United
States
26,312,269
26,714,336
2017-HQA1,
M2,
FRN,
3.699%,
(1-month
USD
LIBOR
+
3.55%),
8/25/29
...........................................
United
States
24,183,120
24,699,510
2017-HQA2,
M2,
FRN,
2.799%,
(1-month
USD
LIBOR
+
2.65%),
12/25/29
..........................................
United
States
2,692,653
2,686,497
v
FNMA
Connecticut
Avenue
Securities
,
2013-C01,
M2,
FRN,
5.399%,
(1-month
USD
LIBOR
+
5.25%),
10/25/23
..........................................
United
States
10,677,235
10,584,620
2014-C01,
M2,
FRN,
4.549%,
(1-month
USD
LIBOR
+
4.4%),
1/25/24
...........................................
United
States
12,847,195
12,227,014
2014-C02,
1M2,
FRN,
2.749%,
(1-month
USD
LIBOR
+
2.6%),
5/25/24
...........................................
United
States
10,632,949
9,407,080
2014-C03,
1M2,
FRN,
3.149%,
(1-month
USD
LIBOR
+
3%),
7/25/24
...........................................
United
States
22,954,534
20,446,671
2014-C03,
2M2,
FRN,
3.049%,
(1-month
USD
LIBOR
+
2.9%),
7/25/24
...........................................
United
States
2,624,077
2,621,927
2015-C01,
1M2,
FRN,
4.449%,
(1-month
USD
LIBOR
+
4.3%),
2/25/25
...........................................
United
States
5,111,514
5,209,534
2015-C01,
2M2,
FRN,
4.699%,
(1-month
USD
LIBOR
+
4.55%),
2/25/25
...........................................
United
States
3,767,209
3,827,137
2015-C02,
1M2,
FRN,
4.149%,
(1-month
USD
LIBOR
+
4%),
5/25/25
...........................................
United
States
15,057,464
15,227,307
2015-C02,
2M2,
FRN,
4.149%,
(1-month
USD
LIBOR
+
4%),
5/25/25
...........................................
United
States
5,282,646
5,369,745
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
35
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Asset-Backed
Securities
(continued)
Thrifts
&
Mortgage
Finance
(continued)
v
FNMA
Connecticut
Avenue
Securities,
(continued)
2015-C03,
1M2,
FRN,
5.149%,
(1-month
USD
LIBOR
+
5%),
7/25/25
...........................................
United
States
17,910,787
$
18,303,726
2015-C03,
2M2,
FRN,
5.149%,
(1-month
USD
LIBOR
+
5%),
7/25/25
...........................................
United
States
6,565,385
6,737,591
2016-C02,
1M2,
FRN,
6.149%,
(1-month
USD
LIBOR
+
6%),
9/25/28
...........................................
United
States
5,396,756
5,696,580
2016-C04,
1M2,
FRN,
4.399%,
(1-month
USD
LIBOR
+
4.25%),
1/25/29
...........................................
United
States
6,560,179
6,806,195
2016-C05,
2M2,
FRN,
4.599%,
(1-month
USD
LIBOR
+
4.45%),
1/25/29
...........................................
United
States
3,651,837
3,789,380
2016-C06,
1M2,
FRN,
4.399%,
(1-month
USD
LIBOR
+
4.25%),
4/25/29
...........................................
United
States
1,663,422
1,726,829
2016-C07,
2M2,
FRN,
4.499%,
(1-month
USD
LIBOR
+
4.35%),
5/25/29
...........................................
United
States
2,551,991
2,665,099
2017-C01,
1M2,
FRN,
3.699%,
(1-month
USD
LIBOR
+
3.55%),
7/25/29
...........................................
United
States
16,152,108
16,665,994
2017-C03,
1M2,
FRN,
3.149%,
(1-month
USD
LIBOR
+
3%),
10/25/29
..........................................
United
States
22,828,778
23,092,363
2017-C04,
2M2,
FRN,
2.999%,
(1-month
USD
LIBOR
+
2.85%),
11/25/29
..........................................
United
States
6,141,829
6,163,853
2017-C05,
1M2,
FRN,
2.349%,
(1-month
USD
LIBOR
+
2.2%),
1/25/30
...........................................
United
States
15,464,270
15,336,681
351,642,799
a
a
a
a
a
a
Total
Asset-Backed
Securities
(Cost
$833,992,434)
..............................
786,897,846
Commercial
Mortgage-Backed
Securities
0.1%
Diversified
Financial
Services
0.1%
w
Commercial
Mortgage
Trust
,
2006-GG7
,
AJ
,
FRN
,
6.012
%
,
7/10/38
United
States
2,421,618
2,180,061
v
MortgageIT
Trust
,
2004-1
,
A2
,
FRN
,
1.049
%
,
(
1-month
USD
LIBOR
+
0.9
%
),
11/25/34
....................................
United
States
1,297,363
1,332,470
3,512,531
a
a
a
a
a
a
Total
Commercial
Mortgage-Backed
Securities
(Cost
$3,590,200)
.................
3,512,531
Mortgage-Backed
Securities
7.7%
x
Federal
Home
Loan
Mortgage
Corp.
(FHLMC)
Adjustable
Rate
0.0%
FHLMC,
3.848%,
(1-year
CMT
T-Note
+/-
MBS
Margin),
1/01/33
..
United
States
10,504
10,507
Federal
Home
Loan
Mortgage
Corp.
(FHLMC)
Fixed
Rate
0.0%
FHLMC
Gold
Pools,
15
Year,
5%,
7/01/22
...................
United
States
16,347
17,259
FHLMC
Gold
Pools,
20
Year,
5%,
5/01/27
-
5/01/30
............
United
States
240,340
266,658
FHLMC
Gold
Pools,
20
Year,
6.5%,
10/01/21
.................
United
States
847
945
FHLMC
Gold
Pools,
20
Year,
7%,
9/01/21
...................
United
States
874
887
FHLMC
Gold
Pools,
30
Year,
4.5%,
10/01/40
.................
United
States
99,716
112,201
FHLMC
Gold
Pools,
30
Year,
5%,
3/01/34
-
2/01/38
............
United
States
524,571
594,085
FHLMC
Gold
Pools,
30
Year,
5.5%,
6/01/33
-
6/01/36
..........
United
States
615,471
708,582
FHLMC
Gold
Pools,
30
Year,
6%,
6/01/33
-
6/01/37
............
United
States
233,501
266,521
FHLMC
Gold
Pools,
30
Year,
6.5%,
12/01/25
-
6/01/36
.........
United
States
78,097
90,439
FHLMC
Gold
Pools,
30
Year,
7%,
4/01/28
-
8/01/32
............
United
States
13,305
14,129
FHLMC
Gold
Pools,
30
Year,
7.5%,
1/01/26
-
1/01/31
..........
United
States
3,920
4,704
FHLMC
Gold
Pools,
30
Year,
8%,
11/01/25
-
1/01/26
...........
United
States
57
57
FHLMC
Gold
Pools,
30
Year,
9%,
12/01/24
..................
United
States
41
45
2,076,512
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
36
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Mortgage-Backed
Securities
(continued)
x
Federal
National
Mortgage
Association
(FNMA)
Adjustable
Rate
0.0%
FNMA,
3.2%,
(1-year
CMT
T-Note
+/-
MBS
Margin),
12/01/34
....
United
States
91,556
$
93,865
Federal
National
Mortgage
Association
(FNMA)
Fixed
Rate
6.6%
FNMA,
15
Year,
2.5%,
7/01/27
...........................
United
States
176,409
183,672
FNMA,
15
Year,
5.5%,
3/01/21
-
4/01/22
....................
United
States
5,658
5,690
FNMA,
20
Year,
4.5%,
3/01/28
...........................
United
States
53,973
58,295
FNMA,
20
Year,
5%,
9/01/23
-
6/01/31
......................
United
States
302,731
335,149
FNMA,
30
Year,
3%,
9/01/48
-
9/01/50
......................
United
States
30,412,928
32,029,239
FNMA,
30
Year,
4.5%,
2/01/41
...........................
United
States
282,774
318,246
FNMA,
30
Year,
5%,
10/01/35
............................
United
States
561,539
647,747
FNMA,
30
Year,
5.5%,
9/01/33
-
12/01/35
...................
United
States
793,946
920,362
FNMA,
30
Year,
6%,
6/01/34
-
5/01/38
......................
United
States
1,763,581
2,025,972
FNMA,
30
Year,
6.5%,
3/01/28
-
10/01/37
...................
United
States
239,076
279,311
FNMA,
30
Year,
7.5%,
10/01/29
...........................
United
States
4,091
4,781
FNMA,
30
Year,
8%,
1/01/25
-
5/01/26
......................
United
States
1,816
2,031
y
FNMA,
Single-family,
15
Year,
1.5%,
11/25/35
................
United
States
15,823,000
16,150,586
y
FNMA,
Single-family,
15
Year,
2%,
11/25/35
.................
United
States
46,650,000
48,373,863
y
FNMA,
Single-family,
30
Year,
2%,
11/25/50
.................
United
States
52,496,000
54,126,246
y
FNMA,
Single-family,
30
Year,
2.5%,
11/25/50
................
United
States
102,832,000
107,150,140
262,611,330
Government
National
Mortgage
Association
(GNMA)
Fixed
Rate
1.1%
GNMA
I,
30
Year,
8%,
2/15/25
............................
United
States
26
28
GNMA
I,
Single-family,
30
Year,
5%,
6/15/34
-
7/15/34
..........
United
States
89,734
103,133
GNMA
I,
Single-family,
30
Year,
5.5%,
2/15/33
-
6/15/36
........
United
States
274,085
312,332
GNMA
I,
Single-family,
30
Year,
6%,
8/15/36
.................
United
States
19,008
22,714
GNMA
I,
Single-family,
30
Year,
6.5%,
2/15/29
-
3/15/32
........
United
States
34,364
37,927
GNMA
I,
Single-family,
30
Year,
7%,
11/15/27
-
5/15/28
.........
United
States
5,207
5,252
GNMA
I,
Single-family,
30
Year,
7.5%,
9/15/23
-
5/15/27
........
United
States
526
545
GNMA
I,
Single-family,
30
Year,
8%,
7/15/26
-
9/15/27
..........
United
States
2,603
2,712
GNMA
I,
Single-family,
30
Year,
8.5%,
8/15/24
................
United
States
36
37
GNMA
I,
Single-family,
30
Year,
9%,
1/15/25
.................
United
States
139
140
GNMA
I,
Single-family,
30
Year,
9.5%,
6/15/25
................
United
States
312
313
y
GNMA
II,
Single-family,
30
Year,
2%,
11/15/50
................
United
States
20,751,000
21,538,079
y
GNMA
II,
Single-family,
30
Year,
2.5%,
11/15/50
..............
United
States
20,554,000
21,527,103
GNMA
II,
Single-family,
30
Year,
5%,
9/20/33
-
11/20/33
.........
United
States
146,376
166,619
GNMA
II,
Single-family,
30
Year,
5.5%,
6/20/34
...............
United
States
74,876
88,847
GNMA
II,
Single-family,
30
Year,
6%,
11/20/34
................
United
States
78,026
90,750
GNMA
II,
Single-family,
30
Year,
6.5%,
7/20/28
-
12/20/31
.......
United
States
42,475
49,528
GNMA
II,
Single-family,
30
Year,
7.5%,
4/20/32
...............
United
States
14,489
16,793
43,962,852
Total
Mortgage-Backed
Securities
(Cost
$307,301,265)
...........................
308,755,066
Municipal
Bonds
1.6%
California
0.3%
City
of
San
Francisco,
Public
Utilities
Commission
Water,
Revenue,
2019
A,
Refunding,
3.473%,
11/01/43
.....................
United
States
2,310,000
2,423,675
San
Bernardino
Community
College
District,
GO,
2019
A-1,
3.271%,
8/01/39
...........................................
United
States
2,160,000
2,306,124
San
Diego
County
Regional
Transportation
Commission,
Revenue,
2019
A,
Refunding,
3.248%,
4/01/48
.....................
United
States
2,360,000
2,422,658
San
Jose
Redevelopment
Agency
Successor
Agency,
Tax
Allocation,
Senior
Lien,
2017A-T,
Refunding,
3.25%,
8/01/29
............
United
States
5,675,000
6,091,942
13,244,399
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
37
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Municipal
Bonds
(continued)
Colorado
0.1%
Metro
Wastewater
Reclamation
District,
Revenue,
2019
B,
Refunding,
3.158%,
4/01/41
............................
United
States
4,880,000
$
5,123,415
Hawaii
0.0%
City
&
County
Honolulu,
Wastewater
System,
Revenue,
2019
B,
Refunding,
2.585%,
7/01/28
............................
United
States
1,180,000
1,253,809
Massachusetts
0.1%
Massachusetts
School
Building
Authority,
Revenue,
2019
B,
Refunding,
3.395%,
10/15/40
...........................
United
States
2,905,000
3,034,127
New
Jersey
0.1%
New
Jersey
Transportation
Trust
Fund
Authority,
Revenue,
2019
B,
Refunding,
4.131%,
6/15/42
............................
United
States
3,535,000
3,310,068
New
York
0.2%
z
Metropolitan
Transportation
Authority,
Revenue,
2020
E,
Refunding,
4%,
11/15/45
.......................................
United
States
3,265,000
3,283,741
New
York
State
Dormitory
Authority,
State
University
of
New
York,
Revenue,
2019B,
Refunding,
3.142%,
7/01/43
..............
United
States
3,145,000
3,266,649
6,550,390
Ohio
0.1%
State
of
Ohio,
Cleveland
Clinic
Health
System
Obligated
Group,
Revenue,
2019G,
Refunding,
3.276%,
1/01/42
..............
United
States
1,975,000
2,136,061
Oregon
0.1%
State
of
Oregon,
Department
of
Transportation,
Revenue,
Senior
Lien,
2019
B,
Refunding,
3.168%,
11/15/38
................
United
States
3,930,000
4,231,667
Pennsylvania
0.1%
University
of
Pittsburgh-of
the
Commonwealth
System
of
Higher
Education,
Revenue,
2017
C,
Refunding,
3.005%,
9/15/41
.....
United
States
5,500,000
5,714,225
Texas
0.3%
City
of
Austin,
Electric
Utility,
Revenue,
2008,
Refunding,
AGMC
Insured,
6.262%,
11/15/32
.............................
United
States
310,000
396,940
State
of
Texas,
GO,
2019,
Refunding,
3.211%,
4/01/44
.........
United
States
5,895,000
6,271,042
Texas
State
University
System
,
Revenue,
2019
B,
Refunding,
2.938%,
3/15/33
..............
United
States
2,315,000
2,499,042
Revenue,
2019
B,
Refunding,
3.289%,
3/15/40
..............
United
States
1,965,000
2,109,742
11,276,766
Utah
0.2%
Salt
Lake
City
Corp.,
Revenue,
2019B,
Refunding,
3.102%,
4/01/38
United
States
2,750,000
2,928,062
Utah
Transit
Authority,
Revenue,
Senior
Lien,
2019
B,
Refunding,
3.443%,
12/15/42
....................................
United
States
3,930,000
4,031,866
6,959,928
Total
Municipal
Bonds
(Cost
$59,973,937)
......................................
62,834,855
Shares/Units
Escrows
and
Litigation
Trusts
0.0%
a
Millennium
Corporate
Claim
Trust,
Escrow
Account
............
United
States
8,736,450
a
Millennium
Lender
Claim
Trust,
Escrow
Account
..............
United
States
8,736,450
a,c,f
Remington
Outdoor
Co.,
Inc.,
Litigation
Units
.................
United
States
124,500
b
Sanchez
Energy
Corp.,
Escrow
Account
....................
United
States
6,000,000
60,000
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
38
a
a
Country
Shares/Units
a
Value
a
a
a
a
a
a
Escrows
and
Litigation
Trusts
(continued)
a,b
Vistra
Energy
Corp.,
Escrow
Account
......................
United
States
30,000,000
$
45,000
Total
Escrows
and
Litigation
Trusts
(Cost
$869,132)
.............................
105,000
Total
Long
Term
Investments
(Cost
$4,245,742,245)
.............................
4,061,217,881
a
Short
Term
Investments
3.2%
a
a
Principal
Amount
*
a
Value
a
a
a
a
a
a
Repurchase
Agreements
1.9%
aa
Joint
Repurchase
Agreement,
0.058%,
11/02/20
(Maturity
Value
$75,752,118)
BNP
Paribas
Securities
Corp.
(Maturity
Value
$40,866,753)
Deutsche
Bank
Securities,
Inc.
(Maturity
Value
$18,538,815)
HSBC
Securities
(USA),
Inc.
(Maturity
Value
$16,346,550)
Collateralized
by
U.S.
Government
Agency
Securities,
3.5%
-
5%,
9/20/45
-
3/20/50;
U.S.
Treasury
Bonds,
7.13%
-
8.13%,
2/15/21
-
11/15/24;
U.S.
Treasury
Bond,
Index
Linked,
2.38%,
1/15/25;
U.S.
Treasury
Note,
1.63%,
2/20/46;
and
U.S.
Treasury
Note,
Index
Linked,
0.13%,
4/15/21
(valued
at
$77,272,881)
.............
75,751,755
75,751,755
Total
Repurchase
Agreements
(Cost
$75,751,755)
...............................
75,751,755
Country
Shares
a
Money
Market
Funds
1.3%
g,bb
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
........
United
States
51,931,261
51,931,261
Total
Money
Market
Funds
(Cost
$51,931,261)
..................................
51,931,261
cc
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
0.0%
a
a
a
a
a
Money
Market
Funds
0.0%
g,bb
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
........
United
States
27,000
27,000
Principal
Amount
*
Repurchase
Agreements
0.0%
aa
Joint
Repurchase
Agreement,
BNP
Paribas
SA,
0.07%,
11/02/20
(Maturity
Value
$7,958)
Collateralized
by
U.S.
Treasury
Bonds,
6.875%
-
8.125%,
5/15/21
-
8/15/25;
U.S.
Treasury
Notes,
0.25%
-
3%,
2/15/21
-
9/30/25,
U.S.
Treasury
Note,
Index
Linked,
1.125%,
1/15/21;
and
U.S.
Treasury
Bill,
Discount
Note,
3/25/21
(valued
at
$8,117)
..............
7,958
7,958
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$34,958)
...............................................................
34,958
Total
Short
Term
Investments
(Cost
$127,717,974
)
...............................
127,717,974
a
Total
Investments
(Cost
$4,373,460,219)
105.1%
................................
$4,188,935,855
Other
Assets,
less
Liabilities
(5.1)%
...........................................
(205,043,581)
Net
Assets
100.0%
...........................................................
$3,983,892,274
*
The
principal
amount
is
stated
in
U.S.
dollars
unless
otherwise
indicated.
Rounds
to
less
than
0.1%
of
net
assets.
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
39
a
Fair
valued
using
significant
unobservable
inputs.
See
Note
14
regarding
fair
value
measurements.
b
Non-income
producing.
c
See
Note
12
regarding
holdings
of
5%
voting
securities.
d
A
portion
or
all
of
the
security
is
on
loan
at
October
31,
2020.
See
Note
1(e)
e
The
security
is
owned
by
FT
Holdings
Corp.
II,
a
wholly-owned
subsidiary
of
the
Fund.
See
Note
1(h).
f
See
Note
9
regarding
restricted
securities.
g
See
Note
3(f)
regarding
investments
in
affiliated
management
investment
companies.
h
Income
may
be
received
in
additional
securities
and/or
cash.
i
Perpetual
security
with
no
stated
maturity
date.
j
Security
was
purchased
pursuant
to
Rule
144A
or
Regulation
S
under
the
Securities
Act
of
1933.
144A
securities
may
be
sold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers
or
in
a
public
offering
registered
under
the
Securities
Act
of
1933.
Regulation
S
securities
cannot
be
sold
in
the
United
States
without
either
an
effective
registration
statement
filed
pursuant
to
the
Securities
Act
of
1933,
or
pursuant
to
an
exemption
from
registration.
At
October
31,
2020,
the
aggregate
value
of
these
securities
was
$1,881,035,668,
representing
47.2%
of
net
assets.
k
The
coupon
rate
shown
represents
the
rate
at
period
end.
l
See
Note
1(k)
regarding
senior
floating
rate
interests.
m
A
portion
or
all
of
the
security
represents
an
unsettled
loan
commitment.
The
coupon
rate
is
to-be
determined
(TBD)
at
the
time
of
the
settlement
and
will
be
based
upon
a
reference
index/floor
plus
a
spread.
n
A
portion
or
all
of
the
security
purchased
on
a
delayed
delivery
basis.
See
Note
1(k).
o
See
Note
7
regarding
defaulted
securities.
p
See
Note
10
regarding
unfunded
loan
commitments.
q
See
Note
1(i)
regarding
Marketplace
Lending.
r
See
Note
1(g)
regarding
loan
participations
and
assignments.
s
A
supranational
organization
is
an
entity
formed
by
two
or
more
central
governments
through
international
treaties.
t
Principal
amount
of
security
is
adjusted
for
inflation.
See
Note
1(m).
u
The
principal
represents
the
notional
amount.
See
Note
1(d)
regarding
value
recovery
instruments.
v
The
coupon
rate
shown
represents
the
rate
inclusive
of
any
caps
or
floors,
if
applicable,
in
effect
at
period
end.
w
Adjustable
rate
security
with
an
interest
rate
that
is
not
based
on
a
published
reference
index
and
spread.  The
rate
is
based
on
the
structure
of
the
agreement
and
current
market
conditions.
The
coupon
rate
shown
represents
the
rate
at
period
end.
x
Adjustable
Rate
Mortgage-Backed
Security
(ARM);
the
rate
shown
is
the
effective
rate
at
period
end.
ARM
rates
are
not
based
on
a
published
reference
rate
and
spread,
but
instead
pass-through
weighted
average
interest
income
inclusive
of
any
caps
or
floors,
if
applicable,
from
the
underlying
mortgage
loans
in
which
the
majority
of
mortgages
pay
interest
based
on
the
index
shown
at
their
designated
reset
dates
plus
a
spread,
less
the
applicable
servicing
and
guaranty
fee
(MBS
margin).
y
Security
purchased
on
a
to-be-announced
(TBA)
basis.
See
Note
1(d).
z
Security
purchased
on
a
when-issued
basis.
See
Note
1(d).
aa
See
Note
1(c)
regarding
joint
repurchase
agreement.
bb
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
cc
See
Note
1(e)
regarding
securities
on
loan.
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
40
At
October
31,
2020,
the
Fund
had
the
following futures
contracts
outstanding.
See
Note
1(f). 
At
October
31,
2020,
the
Fund
had
the
following
forward
exchange
contracts
outstanding.
See
Note
1
(
f
). 
At
October
31,
2020,
the
Fund
had
the
following credit
default
swap
contracts outstanding.
See
Note
1
(
f
). 
Futures
Contracts
Description
Type
Number
of
Contracts
Notional
Amount
*
Expiration
Date
Value/
Unrealized
Appreciation
(Depreciation)
Interest
rate
contracts
Australia
3
Year
Bonds
........................
Long
1,173
$
96,841,491
12/15/20
$
386,755
Canada
10
Year
Bonds
........................
Long
135
15,305,810
12/18/20
(88,397)
U.S.
Treasury
10
Year
Notes
....................
Long
234
32,343,188
12/21/20
(194,102)
U.S.
Treasury
5
Year
Notes
.....................
Long
1,002
125,852,766
12/31/20
(222,350)
U.S.
Treasury
Ultra
Bonds
......................
Long
136
29,240,000
12/21/20
(1,074,453)
Total
Futures
Contracts
......................................................................
$(1,192,547)
*
As
of
period
end.
Forward
Exchange
Contracts
Currency
Counter-
party
a
Type
Quantity
Contract
Amount
*
Settlement
Date
Unrealized
Appreciation
Unrealized
Depreciation
a
a
a
a
a
a
a
a
OTC
Forward
Exchange
Contracts
Brazilian
Real
......
JPHQ
Buy
3,778,007
671,646
11/09/20
$
$
(13,284)
Brazilian
Real
......
JPHQ
Sell
3,778,007
707,128
11/09/20
48,766
Japanese
Yen
......
JPHQ
Buy
1,080,000,000
10,224,174
11/12/20
91,589
Singapore
Dollar
....
JPHQ
Sell
56,900,000
41,439,381
11/12/20
(215,267)
South
African
Rand
..
JPHQ
Buy
65,000,000
3,631,894
11/16/20
355,934
Brazilian
Real
......
JPHQ
Sell
119,495,000
21,711,757
11/30/20
904,867
Indonesian
Rupiah
..
JPHQ
Sell
190,000,000,000
12,367,376
11/30/20
(468,644)
Australian
Dollar
....
JPHQ
Sell
19,000,000
13,826,338
12/07/20
468,901
Canadian
Dollar
....
JPHQ
Sell
28,000,000
21,292,776
12/14/20
270,689
Euro
.............
JPHQ
Buy
21,738,000
25,654,753
12/14/20
(313,560)
Euro
.............
JPHQ
Sell
56,000,000
66,230,640
12/14/20
948,334
Japanese
Yen
......
JPHQ
Buy
4,000,000,000
37,708,101
12/14/20
516,494
Mexican
Peso
......
JPHQ
Buy
297,700,000
14,004,640
12/21/20
(46,686)
Canadian
Dollar
....
JPHQ
Sell
8,500,000
6,403,978
1/11/21
21,056
Turkish
Lira
........
JPHQ
Buy
62,000,000
7,769,423
1/11/21
(627,348)
Mexican
Peso
......
JPHQ
Buy
181,500,000
8,444,276
1/19/21
37,690
Australian
Dollar
....
DBAB
Sell
3,000,000
2,121,060
1/25/21
11,433
Australian
Dollar
....
JPHQ
Sell
52,000,000
36,767,510
1/25/21
200,643
Brazilian
Real
......
JPHQ
Sell
3,778,007
669,919
2/08/21
13,679
Canadian
Dollar
....
JPHQ
Sell
23,800,000
18,159,552
2/25/21
286,245
Japanese
Yen
......
JPHQ
Buy
4,850,000,000
46,061,395
2/25/21
337,498
Total
Forward
Exchange
Contracts
...................................................
$4,513,818
$(1,684,789)
Net
unrealized
appreciation
(depreciation)
............................................
$2,829,029
*
In
U.S.
dollars
unless
otherwise
indicated.
a
May
be
comprised
of
multiple
contracts
with
the
same
counterparty,
currency
and
settlement
date.
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
41
At
October
31,
2020,
the
Fund
had
the
following cross-currency
swap
contracts outstanding.
See
Note
1
(
f
). 
Credit
Default
Swap
Contracts
Description
Periodic
Payment
Rate
Received
(Paid)
Payment
Frequency
Counter-
party
Maturity
Date
Notional
Amount
(a)
Value
Unamortized
Upfront
Payments
(Receipts)
Unrealized
Appreciation
(Depreciation)
Rating
(b)
Centrally
Cleared
Swap
Contracts
Contracts
to
Sell
Protection
(c)(d)
Traded
Index
CDX.NA.HY.35
.....
5.00%
Quarterly
12/20/25
$
76,000,000
$
3,067,541
$
4,821,724
$
(1,754,183)
Non-
Investment
Grade
Total
Centrally
Cleared
Swap
Contracts
.....................................
$3,067,541
$4,821,724
$(1,754,183)
OTC
Swap
Contracts
Contracts
to
Buy
Protection
(c)
Single
Name
Ally
Financial,
Inc.
...
(5.00)%
Quarterly
JPHQ
12/20/24
19,800,000
(3,270,389)
(3,059,973)
(210,416)
Italy
Government
Bond
(1.00)%
Quarterly
BZWS
6/20/23
14,200,000
(176,321)
81,499
(257,820)
Contracts
to
Sell
Protection
(c)(d)
Single
Name
Italy
Government
Bond
1.00%
Quarterly
BZWS
6/20/23
14,200,000
88,694
(357,386)
446,080
NR
Traded
Index
(e)
BNP
Paribas
Bespoke
Rodez2
Index,
Mezzanine
Tranche
5-7%
..........
3.20%
Quarterly
BNDP
12/20/20
3,300,000
(65,407)
(65,407)
Non-
Investment
Grade
(e)
Citibank
Bespoke
Palma
Index,
Mezzanine
Tranche
5-7%
..........
2.30%
Quarterly
CITI
6/20/21
6,700,000
(168,050)
(168,050)
Non-
Investment
Grade
(e)
Citibank
Bespoke
Phoenix
Index,
Mezzanine
Tranche
5-7%
..........
2.90%
Quarterly
CITI
12/20/21
8,500,000
(685,937)
(685,937)
Non-
Investment
Grade
MCDX.NA.31
......
1.00%
Quarterly
CITI
12/20/23
23,060,000
(135,982)
146,325
(282,307)
Investment
Grade
(e)
Morgan
Stanley
Bespoke
Pecan
Index,
Mezzanine
Tranche
5-10%
...
4.10%
Quarterly
MSCO
12/20/21
9,000,000
(2,336,379)
(2,336,379)
Non-
Investment
Grade
(e)
Morgan
Stanley
Bespoke
Pecan
Index,
Mezzanine
Tranche
5-10%
...
3.98%
Quarterly
MSCO
12/20/21
9,000,000
(2,348,153)
(2,348,153)
Non-
Investment
Grade
Total
OTC
Swap
Contracts
..............................................
$(9,097,924)
$(3,189,535)
$(5,908,389)
Total
Credit
Default
Swap
Contracts
....................................
$(6,030,383)
$
1,632,189
$(7,662,572)
(a)
In
U.S.
dollars
unless
otherwise
indicated.
For
contracts
to
sell
protection,
the
notional
amount
is
equal
to
the
maximum
potential
amount
of
the
future
payments
and
no
recourse
provisions
have
been
entered
into
in
association
with
the
contracts.
(b)
Based
on
Standard
and
Poor's
(S&P)
Rating
for
single
name
swaps
and
internal
ratings
for
index
swaps.
Internal
ratings
based
on
mapping
into
equivalent
ratings
from
external
vendors.
(c)
Performance
triggers
for
settlement
of
contract
include
default,
bankruptcy
or
restructuring
for
single
name
swaps,
and
failure
to
pay
or
bankruptcy
of
the
underlying
securities
for
traded
index
swaps.
(d)
The
fund
enters
contracts
to
sell
protection
to
create
a
long
credit
position.
(e)
Represents
a
custom
index
comprised
of
a
basket
of
underlying
instruments.
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
42
At
October
31,
2020,
the
Fund
had
the
following
interest
rate
swap
contracts
outstanding.
See
Note
1(f). 
At
October
31,
2020,
the
Fund
had
the
following inflation index
swap
contracts outstanding.
See
Note
1
(
f
). 
At
October
31,
2020,
the
Fund
had
the
following total
return swap
contracts
outstanding.
See
Note
1(f). 
Cross-Currency
Swap
Contracts
Description
Payment
Frequency
Counter-
party
Maturity
Date
Notional
Amount
Value/
Unrealized
Appreciation
(Depreciation)
aA
aaa
aaa
aaa
OTC
Swap
Contracts
Receive
Floating
3-month
USD
LIBOR
+
2.87%
.....
Quarterly
3,834,600
USD
Pay
Fixed
2.5%
.............................
Annual
CITI
5/04/21
3,300,000
EUR
$
(31,625)
Total
Cross
Currency
Swap
Contracts
...........................................................
$(31,625)
Interest
Rate
Swap
Contracts
Description
Payment
Frequency
Counter-
party
Maturity
Date
Notional
Amount
*
Value
Unamortized
Upfront
Payments
(Receipts)
Unrealized
Appreciation
(Depreciation)
aa
aa
aa
aa
Centrally
Cleared
Swap
Contracts
Receive
Floating
1.956%
Semi-Annual
Pay
Fixed
3-month
CAD
BA
..............
Semi-Annual
7/17/29
55,000,000
CAD
$
3,299,734
$
$
3,299,734
Receive
Floating
1.232%
Semi-Annual
Pay
Fixed
6-month
AUD
BBR
.............
Semi-Annual
9/06/29
55,000,000
AUD
1,943,336
1,943,336
Total
Interest
Rate
Swap
Contracts
...............................
$5,243,070
$
$5,243,070
*
In
U.S.
dollars
unless
otherwise
indicated.
Inflation
Index
Swap
Contracts
Description
Payment
Frequency
Counter-
party
Maturity
Date
Notional
Amount
Value
Unamortized
Upfront
Payments
(Receipts)
Unrealized
Appreciation
(Depreciation)
Centrally
Cleared
Swap
Contracts
Receive
variable
change
  in
USA
CPI-U
........
At
Maturity
Pay
Fixed
1.913%
.....
At
Maturity
1/14/29
$
34,600,000
$
(313,768)
$
$
(313,768)
Receive
variable
change
  in
USA
CPI-U
........
At
Maturity
Pay
Fixed
1.943%
.....
At
Maturity
1/15/29
46,900,000
(564,833)
(564,833)
Total
Inflation
Index
Swap
Contracts
..................................
$(878,601)
$—
$(878,601)
Franklin
Strategic
Series
Consolidated
Statement
of
Investments
(unaudited)
Franklin
Strategic
Income
Fund
(continued)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Semiannual
Report
43
See
Abbreviations
on
page
69
.
Total
Return
Swap
Contracts
Underlying
Instruments
Financing
Rate
Payment
Frequency
Counter-
party
Maturity
Date
Notional
Value
*
Value/
Unrealized
Appreciation
(Depreciation)
OTC
Swap
Contracts
Long
(a)
Markit
iBoxx
USD
Liquid
Leveraged
Loans
Total
Return
Index
...........................
3-month
USD
LIBOR
Quarterly
GSCO
12/21/20
23,600,000
$
(297,253)
Total
Return
Swap
Contracts
....................................................................
$(297,253)
*
In
U.S.
dollars
unless
otherwise
indicated.
(a)
The
Fund
receives
the
total
return
on
the
underlying
instrument
and
pays
a
variable
financing
rate.
Franklin
Strategic
Series
Consolidated
Financial
Statements
Consolidated
Statement
of
Assets
and
Liabilities
October
31,
2020
(unaudited)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
consolidated
financial
statements.
44
Franklin
Strategic
Income
Fund
Assets:
Investments
in
securities:
Cost
-
Unaffiliated
issuers
...................................................................
$4,091,838,717
Cost
-
Controlled
affiliates
(Note
3
f
and
12
)
......................................................
152,217,419
Cost
-
Non-controlled
affiliates
(Note
3
f
and
12
)
...................................................
53,644,370
Cost
-
Unaffiliated
repurchase
agreements
......................................................
75,759,713
Value
-
Unaffiliated
issuers
(Includes
securities
loaned
$
30,000
)
......................................
$3,950,396,273
Value
-
Controlled
affiliates
(Note
3
f
and
12
)
.....................................................
110,821,608
Value
-
Non-controlled
affiliates
(Note
3
f
and
12
)
..................................................
51,958,261
Value
-
Unaffiliated
repurchase
agreements
......................................................
75,759,713
Cash
....................................................................................
20,388,227
Receivables:
Investment
securities
sold
...................................................................
39,670,551
Capital
shares
sold
........................................................................
2,792,066
Dividends
and
interest
.....................................................................
36,093,876
Deposits
with
brokers
for:
OTC
derivative
contracts
..................................................................
15,841,972
TBA
transactions
........................................................................
330,000
Futures
contracts
........................................................................
3,304,135
Centrally
cleared
swap
contracts
............................................................
7,696,627
OTC
swap
contracts
(upfront
payments
$
5,049,604
)
.................................................
227,824
Unrealized
appreciation
on
OTC
forward
exchange
contracts
..........................................
4,513,818
Unrealized
appreciation
on
OTC
swap
contracts
....................................................
446,080
Unrealized
appreciation
on
unfunded
loan
commitments
..............................................
122,307
FT
Subsidiary
deferred
tax
benefit
(Note
1
h
)
.......................................................
402,876
Other
assets
..............................................................................
1,552
Total
assets
..........................................................................
4,320,767,766
Liabilities:
Payables:
Investment
securities
purchased
..............................................................
312,578,021
Capital
shares
redeemed
...................................................................
6,870,062
Management
fees
.........................................................................
1,505,546
Distribution
fees
..........................................................................
880,492
Transfer
agent
fees
........................................................................
544,010
Distributions
to
shareholders
.................................................................
609,560
Variation
margin
on
futures
contracts
...........................................................
186,465
Variation
margin
on
centrally
cleared
swap
contracts
...............................................
1,144,770
OTC
swap
contracts
(upfront
receipts
$
3,417,379
)
..................................................
3,417,359
Unrealized
depreciation
on
OTC
swap
contracts
....................................................
6,683,347
Unrealized
depreciation
on
OTC
forward
exchange
contracts
..........................................
1,684,789
Payable
upon
return
of
securities
loaned
.........................................................
34,958
Deferred
tax
...............................................................................
211,953
Accrued
expenses
and
other
liabilities
...........................................................
524,160
Total
liabilities
.........................................................................
336,875,492
Net
assets,
at
value
.................................................................
$3,983,892,274
Net
assets
consist
of:
Paid-in
capital
.............................................................................
$4,792,879,456
Total
distributable
earnings
(losses)
.............................................................
(808,987,182)
Net
assets,
at
value
.................................................................
$3,983,892,274
Franklin
Strategic
Series
Consolidated
Financial
Statements
Consolidated
Statement
of
Assets
and
Liabilities
(continued)
October
31,
2020
(unaudited)
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
consolidated
financial
statements.
Semiannual
Report
45
Franklin
Strategic
Income
Fund
Class
A:
Net
assets,
at
value
.......................................................................
$2,837,732,207
Shares
outstanding
........................................................................
307,909,999
Net
asset
value
per
share
a
..................................................................
$9.22
Maximum
offering
price
per
share
(net
asset
value
per
share
÷
96
.25
%
)
................................
$9.58
Class
C:
Net
assets,
at
value
.......................................................................
$448,599,926
Shares
outstanding
........................................................................
48,665,691
Net
asset
value
and
maximum
offering
price
per
share
a
.............................................
$9.22
Class
R:
Net
assets,
at
value
.......................................................................
$62,763,573
Shares
outstanding
........................................................................
6,838,939
Net
asset
value
and
maximum
offering
price
per
share
.............................................
$9.18
Class
R6:
Net
assets,
at
value
.......................................................................
$126,053,559
Shares
outstanding
........................................................................
13,657,823
Net
asset
value
and
maximum
offering
price
per
share
.............................................
$9.23
Advisor
Class:
Net
assets,
at
value
.......................................................................
$508,743,009
Shares
outstanding
........................................................................
55,133,697
Net
asset
value
and
maximum
offering
price
per
share
.............................................
$9.23
a
Redemption
price
is
equal
to
net
asset
value
less
contingent
deferred
sales
charges,
if
applicable.
Franklin
Strategic
Series
Financial
Statements
Consolidated
Statement
of
Operations
for
the
six
months
ended
October
31,
2020
(unaudited)
franklintempleton.com
Semiannual
Report
The
accompanying
notes
are
an
integral
part
of
these
consolidated
financial
statements.
46
Franklin
Strategic
Income
Fund
Investment
income:
Dividends:
Unaffiliated
issuers
........................................................................
$3,710,350
Controlled
affiliates
(Note
3
f
and
12
)
...........................................................
661,683
Interest:
(net
of
foreign
taxes
$125,635)
Unaffiliated
issuers
........................................................................
117,575,409
Total
investment
income
...................................................................
121,947,442
Expenses:
Management
fees
(Note
3
a
)
...................................................................
9,312,201
Distribution
fees:
(Note
3c
)
    Class
A
................................................................................
3,567,437
    Class
C
................................................................................
1,618,366
    Class
R
................................................................................
160,985
Transfer
agent
fees:
(Note
3e
)
    Class
A
................................................................................
1,815,646
    Class
C
................................................................................
317,466
    Class
R
................................................................................
41,110
    Class
R6
...............................................................................
30,628
    Advisor
Class
............................................................................
337,963
Custodian
fees
(Note
4
)
......................................................................
69,440
Reports
to
shareholders
......................................................................
238,229
Registration
and
filing
fees
....................................................................
84,728
Professional
fees
...........................................................................
72,779
Marketplace
lending
fees
(Note
1i)
..............................................................
215,319
Other
....................................................................................
138,682
Total
expenses
.........................................................................
18,020,979
Expense
reductions
(Note
4
)
...............................................................
(116,588)
Expenses
waived/paid
by
affiliates
(Note
3
f
and
3
g
)
..............................................
(343,251)
Net
expenses
.........................................................................
17,561,140
Net
investment
income
................................................................
104,386,302
Realized
and
unrealized
gains
(losses):
Net
realized
gain
(loss)
from:
Investments:
Unaffiliated
issuers
......................................................................
(33,586,141)
Foreign
currency
transactions
................................................................
(3,927,507)
Forward
exchange
contracts
.................................................................
(19,884,494)
Futures
contracts
.........................................................................
4,608,297
TBA
sale
commitments
.....................................................................
574,777
Swap
contracts
...........................................................................
(25,195,175)
Net
realized
gain
(loss)
..................................................................
(77,410,243)
Net
change
in
unrealized
appreciation
(depreciation)
on:
Investments:
Unaffiliated
issuers
......................................................................
244,425,250
Controlled
affiliates
(Note
3
f
)
...............................................................
2,743,864
Non-controlled
affiliates
(Note
3
f
and
12
)
......................................................
(661,219)
Translation
of
other
assets
and
liabilities
denominated
in
foreign
currencies
..............................
(935,907)
Forward
exchange
contracts
.................................................................
6,255,398
Futures
contracts
.........................................................................
(4,409,398)
Swap
contracts
...........................................................................
47,791,427
Change
in
deferred
taxes
on
unrealized
appreciation
...............................................
(95,981)
Net
change
in
unrealized
appreciation
(depreciation)
............................................
295,113,434
Net
realized
and
unrealized
gain
(loss)
............................................................
217,703,191
Net
increase
(decrease)
in
net
assets
resulting
from
operations
..........................................
$322,089,493
Franklin
Strategic
Series
Consolidated
Financial
Statements
Consolidated
Statement
of
Changes
in
Net
Assets
franklintempleton.com
The
accompanying
notes
are
an
integral
part
of
these
consolidated
financial
statements.
Semiannual
Report
47
Franklin
Strategic
Income
Fund
Six
Months
Ended
October
31,
2020
(unaudited)
Year
Ended
April
30,
2020
Increase
(decrease)
in
net
assets:
Operations:
Net
investment
income
.................................................
$104,386,302
$182,627,278
Net
realized
gain
(loss)
.................................................
(77,410,243)
(42,550,243)
Net
change
in
unrealized
appreciation
(depreciation)
...........................
295,113,434
(382,746,373)
Net
increase
(decrease)
in
net
assets
resulting
from
operations
................
322,089,493
(242,669,338)
Distributions
to
shareholders:
Class
A
.............................................................
(53,891,254)
(133,707,047)
Class
C
.............................................................
(8,181,509)
(25,071,873)
Class
R
.............................................................
(1,140,995)
(3,171,248)
Class
R6
............................................................
(2,634,805)
(9,963,217)
Advisor
Class
........................................................
(10,585,354)
(26,896,542)
Total
distributions
to
shareholders
..........................................
(76,433,917)
(198,809,927)
Capital
share
transactions:
(Note
2
)
Class
A
.............................................................
(17,489,095)
(141,906,067)
Class
C
.............................................................
(102,792,212)
(138,604,206)
Class
R
.............................................................
(3,205,513)
(16,035,134)
Class
R6
............................................................
(15,127,948)
(159,106,633)
Advisor
Class
........................................................
(41,626,726)
(33,579,296)
Total
capital
share
transactions
............................................
(180,241,494)
(489,231,336)
Net
increase
(decrease)
in
net
assets
...................................
65,414,082
(930,710,601)
Net
assets:
Beginning
of
period
.....................................................
3,918,478,192
4,849,188,793
End
of
period
..........................................................
$3,983,892,274
$3,918,478,192
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
Franklin
Strategic
Income
Fund
48
franklintempleton.com
Semiannual
Report
1.
Organization
and
Significant
Accounting
Policies
Franklin
Strategic
Series (Trust)
is
registered
under
the
Investment
Company
Act
of
1940
(1940
Act)
as
an
open-end
management
investment
company,
consisting
of ten separate
funds
and
applies
the
specialized
accounting
and
reporting
guidance
in
U.S.
Generally
Accepted
Accounting
Principles
(U.S.
GAAP).
Franklin
Strategic
Income
Fund
(Fund)
is
included
in
this
report.
The
Fund
offers five
classes
of
shares:
Class A,
Class C,
Class R,
Class R6
and
Advisor
Class. Class
C
shares
automatically
convert
to
Class
A
shares
after
they
have
been
held
for
10
years.
Each
class
of
shares
may
differ
by
its
initial
sales
load,
contingent
deferred
sales
charges,
voting
rights
on
matters
affecting
a
single
class,
its
exchange
privilege
and
fees
due
to
differing
arrangements
for
distribution
and
transfer
agent
fees. 
The
following
summarizes
the Fund's
significant
accounting
policies.
a.
Financial
Instrument
Valuation 
The
Fund's
investments
in
financial
instruments
are
carried
at
fair
value
daily.
Fair
value
is
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
on
the
measurement
date.
The
Fund
calculates
the
net
asset
value
(NAV)
per
share
each business
day as
of
4
p.m.
Eastern
time
or
the
regularly
scheduled
close
of
the
New
York
Stock
Exchange
(NYSE),
whichever
is
earlier.
Under
compliance
policies
and
procedures
approved
by
the
Trust’s Board
of
Trustees
(the
Board),
the Fund's
administrator
has
responsibility
for
oversight
of
valuation,
including
leading
the
cross-functional
Valuation
Committee
(VC).
The
Fund
may
utilize
independent
pricing
services,
quotations
from
securities
and
financial
instrument
dealers,
and
other
market
sources
to
determine
fair
value. 
Equity
securities
and
derivative
financial
instruments
listed
on
an
exchange
or
on
the
NASDAQ
National
Market
System
are
valued
at
the
last
quoted
sale
price
or
the
official
closing
price of
the
day,
respectively.
Foreign
equity
securities
are
valued
as
of
the
close
of
trading
on
the
foreign
stock
exchange
on
which
the
security
is
primarily
traded,
or
as
of
4
p.m.
Eastern
time.
The
value
is
then
converted
into
its
U.S.
dollar
equivalent
at
the
foreign
exchange
rate
in
effect
at
4
p.m.
Eastern
time
on
the
day
that
the
value
of
the
security
is
determined.
Over-the-counter
(OTC)
securities
are
valued
within
the
range
of
the
most
recent
quoted
bid
and
ask
prices.
Securities
that
trade
in
multiple
markets
or
on
multiple
exchanges
are
valued
according
to
the
broadest
and
most
representative
market.
Certain
equity
securities
are
valued
based
upon
fundamental
characteristics
or
relationships
to
similar
securities. 
Debt
securities
generally
trade
in
the
OTC
market
rather
than
on
a
securities
exchange.
The
Fund's
pricing
services
use
multiple
valuation
techniques
to
determine
fair
value.
In
instances
where
sufficient
market
activity
exists,
the
pricing
services
may
utilize
a
market-based
approach
through
which
quotes
from
market
makers
are
used
to
determine
fair
value.
In
instances
where
sufficient
market
activity
may
not
exist
or
is
limited,
the
pricing
services
also
utilize
proprietary
valuation
models
which
may
consider
market
characteristics
such
as
benchmark
yield
curves,
credit
spreads,
estimated
default
rates,
anticipated
market
interest
rate
volatility,
coupon
rates,
anticipated
timing
of
principal
repayments,
underlying
collateral,
and
other
unique
security
features
in
order
to
estimate
the
relevant
cash
flows,
which
are
then
discounted
to
calculate
the
fair
value.
Securities
denominated
in
a
foreign
currency
are
converted
into
their
U.S.
dollar
equivalent
at
the
foreign
exchange
rate
in
effect
at
4
p.m.
Eastern
time
on
the
date
that
the
values
of
the
foreign
debt
securities
are
determined. 
Investments
in 
open-end mutual
funds
are
valued
at
the
closing
NAV.
Investments
in
repurchase
agreements
are
valued
at
cost,
which
approximates
fair
value.
Certain
derivative
financial
instruments
are
centrally
cleared
or
trade
in
the
OTC
market.
The
Fund's
pricing
services
use
various
techniques
including
industry
standard
option
pricing
models
and
proprietary
discounted
cash
flow
models
to
determine
the
fair
value
of
those
instruments.
The
Fund's
net
benefit
or
obligation
under
the
derivative
contract,
as
measured
by
the
fair
value
of
the
contract,
is
included
in
net
assets.
The
Fund
has
procedures
to
determine
the
fair
value
of
financial
instruments
for
which
market
prices
are
not
reliable
or
readily
available.
Under
these
procedures,
the Fund
primarily
employs
a
market-based
approach
which
may
use
related
or
comparable
assets
or
liabilities,
recent
transactions,
market
multiples,
book
values,
and
other
relevant
information
for
the
investment
to
determine
the
fair
value
of
the
investment.
An
income-based
valuation
approach
may
also
be
used
in
which
the
anticipated
future
cash
flows
of
the
investment
are
discounted
to
calculate
fair
value.
Discounts
may
also
be
applied
due
to
the
nature
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
49
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
or
duration
of
any
restrictions
on
the
disposition
of
the
investments.
Due
to
the
inherent
uncertainty
of
valuations
of
such
investments,
the
fair
values
may
differ
significantly
from
the
values
that
would
have
been
used
had
an
active
market
existed.
Trading
in
securities
on
foreign
securities
stock
exchanges
and
OTC
markets
may
be
completed
before
4
p.m.
Eastern
time.
In
addition,
trading
in
certain
foreign
markets
may
not
take
place
on
every
Fund's
business
day.
Occasionally,
events
occur
between
the
time
at
which
trading
in
a
foreign
security
is
completed
and
4
p.m.
Eastern
time
that
might
call
into
question
the
reliability
of
the
value
of
a
portfolio
security
held
by
the
Fund.
As
a
result,
differences
may
arise
between
the
value
of
the
Fund's
portfolio
securities
as
determined
at
the
foreign
market
close
and
the
latest
indications
of
value
at
4
p.m.
Eastern
time. In
order
to
minimize
the
potential
for
these
differences,
an
independent
pricing
service
may
be
used
to
adjust
the
value
of
the
Fund's
securities
to
the
latest
indications
of
fair
value
at
4
p.m.
Eastern
time.
At
October
31,
2020,certain
securities
may
have
been
fair
valued
using
these
procedures,
in
which
case
the
securities
were
categorized
as
Level
2
inputs
within
the
fair
value
hierarchy.
See
the
Fair
Value
Measurements
note
for
more
information.
When
the
last
day
of
the
reporting
period
is
a
non-business
day,
certain
foreign
markets
may
be
open
on
those
days
that
the
Fund's
NAV
is
not
calculated,
which
could
result
in
differences
between
the
value
of
the
Fund's
portfolio
securities
on
the
last
business
day
and
the
last
calendar
day
of
the
reporting
period.
Any
security
valuation
changes
due
to
an
open
foreign
market
are
adjusted
and
reflected
by
the
Fund
for
financial
reporting
purposes.
b.
Foreign
Currency
Translation 
Portfolio
securities
and
other
assets
and
liabilities
denominated
in
foreign
currencies
are
translated
into
U.S.
dollars
based
on
the
exchange
rate
of
such
currencies
against
U.S.
dollars
on
the
date
of
valuation.
The
Fund
may
enter
into
foreign
currency
exchange
contracts
to
facilitate
transactions
denominated
in
a
foreign
currency.
Purchases
and
sales
of
securities,
income
and
expense
items
denominated
in
foreign
currencies
are
translated
into
U.S.
dollars
at
the
exchange
rate
in
effect
on
the
transaction
date.
Portfolio
securities
and
assets
and
liabilities
denominated
in
foreign
currencies
contain
risks
that
those
currencies
will
decline
in
value
relative
to
the
U.S.
dollar.
Occasionally,
events
may
impact
the
availability
or
reliability
of
foreign
exchange
rates
used
to
convert
the
U.S.
dollar
equivalent
value.
If
such
an
event
occurs,
the
foreign
exchange
rate
will
be
valued
at
fair
value
using
procedures
established
and
approved
by
the
Board.
The
Fund
does
not
separately
report
the
effect
of
changes
in
foreign
exchange
rates
from
changes
in
market
prices
on
securities
held.
Such
changes
are
included
in
net
realized
and
unrealized
gain
or
loss
from
investments
in
the
Consolidated
Statement of
Operations.
Realized
foreign
exchange
gains
or
losses
arise
from
sales
of
foreign
currencies,
currency
gains
or
losses
realized
between
the
trade
and
settlement
dates
on
securities
transactions
and
the
difference
between
the
recorded
amounts
of
dividends,
interest,
and
foreign
withholding
taxes
and
the
U.S.
dollar
equivalent
of
the
amounts
actually
received
or
paid.
Net
unrealized
foreign
exchange
gains
and
losses
arise
from
changes
in
foreign
exchange
rates
on
foreign
denominated
assets
and
liabilities
other
than
investments
in
securities
held
at
the
end
of
the
reporting
period.
c.
Joint
Repurchase
Agreement
The
Fund
enters
into
a
joint
repurchase
agreement
whereby
its
uninvested
cash
balance
is
deposited
into
a
joint
cash
account
with
other
funds
managed
by
the
investment
manager
or
an
affiliate
of
the
investment
manager
and
is
used
to
invest
in
one
or
more
repurchase
agreements.
The
value
and
face
amount
of
the
joint
repurchase
agreement
are
allocated
to
the
funds
based
on
their
pro-rata
interest.
A
repurchase
agreement
is
accounted
for
as
a
loan
by
the
Fund
to
the
seller,
collateralized
by
securities
which
are
delivered
to
the
Fund's
custodian.
The
fair
value,
including
accrued
interest,
of
the
initial
collateralization
is
required
to
be
at
least
102%
of
the
dollar
amount
invested
by
the
funds,
with
the
value
of
the
underlying
securities
marked
to
market
daily
to
maintain
coverage
of
at
least
100%.
Repurchase
agreements
are
subject
to
the
terms
of
Master
Repurchase
Agreements
(MRAs)
with
approved
counterparties
(sellers).
The
MRAs
contain
various
provisions,
including
but
not
limited
to
events
of
default
and
maintenance
of
collateral
for
repurchase
agreements.
In
the
event
of
default
by
either
the
seller
or
the
Fund,
certain
MRAs
may
permit
the
non-
defaulting
party
to
net
and
close-out
all
transactions,
if
any,
traded
under
such
agreements.
The
Fund
may
sell
securities
1.
Organization
and
Significant
Accounting
Policies
(continued)
a.
Financial
Instrument
Valuation 
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
50
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
it
holds
as
collateral
and
apply
the
proceeds
towards
the
repurchase
price
and
any
other
amounts
owed
by
the
seller
to
the
Fund
in
the
event
of
default
by
the
seller.
This
could
involve
costs
or
delays
in
addition
to
a
loss
on
the
securities
if
their
value
falls
below
the
repurchase
price
owed
by
the
seller.
The
joint
repurchase
agreement
held
by
the Fund
at
period
end,
as
indicated
in
the
Consolidated
Statement
of
Investments,
had
been
entered
into
on
October
30,
2020.
d.
Securities
Purchased
on
Delayed
Delivery
and
TBA
Basis
The
Fund
purchases
securities
on
a
when-issued
or
delayed
delivery
and
to-be-announced
(TBA)
basis,
with
payment
and
delivery
scheduled
for
a
future
date.
These
transactions
are
subject
to
market
fluctuations
and
are
subject
to
the
risk
that
the
value
at
delivery
may
be
more
or
less
than
the
trade
date
purchase
price.
Although
the
Fund
will
generally
purchase
these
securities
with
the
intention
of
holding
the
securities,
it
may
sell
the
securities
before
the
settlement
date.
Sufficient
assets
have
been
segregated
for
these
securities
and
collateral
has
been
pledged
and/or
received
for
open
TBA
trades.
e.
Securities
Lending
The
Fund
participates
in
an
agency
based
securities
lending
program
to
earn
additional
income.
The
Fund
receives
collateral
in
the
form
of
cash
and/or
U.S.
Government
and
Agency
securities
against
the
loaned
securities
in
an
amount
equal
to
at
least
102%
of
the
fair
value
of
the
loaned
securities.
Collateral
is
maintained
over
the
life
of
the
loan
in
an
amount
not
less
than
100%
of
the
fair
value
of
loaned
securities,
as
determined
at
the
close
of
Fund
business
each
day;
any
additional
collateral
required
due
to
changes
in
security
values
is
delivered
to
the
Fund
on
the
next
business
day.
Any
cash
collateral
received
is
deposited
into
a
joint
cash
account
with
other
funds
and
is
used
to
invest
in
a
money
market
fund
managed
by
Franklin
Advisers,
Inc.,
an
affiliate
of
the Fund,
and/or
a
joint
repurchase
agreement
in
the
Consolidated
Statement
of
Assets
and
Liabilities.
The
Fund
may
receive
income
from
the
investment
of
cash
collateral,
in
addition
to
lending
fees
and
rebates
paid
by
the
borrower.
Income
from
securities
loaned,
net
of
fees
paid
to
the
securities
lending
agent
and/or
third-party
vendor,
is
reported
separately
in
the
Consolidated
Statement
of
Operations.
The
Fund
bears
the
market
risk
with
respect
to any
cash collateral
investment,
securities
loaned,
and
the
risk
that
the
agent
may
default
on
its
obligations
to
the
Fund.
If
the
borrower
defaults
on
its
obligation
to
return
the
securities
loaned,
the
Fund
has
the
right
to
repurchase
the
securities
in
the
open
market
using
the
collateral
received.
f.
Derivative
Financial
Instruments
The
Fund
invested
in
derivative
financial
instruments
in
order
to
manage
risk
or
gain
exposure
to
various
other
investments
or
markets.
Derivatives
are
financial
contracts
based
on
an
underlying
or
notional
amount,
require
no
initial
investment
or
an
initial
net
investment
that
is
smaller
than
would
normally
be
required
to
have
a
similar
response
to
changes
in
market
factors,
and
require
or
permit
net
settlement.
Derivatives
contain
various
risks
including
the
potential
inability
of
the
counterparty
to
fulfill
their
obligations
under
the
terms
of
the
contract,
the
potential
for
an
illiquid
secondary
market,
and/or
the
potential
for
market
movements
which
expose
the
Fund
to
gains
or
losses
in
excess
of
the
amounts
shown
in
the Consolidated
Statement
of
Assets
and
Liabilities.
Realized
gain
and
loss
and
unrealized
appreciation
and
depreciation
on
these
contracts
for
the
period
are
included
in
the Consolidated
Statement
of
Operations. 
Derivative
counterparty
credit
risk
is
managed
through
a
formal
evaluation
of
the
creditworthiness
of
all
potential
counterparties.
The
Fund
attempts
to
reduce its
exposure
to
counterparty
credit
risk
on
OTC
derivatives,
whenever
possible,
by
entering
into
International
Swaps
and
Derivatives
Association
(ISDA)
master
agreements
with
certain
counterparties.
These
agreements
contain
various
provisions,
including
but
not
limited
to
collateral
requirements,
events
of
default,
or
early
termination.
Termination
events
applicable
to
the
counterparty
include
certain
deteriorations
in
the
credit
quality
of
the
counterparty.
Termination
events
applicable
to
the Fund
include
failure
of
the
Fund
to
maintain
certain
net
asset
levels
and/
or
limit
the
decline
in
net
assets
over
various
periods
of
time.
In
the
event
of
default
or
early
termination,
the
ISDA
master
agreement
gives
the
non-defaulting
party
the
right
to
net
and
close-out
all
transactions
traded,
whether
or
not
arising
under
the
ISDA
agreement,
to
one
net
amount
payable
by
one
counterparty
to
the
other.
However,
absent
an
event
of
default
or
early
termination,
OTC
derivative
assets
and
liabilities
are
presented
gross
and
not
offset
in
the
Consolidated
Statement
of
Assets
and
Liabilities.
Early
1.
Organization
and
Significant
Accounting
Policies
(continued)
c.
Joint
Repurchase
Agreement
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
51
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
termination
by
the
counterparty
may
result
in
an
immediate
payment
by
the
Fund
of
any
net
liability
owed
to
that
counterparty
under
the
ISDA
agreement.
Collateral
requirements
differ
by
type
of
derivative.
Collateral
or
initial
margin
requirements
are
set
by
the
broker
or
exchange
clearing
house
for
exchange
traded
and
centrally
cleared
derivatives.
Initial
margin
deposited
is
held
at
the
exchange
and
can
be
in
the
form
of
cash
and/or
securities.
For
OTC
derivatives
traded
under
an
ISDA
master
agreement,
posting
of
collateral
is
required
by
either
the
Fund
or
the
applicable
counterparty
if
the
total
net
exposure
of
all
OTC
derivatives
with
the
applicable
counterparty
exceeds
the
minimum
transfer
amount,
which
typically
ranges
from
$100,000
to
$250,000,
and
can
vary
depending
on
the
counterparty
and
the
type
of
the
agreement.
Generally,
collateral
is
determined
at
the
close
of
Fund
business
each
day
and
any
additional
collateral
required
due
to
changes
in
derivative
values
may
be
delivered
by
the
Fund
or
the
counterparty
the
next
business
day,
or
within
a
few
business
days.
Collateral
pledged
and/or
received
by
the
Fund
for
OTC
derivatives,
if
any,
is
held
in
segregated
accounts
with
the
Fund's
custodian/counterparty
broker
and
can
be
in
the
form
of
cash
and/or
securities.
Unrestricted
cash
may
be
invested
according
to
the
Fund's
investment
objectives.
To
the
extent
that
the
amounts
due
to
the
Fund
from
its
counterparties
are
not
subject
to
collateralization
or
are
not
fully
collateralized,
the
Fund
bears
the
risk
of
loss
from
counterparty
non-performance.
The
Fund
entered
into
exchange
traded
futures
contracts
primarily
to
manage
and/or
gain
exposure
to
interest
rate
risk.
A
futures
contract
is
an
agreement
between
the
Fund
and
a
counterparty
to
buy
or
sell
an
asset
at
a
specified
price
on
a
future
date.
Required
initial
margins
are
pledged
by
the
Fund,
and
the
daily
change
in
fair
value
is
accounted
for
as
a
variation
margin
payable
or
receivable
in
the
Consolidated
Statement
of
Assets
and
Liabilities.
The
Fund
entered
into
OTC
forward
exchange
contracts
primarily
to
manage
and/or
gain
exposure
to
certain
foreign
currencies.
A
forward
exchange
contract
is
an
agreement
between
the
Fund
and
a
counterparty
to
buy
or
sell
a
foreign
currency
at
a
specific
exchange
rate
on
a
future
date.
The
Fund
entered
into
credit
default
swap
contracts
primarily
to
manage
and/or
gain
exposure
to
credit
risk.
A
credit
default
swap
is
an
agreement
between
the
Fund
and
a
counterparty
whereby
the
buyer
of
the
contract
receives
credit
protection
and
the
seller
of
the
contract
guarantees
the
credit
worthiness
of
a
referenced
debt
obligation.
These
agreements
may
be
privately
negotiated
in
the
over-the-
counter
market
(OTC
credit
default
swaps)
or
may
be
executed
in
a
multilateral
trade
facility
platform,
such
as
a
registered
exchange
(centrally
cleared
credit
default
swaps).
The
underlying
referenced
debt
obligation
may
be
a
single
issuer
of
corporate
or
sovereign
debt,
a
credit
index,
a
basket
of
issuers
or
indices,
or
a
tranche
of
a
credit
index
or
basket
of
issuers
or
indices.
In
the
event
of
a
default
of
the
underlying
referenced
debt
obligation,
the
buyer
is
entitled
to
receive
the
notional
amount
of
the
credit
default
swap
contract
from
the
seller
in
exchange
for
the
referenced
debt
obligation,
a
net
settlement
amount
equal
to
the
notional
amount
of
the
credit
default
swap
less
the
recovery
value
of
the
referenced
debt
obligation,
or
other
agreed
upon
amount.
For
centrally
cleared
credit
default
swaps,
required
initial
margins
are
pledged
by
the
Fund,
and
the
daily
change
in
fair
value
is
accounted
for
as
a
variation
margin
payable
or
receivable
in
the
Consolidated
Statement
of
Assets
and
Liabilities.
Over
the
term
of
the
contract,
the
buyer
pays
the
seller
a
periodic
stream
of
payments,
provided
that
no
event
of
default
has
occurred.
Such
periodic
payments
are
accrued
daily
as
an
unrealized
appreciation
or
depreciation
until
the
payments
are
made,
at
which
time
they
are
realized.
Upfront
payments
and
receipts
are
reflected
in
the Consolidated
Statement
of
Assets
and
Liabilities
and
represent
compensating
factors
between
stated
terms
of
the
credit
default
swap
agreement
and
prevailing
market
conditions
(credit
spreads
and
other
relevant
factors).
These
upfront
payments
and
receipts
are
amortized
over
the
term
of
the
contract
as
a
realized
gain
or
loss
in
the Consolidated
Statement
of
Operations.
The
Fund
entered
into
OTC
cross
currency
swap
contracts
primarily
to
manage
and/or
gain
exposure
to
interest
rate
risk
and
certain
foreign
currencies.
A
cross
currency
swap
is
an
agreement
between
the
Fund
and
a
counterparty
to
exchange
cash
flows
(determined
using
either
a
fixed
or
floating
rate)
based
on
the
notional
amounts
of
two
different
currencies.
The
notional
amounts
are
typically
determined
based
on
the
spot
exchange
rates
at
the
opening
of
the
contract.
Cross
currency
swaps
may
require
the
exchange
of
notional
amounts
at
the
opening
and/or
closing
of
the
contract.
Over
the
term
of
the
contract,
contractually
required
1.
Organization
and
Significant
Accounting
Policies
(continued)
f.
Derivative
Financial
Instruments
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
52
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
payments
to
be
paid
and
to
be
received
are
accrued
daily
and
recorded
as
unrealized
depreciation
and
appreciation
until
the
payments
are
made,
at
which
time
they
are
realized.
Upfront
payments
and
receipts
are
reflected
in
the
Consolidated
Statement
of
Assets
and
Liabilities
and
represent
compensating
factors
between
stated
terms
of
the
cross
currency
swap
contract
and
prevailing
market
conditions
(interest
rate
spreads
and
other
relevant
factors).
These
upfront
payments
and
receipts
are
amortized
over
the
term
of
the
contract
as
a
realized
gain
or
loss
in
the
Consolidated
Statement
of
Operations.
The
Fund
entered
into
inflation
index
swap
contracts
primarily
to
manage
and/or
gain
exposure
to
inflation
risk.
An
inflation
index
swap
is
an
agreement
between
the
Fund
and
a
counterparty
to
exchange
cash
flows
whereby
one
party
makes
payments
based
on
the
percentage
change
in
an
index
that
serves
as
a
measure
of
inflation
and
the
other
party
makes
a
regular
payment
based
on
a
compounded
fixed
rate,
applied
to
a
notional
amount.
These
agreements
may
be
privately
negotiated
in
the
over-the-counter
market
(OTC
inflation
index
swap)
or
may
be
executed
on
a
registered
exchange
(centrally
cleared
inflation
index
swap).
For
centrally
cleared
inflation
index
swaps,
required
initial
margins
are
pledged
by
the
Fund,
and
the
daily
change
in
fair
value
is
accounted
for
as
a
variation
margin
payable
or
receivable.
Over
the
term
of
the
contract,
contractually
required
payments
to
be
paid
and
to
be
received
are
accrued
daily
and
recorded
as
unrealized
depreciation
and
appreciation
until
the
payments
are
made,
at
which
time
they
are
realized.
Typically,
an
inflation
index
swap
has
payment
obligations
netted
and
exchanged
upon
maturity.
The
Fund
entered
into
interest
rate
swap
contracts
primarily
to
manage
interest
rate
risk.
An
interest
rate
swap
is
an
agreement
between
the
Fund
and
a
counterparty
to
exchange
cash
flows
based
on
the
difference
between
two
interest
rates,
applied
to
a
notional
amount.
These
agreements
may
be
privately
negotiated
in
the
over-the-
counter
market
(OTC
interest
rate
swaps)
or
may
be
executed
on
a
registered
exchange
(centrally
cleared
interest
rate
swaps).
For
centrally
cleared
interest
rate
swaps,
required
initial
margins
are
pledged
by
the
Fund,
and
the
daily
change
in
fair
value
is
accounted
for
as
a
variation
margin
payable
or
receivable
in
the
Consolidated
Statement
of
Assets
and
Liabilities.
Over
the
term
of
the
contract,
contractually
required
payments
to
be
paid
and
to
be
received
are
accrued
daily
and
recorded
as
unrealized
depreciation
and
appreciation
until
the
payments
are
made,
at
which
time
they
are
realized.
The
Fund
entered
into
OTC
total
return
swap
contracts
primarily
to
manage
and/or
gain
exposure
to
the
interest
rate
risk
of
an
underlying
instrument
such
as
a
stock,
bond,
index
or
basket
of
securities
or
indices.
A
total
return
swap
is
an
agreement
between
the
Fund
and
a
counterparty
to
exchange
a
return
linked
to
an
underlying
instrument
for
a
floating
or
fixed
rate
payment,
both
based
upon
a
notional
amount.
Over
the
term
of
the
contract,
contractually
required
payments
to
be
paid
or
received
are
accrued
daily
and
recorded
as
unrealized
appreciation
or
depreciation
until
the
payments
are
made,
at
which
time
they
are
recognized
as
realized
gain
or
loss.
The
Fund
purchased
or
wrote
exchange
traded
and/or
OTC
option
contracts
primarily
to
manage
and/or
gain
exposure
to
interest
rate,
foreign
exchange
rate
and
credit
risk.
An
option
is
a
contract
entitling
the
holder
to
purchase
or
sell
a
specific
amount
of
shares
or
units
of
an
asset
or
notional
amount
of
a
swap
(swaption),
at
a
specified
price.
When
an
option
is
purchased
or
written,
an
amount
equal
to
the
premium
paid
or
received
is
recorded
as
an
asset
or
liability,
respectively.
Upon
exercise
of
an
option,
the
acquisition
cost
or
sales
proceeds
of
the
underlying
investment
is
adjusted
by
any
premium
received
or
paid.
Upon
expiration
of
an
option,
any
premium
received
or
paid
is
recorded
as
a
realized
gain
or
loss.
Upon
closing
an
option
other
than
through
expiration
or
exercise,
the
difference
between
the
premium
received
or
paid
and
the
cost
to
close
the
position
is
recorded
as
a
realized
gain
or
loss.
The
Fund
invests
in
value
recovery
instruments
(VRI)
primarily
to
gain
exposure
to
economic
growth.
Periodic
payments
from
VRI
are
dependent
on
established
benchmarks
for
underlying
variables.
VRI
has
a
notional
amount,
which
is
used
to
calculate
amounts
of
payments
to
holders.
Payments
are
recorded
upon
receipt
as
realized
gains
in
the
Consolidated
Statement
of
Operations.
The
risks
of
investing
in
VRI
include
growth
risk,
liquidity,
and
the
potential
loss
of
investment.
See
Note
11 regarding
other
derivative
information.
1.
Organization
and
Significant
Accounting
Policies
(continued)
f.
Derivative
Financial
Instruments
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
53
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
g.
Loan
Participation
Notes
The
Fund
invests
in
loan
participation
notes
(Participations).
Participations
are
loans
originally
issued
to
a
borrower
by
one
or
more
financial
institutions
(the
Lender)
and
subsequently
sold
to
other
investors,
such
as
the Fund.
Participations
typically
result
in
the
Fund
having
a
contractual
relationship
only
with
the
Lender
and
not
with
the
borrower.
The
Fund
has
the
right
to
receive
from
the
Lender
any
payments
of
principal,
interest
and
fees
which
the
Lender
received
from
the
borrower.
The
Fund
generally
has
no
rights
to
either
enforce
compliance
by
the
borrower
with
the
terms
of
the
loan
agreement
or
to
any
collateral
relating
to
the
original
loan.
As
a
result,
the Fund
assumes
the
credit
risk
of
both
the
borrower
and
the
Lender
that
is
selling
the
Participation.
The
Participations
may
also
involve
interest
rate
risk
and
liquidity
risk,
including
the
potential
default
or
insolvency
of
the
borrower
and/or
the
Lender.
h.
FT
Holdings
Corporation
II
(FT
Subsidiary)
The
Fund
invests
in
certain
financial
instruments
through
its
investment
in
FT
Subsidiary.
FT
Subsidiary
is
a
Delaware
Corporation,
is
a
wholly-owned
subsidiary
of
the
Fund,
and
is
able
to
invest
in
certain
financial
instruments
consistent
with
the
investment
objective
of
the
Fund.
At
October
31,
2020,
FT
Subsidiary’s
investment,
Turtle
Bay
Resort,
as
well
as
any
other
assets
and
liabilities
of
FT
Subsidiary
are
reflected
in
the
Fund’s
Consolidated
Statement
of
Investments
and
Consolidated
Statement
of
Assets
and
Liabilities.
At
October
31,
2020,
FT
Subsidiary,
which
is
a
tax
paying
entity,
recognized
an
unrealized
loss
on
its
Turtle
Bay
investment.
An
estimated
deferred
tax
asset
based
on
such
unrealized
loss
is
reflected
as
FT
Subsidiary
deferred
tax
benefit
in
the
Consolidated
Statement
of
Assets
and
Liabilities.
The
estimated
benefit
was
calculated
using
a
federal
rate
of
21%.
When
the
Turtle
Bay
investment
liquidates,
FT
Subsidiary
will
recognize
a
capital
loss
which
can
be
carried-back
to
offset
prior
year
capital
gains,
resulting
in
a
tax
refund
which
will
relieve
the
deferred
tax
asset.
The
financial
statements
have
been
consolidated
and
include
the
accounts
of
the
Fund
and
FT
Subsidiary.
All
intercompany
transactions
and
balances
have
been
eliminated.
At
October
31,
2020,
the
net
assets
of
FT
Subsidiary
were
$18,474,750,
representing
less
than
1%
of
the
Fund’s
consolidated
net
assets.
The
Fund’s
investment
in
FT
Subsidiary
is
limited
to
25%
of
consolidated
assets.
i.
Marketplace
Lending
The
Fund
invests
in
loans
obtained
through
marketplace
lending.
Marketplace
lending,
sometimes
referred
to
as
peer-to-peer
lending,
is
a
method
of
financing
in
which
a
platform
facilitates
the
borrowing
and
lending
of
money.
It
is
considered
an
alternative
to
more
traditional
forms
of
debt
financing.
Prospective
borrowers
are
required
to
provide
certain
financial
information
to
the
platform,
including,
but
not
limited
to,
the
intended
purpose
of
the
loan,
income,
employment
information,
credit
score,
debt-to-income
ratio,
credit
history
(including
defaults
and
delinquencies)
and
home
ownership
status.
Based
on
this
and
other
information,
the
platform
assigns
its
own
credit
rating
to
the
borrower
and
sets
the
interest
rate
for
the
requested
loan.
The
platform
then
posts
the
borrowing
requests
online,
giving
investors
the
opportunity
to
purchase
the
loans
based
on
factors
such
as
the
interest
rates
and
expected
yields
of
the
loans,
the
borrower
background
data,
and
the
credit
rating
assigned
by
the
platform.
When
the
Fund
invests
in
these
loans,
it
usually
purchases
all
rights,
title
and
interest
in
the
loans
pursuant
to
a
loan
purchase
agreement
directly
from
the
platform.
The
platform
or
a
third-party
servicer
typically
continues
to
service
the
loans,
collecting
payments
and
distributing
them
to
the
Fund,
less
any
servicing
fees
assessed.
The
servicer
is
typically
responsible
for
taking
actions
against
a
borrower
in
the
event
of
a
default
on
the
loan.
Servicing
fees,
along
with
other
administration
fees,
are
included
in
marketplace
lending
fees
in
the
Statement
of
Operations.
The Fund,
as
an
investor
in
a
loan,
would
be
entitled
to
receive
payment
only
from
the
borrower
and
would
not
be
able
to
recover
any
deficiency
from
the
platform,
except
under
very
narrow
circumstances.
The
loans
in
which
the
Fund
may
invest
are
unsecured.
j.
Mortgage
Dollar
Rolls
The
Fund
enters
into
mortgage
dollar
rolls,
typically
on
a
TBA
basis.
Mortgage
dollar
rolls
are
agreements
between
the
Fund
and
a
financial
institution
where
the
Fund
sells
(or
buys)
mortgage-backed
securities
for
delivery
on
a
specified
date
and
simultaneously
contracts
to
repurchase
(or
sell)
substantially
similar
(same
type,
coupon,
and
maturity)
securities
at
a
future
date
and
at
a
predetermined
price.
Gains
or
losses
are
realized
on
the
initial
sale,
and
1.
Organization
and
Significant
Accounting
Policies
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
54
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
the
difference
between
the
repurchase
price
and
the
sale
price
is
recorded
as
an
unrealized
gain
or
loss
to
the
Fund
upon
entering
into
the
mortgage
dollar
roll.
In
addition,
the
Fund
may
invest
the
cash
proceeds
that
are
received
from
the
initial
sale.
During
the
period
between
the
sale
and
repurchase,
the
Fund
is
not
entitled
to
principal
and
interest
paid
on
the
mortgage
backed
securities.
Transactions
in
mortgage
dollar
rolls
are
accounted
for
as
purchases
and
sales
and
may
result
in
an
increase
to
the
Fund's
portfolio
turnover
rate.
The
risks
of
mortgage
dollar
roll
transactions
include
the
potential
inability
of
the
counterparty
to
fulfill
its
obligations.
k.
Senior
Floating
Rate
Interests
The
Fund
invests
in
senior
secured
corporate
loans
that
pay
interest
at
rates
which
are
periodically
reset
by
reference
to
a
base
lending
rate
plus
a
spread.
These
base
lending
rates
are
generally
the
prime
rate
offered
by
a
designated
U.S.
bank
or
the
London
InterBank
Offered
Rate
(LIBOR).
Senior
secured
corporate
loans
often
require
prepayment
of
principal
from
excess
cash
flows
or
at
the
discretion
of
the
borrower.
As
a
result,
actual
maturity
may
be
substantially
less
than
the
stated
maturity.
Senior
secured
corporate
loans
in
which
the Fund
invests
are
generally
readily
marketable,
but
may
be
subject
to
certain
restrictions
on
resale.
On
July
27,
2017,
the
United
Kingdom's
Financial
Conduct
Authority
announced
its
intention
to
cease
sustaining
LIBOR
after
2021.
There
remains
uncertainty
regarding
the
future
utilization
of
LIBOR
and
the
nature
of
any
replacement
rate.
As
such,
the
potential
effect
of
a
transition
away
from
LIBOR
on
the
Fund
or
the
Fund's
investments
that
use
or
may
use
a
floating
rate
based
on
LIBOR
cannot
yet
be
determined.
l.
Income
and
Deferred
Taxes
It
is the Fund's
policy
to
qualify
as
a
regulated
investment
company
under
the
Internal
Revenue
Code. The Fund
intends
to
distribute
to
shareholders
substantially
all
of
its
taxable
income
and
net
realized
gains
to
relieve
it
from
federal
income
and excise
taxes.
As
a
result,
no
provision
for
U.S.
federal
income
taxes
is
required.
The Fund
may
be
subject
to
foreign
taxation
related
to
income
received,
capital
gains
on
the
sale
of
securities
and
certain
foreign
currency
transactions
in
the
foreign
jurisdictions
in
which
it
invests.
Foreign
taxes,
if
any,
are
recorded
based
on
the
tax
regulations
and
rates
that
exist
in
the
foreign
markets
in
which
the
Fund
invests.
When
a
capital
gain
tax
is
determined
to
apply,
the
Fund
records
an
estimated
deferred
tax
liability
in
an
amount
that
would
be
payable
if
the
securities
were
disposed
of
on
the
valuation
date.
The
Fund
may
recognize
an
income
tax
liability
related
to
its
uncertain
tax
positions
under
U.S.
GAAP
when
the
uncertain
tax
position
has
a
less
than
50%
probability
that
it
will
be
sustained
upon
examination
by
the
tax
authorities
based
on
its
technical
merits.
As
of
October
31,
2020,
the
Fund
has
determined
that
no
tax
liability
is
required
in
its
consolidated
financial
statements
related
to
uncertain
tax
positions
for
any
open
tax
years
(or
expected
to
be
taken
in
future
tax
years).
Open
tax
years
are
those
that
remain
subject
to
examination
and
are
based
on
the
statute
of
limitations
in
each
jurisdiction
in
which
the
Fund
invests. 
m.
Security
Transactions,
Investment
Income,
Expenses
and
Distributions
Security
transactions
are
accounted
for
on
trade
date.
Realized
gains
and
losses
on
security
transactions
are
determined
on
a
specific
identification
basis.
Interest
income
and
estimated
expenses
are
accrued
daily.
Amortization
of
premium
and
accretion
of
discount
on
debt
securities
are
included
in
interest
income.
Paydown
gains
and
losses
are
recorded
as
an
adjustment
to
interest
income.
Facility
fees
are
recognized
as
income
over
the
expected
term
of
the
loan.
Dividend
income
is
recorded
on
the
ex-dividend
date
except
for
certain
dividends
from
securities
where
the
dividend
rate
is
not
available.
In
such
cases,
the
dividend
is
recorded
as
soon
as
the
information
is
received
by
the
Fund.
Distributions
to shareholders
are
recorded
on
the
ex-dividend
date.
Distributable
earnings
are
determined
according
to
income
tax
regulations
(tax
basis)
and
may
differ
from
earnings
recorded
in
accordance
with
U.S.
GAAP.
These
differences
may
be
permanent
or
temporary.
Permanent
differences
are
reclassified
among
capital
accounts
to
reflect
their
tax
character.
These
reclassifications
have
no
impact
on
net
assets
or
the
results
of
operations.
Temporary
differences
are
not
reclassified,
as
they
may
reverse
in
subsequent
periods.
Common
expenses
incurred
by
the
Trust
are
allocated
among
the
Funds
based
on
the
ratio
of
net
assets
of
each
Fund
to
the
combined
net
assets
of
the
Trust
or
based
on
the
ratio
of
number
of
shareholders
of
each
Fund
to
the
1.
Organization
and
Significant
Accounting
Policies
(continued)
j.
Mortgage
Dollar
Rolls
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
55
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
combined
number
of
shareholders
of
the
Trust.
Fund
specific
expenses
are
charged
directly
to
the
Fund
that
incurred
the
expense.
Realized
and
unrealized
gains
and
losses
and
net
investment
income,
excluding
class
specific
expenses,
are
allocated
daily
to
each
class
of
shares
based
upon
the
relative
proportion
of
net
assets
of
each
class.
Differences
in
per
share
distributions
by
class
are
generally
due
to
differences
in
class
specific
expenses.
Inflation-indexed
bonds
are
adjusted
for
inflation
through
periodic
increases
or
decreases
in
the
security's
interest
accruals,
face
amount,
or
principal
redemption
value,
by
amounts
corresponding
to
the
rate
of
inflation
as
measured
by
an
index.
Any
increase
or
decrease
in
the
face
amount
or
principal
redemption
value
will
be
included
as
interest
income
in
the
Consolidated
Statement
of
Operations.
n.
Accounting
Estimates
The
preparation
of
financial
statements
in
accordance
with
U.S.
GAAP
requires
management
to
make
estimates
and
assumptions
that
affect
the
reported
amounts
of
assets
and
liabilities
at
the
date
of
the
financial
statements
and
the
amounts
of
income
and
expenses
during
the
reporting
period.
Actual
results
could
differ
from
those
estimates.
o.
Guarantees
and
Indemnifications
Under
the
Trust's
organizational
documents,
its
officers
and
trustees
are
indemnified
by
the
Trust
against
certain
liabilities
arising
out
of
the
performance
of
their
duties
to
the
Trust.
Additionally,
in
the
normal
course
of
business,
the
Trust,
on
behalf
of
the
Fund,
enters
into
contracts
with
service
providers
that
contain
general
indemnification
clauses.
The
Trust's
maximum
exposure
under
these
arrangements
is
unknown
as
this
would
involve
future
claims
that
may
be
made
against
the
Trust
that
have
not
yet
occurred.
Currently,
the
Trust
expects
the
risk
of
loss
to
be
remote.
2.
Shares
of
Beneficial
Interest
At
October
31,
2020,
there
were
an
unlimited
number
of
shares
authorized
(without
par
value).
Transactions
in
the
Fund’s
shares
were
as
follows:
Six
Months
Ended
October
31,
2020
Year
Ended
April
30,
2020
Shares
Amount
Shares
Amount
Class
A
Shares:
Shares
sold
a
...................................
23,510,485
$216,617,390
51,808,122
$493,501,422
Shares
issued
in
reinvestment
of
distributions
..........
5,547,015
50,959,567
13,278,919
125,575,767
Shares
redeemed
...............................
(31,059,888)
(285,066,052)
(80,974,998)
(760,983,256)
Net
increase
(decrease)
..........................
(2,002,388)
$(17,489,095)
(15,887,957)
$(141,906,067)
Class
C
Shares:
Shares
sold
...................................
2,311,887
$21,342,609
7,181,894
$68,377,407
Shares
issued
in
reinvestment
of
distributions
..........
845,987
7,767,359
2,436,459
23,072,271
Shares
redeemed
a
..............................
(14,338,133)
(131,902,180)
(24,298,180)
(230,053,884)
Net
increase
(decrease)
..........................
(11,180,259)
$(102,792,212)
(14,679,827)
$(138,604,206)
Class
R
Shares:
Shares
sold
...................................
788,602
$7,201,344
1,421,183
$13,393,410
Shares
issued
in
reinvestment
of
distributions
..........
123,452
1,128,991
332,487
3,136,111
Shares
redeemed
...............................
(1,262,310)
(11,535,848)
(3,490,157)
(32,564,655)
Net
increase
(decrease)
..........................
(350,256)
$(3,205,513)
(1,736,487)
$(16,035,134)
1.
Organization
and
Significant
Accounting
Policies
(continued)
m.
Security
Transactions,
Investment
Income,
Expenses
and
Distributions
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
56
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
3.
Transactions
with
Affiliates
Franklin
Resources,
Inc.
is
the
holding
company
for
various
subsidiaries
that
together
are
referred
to
as
Franklin
Templeton.
Certain
officers
and
trustees
of
the
Trust
are
also
officers
and/or
directors
of
the
following
subsidiaries:
a.
Management
Fees
The
Fund
pays
an
investment
management
fee
to
Advisers
based
on
the
average
daily
net
assets
of
the
Fund
as
follows:
For
the
period
ended
October
31,
2020,
the
annualized
gross
effective
investment
management
fee
rate
was
0.457%
of
the
Fund’s
average
daily
net
assets. 
Six
Months
Ended
October
31,
2020
Year
Ended
April
30,
2020
Shares
Amount
Shares
Amount
Class
R6
Shares:
Shares
sold
...................................
1,670,937
$15,367,313
5,527,397
$52,655,227
Shares
issued
in
reinvestment
of
distributions
..........
248,391
2,284,739
958,906
9,140,302
Shares
redeemed
...............................
(3,646,150)
(32,780,000)
(23,024,591)
(220,902,162)
Net
increase
(decrease)
..........................
(1,726,822)
$(15,127,948)
(16,538,288)
$(159,106,633)
Advisor
Class
Shares:
Shares
sold
...................................
6,566,998
$59,993,059
16,576,637
$155,346,108
Shares
issued
in
reinvestment
of
distributions
..........
1,090,749
10,028,606
2,676,518
25,356,333
Shares
redeemed
...............................
(12,152,454)
(111,648,391)
(22,833,202)
(214,281,737)
Net
increase
(decrease)
..........................
(4,494,707)
$(41,626,726)
(3,580,047)
$(33,579,296)
a
May
include
a
portion
of
Class
C
shares
that
were
automatically
converted
to
Class
A.
Subsidiary
Affiliation
Franklin
Advisers,
Inc.
(Advisers)
Investment
manager
Franklin
Templeton
Services,
LLC
(FT
Services)
Administrative
manager
Franklin
Templeton
Distributors,
Inc.
(Distributors)
Principal
underwriter
Franklin
Templeton
Investor
Services,
LLC
(Investor
Services)
Transfer
agent
Annualized
Fee
Rate
Net
Assets
0.625%
Up
to
and
including
$100
million
0.500%
Over
$100
million,
up
to
and
including
$250
million
0.450%
Over
$250
million,
up
to
and
including
$7.5
billion
0.440%
Over
$7.5
billion,
up
to
and
including
$10
billion
0.430%
Over
$10
billion,
up
to
and
including
$12.5
billion
0.420%
Over
$12.5
billion,
up
to
and
including
$15
billion
0.400%
Over
$15
billion,
up
to
and
including
$17.5
billion
0.380%
Over
$17.5
billion,
up
to
and
including
$20
billion
0.360%
Over
$20
billion,
up
to
and
including
$35
billion
0.355%
Over
$35
billion,
up
to
and
including
$50
billion
0.350%
In
excess
of
$50
billion
2.
Shares
of
Beneficial
Interest
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
57
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
b.
Administrative
Fees
Under
an
agreement
with
Advisers,
FT
Services
provides
administrative
services
to
the
Fund.
The
fee
is
paid
by
Advisers
based
on
the
Fund’s
average
daily
net
assets,
and
is
not
an
additional
expense
of
the
Fund.
c.
Distribution
Fees
The
Board
has
adopted
distribution
plans
for
each
share
class,
with
the
exception
of
Class
R6
and
Advisor
Class
shares,
pursuant
to
Rule
12b-1
under
the
1940
Act.
Under
the
Fund’s
Class A reimbursement
distribution
plan,
the
Fund
reimburses
Distributors
for
costs
incurred
in
connection
with
the
servicing,
sale
and
distribution
of
the
Fund's
shares
up
to
the
maximum
annual
plan
rate.
Under
the
Class
A
reimbursement
distribution
plan,
costs
exceeding
the
maximum
for
the
current
plan
year
cannot
be
reimbursed
in
subsequent
periods.
In
addition,
under
the
Fund’s
Class C
and
R
compensation
distribution
plans,
the
Fund
pays
Distributors
for
costs
incurred
in
connection
with
the
servicing,
sale
and
distribution
of
the
Fund's
shares
up
to
the
maximum
annual
plan
rate
for
each
class.
The
plan
year,
for
purposes
of
monitoring
compliance
with
the
maximum
annual
plan
rates,
is
February
1
through
January
31.
The
maximum
annual
plan
rates,
based
on
the
average
daily
net
assets,
for
each
class,
are
as
follows:
d.
Sales
Charges/Underwriting
Agreements
Front-end
sales
charges
and
contingent
deferred
sales
charges
(CDSC)
do
not
represent
expenses
of
the
Fund.
These
charges
are
deducted
from
the
proceeds
of
sales
of
Fund
shares
prior
to
investment
or
from
redemption
proceeds
prior
to
remittance,
as
applicable.
Distributors
has
advised
the
Fund
of
the
following
commission
transactions
related
to
the
sales
and
redemptions
of
the
Fund's
shares
for
the
period:
e.
Transfer
Agent
Fees
Each
class
of
shares pays
transfer
agent
fees
to
Investor
Services
for
its
performance
of
shareholder
servicing
obligations.
The
fees
are
based
on
an
annualized
asset
based
fee
of
0.02%
plus
a
transaction
based
fee.
In
addition,
each
class reimburses
Investor
Services
for
out
of
pocket
expenses
incurred
and,
except
for
Class
R6,
reimburses
shareholder
servicing
fees
paid
to
third
parties.
These
fees
are
allocated
daily
based
upon
their
relative
proportion
of
such
classes'
aggregate
net
assets.
Class
R6
pays
Investor
Services
transfer
agent
fees
specific
to
that
class.
For
the
period
ended
October
31,
2020,
the
Fund
paid
transfer
agent
fees
of
$2,542,813,
of
which $1,237,154
was
retained
by
Investor
Services.
f.
Investments
in
Affiliated
Management
Investment
Companies
The
Fund
invests
in
one
or
more
affiliated
management
investment
companies
for
purposes
other
than
exercising
a
controlling
influence
over
the
management
or
policies.
Management
fees
paid
by
the
Fund
are
waived
on
assets
invested
in
the
affiliated
management
investment
companies,
as
noted
in
the
Consolidated
Statement
of
Operations,
in
an
amount
not
to
exceed
the
management
and
administrative
fees
paid
directly
or
indirectly
by
each
affiliate.
During
the
period
ended
October
31,
2020,
the
Fund
held
investments
in
affiliated
management
investment
companies
as
follows:
Class
A
....................................................................................
0.25%
Class
C
....................................................................................
0.65%
Class
R
....................................................................................
0.50%
Sales
charges
retained
net
of
commissions
paid
to
unaffiliated
brokers/dealers
..............................
$44,525
CDSC
retained
..............................................................................
$46,110
3.
Transactions
with
Affiliates
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
58
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
g.
Waiver
and
Expense
Reimbursements
Investor
Services
has
contractually
agreed
in
advance
to
waive
or
limit
its
fees
so
that
the
Class
R6
transfer
agent
fees
do
not
exceed
0.03%
based
on
the
average
net
assets
of
the
class
until
August
31,
2021.
h.
Interfund
Transactions
The
Fund
engaged
in
purchases
and
sales
of
investments
with
funds
or
other
accounts
that
have
common
investment
managers
(or
affiliated
investment
managers),
directors,
trustees
or
officers.
During
the
period
ended
October
31,
2020,
these
purchase
and
sale
transactions
aggregated
$0,and
$40,633,306,
respectively.
4.
Expense
Offset
Arrangement
The Fund has
entered
into
an
arrangement
with
its
custodian
whereby
credits
realized
as
a
result
of
uninvested
cash
balances
are
used
to
reduce
a
portion
of
the
Fund's
custodian
expenses.
During
the
period
ended
October
31,
2020,
the
custodian
fees
were
reduced
as
noted
in
the
Consolidated
Statement
of
Operations. 
5.
Income
Taxes
For
tax
purposes,
capital
losses
may
be
carried
over
to
offset
future
capital
gains.
At
April
30,
2020,
the
capital
loss
carryforwards
were
as
follows:
A
Value
at
Beginning
of
Period
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Period
Number
of
Shares
Held
at
End
of
Period
Investment
Income
A
a
a
a
a
a
a
a
a
Franklin
Strategic
Income
Fund
Non-Controlled
Affiliates
Dividends
Franklin
Floating
Rate
Income
Fund
$108,077,744
$—
$—
$—
$2,743,864
$110,821,608
15,243,687
$661,683
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
.........
$51,021,802
$35,429,868
$(34,520,409)
$—
$—
$51,931,261
51,931,261
$—
Total
Non-Controlled
Affiliates
$159,099,546
$35,429,868
$(34,520,409)
$
$
2,743,864
$162,752,869
$
661,683
Non-Controlled
Affiliates
Income
from
securities
loaned
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
0%
.........
$—
$48,000
$(21,000)
$
$
$27,000
27,000
$—
Total
Affiliated
Securities
....
$159,099,546
$35,477,868
$(34,541,409)
$—
$2,743,864
$162,779,869
$661,683
Capital
loss
carryforwards
not
subject
to
expiration:
Short
term
................................................................................
$52,700,821
Long
term
................................................................................
513,263,033
Total
capital
loss
carryforwards
...............................................................
$565,963,854
3.
Transactions
with
Affiliates
(continued)
f.
Investments
in
Affiliated
Management
Investment
Companies
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
59
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
At
October
31,
2020,
the
cost
of
investments
and
net
unrealized
appreciation
(depreciation)
for
income
tax
purposes
were
as
follows:
Differences
between
income
and/or
capital
gains
as
determined
on
a
book
basis
and
a
tax
basis
are
primarily
due
to
differing
treatments
of
foreign
currency
transactions,
paydown
losses,
bond
discounts
and
premiums
and
swaps.
6.
Investment
Transactions
Purchases
and
sales
of
investments
(excluding
short
term
securities)
for
the
period
ended
October
31,
2020,
aggregated
$6,488,043,743
and
$6,715,175,583,
respectively.
At
October
31,
2020,
in
connection
with
securities
lending
transactions,
the
Fund
loaned
equity
investments
and
received
$34,958
of
cash
collateral.
The
gross
amount
of
recognized
liability
for
such
transactions
is
included
in
payable
upon
return
of
securities
loaned
in
the
Consolidated
Statement
of
Assets
and
Liabilities.
The
agreements
can
be
terminated
at
any
time.
7.
Credit Risk
and
Defaulted
Securities
At
October
31,
2020,
the
Fund
had
42.0%
of
its
portfolio
invested
in
high
yield,
senior
secured
floating
rate
loans,
or
other
securities
rated
below
investment
grade
and
unrated
securities,
if
any.
These
securities
may
be
more
sensitive
to
economic
conditions
causing
greater
price
volatility
and
are
potentially
subject
to
a
greater
risk
of
loss
due
to
default
than
higher
rated
securities.
The
Fund
held
defaulted
securities
and/or
other
securities
for
which
the
income
has
been
deemed
uncollectible.
At
October
31,
2020,
the
aggregate
value
of
these
securities
was
$1,648,027,
representing
0.4%
of
the
Fund's
net
assets.
The
Fund
discontinues
accruing
income
on
securities
for
which
income
has
been
deemed
uncollectible
and
provides
an
estimate
for
losses
on
interest
receivable.
The
securities
have
been
identified
in
the
accompanying
Consolidated
Statement
of
Investments.
8.
Novel
Coronavirus
Pandemic 
The
global
outbreak
of
the
novel
coronavirus
disease,
known
as
COVID-19, has
caused
adverse
effects
on
many
companies,
sectors,
nations,
regions
and
the
markets
in
general, and
may
continue for
an unpredictable duration.
The
effects
of
this
pandemic
may
materially
impact
the
value
and
performance
of
the Fund, its ability
to
buy
and
sell
fund
investments
at
appropriate
valuations
and its ability
to
achieve its investment
objectives.
9.
Restricted
Securities
The
Fund
invests
in
securities
that
are
restricted
under
the
Securities
Act
of
1933
(1933
Act).
Restricted
securities
are
often
purchased
in
private
placement
transactions,
and
cannot
be
sold
without
prior
registration
unless
the
sale
is
pursuant
to
an
exemption
under
the
1933
Act.
Disposal
of
these
securities
may
require
greater
effort
and
expense,
and
prompt
sale
at
an
acceptable
price
may
be
difficult.
The Fund
may
have
registration
rights
for
restricted
securities.
The
issuer
generally
incurs
all
registration
costs.
Cost
of
investments
..........................................................................
$4,402,203,775
Unrealized
appreciation
........................................................................
$19,578,377
Unrealized
depreciation
........................................................................
(213,382,705)
Net
unrealized
appreciation
(depreciation)
..........................................................
$(193,804,327)
5.
Income
Taxes
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
60
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
At
October
31,
2020,
investments
in
restricted
securities,
excluding
securities
exempt
from
registration
under
the
1933
Act,
were
as
follows:
10.
Unfunded
Loan
Commitments
The
Fund
enters
into
certain
credit
agreements,
all
or
a
portion
of
which
may
be
unfunded.
The Fund
is
obligated
to
fund
these
loan
commitments
at
the
borrowers’
discretion.
Unfunded
loan
commitments
and
funded
portions
of
credit
agreements
are
marked
to
market
daily
and
any
unrealized
appreciation
or
depreciation
is
included
in
the
Consolidated
Statement
of
Assets
and
Liabilities
and
the
Consolidated
Statement
of
Operations.
Funded
portions
of
credit
agreements
are
presented
in
the
Consolidated Statement
of
Investments.
At
October
31,
2020,
unfunded
commitments
were
as
follows:
11.
Other
Derivative
Information
At
October
31,
2020,
investments
in
derivative
contracts
are
reflected
in
the
Consolidated
Statement of
Assets
and
Liabilities
as
follows:
Principal
Amount
/
Shares
/
Units
Issuer
Acquisition
Date
Cost
Value
Franklin
Strategic
Income
Fund
331,326
a
Appvion
Operations,
Inc.
......................
4/12/19
$
4,481,262
$
4,917,645
125,940,079
b
K2016470219
South
Africa
Ltd.,
A
...............
2/08/13-2/01/17
977,123
12,532,821
b
K2016470219
South
Africa
Ltd.,
B
...............
2/01/17
9,307
124,500
Remington
Outdoor
Co.,
Inc.,
Litigation
Units
.......
4/12/19
Total
Restricted
Securities
(Value
is
0.12%
of
Net
Assets)
.............
$5,467,692
$4,917,645
a
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$4,738,889
as
of
October
31,
2020.
b
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$15,007
as
of
October
31,
2020.
Borrower
Unfunded
Commitment
Franklin
Strategic
Income
Fund
Fieldwood
Energy
LLC
$3,480,774
UTEX
Industries,
Inc
95,909
$3,576,683
Asset
Derivatives
Liability
Derivatives
Derivative
Contracts
Not
Accounted
for
as
Hedging
Instruments
Consolidated
Statement
of
Assets
and
Liabilities
Location
Fair
Value
Consolidated
Statement
of
Assets
and
Liabilities
Location
Fair
Value
Franklin
Strategic
Income
Fund
Interest
rate
contracts
.......
Variation
margin
on
futures
contracts
$
386,755
a
Variation
margin
on
futures
contracts
$
1,579,302
a
Variation
margin
on
centrally
cleared
swap
contracts
5,243,070
b
Variation
margin
on
centrally
cleared
swap
contracts
b
9.
Restricted
Securities
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
61
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
For
the
period
ended
October
31,
2020,
the
effect
of
derivative
contracts
in
the
Consolidated
Statement
of
Operations
was
as
follows:
Asset
Derivatives
Liability
Derivatives
Derivative
Contracts
Not
Accounted
for
as
Hedging
Instruments
Consolidated
Statement
of
Assets
and
Liabilities
Location
Fair
Value
Consolidated
Statement
of
Assets
and
Liabilities
Location
Fair
Value
Franklin
Strategic
Income
Fund
(continued)
Unrealized
appreciation
on
OTC
swap
contracts
$
Unrealized
depreciation
on
OTC
swap
contracts
$
31,625
Foreign
exchange
contracts
..
Unrealized
appreciation
on
OTC
forward
exchange
contracts
4,513,818
Unrealized
depreciation
on
OTC
forward
exchange
contracts
1,684,789
Credit
contracts
............
Variation
margin
on
centrally
cleared
swap
contracts
Variation
margin
on
centrally
cleared
swap
contracts
1,754,183
b
OTC
swap
contracts
(upfront
payments)
227,824
OTC
swap
contracts
(upfront
receipts)
3,417,359
Unrealized
appreciation
on
OTC
swap
contracts
446,080
Unrealized
depreciation
on
OTC
swap
contracts
6,651,722
Inflation
contracts
..........
Variation
margin
on
centrally
cleared
swap
contracts
Variation
margin
on
centrally
cleared
swap
contracts
878,601
b
Value
recovery
instruments
...
Investments
in
securities,
at
value
8,685,606
c
Investments
in
securities,
at
value
Total
....................
$19,503,153
$15,997,581
a
This
amount
reflects
the
cumulative
appreciation
(depreciation)
of
futures
contracts
as
reported
in
the
Consolidated
Statement
of
Investments.
Only
the
variation
margin
receivable/payable
at
period
end
is
separately
reported
within
the
Consolidated
Statement
of
Assets
and
Liabilities.
Prior
variation
margin
movements
were
recorded
to
cash
upon
receipt
or
payment.
b
This
amount
reflects
the
cumulative
appreciation
(depreciation)
of
centrally
cleared
swap
contracts
as
reported
in
the
Consolidated
Statement
of
Investments.
Only
the
variation
margin
receivable/payable
at
period
end
is
separately
reported
within
the
Consolidated
Statement
of
Assets
and
Liabilities.
Prior
variation
margin
movements
were
recorded
to
cash
upon
receipt
or
payment.
C
VRI
are
included
in
investments
in
securities,
at
value
in
the
Consolidated
Statement
of
Assets
and
Liabilities.
11.
Other
Derivative
Information
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
62
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
For
the period
ended
October
31,
2020,
the
average
month
end
notional
amount
of
futures
contracts
and
swap
contracts,
the
average
month
end
contract
value
for
forward
exchange
contracts
and
average
month
end
fair
value
of
VRI
were
as
follows:
At
October
31,
2020,
the
Fund's
OTC
derivative
assets
and
liabilities
are
as
follows:
Derivative
Contracts
Not
Accounted
for
as
Hedging
Instruments
Consolidated
Statement
of
Operations
Location
Net
Realized
Gain
(Loss)
for
the
Period
Consolidated
Statement
of
Operations
Location
Net
Change
in
Unrealized
Appreciation
(Depreciation)
for
the
Period
Net
realized
gain
(loss)
from:
Net
change
in
unrealized
  appreciation
(depreciation)
on:
Franklin
Strategic
Income
Fund
Interest
rate
contracts
.......
Futures
contracts
$4,608,297
Futures
contracts
$(4,409,398)
Swap
contracts
(6,139,210)
Swap
contracts
71,601
Foreign
exchange
contracts
..
Forward
exchange
contracts
(19,884,494)
Forward
exchange
contracts
6,255,398
Credit
contracts
............
Swaps
contracts
(19,055,965)
Swap
contracts
34,844,430
Inflation
contracts
..........
Swap
contracts
Swap
contracts
12,875,396
Value
recovery
instruments
Investments
Investments
$1,252,876
a
Total
....................
$(40,471,372)
$50,890,303
a
Purchased
option
contracts
and
VRI
are
included
in
net
reailzed
gain
(loss)
from
investments
and
net
change
in
unreailized
appreciation
(depreciation)
on
investments
in
the
Consolidated
Statement
of
Operations.
Franklin
Strategic
Income
Fund
Futures
contracts
.........................
$582,282,228
Swap
Contracts
..........................
504,915,455
Forward
exchange
contracts
.................
841,382,986
VRI
....................................
8,790,415
Gross
Amounts
of
Assets
and
Liabilities
Presented
in
the
Consolidated
Statement
of
Assets
and
Liabilities
Assets
a
Liabilities
a
Derivatives
Franklin
Strategic
Income
Fund
Forward
exchange
contracts
.............................
$
4,513,818
$
1,684,789
Swap
contracts
.......................................
673,904
10,100,706
Total
.............................................
$5,187,722
$11,785,495
a
Absent
an
event
of
default
or
early
termination,
OTC
derivative
assets
and
liabilities
are
presented
gross
and
not
offset
in
the
Consolidated
Statement
of
Assets
and
Liabilities.
11.
Other
Derivative
Information
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
63
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
At
October
31,
2020,
OTC
derivative
assets,
which
may
be
offset
against
OTC
derivative
assets
and
collateral
pledged
to
the
counterparty,
are
as
follows:
At
October
31,
2020,
OTC
derivative
liabilities,
which
may
be
offset
against
OTC
derivative
liabilities
and
collateral
received
from
the
counterparty,
are
as
follows:
Amounts
Not
Offset
in
the
Consolidated
Statement
of
Assets
and
Liabilities
Gross
Amounts
of
Assets
Presented
in
the
Consolidated
Statement
of
Assets
and
Liabilities
Financial
Instruments
Available
for
Offset
Financial
Instruments
Collateral
Received
Cash
Collateral
Received
Net
Amount
(Not
less
than
zero)
Franklin
Strategic
Income
Fund
Counterparty
BNDP
...................
$—
$—
$—
$—
$—
BNY
BZWS
...................
527,579
(527,579)
CITI
.....................
146,325
(146,325)
DBAB
...................
11,433
11,433
GSCO
...................
JPHQ
...................
4,502,385
(4,502,386)
MSCO
...................
Total
...................
$5,187,722
$(5,176,290)
$
$—
$11,433
$
1
Amounts
Not
Offset
in
the
Consolidated
Statement
of
Assets
and
Liabilities
Gross
Amounts
of
Liabilities
Presented
in
the
Consolidated
Statement
of
Assets
and
Liabilities
Financial
Instruments
Available
for
Offset
Financial
Instruments
Collateral
Pledged
a
Cash
Collateral
Pledged
a
Net
Amount
(Not
less
than
zero)
Franklin
Strategic
Income
Fund
Counterparty
BNDP
...................
$65,407
$—
$—
$(65,407)
$—
BNY
BZWS
...................
615,207
(527,579)
(87,627)
CITI
.....................
1,167,918
(146,325)
(1,021,594)
DBAB
...................
GSCO
...................
297,253
(230,000)
67,253
JPHQ
...................
4,955,178
(4,502,386)
(452,793)
MSCO
...................
4,684,532
(4,684,532)
Total
...................
$11,785,495
$(5,176,290)
$—
$(6,541,953)
$67,253
11.
Other
Derivative
Information
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
64
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
See
Note
1(f)
regarding
derivative
financial
instruments. 
See
Abbreviations
on
page
69
.
12.
Holdings
of
5%
Voting
Securities
of
Portfolio
Companies
The
1940
Act
defines
"affiliated
companies"
to
include
investments
in
portfolio
companies
in
which
a
fund
owns
5%
or
more
of
the
outstanding
voting
securities.
During
the
period
ended
October
31,
2020,
investments
in
“affiliated
companies”
were
as
follows:
13.
Credit
Facility
The
Fund,
together
with
other
U.S.
registered
and
foreign
investment
funds
(collectively,
Borrowers),
managed
by
Franklin
Templeton,
are
borrowers
in
a
joint
syndicated
senior
unsecured
credit
facility
totaling
$2
billion
(Global
Credit
Facility)
which
matures
on
February
5,
2021.
This
Global
Credit
Facility
provides
a
source
of
funds
to
the
Borrowers
for
temporary
and
emergency
purposes,
including
the
ability
to
meet
future
unanticipated
or
unusually
large
redemption
requests.
Under
the
terms
of
the
Global
Credit
Facility,
the
Fund
shall,
in
addition
to
interest
charged
on
any
borrowings
made
by
the
Fund
and
other
costs
incurred
by
the Fund,
pay
its
share
of
fees
and
expenses
incurred
in
connection
with
the
implementation
and
maintenance
of
the
Global
Credit
Facility,
based
upon
its
relative
share
of
the
aggregate
net
assets
of
all
of
the
Borrowers,
including
an
annual
commitment
fee
of
0.15%
based
upon
the
unused
portion
of
the
Global
Credit
Facility.
These
fees
are
reflected
in
other
expenses
in
the
Consolidated
Statement
of
Operations.
During
the
period
ended
October
31,
2020,
the Fund
did
not
use
the
Global
Credit
Facility.
14.
Fair
Value
Measurements
The
Fund
follows
a
fair
value
hierarchy
that
distinguishes
between
market
data
obtained
from
independent
sources
(observable
inputs)
and
the Fund's
own
market
assumptions
(unobservable
inputs).
These
inputs
are
used
in
determining
the
value
of
the
Fund's financial
instruments
and
are
summarized
in
the
following
fair
value
hierarchy:
Level
1
quoted
prices
in
active
markets
for
identical
financial
instruments
a
In
some
instances,
the
collateral
amounts
disclosed
in
the
table
above
were
adjusted
due
to
the
requirement
to
limit
collateral
amounts
to
avoid
of
over
collateralization.  Actual
collateral
received
and/or
pledged
may
be
more
than
the
amounts
disclosed
herein.
Value
at
Beginning
of
Period
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Period
Number
of
Shares/Principal
Amount
Held
at
End
of
Period
Investment
Income
Franklin
Strategic
Income
Fund
Non-Controlled
Affiliates
Dividends
Remington
Outdoor
Co.,
Inc.
.
$
661,219
$
$
$
$
(661,219)
$
1,322,439
$
Remington
Outdoor
Co.,
Inc.,
Litigation
Units
.........
124,500
Total
Affiliated
Securities
(Value
is
—%
of
Net
Assets)
$661,219
$—
$—
(661,219)
$—
$—
11.
Other
Derivative
Information
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
65
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
Level
2
other
significant
observable
inputs
(including
quoted
prices
for
similar
financial
instruments,
interest
rates,
prepayment
speed,
credit
risk,
etc.)
Level
3
significant
unobservable
inputs
(including
the
Fund's
own
assumptions
in
determining
the
fair
value
of
financial
instruments)
The
input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level.
A
summary
of
inputs
used
as
of
October
31,
2020,
in
valuing
the
Fund's
assets
and
liabilities
carried
at
fair
value,
is
as
follows:
Level
1
Level
2
Level
3
Total
Franklin
Strategic
Income
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Aerospace
&
Defense
...................
$
$
$
a
$
Energy
Equipment
&
Services
.............
316,729
316,729
Entertainment
.........................
33,335
33,335
Hotels,
Restaurants
&
Leisure
.............
122,759
122,759
Machinery
............................
1,985,626
1,985,626
Media
...............................
1,201,285
14,838
1,216,123
Multiline
Retail
........................
a
Oil,
Gas
&
Consumable
Fuels
.............
29,157
29,157
Paper
&
Forest
Products
.................
302,681
4,917,645
5,220,326
Road
&
Rail
..........................
a
Specialty
Retail
........................
233,596
233,596
Management
Investment
Companies
.........
110,821,608
110,821,608
Warrants
:
Diversified
Financial
Services
.............
a
Media
...............................
9
9
Oil,
Gas
&
Consumable
Fuels
.............
144
144
Paper
&
Forest
Products
.................
2,109
2,109
Software
&
Services
....................
750,000
750,000
Convertible
Bonds
.......................
80,293
80,293
Corporate
Bonds
:
Aerospace
&
Defense
...................
5,218,775
5,218,775
Air
Freight
&
Logistics
...................
9,155,932
9,155,932
Airlines
..............................
10,563,571
10,563,571
Auto
Components
......................
29,439,564
29,439,564
Banks
...............................
84,908,354
84,908,354
Beverages
...........................
18,533,383
18,533,383
Biotechnology
.........................
21,967,741
21,967,741
Building
Products
......................
26,122,435
26,122,435
Capital
Markets
........................
39,487,379
39,487,379
Chemicals
...........................
110,746,635
110,746,635
Commercial
Services
&
Supplies
...........
14,182,907
14,182,907
Communications
Equipment
..............
12,560,020
12,560,020
Construction
&
Engineering
...............
846,000
846,000
Construction
Materials
..................
13,364,000
13,364,000
Consumer
Finance
.....................
22,556,523
22,556,523
Containers
&
Packaging
.................
67,299,310
67,299,310
Distributors
...........................
4,837,500
4,837,500
Diversified
Financial
Services
.............
15,018,919
15,018,919
Diversified
Telecommunication
Services
.....
55,305,799
55,305,799
Electric
Utilities
........................
90,281,576
90,281,576
Electronic
Equipment,
Instruments
&
Components
........................
33,856,185
33,856,185
14.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
66
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
Level
1
Level
2
Level
3
Total
Franklin
Strategic
Income
Fund
(continued)
Assets:
Investments
in
Securities:
Corporate
Bonds:
Energy
Equipment
&
Services
.............
$
$
9,935,758
$
$
9,935,758
Entertainment
.........................
33,885,134
33,885,134
Equity
Real
Estate
Investment
Trusts
(REITs)
.
41,549,768
41,549,768
Food
&
Staples
Retailing
.................
9,442,951
9,442,951
Food
Products
........................
44,060,650
44,060,650
Gas
Utilities
..........................
2,988,646
2,988,646
Health
Care
Providers
&
Services
..........
46,645,512
46,645,512
Hotels,
Restaurants
&
Leisure
.............
66,837,152
66,837,152
Household
Durables
....................
33,854,489
33,854,489
Household
Products
....................
13,290,437
13,290,437
Independent
Power
and
Renewable
Electricity
Producers
..........................
63,163,190
63,163,190
Insurance
............................
40,421,011
40,421,011
Interactive
Media
&
Services
..............
17,310,722
17,310,722
Internet
&
Direct
Marketing
Retail
..........
13,160,456
13,160,456
IT
Services
...........................
35,492,534
35,492,534
Machinery
............................
21,920,212
21,920,212
Marine
..............................
12,612,180
12,612,180
Media
...............................
113,927,067
113,927,067
Metals
&
Mining
.......................
34,550,542
34,550,542
Multiline
Retail
........................
1,989,308
15,007
a
2,004,315
Multi-Utilities
..........................
9,579,330
9,579,330
Oil,
Gas
&
Consumable
Fuels
.............
179,052,255
179,052,255
Paper
&
Forest
Products
.................
3,814,145
3,814,145
Pharmaceuticals
.......................
41,300,346
41,300,346
Real
Estate
Management
&
Development
....
26,677,263
26,677,263
Road
&
Rail
..........................
46,085,455
4,101,072
50,186,527
Semiconductors
&
Semiconductor
Equipment
.
13,141,875
13,141,875
Software
.............................
11,912,325
11,912,325
Specialty
Retail
........................
15,324,893
15,324,893
Textiles,
Apparel
&
Luxury
Goods
..........
10,827,800
10,827,800
Thrifts
&
Mortgage
Finance
...............
43,030,318
43,030,318
Tobacco
.............................
21,592,031
21,592,031
Trading
Companies
&
Distributors
..........
28,351,780
28,351,780
Wireless
Telecommunication
Services
.......
49,067,961
49,067,961
Senior
Floating
Rate
Interests
...............
100,093,915
61,531,323
161,625,238
Marketplace
Loans
......................
7,643,077
7,643,077
Loan
Participations
and
Assignments
.........
18,699,014
18,699,014
Foreign
Government
and
Agency
Securities
....
569,812,903
569,812,903
U.S.
Government
and
Agency
Securities
.......
173,356,454
173,356,454
Asset-Backed
Securities
..................
786,897,846
786,897,846
Commercial
Mortgage-Backed
Securities
......
3,512,531
3,512,531
Mortgage-Backed
Securities
................
308,755,066
308,755,066
Municipal
Bonds
.........................
62,834,855
62,834,855
Escrows
and
Litigation
Trusts
...............
60,000
45,000
a
105,000
Short
Term
Investments
...................
51,958,261
75,759,713
127,717,974
Total
Investments
in
Securities
...........
$164,896,661
$3,942,912,703
$81,126,491
$4,188,935,855
Other
Financial
Instruments:
Forward
exchange
contracts
...............
$
$
4,513,818
$
$
4,513,818
Futures
contracts
........................
386,755
386,755
Swap
contracts
.........................
5,689,150
5,689,150
Unfunded
Loan
Commitments
..............
122,307
122,307
Total
Other
Financial
Instruments
.........
$386,755
$10,325,275
$—
$10,712,030
14.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
67
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
A
reconciliation
in
which
Level
3
inputs
are
used
in
determining
fair
value
is
presented
when
there
are
significant
Level
3
assets
and/or
liabilities
at
the
beginning
and/or
end
of
the
period.
At October
31,
2020,
the
reconciliation
is
as
follows:
Level
1
Level
2
Level
3
Total
Franklin
Strategic
Income
Fund
(continued)
Liabilities:
Other
Financial
Instruments:
Forward
exchange
contracts
................
1,684,789
1,684,789
Futures
contracts
........................
1,579,302
1,579,302
Swap
contracts
..........................
9,316,131
9,316,131
Total
Other
Financial
Instruments
.........
$1,579,302
$11,000,920
$—
$12,580,222
a
Includes
securities
determined
to
have
no
value
at
October
31,
2020.
Balance
at
Beginning
of
Period
Purchases
Sales
Transfer
Into
Level
3
a
Transfer
Out
of
Level
3
Cost
Basis
Adjust-
ments
b
Net
Realized
Gain
(Loss)
Net
Unr
ealized
Appreciatio
n
(
Depreciation
)
Balance
at
End
of
Period
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Period
End
a
a
a
a
a
a
a
a
a
a
a
Franklin
Strategic
Income
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Aerospace
&
Defense
.
$
$
$
$
661,220
$
$
$
$
(661,220)
$
$
(661,220)
Hotels,
Restaurants
&
Leisure
.........
122,759
122,759
Machinery
.........
1,985,626
1,985,626
Media
...........
11,582
3,256
14,838
3,256
Multiline
Retail
......
Paper
&
Forest
Products
6,144,820
(1,227,175)
4,917,645
(1,227,175)
Road
&
Rail
.......
Warrants
:
Diversified
Financial
Services
........
Oil,
Gas
&
Consumable
Fuels
..........
119,805
(119,661)
144
(119,661)
Software
&
Services
..
750,000
750,000
Corporate
Bonds
:
Diversified
Financial
Services
........
121,350
(1,498,232)
1,376,882
Multiline
Retail
......
24,852
1,667
(1,036,687)
1,025,175
15,007
1,025,175
Road
&
Rail
.......
3,404,098
264,424
432,550
4,101,072
432,550
Senior
Floating
Rate
Interests
:
Household
Products
..
41,728,693
8,607
(3,246,257)
38,491,043
(3,246,257)
Road
&
Rail
.......
2,855,822
4,185
269,145
3,129,152
269,145
Software
..........
19,604,573
83,997
222,558
19,911,128
222,558
Marketplace
Loans
:
Diversified
Financial
Services
........
6,389,054
2,879,455
1,160,476
3,764,246
(389,937)
(10,685)
(6,149,532)
7,643,077
(6,129,743)
Commercial
Mortgage-
Backed
Securities
:
Thrifts
&
Mortgage
Finance
........
8,697,031
(10,835,111)
2,138,080
Asset-Backed
Securities
:
Diversified
Financial
Services
........
5,585,223
(5,116,944)
(258,337)
(209,942)
14.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
68
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
Significant
unobservable
valuation
inputs
for
material
Level
3 assets
and/or
liabilities and
impact
to
fair
value
as
a
result
of
changes
in
unobservable
valuation
inputs
as
of
October
31,
2020,
are
as
follows:
Balance
at
Beginning
of
Period
Purchases
Sales
Transfer
Into
Level
3
a
Transfer
Out
of
Level
3
Cost
Basis
Adjust-
ments
b
Net
Realized
Gain
(Loss)
Net
Unrealized
Appreciation
(Depreciation)
Balance
at
End
of
Period
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Period
End
a
a
a
a
a
a
a
a
a
a
a
Franklin
Strategic
Income
Fund
(continued)
Assets:
Investments
in
Securities:
Escrows
and
Litigation
Trusts
...........
$
c
$
$
$
60,000
$
$
$
$
(15,000)
$
45,000
$
(15,000)
Total
Investments
in
Securities
.
$94,689,466
$2,881,122
$1,160,476
$7,341,288
$(15,952,055)
$(2,821,980)
$(10,685)
$(6,161,141)
$81,126,491
$(9,446,372)
a
Transferred
into
Level
3
as
a
result
of
the
unavailability
of
a
quoted
market
price
in
an
active
market
for
identical
securities
and
other
significant
observable
valuation
inputs.
b
May
include
accretion,
amortization,
partnership
adjustments,
and/or
other
cost
basis
adjustments.
c
Includes
securities
determined
to
have
no
value.
Description
Fair
Value
at
End
of
Period
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
Impact
to
Fair
Value
if
Input
Increases
a
Franklin
Strategic
Income
Fund
Assets:
Investments
in
Securities:
Common
Stocks:
Paper
&
Forest
Products
....
$4,917,645
Discounted
cash
flow
Weighted
average
cost
of
capital
20.5%
Decrease
b
Unlevered
free
cash
flows
$141.4
mil
Increase
Discount
for
lack
of
marketability
20.0%
Decrease
b
Long
term
growth
0.0%
Increase
Corporate
Bonds:
Road
&
Rail
.............
4,101,072
Discounted
cash
flow
Discount
rate
15.8%
Decrease
b
Free
cash
flow
$4.5
mil
Increase
b
Senior
Floating
Rate
Interests:
Household
...............
38,491,043
Recovery
value
Asset
value
estimate
$220.0
mil
Increase
b
Software
19,911,128 
Discounted
cash
flow
Discount
rate
18.2%
Decrease
......................
Free
cash
flow
$22.6
mil
Increase
b
All
other
Investments
..........
13,705,603
c,d
Total
.......................
$81,126,491
a
Represents
the
directional
change
in
the
fair
value
that
would
result
from
a
significant
and
reasonable
increase
in
the
corresponding
input.
A
significant
and
reasonable
decrease
in
the
input
would
have
the
opposite
effect.
Significant
impacts,
if
any,
to
fair
value
and/or
net
assets
have
been
indicated.
b
Represents
a
significant
impact
to
fair
value
but
not
net
assets.
c
Includes
fair
value
of
immaterial
assets
and/or
liabilities
developed
using
various
valuation
techniques
and
unobservable
inputs.
May
also
include
values
derived
using
private
transaction
prices
or
non-public
third
party
pricing
information
which
is
unobservable.
14.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Consolidated
Financial
Statements
(unaudited)
69
franklintempleton.com
Semiannual
Report
Franklin
Strategic
Income
Fund
(continued)
15.
New
Accounting
Pronouncements
In
March
2020,
the
Financial
Accounting
Standards
Board
issued
Accounting
Standards
Update
(ASU)
No.
2020-04,
Reference
Rate
Reform
(Topic
848)
Facilitation
of
the
Effects
of
Reference
Rate
Reform
on
Financial
Reporting.
The
amendments
in
the
ASU
provides
optional
temporary
financial
reporting
relief
from
the
effect
of
certain
types
of
contract
modifications
due
to
the
planned
discontinuation
of
the
London
Interbank
Offered
Rate
and
other
interbank-offered
based
reference
rates
as
of
the
end
of
2021.
The
ASU
is
effective
for
certain
reference
rate-related
contract
modifications
that
occur
during
the
period
March
12,
2020
through
December
31,
2022. Management
has
reviewed
the
requirements
and
believes
the
adoption
of
this
ASU
will
not
have
a
material
impact
on
the
consolidated
financial
statements.
16.
Subsequent
Events
The
Fund
has
evaluated
subsequent
events
through
the
issuance
of
the financial
statements
and
determined
that
no
events
have
occurred
that
require
disclosure.
Abbreviations
d
Includes
securities
determined
to
have
no
value
at
October
31,
2020.
Counterparty
DBAB
Deutsche
Bank
AG
JPHQ
JP
Morgan
Chase
Bank,
N.A.
Selected
Portfolio
AGMC
Assured
Guaranty
Municipal
Corp.
BA
Banker's
Acceptance
BBR
Bank
of
England
Base
Rate
BZDIOVRA
Brazil
Inter-Bank
Deposit
Rate
CLO
Collateralized
Loan
Obligation
CMT
Constant
Monthly
U.S.
Treasury
Securities
Yield
Curve
Rate
Index
CVR
Contingent
Voting
Rights
EURIBOR
Euro
Inter-Bank
Offer
Rate
FHLMC
Federal
Home
Loan
Mortgage
Corp.
FNMA
Federal
National
Mortgage
Association
FRN
Floating
Rate
Note
GDP
Gross
Domestic
Product
GNMA
Government
National
Mortgage
Association
GO
General
Obligation
LIBOR
London
Inter-Bank
Offered
Rate
MBS
Mortgage-Backed
Security
PIK
Payment-In-Kind
SOFR
Secured
Overnight
Financing
Rate
TBD
To
Be
Determined
T-Note
Treasury
Note
VRI
Value
Recovery
Instrument
Currency
AUD
Australian
Dollar
BRL
Brazilian
Real
CAD
Canadian
Dollar
COP
Colombian
Peso
DOP
Dominican
Peso
EUR
Euro
IDR
Indonesian
Rupiah
USD
United
States
Dollar
UYU
Uruguayan
Peso
ZAR
South
African
Rand
14.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Shareholder
Information
70
franklintempleton.com
Semiannual
Report
Liquidity
Risk
Management
Program
Funds
no
HLIM
Each
of
the
Funds
has
adopted
and
implemented
a
written
Liquidity
Risk
Management
Program
(the
“LRMP”)
as
required
by
Rule
22e-4
under
the
Investment
Company
Act
of
1940
(the
“Liquidity
Rule”).
The
LRMP
is
designed
to
assess
and
manage
each
Fund’s
liquidity
risk,
which
is
defined
as
the
risk
that
the
Fund
could
not
meet
requests
to
redeem
shares
issued
by
the
Fund
without
significant
dilution
of
remaining
investors’
interests
in
the
Fund.
In
accordance
with
the
Liquidity
Rule,
the
LRMP
includes
policies
and
procedures
that
provide
for:
(1)
assessment,
management,
and
review
(no
less
frequently
than
annually)
of
each
Fund’s
liquidity
risk;
(2)
classification
of
each
Fund’s
portfolio
holdings
into
one
of
four
liquidity
categories
(Highly
Liquid,
Moderately
Liquid,
Less
Liquid,
and
Illiquid);
(3)
for
Funds
that
do
not
primarily
hold
assets
that
are
Highly
Liquid,
establishing
and
maintaining
a
minimum
percentage
of
the
Fund’s
net
assets
in
Highly
Liquid
investments
(called
a
“Highly
Liquid
Investment
Minimum”
or
“HLIM”);
and
(4)
prohibiting
the
Fund’s
acquisition
of
Illiquid
investments
that
would
result
in
the
Fund
holding
more
than
15%
of
its
net
assets
in
Illiquid
assets.
The
LRMP
also
requires
reporting
to
the
Securities
and
Exchange
Commission
(“SEC”)
(on
a
non-public
basis)
and
to
the
Board
if
the
Fund’s
holdings
of
Illiquid
assets
exceed
15%
of
the
Fund’s
net
assets.
Funds
with
HLIMs
must
have
procedures
for
addressing
HLIM
shortfalls,
including
reporting
to
the
Board
and,
with
respect
to
HLIM
shortfalls
lasting
more
than
seven
consecutive
calendar
days,
reporting
to
the
SEC
(on
a
non-public
basis).
The
Funds’
Board
of
Trustees
approved
the
appointment
of
the
Director
of
Liquidity
Risk
within
the
Investment
Risk
Management
Group
(the
“IRMG”)
as
the
Administrator
of
the
LRMP.
The
IRMG
maintains
the
Investment
Liquidity
Committee
(the
“ILC”)
to
provide
oversight
and
administration
of
policies
and
procedures
governing
liquidity
risk
management
for
FT
products
and
portfolios.
The
ILC
includes
representatives
from
Franklin
Templeton’s
Risk,
Trading,
Global
Compliance,
Investment
Compliance,
Investment
Operations,
Valuation
Committee
and
Product
Management
groups.
In
assessing
and
managing
each
Fund’s
liquidity
risk,
the
ILC
considers,
as
relevant,
a
variety
of
factors,
including
the
Fund’s
investment
strategy
and
the
liquidity
of
its
portfolio
investments
during
both
normal
and
reasonably
foreseeable
stressed
conditions;
its
short
and
long-term
cash
flow
projections;
and
its
cash
holdings
and
access
to
other
funding
sources
including
the
Funds’
interfund
lending
facility
and
line
of
credit.
Classification
of
the
Fund’s
portfolio
holdings
in
the
four
liquidity
categories
is
based
on
the
number
of
days
it
is
reasonably
expected
to
take
to
convert
the
investment
to
cash
(for
Highly
Liquid
and
Moderately
Liquid
holdings)
or
sell
or
dispose
of
the
investment
(for
Less
Liquid
and
Illiquid
investments),
in
current
market
conditions
without
significantly
changing
the
investment’s
market
value.
Each
Fund
primarily
holds
liquid
assets
that
are
defined
under
the
Liquidity
Rule
as
"Highly
Liquid
Investments,"
and
therefore
is
not
required
to
establish
an
HLIM.
Highly
Liquid
Investments
are
defined
as
cash
and
any
investment
reasonably
expected
to
be
convertible
to
cash
in
current
market
conditions
in
three
business
days
or
less
without
the
conversion
to
cash
significantly
changing
the
market
value
of
the
investment.
At
meetings
of
the
Funds’
Board
of
Trustees
held
in
May
2020,
the
Program
Administrator
provided
a
written
report
to
the
Board
addressing
the
adequacy
and
effectiveness
of
the
program
during
the
period
December
1,
2018
to
December
31,
2019.
The
Program
Administrator
report
concluded
that
(i.)
the
LRMP,
as
adopted
and
implemented,
remains
reasonably
designed
to
assess
and
manage
each
Fund’s
liquidity
risk;
(ii.)
the
LRMP,
including
the
Highly
Liquid
Investment
Minimum
(“HLIM”)
where
applicable,
was
implemented
and
operated
effectively
to
achieve
the
goal
of
assessing
and
managing
each
Fund’s
liquidity
risk;
and
(iii.)
each
Fund
was
able
to
meet
requests
for
redemption
without
significant
dilution
of
remaining
investors’
interests
in
the
Fund.
At
the
same
time,
the
Program
Administrator
also
presented
the
Fund
Board
of
Trustees
an
update
on
liquidity
during
the
first
quarter
of
2020
in
relation
to
the
COVID-19
pandemic.
Proxy
Voting
Policies
and
Procedures
The
Fund’s
investment
manager
has
established
Proxy
Voting
Policies
and
Procedures
(Policies)
that
the
Fund
uses
to
determine
how
to
vote
proxies
relating
to
portfolio
securities.
Shareholders
may
view
the
Fund’s
complete
Policies
online
at
franklintempleton.com.
Alternatively,
shareholders
may
request
copies
of
the
Policies
free
of
charge
by
calling
the
Proxy
Group
collect
at
(954)
527-
7678
or
by
sending
a
written
request
to:
Franklin
Templeton
Companies,
LLC,
300
S.E.
2nd
Street,
Fort
Lauderdale,
FL
33301,
Attention:
Proxy
Group.
Copies
of
the
Fund’s
Franklin
Strategic
Series
Shareholder
Information
71
franklintempleton.com
Semiannual
Report
proxy
voting
records
are
also
made
available
online
at
franklintempleton.com
and
posted
on
the
U.S.
Securities
and
Exchange
Commission’s
website
at
sec.gov
and
reflect
the
most
recent
12-month
period
ended
June
30.
Quarterly
Statement
of
Investments
The
Trust,
on
behalf
of
the
Fund,
files
a
complete
statement
of
investments
with
the
U.S.
Securities
and
Exchange
Commission
for
the
first
and
third
quarters
for
each
fiscal
year
as
an
exhibit
to
its
report
on
Form
N-PORT.
Shareholders
may
view
the
filed
Form
N-PORT
by
visiting
the
Commission’s
website
at
sec.gov.
The
filed
form
may
also
be
viewed
and
copied
at
the
Commission’s
Public
Reference
Room
in
Washington,
DC.
Information
regarding
the
operations
of
the
Public
Reference
Room
may
be
obtained
by
calling
(800)
SEC-0330.
Householding
of
Reports
and
Prospectuses
You
will
receive
the
Fund’s
financial
reports
every
six
months
as
well
as
an
annual
updated
summary
prospectus
(prospectus
available
upon
request).
To
reduce
Fund
expenses,
we
try
to
identify
related
shareholders
in
a
household
and
send
only
one
copy
of
the
financial
reports
and
summary
prospectus.
This
process,
called
“householding,”
will
continue
indefinitely
unless
you
instruct
us
otherwise.
If
you
prefer
not
to
have
these
documents
householded,
please
call
us
at
(800)
632-2301.
At
any
time
you
may
view
current
prospectuses/summary
prospectuses
and
financial
reports
on
our
website.
If
you
choose,
you
may
receive
these
documents
through
electronic
delivery.
194
S
12/20
©
2020
Franklin
Templeton
Investments.
All
rights
reserved.
Authorized
for
distribution
only
when
accompanied
or
preceded
by
a
summary
prospectus
and/or
prospectus.
Investors
should
carefully
consider
a
fund’s
investment
goals,
risks,
charges
and
expenses
before
investing.
A
prospectus
contains
this
and
other
information;
please
read
it
carefully
before
investing.
To
help
ensure
we
provide
you
with
quality
service,
all
calls
to
and
from
our
service
areas
are
monitored
and/or
recorded.
Semiannual
Report
and
Shareholder
Letter
Franklin
Strategic
Income
Fund
Investment
Manager
Distributor
Shareholder
Services
Franklin
Advisers,
Inc.
Franklin
Templeton
Distributors,
Inc.
(800)
DIAL
BEN
®
/
342-5236
franklintempleton.com
(800)
632-2301
Item 2. Code of Ethics.
 
(a) The Registrant has adopted a code of ethics that applies to its principal executive officers and principal financial and accounting officer. 
 
(c) N/A
 
(d) N/A
 
(f) Pursuant to Item 13(a)(1), the Registrant is attaching as an exhibit a copy of its code of ethics that applies to its principal executive officers and principal financial and accounting officer.
 
 
Item 3. Audit Committee Financial Expert.
 
(a)(1) The Registrant has an audit committee financial expert serving on its audit committee.
 
(2) The audit committee financial expert is Mary C. Choksi and she is "independent" as defined under the relevant Securities and Exchange Commission Rules and Releases.
 
 
Item 4.
Principal Accountant Fees and Services.
N/A


 
Item 5. Audit Committee
 
of Listed Registrants. N/A
 
 
Item 6. Schedule of Investments. N/A

 
Item 7.  Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies. N/A
 
 
Item 8.  Portfolio Managers of Closed-End Management Investment Companies. N/A
 
 
Item 9.  Purchases of Equity Securities by Closed-End Management Investment Company and
Affiliated Purchasers. N/A
 
 
Item 10.  Submission of Matters to a Vote of Security Holders.
 
There have been no changes to the procedures by which shareholders may recommend nominees to the Registrant's Board of Trustees that would require disclosure herein.
 
 
Item 11. Controls and Procedures.
 
(a)
  Evaluation of Disclosure Controls and Procedures
The Registrant maintains disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in the Registrant’s filings under the Securities Exchange Act of 1934, as amended, and the Investment Company Act of 1940 is recorded, processed, summarized and reported within the periods specified in the rules and forms of the Securities and Exchange Commission. Such information is accumulated and communicated to the Registrant’s management, including its principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. The Registrant’s management, including the principal executive officer and the principal financial officer, recognizes that any set of controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.
 
Within 90 days prior to the filing date of this Shareholder Report on Form N-CSR, the Registrant had carried out an evaluation, under the supervision and with the participation of the Registrant’s management, including the Registrant’s principal executive officer and the Registrant’s principal financial officer, of the effectiveness of the design and operation of the Registrant’s disclosure controls and procedures. Based on such evaluation, the Registrant’s principal executive officer and principal financial officer concluded that the Registrant’s disclosure controls and procedures are effective.
 
(b)   Changes in Internal Controls
During the period covered by this report, a third-party service provider commenced performing certain accounting and administrative services for the Registrant that are subject to Franklin Templeton’s oversight.
 
 
Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Company. N/A
 
 
Item 13. Exhibits.
 
(a) (1) Code of Ethics
 
 
(a) (2) Certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of Matthew T. Hinkle, Chief Executive Officer - Finance and Administration, and Gaston Gardey, Chief Financial Officer and Chief Accounting Officer
 
 
(b)   Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 of Matthew T. Hinkle, Chief Executive Officer - Finance and Administration, and Gaston Gardey, Chief Financial Officer and Chief Accounting Officer
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
FRANKLIN
STRATEGIC SERIES
 
 
 
By S\MATTHEW T. HINKLE________________________
Matthew T. Hinkle
Chief Executive Officer – Finance and Administration
Date December 28, 2020
 
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
 
 
 
By S\MATTHEW T. HINKLE________________________
Matthew T. Hinkle
Chief Executive Officer – Finance and Administration
Date December 28, 2020
 
 
 
By S\GASTON GARDEY__________________________
Gaston Gardey
Chief Financial Officer and Chief Accounting Officer
Date December 28, 2020
EX-99.CERT 2 section302.htm
 
 
I, Gaston Gardey, certify that:
 
1. I have reviewed this report on Form N-CSR of Franklin Strategic Series;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
 
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 
5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
12/28/2020
 
 
 
S\GASTON GARDEY
 
Gaston Gardey
Chief Financial Officer and Chief Accounting Officer
 

 
 
I, Matthew T. Hinkle, certify that:
 
1. I have reviewed this report on Form N-CSR of Franklin Strategic Series;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
 
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 
5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
12/28/2020
 
 
 
S\MATTHEW T. HINKLE
 
Matthew T. Hinkle
Chief Executive Officer - Finance and Administration
 

 
 
EX-99.906 CERT 3 section906.htm
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 
I, Gaston Gardey, Chief Financial Officer of the Franklin Strategic Series (the “Registrant”), certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
 
1.
                 
The periodic report on Form N-CSR of the Registrant for the period ended 10/31/2020 (the “Form N-CSR”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2.
                 
The information contained in the Form N-CSR fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
 
Dated:  12/28/2020
 
                                                S\GASTON GARDEY
 
                                                Gaston Gardey
Chief Financial Officer and Chief Accounting Officer
                        

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 
I, Matthew T. Hinkle, Chief Executive Officer of the Franklin Strategic Series (the “Registrant”), certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
 
1.
                 
The periodic report on Form N-CSR of the Registrant for the period ended 10/31/2020 (the “Form N-CSR”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2.
                 
The information contained in the Form N-CSR fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
 
Dated:  12/28/2020
 
                                                S\MATTHEW T. HINKLE
 
                                                Matthew T. Hinkle
Chief Executive Officer - Finance and Administration
                        

 
 
EX-99.CODE ETH 4 coe.htm
Code of Ethics for Principal Executives
&
Senior Financial
Officers
 
 
 
Procedures              
Revised December 10, 2018
 
 
 
 

FRANKLIN
TEMPLETON
FUNDS

 
CODE OF ETHICS
FOR
PRINCIPAL
EXECUTIVES
AND
SENIOR FINANCIAL OFFICERS
 

I.
            
Covered
Officers and Purpose of the Code

 
This
code
of
ethics
(the
"Code")
applies
to
the
Principal
Executive
Officers,
Principal
Financial
Officer
and
Principal
Accounting
Officer
(the
"Covered
Officers,"
each
of
whom
is
set
forth in
Exhibit
A)
of
each investment
company
advised by
a
Franklin
Resources
subsidiary
and
that
is
registered
with
the
United
States
Securities
&
Exchange
Commission
(“SEC”)
(collectively,
"FT
Funds")
for
the
purpose
of
promoting:
 
·
        
Honest
and
ethical
conduct,
including
the
ethical
resolution
of
actual
or
apparent
conflicts
of
interest
between
personal
and
professional
relationships;
·
        
Full,
fair,
accurate,
timely
and
understandable
disclosure
in
reports
and
documents
that
a
registrant
files
with,
or
submits
to,
the
SEC
and
in
other
public
communications
made
by
or
on
behalf
of
the
FT
Funds;
·
        
Compliance
with
applicable
laws
and
governmental
rules
and
regulations;
·
        
The
prompt
internal
reporting
of
violations
of
the
Code
to
an
appropriate
person
or
persons
identified
in
the
Code;
and
·
        
Accountability
for
adherence
to
the
Code.
 
Each
Covered
Officer
will
be
expected
to
adhere
to
a
high
standard
of
business
ethics
and
must
be
sensitive
to
situations
that
may
give
rise
to
actual
as
well
as
apparent
conflicts
of
interest.
 
 
 
 
*
Rule 38a-1
under
the
Investment
Company
Act of 1940
(“1940
Act”)
and
Rule
206(4)-7
under
the
Investment
Advisers
Act
of
1940 (“Advisers Act”)
(together
the “Compliance Rule”)
require registered
investment
companies
and
registered
investment
advisers
to,
among other
things, adopt and implement
written
policies
and
procedures reasonably
designed to
prevent
violations
of the
federal
securities
laws
(“Compliance
Rule
Policies
and
Procedures”).
 
CONFIDENTIAL
INFORMATION.
 
This
document
is
the
proprietary
product
of
Franklin
Templeton
Investments.
It
may
NOT
be
distributed
outside
the
company
unless
it is
made subject to
a
non-disclosure agreement
and/or
such
release
receives
authorization
by
an FTI
Chief Compliance
Officer.
 
Any
unauthorized
use,
reproduction
or
transfer
of this
document
is strictly
prohibited.
Franklin
Templeton
Investments
©
2014.
All
Rights Reserved.
 

II.
             
Other Policies and Procedures
 
This
Code
shall
be
the
sole
code
of
ethics
adopted
by
the
Funds
for
purposes
of
Section
406
of
the
Sarbanes-Oxley
Act
and
the
rules
and
forms
applicable
to
registered
investment
companies
thereunder.
 
Franklin
Resources,
Inc.
has
separately
adopted
the
Code
of
Ethics
and
Business
Conduct
(“Business
Conduct”),
which
is
applicable
to
all
officers,
directors
and
employees
of
Franklin
Resources,
Inc.,
including
Covered
Officers.
It
summarizes
the
values,
principles
and
business
practices
that
guide
the
employee’s
business
conduct
and
also
provides a set of basic
principles
to
guide
officers,
directors
and
employees  regarding  the
minimum
ethical
requirements
expected
of
them.
It
supplements
the
values,
principles
and
business
conduct
identified
in
the
Code
and
other
existing
employee
policies.
 
Additionally,
the
Franklin
Templeton
Funds
have
separately
adopted
the
FTI
Personal
Investments
and
Insider
Trading
Policy
governing
personal
securities
trading
and
other
related
matters.
The
Code
for
Insider
Trading
provides
for
separate
requirements
that
apply
to
the
Covered
Officers
and
others,
and
therefore
is
not
part
of
this
Code.
 
Insofar
as
other
policies
or
procedures
of
Franklin
Resources,
Inc.,
the
Funds,
the
Funds’
adviser,
principal
underwriter,
or
other
service
providers
govern
or
purport
to
govern
the
behavior
or
activities
of
the
Covered Officers
who
are subject
to this Code, they are
superceded
by
this
Code
to
the
extent
that
they
overlap
or
conflict
with
the
provisions
of
this
Code.
Please
review these other documents or consult with
the
Legal
Department
if have questions regarding
the
applicability
of
these
policies
to
you.
 

III.
             
Covered Officers Should Handle
Ethically
Actual and
Apparent
Conflicts of
Interest

 
Overview.
A
"conflict
of
interest"
occurs
when
a
Covered
Officer's
private
interest
interferes
with
the
interests
of,
or
his
or
her
service
to,
the
FT
Funds.
For
example,
a
conflict
of
interest
would
arise
if
a
Covered
Officer,
or
a
member
of
his
family,
receives
improper
personal
benefits
as
a
result
of
apposition
with
the
FT
Funds.
 
Certain
conflicts
of
interest
arise
out
of
the
relationships
between
Covered
Officers
and
the
FT
Funds
and
already
are
subject
to
conflict
of
interest
provisions
in
the
Investment
Company
Act
of
1940
("Investment
Company
Act")
and
the
Investment
Advisers
Act
of
1940
("Investment
Advisers
Act").
For
example,
Covered
Officers
may
not
individually
engage
in
certain
transactions
(such
as
the
purchase
or
sale
of
securities
or
other
property)
with
the
FT
Funds
because
of
their
status
as
"affiliated
persons"
of
the
FT
Funds.
The
FT
Funds’
and
the
investment
advisers’
compliance
programs
and
procedures
are
designed
to
prevent,
or
identify
and
correct,
violations
of
these
provisions.
This
Code
does not,
and
is not
intended
to,
repeat
or replace
these
programs
and
procedures,
and
such
conflicts
fall
outside
of
the
parameters
of
this
Code.
 
Although
typically
not
presenting
an
opportunity
for
improper
personal
benefit,
conflicts
arise
from,
or
as
a
result
of,
the
contractual
relationship
between
the
FT
Funds,
the
investment
advisers
and
the
fund
administrator
of
which
the
Covered
Officers
are
also
officers
or
employees.
As
a
result,
this
Code
recognizes
that
the
Covered
Officers
will,
in
the
normal
course
of
their
duties
(whether
formally
for
the
FT
Funds,
for
the
adviser,
the
administrator,
or

 

for
all
three),
be
involved
in
establishing
policies
and
implementing
decisions
that
will
have
different
effects
on
the
adviser,
administrator
and
the
FT
Funds.
The
participation
of
the
Covered
Officers
in
such
activities
is
inherent
in
the
contractual
relationship
between
the
FT
Funds,
the
adviser,
and
the
administrator
and
is
consistent
with
the
performance
by
the
Covered
Officers
of
their
duties
as
officers
of
the
FT
Funds.
Thus,
if
performed
in
conformity
with
the
provisions
of
the
Investment
Company
Act
and
the
Investment
Advisers
Act,
such
activities
will
be
deemed
to
have
been
handled
ethically.
In
addition,
it
is
recognized
by
the
FT
Funds'
Boards
of
Directors
("Boards")
that
the
Covered
Officers
may
also
be
officers
or
employees
of
one
or
more
other
investment
companies
covered
by
this
or
other
codes.
 
Other
conflicts
of
interest
are
covered
by
the
Code,
even
if
such
conflicts
of
interest
are
not
subject
to
provisions
in
the
Investment
Company
Act
and
the
Investment
Advisers
Act.
The
following
list
provides
examples
of
conflicts
of
interest
under
the
Code,
but
Covered
Officers
should
keep
in
mind
that
these
examples
are
not
exhaustive.
The
overarching
principle
is
that
the
personal
interest
of
a
Covered
Officer
should
not
be
placed
improperly
before
the
interest
of
the
FT
Funds.
 
Each
Covered
Officer
must:
·
        
Not
use
his
or
her
personal
influence
or
personal
relationships
improperly
to
influence
investment
decisions
or
financial
reporting
by
the
FT
Funds
whereby
the
Covered
Officer
would
benefit
personally
to
the
detriment
of
the
FT
Funds;
·
        
Not
cause
the
FT
Funds
to
take
action,
or
fail
to
take
action,
for
the
individual
personal
benefit
of
the
Covered
Officer
rather
than
the
benefit
the
FT
Funds;
·
        
Not
retaliate
against
any
other
Covered
Officer
or
any
employee
of
the
FT
Funds
or
their
affiliated
persons
for
reports
of
potential
violations
that
are
made
in
good
faith;
·
        
Report
at
least
annually
the
following
affiliations
or
other
relationships:
1
o
   
all
directorships
for
public
companies
and
all
companies
that
are
required
to
file
reports
with
the
SEC;
o
   
any
direct
or
indirect
business
relationship
with
any
independent
directors
of
the
FT
Funds;
o
   
any
direct
or
indirect
business
relationship
with
any
independent
public
accounting
firm
(which
are
not
related
to
the
routine
issues
related
to
the
firm’s
service
as
the
Covered
Persons
accountant);
and
o
   
any
direct
or
indirect
interest
in
any
transaction
with
any
FT
Fund
that
will
benefit
the
officer
(not
including
benefits
derived
from
the
advisory,
sub-advisory,
distribution
or
service
agreements
with
affiliates
of
Franklin
Resources).
These
reports
will
be
reviewed
by
the
Legal
Department
for
compliance
with
the
Code.
There
are
some
conflict
of
interest
situations
that
should
always
be
approved
in
writing
by
Franklin
Resources
General
Counsel
or
Deputy
General
Counsel,
if
material.
Examples
of
these
include
2
:
·
        
Service
as
a
director
on
the
board
of
any
public
or
private
Company.
 
 
 
1
Reporting
of
these
affiliations
or
other
relationships
shall
be
made
by
completing
the
annual
Directors
and
Officers
Questionnaire
and
returning
the
questionnaire
to
Franklin
Resources
Inc,
General
Counsel
or
Deputy
General
Counsel.
2
 
Any
activity
or
relationship
that
would
present
a
conflict
for
a
Covered
Officer
may
also
present
a
conflict
for
the
Covered
Officer
if
a
member
of
the
Covered
Officer's
immediate
family
engages
in
such
an
activity
or
has
such
a
relationship.
The
Cover
Person
should
also
obtain
written
approval
by
FT’s
General
Counsel
in
such
situations.
·
        
The
receipt
of
any
gifts
in
excess
of
$100
from
any
person,
from
any
corporation
or
association.
·
        
The
receipt
of
any
entertainment
from
any
Company
with
which
the
FT
Funds
has
current
or
prospective
business
dealings
unless
such
entertainment
is
business
related,
reasonable
in
cost,
appropriate
as
to
time
and
place,
and
not
so
frequent
as
to
raise
any
question
of
impropriety.
Notwithstanding
the
foregoing,
the
Covered
Officers
must
obtain
prior
approval
from
the
Franklin
Resources
General
Counsel
for
any
entertainment
with
a
value
in
excess
of
$1000.
·
        
Any
ownership
interest
in,
or
any
consulting
or
employment
relationship
with,
any
of
the
FT
Fund’s
service
providers,
other
than
an
investment
adviser,
principal
underwriter,
administrator
or
any
affiliated
person
thereof.
·
        
A
direct
or
indirect
financial
interest
in
commissions,
transaction
charges
or
spreads
paid
by
the
FT
Funds
for
effecting
portfolio
transactions
or
for
selling
or
redeeming
shares
other
than
an
interest
arising
from
the
Covered
Officer's
employment,
such
as
compensation
or
equity
ownership.
·
        
Franklin
Resources
General
Counsel
or
Deputy
General
Counsel
will
provide
a
report
to
the
FT
Funds
Audit
Committee
of
any
approvals
granted
at
the
next
regularly
scheduled
meeting.
 

IV.
            
Disclosure and Compliance

 
·
        
Each
Covered
Officer
should
familiarize
himself
with
the
disclosure
requirements
generally
applicable
to
the
FT
Funds;
·
        
Each
Covered
Officer
should
not
knowingly
misrepresent,
or
cause
others
to
misrepresent,
facts
about
the
FT
Funds
to
others,
whether
within
or
outside
the
FT
Funds,
including
to
the
FT
Funds’
directors
and
auditors,
and
to
governmental
regulators
and
self-regulatory
organizations;
·
        
Each
Covered
Officer
should,
to
the
extent
appropriate
within
his
or
her
area
of
responsibility,
consult
with
other
officers
and
employees
of
the
FT
Funds,
the
FT
Fund’s
adviser
and
the
administrator
with
the
goal
of
promoting
full,
fair,
accurate,
timely
and
understandable
disclosure
in
the
reports
and
documents
the
FT
Funds
file
with,
or
submit
to,
the
SEC
and
in
other
public
communications
made
by
the
FT
Funds;
and
·
        
It
is
the
responsibility
of
each
Covered
Officer
to
promote
compliance
with
the
standards
and
restrictions
imposed
by
applicable
laws,
rules
and
regulations.
 

V.
            
Reporting
and Accountability

 
Each
Covered
Officer
must:
·
        
Upon
becoming
a
covered
officer
affirm
in
writing
to
the
Board
that
he
or
she
has
received,
read,
and
understands
the
Code
(see
Exhibit
B);
·
        
Annually
thereafter
affirm
to
the
Board
that
he
has
complied
with
the
requirements
of
the
Code;
and
·
        
Notify
Franklin
Resources’
General
Counsel
or
Deputy
General
Counsel
promptly
if
he
or
she
knows
of
any
violation
of
this
Code.
Failure
to
do
so
is
itself
is
a
violation
of
this

 

Code.
Franklin
Resources’
General
Counsel
and
Deputy
General
Counsel
are
responsible
for
applying
this
Code
to
specific
situations
in
which
questions
are
presented
under
it
and
have
the
authority
to
interpret
this
Code
in
any
particular
situation.
3
 
However,
the
Independent
Directors
of
the
respective
FT
Funds
will
consider
any
approvals
or
waivers
4
sought
by
any
Chief
Executive
Officers
of
the
Funds.
 
The
FT
Funds
will
follow
these
procedures
in
investigating
and
enforcing
this
Code:
 
·
        
Franklin
Resources
General
Counsel
or
Deputy
General
Counsel
will
take
all
appropriate
action
to
investigate
any
potential
violations
reported
to
the
Legal
Department;
·
        
If,
after
such
investigation,
the
General
Counsel
or
Deputy
General
Counsel
believes
that
no
violation
has
occurred,
The
General
Counsel
is
not
required
to
take
any
further
action;
·
        
Any
matter
that
the
General
Counsel
or
Deputy
General
Counsel
believes
is
a
violation
will
be
reported
to
the
Independent
Directors
of
the
appropriate
FT
Fund;
·
        
If
the
Independent
Directors
concur
that
a
violation
has
occurred,
it
will
inform
and
make
a
recommendation
to
the
Board
of
the
appropriate
FT
Fund
or
Funds,
which
will
consider
appropriate
action,
which
may
include
review
of,
and
appropriate
modifications
to, applicable
policies
and
procedures;
notification
to
appropriate
personnel
of
the
investment
adviser
or
its
board;
or
a
recommendation
to
dismiss
the
Covered
Officer;
·
        
The
Independent
Directors
will
be
responsible
for
granting
waivers,
as
appropriate;
and
·
        
Any
changes
to
or
waivers
of
this
Code
will,
to
the
extent
required,
are
disclosed
as
provided
by
SEC
rules.
5

VI.
            
Other Policies and Procedures

 
This
Code
shall
be
the
sole
code
of
ethics
adopted
by
the
FT
Funds
for
purposes
of
Section
406
of
the
Sarbanes-Oxley
Act
and
the
rules
and
forms
applicable
to
registered
investment
companies
thereunder.
Insofar
as
other
policies
or
procedures
of
the
FT
Funds,
the
FT
Funds'
advisers,
principal
underwriter,
or
other
service
providers
govern
or
purport
to
govern
the
behavior
or
activities
of
the
Covered
Officers
who
are
subject
to
this
Code,
they
are
superseded
by
this
Code
to
the
extent
that
they
overlap
or
conflict
with
the
provisions
of
this
Code.
The
FTI
Personal
Investments
and
Insider
Trading
Policy,
adopted
by
the
FT
Funds,
FT
investment
advisers
and
FT
Fund’s
principal
underwriter
pursuant
to
Rule
17j-1
under
the
Investment
Company
Act,
the
Code
of
Ethics
and
Business
Conduct
and
more
detailed
policies
and
procedures
set
forth
in
FT’s
Employee
Handbook
are
separate
requirements
applying
to
the
Covered
Officers
and
others,
and
are
not
part
of
this
Code.
 
 
 
 
 
3
Franklin
Resources
General
Counsel
and
Deputy
General
Counsel
are
authorized
to
consult,
as
appropriate,
with
members
of
the
Audit
Committee,
counsel
to
the
FT
Funds
and
counsel
to
the
Independent
Directors,
and
are
encouraged
to
do
so.
4
Item
2
of
Form
N-CSR
defines
"waiver"
as
"the
approval
by
the
registrant
of
a
material
departure
from
a
provision
of
the
code
of
ethics"
and
"implicit
waiver,"
which
must
also
be
disclosed,
as
"the
registrant's
failure
to
take
action
within
a
reasonable
period
of
time
regarding
a
material
departure
from
a
provision
of
the
code
of
ethics
that
has
been
made
known
to
an
executive
officer"
of
the
registrant.
See
Part
X.
5
 
See
Part
X.

 

VII.
             
Amendments

 
Any
amendments
to
this
Code,
other
than
amendments
to
Exhibit
A,
must
be
approved
or
ratified
by
a
majority
vote
of
the
FT
Funds’
Board
including
a
majority
of
independent
directors.

VIII.
             
Confidentiality

 
All
reports
and
records
prepared
or
maintained
pursuant
to
this
Code
will
be
considered
confidential
and
shall
be
maintained
and
protected
accordingly.
Except
as
otherwise
required
by
law or
this Code,
such matters
shall
not
be disclosed
to anyone
other than
the FT
Funds’ Board
and
their
counsel.

IX.
            
Internal Use

 
The
Code
is
intended
solely
for
the
internal
use
by
the
FT
Funds
and
does
not
constitute
an
admission,
by
or
on
behalf
of
any
FT
Funds,
as
to
any
fact,
circumstance,
or
legal
conclusion.
 
X.
                 
Disclosure
on
Form
N-CSR
 
Item
2
of
Form
N-CSR
requires
a
registered
management
investment
company
to
disclose
annually
whether,
as
of
the
end
of
the
period
covered
by
the
report,
it
has
adopted
a
code
of
ethics
that
applies
to
the
registrant's
principal
executive
officer,
principal
financial
officer,
principal
accounting
officer
or
controller,
or
persons
performing
similar
functions,
regardless
of
whether
these
officers
are
employed
by
the
registrant
or
a
third
party.
If
the
registrant
has
not
adopted
such
a
code
of
ethics,
it
must
explain
why
it
has
not
done
so.
The
registrant
must
also:
(1)
file
with
the
SEC
a
copy
of
the
code
as
an
exhibit
to
its
annual
report;
(2)
post
the
text
of
the
code
on
its
Internet
website
and
disclose,
in
its
most
recent
report
on
Form
N-CSR,
its
Internet
address
and
the
fact
that
it
has
posted
the
code
on
its
Internet
website;
or
(3)
undertake
in
its
most
recent
report
on
Form
N-CSR
to
provide
to
any
person
without
charge,
upon
request,
a
copy
of
the
code
and
explain
the
manner
in
which
such
request
may
be
made.
Disclosure
is
also
required
of
amendments
to,
or
waivers
(including
implicit
waivers)
from,
a
provision
of
the
code
in
the
registrant's
annual
report
on
Form
N-CSR
or
on
its
website.
If
the
registrant
intends
to
satisfy
the
requirement
to
disclose
amendments
and
waivers
by
posting
such
information
on
its
website,
it
will
be
required
to
disclose
its
Internet
address
and
this
intention.
The
Legal
Department
shall
be
responsible
for
ensuring
that:
·
        
a
copy
of
the
Code
is
filed
with
the
SEC
as
an
exhibit
to
each
Fund’s
annual
report;
and
·
        
any
amendments
to,
or
waivers
(including
implicit
waivers)
from,
a
provision
of
the
Code
is
disclosed
in
the
registrant's
annual
report
on
Form
N-CSR.
In
the
event
that
the
foregoing
disclosure
is
omitted
or
is
determined
to
be
incorrect,
the
Legal
Department
shall
promptly
file
such
information
with
the
SEC
as
an
amendment
to
Form
N-CSR.
In
such
an
event,
the
Fund
Chief
Compliance
Officer
shall
review
the
Code
and
propose
such
changes
to
the
Code
as
are
necessary
or
appropriate
to
prevent
reoccurrences.
 

EXHIBIT
A

 
Persons
Covered
by
the
Franklin
Templeton
Funds
Code
of
Ethics
December
2018
 
 
 

FRANKLIN GROUP
OF FUNDS

 
Edward
Perks                           President
and
Chief Executive Officer
Investment
Management
Rupert H. Johnson, Jr.                                            Chairman
of the Board and
Vice President– Investment
Management
Don
Taylor                                                President
and
Chief Executive Officer
Investment
Management
Sonal
Desai)                             President
and
Chief
Executive
Officer
Investment
Management
Matthew Hinkle                          Chief Executive Officer
Finance
and Administration
Gaston R. Gardey                     Chief Financial Officer and Chief Accounting Officer and
Treasurer
 
 
 

FRANKLIN MUTUAL
SERIES FUNDS

 
Peter Langerman                       Chief Executive Officer
Investment Management
Matthew Hinkle                                                Chief Executive Officer
Finance
and Administration
Robert G. Kubilis                                                Chief Financial Officer and Chief Accounting Officer
 
 

FRANKLIN ALTERNATIVE STRATEGIES FUNDS

 
Mat S. Gulley                            Chief Executive Officer
Investment
Management
Matthew Hinkle                                                Chief Executive
Officer
Finance
and Administration
Robert G. Kubilis                                      Chief Financial Officer and Chief Accounting
Officer
 
 
 

TEMPLETON
GROUP
OF FUNDS

 
Manraj S. Sekhon                      President and
Chief Executive Officer
Investment
Management
Michael
Hasenstab,
Ph.D.
President and Chief Executive Officer
Investment
Management
Norman
Boersma                                                   President
and
Chief Executive Officer
Investment
Management
Matthew Hinkle                                                Chief Executive Officer
Finance
and Administration
Robert G. Kubilis                       Chief Financial Officer, Chief Accounting Officer and Treasurer

 

Exhibit
B
ACKNOWLEDGMENT FORM

 

Franklin
Templeton
Funds
Code
of
Ethics

For
Principal
Executives
and
Senior
Financial
Officers
 
 
Instructions:
1.
     
Complete
all
sections
of
this
form.
2.
     
Print
the
completed
form,
sign,
and
date.
3.
 
Submit
completed
form
to
FT’s
General
Counsel
c/o
Code
of
Ethics
Administration
within
10
days
of
becoming
a
Covered
Officer
and
by
February
15
th
of
each
subsequent
year.
 
Inter-office
mail:
Code
of
Ethics
Administration,
Global
Compliance
SM-920/2
Fax:                       
(650)
312-5646
E-mail:                     
Code
of
Ethics
Inquiries
&
Requests
(internal
address);
lpreclear@franklintempleton.com
(external
address)
 
 
Covered
Officer’s
Name:
 
Title:
 
Department:
 
Location:
 
Certification
for
Year
Ending:
 
 
 
To:   
 
Franklin
Resources
General
Counsel,
Legal
Department
 
I
acknowledge
receiving,
reading
and
understanding
the
Franklin
Templeton
Fund’s
Code
of
Ethics
for
Principal
Executive
Officers
and
Senior
Financial
Officers
(the
“Code”).
I
will
comply
fully
with
all
provisions
of
the
Code
to
the
extent
they
apply
to
me
during
the
period
of
my
employment.
I
further
understand
and
acknowledge
that
any
violation
of
the
Code
may
subject
me
to
disciplinary
action,
including
termination
of
employment.
 
 
 
 
 
                                                                                                                                                                                                                                                                                                           
Signature                                                               Date signed
GRAPHIC 5 word3959959846912.gif begin 644 word3959959846912.gif M1TE&.#EA<@(" '< ,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "'Y M! $ + !R @( @ ) 1(ZIR^T/HYRTVHNSWKS[#X;B2);F M*0+&&K!N"[]R3,]VC=]ZSN]^#_P)@\2AL8@\*I/,I;,)?4JCU*FUBK4""@ [ end